Citations to Excluded Studies

1.

Idiopathic granulomatous mastitis in Hispanic women - Indiana, 2006–2008. MMWR Morb Mortal Wkly Rep. 2009 Dec 4;58(47):1317–21. [PubMed: 19959984]

2.

Abrari A. Pseudoangiomatous stromal hyperplasia (PASH) tumour at the surgical scar site in a patient of carcinoma breast. BMJ Case Rep. 2011. 2011. [PMC free article: PMC3158354] [PubMed: 22688488]

3.

Baker KS, Davey DD, Stelling CB. Ductal abnormalities detected with galactography: frequency of adequate excisional biopsy. AJR Am J Roentgenol. 1994 Apr;162(4):821–4. [PubMed: 8140998]

4.

Beatty JS, Williams HT, Aldridge BA, et al. Incidental PET/CT findings in the cancer patient: how should they be managed? Surgery. 2009 Aug;146(2):274–81. [PubMed: 19628085]

5.

Bitencourt AG, Cohen MP, Graziano L, et al. Pseudoaneurysm after ultrasound-guided vacuum-assisted core breast biopsy. Breast J. 2012 Mar–Apr;18(2):177–8. [PubMed: 22211950]

6.

Chung A, Schoder H, Sampson M, et al. Incidental breast lesions identified by 18F-fluorodeoxyglucose-positron emission tomography. Ann Surg Oncol. 2010 Aug;17(8):2119–25. [PubMed: 20162459]

7.

Dey D, Nicol A, Singer S. Benign phyllodes tumor of the breast with intracytoplasmic inclusion bodies identical to infantile digital fibromatosis. Breast J. 2008 Mar–Apr;14(2):198–9. [PubMed: 18266786]

8.

Drubin D, Smith JS, Liu W, et al. Comparison of cryopreservation and standard needle biopsy for gene expression profiling of human breast cancer specimens. Breast Cancer Res Treat. 2005 Mar;90(1):93–6. [PubMed: 15770532]

9.

Dutta Roy S, Kasipandian V, Scally J. Suspicious breast mass in an anticoagulated patient--is core biopsy safe? Int J Clin Pract. 2008 Oct;62(10):1632–4. [PubMed: 18822034]

10.

Erdil I, Dursun M, Salmaslioglu A, et al. Pseudoaneurysm in the breast after core biopsy: doppler US and MRI findings. Breast J. 2010 Jul–Aug;16(4):427–9. [PubMed: 20545941]

11.

Fischman AM, Epelboym Y, Siegelbaum RH, et al. Emergent embolization of arterial bleeding after vacuum-assisted breast biopsy. Cardiovasc Intervent Radiol. 2012 Feb;35(1):194–7. [PubMed: 21553162]

12.

Fong CY, Mak WS, Lui CY, et al. Stereotactic biopsy of thin breasts: A previously unfeasible task. Hong Kong. 2011;14(1):4–9.

13.

Kamer E, Unalp HR, Akguner T, et al. Thick-needle vacuum-assisted biopsy technique for inflammatory breast carcinoma diagnosis. Acta Cirurgica Brasileira. 2006;21(6):422–4. [PubMed: 17160256]

14.

Kamer E, Unalp HR, Akguner T, et al. [Thick-needle vacuum-assisted biopsy technique for inflammatory breast carcinoma diagnosis]. Acta Cir Bras. 2006 Nov–Dec;21(6):422–4. [PubMed: 17160256]

15.

Kiyoto S, Sugawara Y, Inoue T, et al. False-positive (18)F-fluorodeoxyglucose positron emission tomography/computed tomography caused by incidental injury in a bulky intracystic carcinoma of the breast. Jpn J Radiol. 2010 May;28(4):305–8. [PubMed: 20512549]

16.

Kuhl CK, Elevelt A, Leutner CC, et al. Interventional breast MR imaging: clinical use of a stereotactic localization and biopsy device. Radiology. 1997 Sep;204(3):667–75. [PubMed: 9280242]

17.

Magro G. Epithelioid-cell myofibroblastoma of the breast: expanding the morphologic spectrum. Am J Surg Pathol. 2009 Jul;33(7):1085–92. [PubMed: 19390423]

18.

Mendel JB, Long M, Slanetz PJ. CT-guided core needle biopsy of breast lesions visible only on MRI. AJR Am J Roentgenol. 2007 Jul;189(1):152–4. [PubMed: 17579165]

19.

Nath ME, Robinson TM, Tobon H, et al. Automated large-core needle biopsy of surgically removed breast lesions: comparison of samples obtained with 14-, 16-, and 18-gauge needles. Radiology. 1995 Dec;197(3):739–42. [PubMed: 7480748]

20.

O’Driscoll D, Britton P, Bobrow L, et al. Lobular carcinoma in situ on core biopsy-what is the clinical significance? Clin Radiol. 2001 Mar;56(3):216–20. [PubMed: 11247699]

21.

Ogawa T, Tsuji E, Shirakawa K, et al. Primary non-Hodgkin’s lymphoma of the breast treated nonsurgically: report of three cases. Breast Cancer. 2011 Jan;18(1):68–72. [PubMed: 19350354]

22.

O’Sullivan-Mejia E, Idowu MO, Davis Masssey H, et al. Lymphoepithelioma-like carcinoma of the breast: diagnosis by core needle biopsy. Breast J. 2009 Nov–Dec;15(6):658–60. [PubMed: 19824996]

23.

Romero-Guadarrama MB, Hernandez-Gonzalez MM, Duran-Padilla MA, et al. Primary lymphomas of the breast: a report on 5 cases studied in a period of 5 years at the Hospital General de Mexico. Ann Diagn Pathol. 2009 Apr;13(2):78–81. [PubMed: 19302954]

24.

Roque DR, MacLaughlan S, Tejada-Berges T. Necrotizing infection of the breast after core needle biopsy. Breast J. 2013 Mar–Apr;19(2):201–2. [PubMed: 23294339]

25.

Ruiz Tovar J, Reguero Callejas ME, Alaez Chillaron AB, et al. Mammary hamartoma. Clin Transl Oncol. 2006 Apr;8(4):290–3. [PubMed: 16648106]

26.

Ruiz-Delgado ML, Lopez-Ruiz JA, Saiz-Lopez A. Abnormal mammography and sonography associated with foreign-body giant-cell reaction after stereotactic vacuum-assisted breast biopsy with carbon marking. Acta Radiol. 2008 Dec;49(10):1112–8. [PubMed: 18932053]

27.

Samimi M, Bonneau C, Lebas P, et al. Mastectomies after vacuum core biopsy procedure for microcalcification clusters: value of clip. Eur J Radiol. 2009 Feb;69(2):296–9. [PubMed: 18178050]

28.

Singh E, Selis JE. Ultrasound-guided percutaneous biopsy of the augmented breast using implant displacement: a new technique. Ultrasound Q. 2010 Sep;26(3):179–81. [PubMed: 20823752]

29.

Soo MS, Walsh R, Patton J. Prone table stereotactic breast biopsy: facilitating biopsy of posterior lesions using the arm-through-the-hole technique. AJR Am J Roentgenol. 1998 Sep;171(3):615–7. [PubMed: 9725284]

30.

Tilve A, Mallo R, Perez A, et al. Breast hemangiomas: correlation between imaging and pathologic findings. J Clin Ultrasound. 2012 Oct;40(8):512–7. [PubMed: 22434703]

31.

Wahner-Roedler DL, Whaley DH, Brandt KR, et al. Vacuum-assisted breast biopsy device (mammotome) malfunction simulating microcalcifications. Breast J. 2005 Nov–Dec;11(6):474–5. [PubMed: 16297098]

32.

Wang CF, Zhou Z, Yan YJ, et al. Clinical analyses of clustered microcalcifications after autologous fat injection for breast augmentation. Plast Reconstr Surg. 2011 Apr;127(4):1669–73. [PubMed: 21187809]

33.

Wei H, Jiayi F, Qinping Z, et al. Ultrasound-guided vacuum-assisted breast biopsy system for diagnosis and minimally invasive excision of intraductal papilloma without nipple discharge. World J Surg. 2009 Dec;33(12):2579–81. [PubMed: 19777298]

34.

Yalcin S, Ergul E, Ucar AE, et al. Glomus tumor of the breast: first report. Langenbecks Arch Surg. 2009 Mar;394(2):399–400. [PubMed: 18446361]

35.

Yoshida M, Kinoshita T. A case of ductal carcinoma in situ of the breast. Jpn J Clin Oncol. 2009;39(2):132. [PubMed: 19155284]

36.

Abe H, Schmidt RA, Shah RN, et al. MR-directed (“Second-Look”) ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol. 2010 Feb;194(2):370–7. [PubMed: 20093598]

37.

Berg WA, Arnoldus CL, Teferra E, et al. Biopsy of Amorphous Breast Calcifications: Pathologic Outcome and Yield at Stereotactic Biopsy 1. Radiology. 2001;221(2):495–503. [PubMed: 11687695]

38.

Berg WA, Madsen KS, Schilling K, et al. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer. AJR Am J Roentgenol. 2012 Jan;198(1):219–32. [PubMed: 22194501]

39.

Bernik SF, Troob S, Ying BL, et al. Papillary lesions of the breast diagnosed by core needle biopsy: 71 cases with surgical follow-up. Am J Surg. 2009 Apr;197(4):473–8. [PubMed: 18723154]

40.

Brennan S, Liberman L, Dershaw DD, et al. Breast MRI screening of women with a personal history of breast cancer. AJR Am J Roentgenol. 2010 Aug;195(2):510–6. [PubMed: 20651211]

41.

Brennan SB, Sung JS, Dershaw DD, et al. Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-up. Radiology. 2011 Oct;261(1):92–9. [PubMed: 21852565]

42.

Britton PD, Provenzano E, Barter S, et al. Ultrasound guided percutaneous axillary lymph node core biopsy: how often is the sentinel lymph node being biopsied? Breast. 2009 Feb;18(1):13–6. [PubMed: 18993074]

43.

Carbognin G, Girardi V, Brandalise A, et al. MR-guided vacuum-assisted breast biopsy in the management of incidental enhancing lesions detected by breast MR imaging. Radiol Med. 2011 Sep;116(6):876–85. [PubMed: 21293942]

44.

Chae EY, Cha JH, Kim HH, et al. Evaluation of residual disease using breast MRI after excisional biopsy for breast cancer. AJR Am J Roentgenol. 2013 May;200(5):1167–73. [PubMed: 23617506]

45.

Chan A, Morey A, Brown B, et al. A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease. BMC Cancer. 2012;12:555. [PMC free article: PMC3517741] [PubMed: 23176370]

46.

Choi HY, Kim SM, Jang M, et al. MRI-guided intervention for breast lesions using the freehand technique in a 3.0-T closed-bore MRI scanner: feasibility and initial results. Korean J Radiol. 2013 Mar–Apr;14(2):171–8. [PMC free article: PMC3590327] [PubMed: 23482868]

47.

Crystal P, Sadaf A, Bukhanov K, et al. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: can underestimation be predicted? Eur Radiol. 2011 Mar;21(3):582–9. [PubMed: 20839000]

48.

Davis KL, Barth RJ Jr, Gui J, et al. Use of MRI in preoperative planning for women with newly diagnosed DCIS: risk or benefit? Ann Surg Oncol. 2012 Oct;19(10):3270–4. [PMC free article: PMC3809001] [PubMed: 22911365]

49.

Demartini WB, Eby PR, Peacock S, et al. Utility of targeted sonography for breast lesions that were suspicious on MRI. AJR Am J Roentgenol. 2009 Apr;192(4):1128–34. [PubMed: 19304724]

50.

DeMartini WB, Liu F, Peacock S, et al. Background parenchymal enhancement on breast MRI: impact on diagnostic performance. AJR Am J Roentgenol. 2012 Apr;198(4):W373–80. [PubMed: 22451576]

51.

Destounis S, Arieno A, Somerville PA, et al. Community-based practice experience of unsuspected breast magnetic resonance imaging abnormalities evaluated with second-look sonography. J Ultrasound Med. 2009 Oct;28(10):1337–46. [PubMed: 19778880]

52.

Deurloo EE, Sriram JD, Teertstra HJ, et al. MRI of the breast in patients with DCIS to exclude the presence of invasive disease. Eur Radiol. 2012 Jul;22(7):1504–11. [PubMed: 22367470]

53.

Dogan BE, Le-Petross CH, Stafford JR, et al. MRI-guided vacuum-assisted breast biopsy performed at 3 T with a 9-gauge needle: preliminary experience. AJR Am J Roentgenol. 2012 Nov;199(5):W651–3. [PubMed: 23096211]

54.

Eliahou R, Sella T, Allweis T, et al. Magnetic resonance-guided interventional procedures of the breast: initial experience. Isr Med Assoc J. 2009 May;11(5):275–9. [PubMed: 19637504]

55.

Elmore L, Margenthaler JA. Breast MRI surveillance in women with prior curative-intent therapy for breast cancer. J Surg Res. 2010 Sep;163(1):58–62. [PubMed: 20605594]

56.

Friedman P, Enis S, Pinyard J. Magnetic resonance imaging-guided vacuum-assisted breast biopsy: an initial experience in a community hospital. Can Assoc Radiol J. 2009 Oct;60(4):196–200. [PubMed: 19782886]

57.

Ginter PS, Winant AJ, Hoda SA. Cystic apocrine hyperplasia is the most common finding in MRI detected breast lesions. J Clin Pathol. 2014 Feb;67(2):182–6. [PubMed: 24151291]

58.

Grobmyer SR, Mortellaro VE, Marshall J, et al. Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy? J Am Coll Surg. 2008 May;206(5):1045–50. discussion 50-2. [PubMed: 18471753]

59.

Gutierrez RL, Demartini WB, Eby P, et al. Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions. Acad Radiol. 2009 Oct;16(10):1281–5. [PubMed: 19733804]

60.

Gutierrez RL, DeMartini WB, Eby PR, et al. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. AJR Am J Roentgenol. 2009 Oct;193(4):994–1000. [PubMed: 19770321]

61.

Han BK, Schnall MD, Orel SG, et al. Outcome of MRI-guided breast biopsy. AJR Am J Roentgenol. 2008 Dec;191(6):1798–804. [PubMed: 19020252]

62.

Hauth EA, Jaeger HJ, Lubnau J, et al. MR-guided vacuum-assisted breast biopsy with a handheld biopsy system: clinical experience and results in postinterventional MR mammography after 24 h. Eur Radiol. 2008 Jan;18(1):168–76. [PubMed: 17609959]

63.

He Q, Fan X, Guan Y, et al. Percutaneous excisional biopsy of impalpable breast lesions under ultrasound visualization. The Breast. 2008;17(6):666–70. [PubMed: 18835778]

64.

Heller SL, Moy L. Imaging features and management of high-risk lesions on contrast-enhanced dynamic breast MRI. AJR Am J Roentgenol. 2012 Feb;198(2):249–55. [PubMed: 22268165]

65.

Johnson KS, Baker JA, Lee SS, et al. Suspicious breast lesions detected at 3.0 T magnetic resonance imaging: clinical and histological outcomes. Acad Radiol. 2012 Jun;19(6):667–74. [PubMed: 22459645]

66.

Kalinyak JE, Schilling K, Berg WA, et al. PET-guided breast biopsy. Breast J. 2011 Mar–Apr;17(2):143–51. [PubMed: 21276128]

67.

Lee JH, Kim EK, Oh JY, et al. US screening for detection of nonpalpable locoregional recurrence after mastectomy. Eur J Radiol. 2013 Mar;82(3):485–9. [PubMed: 23131395]

68.

Lee JM, Kaplan JB, Murray MP, et al. Imaging histologic discordance at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol. 2007 Oct;189(4):852–9. [PubMed: 17885056]

69.

Lee JM, Kaplan JB, Murray MP, et al. Underestimation of DCIS at MRI-guided vacuum-assisted breast biopsy. AJR Am J Roentgenol. 2007 Aug;189(2):468–74. [PubMed: 17646475]

70.

Lee J-M, Kaplan JB, Murray MP, et al. Imaging–histologic discordance at MRI-guided 9-gauge vacuum-assisted breast biopsy. American Journal of Roentgenology. 2007;189(4):852–9. [PubMed: 17885056]

71.

Liberman L, Bracero N, Morris E, et al. MRI-guided 9-gauge vacuum-assisted breast biopsy: initial clinical experience. AJR Am J Roentgenol. 2005 Jul;185(1):183–93. [PubMed: 15972421]

72.

Liberman L, Dershaw DD, Durfee S, et al. Recurrent carcinoma after breast conservation: diagnosis with stereotaxic core biopsy. Radiology. 1995 Dec;197(3):735–8. [PubMed: 7480747]

73.

Liberman L, Morris EA, Dershaw DD, et al. Fast MRI-guided vacuum-assisted breast biopsy: initial experience. American Journal of Roentgenology. 2003;181(5):1283–93. [PubMed: 14573421]

74.

Linda A, Zuiani C, Lorenzon M, et al. Hyperechoic lesions of the breast: not always benign. AJR Am J Roentgenol. 2011 May;196(5):1219–24. [PubMed: 21512095]

75.

Malhaire C, El Khoury C, Thibault F, et al. Vacuum-assisted biopsies under MR guidance: results of 72 procedures. Eur Radiol. 2010 Jul;20(7):1554–62. [PubMed: 20119729]

76.

Mameri CS, Kemp C, Goldman SM, et al. Impact of breast MRI on surgical treatment, axillary approach, and systemic therapy for breast cancer. Breast J. 2008 May–Jun;14(3):236–44. [PubMed: 18476882]

77.

Masroor I, Afzal S, Shafqat G, et al. Comparison of stereotactic core breast biopsy and open surgical biopsy results at a tertiary care hospital in Pakistan. Int J Womens Health. 2011;3:193–6. [PMC free article: PMC3140815] [PubMed: 21792341]

78.

Meeuwis C, Mann RM, Mus RD, et al. MRI-guided breast biopsy at 3T using a dedicated large core biopsy set: feasibility and initial results. Eur J Radiol. 2011 Aug;79(2):257–61. [PubMed: 20541338]

79.

Meeuwis C, Veltman J, van Hall HN, et al. MR-guided breast biopsy at 3T: diagnostic yield of large core needle biopsy compared with vacuum-assisted biopsy. Eur Radiol. 2012 Feb;22(2):341–9. [PMC free article: PMC3249028] [PubMed: 21915606]

80.

Meissnitzer M, Dershaw DD, Lee CH, et al. Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommended. AJR Am J Roentgenol. 2009 Oct;193(4):1025–9. [PubMed: 19770325]

81.

Noroozian M, Gombos EC, Chikarmane S, et al. Factors that impact the duration of MRI-guided core needle biopsy. AJR Am J Roentgenol. 2010 Feb;194(2):W150–7. [PubMed: 20093566]

82.

Onega T, Weiss J, Diflorio R, et al. Evaluating surveillance breast imaging and biopsy in older breast cancer survivors. Int J Breast Cancer. 2012;2012:347646. [PMC free article: PMC3477570] [PubMed: 23097709]

83.

Orel SG, Rosen M, Mies C, et al. MR Imaging–guided 9-gauge Vacuum-assisted Core-Needle Breast Biopsy: Initial Experience 1. Radiology. 2006;238(1):54–61. [PubMed: 16304093]

84.

Oxner CR, Vora L, Yim J, et al. Magnetic resonance imaging-guided breast biopsy in lesions not visualized by mammogram or ultrasound. Am Surg. 2012 Oct;78(10):1087–90. [PubMed: 23025947]

85.

Parikh RP, Doren EL, Mooney B, et al. Differentiating fat necrosis from recurrent malignancy in fat-grafted breasts: an imaging classification system to guide management. Plast Reconstr Surg. 2012 Oct;130(4):761–72. [PubMed: 23018689]

86.

Perlet C, Heinig A, Prat X, et al. Multicenter study for the evaluation of a dedicated biopsy device for MR-guided vacuum biopsy of the breast. Eur Radiol. 2002 Jun;12(6):1463–70. [PubMed: 12042955]

87.

Perlet C, Heywang-Kobrunner SH, Heinig A, et al. Magnetic resonance-guided, vacuum-assisted breast biopsy. Cancer. 2006;106(5):982–90. [PubMed: 16456807]

88.

Perretta T, Pistolese CA, Bolacchi F, et al. MR imaging-guided 10-gauge vacuum-assisted breast biopsy: histological characterisation. Radiol Med. 2008 Sep;113(6):830–40. [PubMed: 18633687]

89.

Pfleiderer SO, Marx C, Vagner J, et al. Magnetic resonance-guided large-core breast biopsy inside a 1.5-T magnetic resonance scanner using an automatic system: in vitro experiments and preliminary clinical experience in four patients. Invest Radiol. 2005 Jul;40(7):458–63. [PubMed: 15973138]

90.

Pijnappel RM, Peeters PH, van den Donk M, et al. Diagnostic strategies in non-palpable breast lesions. Eur J Cancer. 2002 Mar;38(4):550–5. [PubMed: 11872348]

91.

Pijnappel RM, van den Donk M, Holland R, et al. Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions. Br J Cancer. 2004 Feb 9;90(3):595–600. [PMC free article: PMC2409591] [PubMed: 14760370]

92.

Popiela TJ, Herman-Sucharska I, Kleinrok K, et al. Core breast biopsy under MR control - Preliminary results. Pol Przegl Radiol. 2007;72(2):15–24.

93.

Rauch GM, Dogan BE, Smith TB, et al. Outcome analysis of 9-gauge MRI-guided vacuum-assisted core needle breast biopsies. AJR Am J Roentgenol. 2012 Feb;198(2):292–9. [PMC free article: PMC4111151] [PubMed: 22268171]

94.

Raza S, Sekar M, Ong EM, et al. Small masses on breast MR: is biopsy necessary? Acad Radiol. 2012 Apr;19(4):412–9. [PubMed: 22277636]

95.

Salem C, Sakr R, Chopier J, et al. Pain and complications of directional vacuum-assisted stereotactic biopsy: comparison of the Mammotome and Vacora techniques. Eur J Radiol. 2009 Nov;72(2):295–9. [PubMed: 18755562]

96.

Salem C, Sakr R, Chopier J, et al. Accuracy of stereotactic vacuum-assisted breast biopsy with a 10-gauge hand-held system. Breast. 2009 Jun;18(3):178–82. [PubMed: 19364652]

97.

Schneider JP, Schulz T, Horn LC, et al. MR-guided percutaneous core biopsy of small breast lesions: first experience with a vertically open 0.5T scanner. J Magn Reson Imaging. 2002 Apr;15(4):374–85. [PubMed: 11948826]

98.

Schrading S, Simon B, Braun M, et al. MRI-guided breast biopsy: influence of choice of vacuum biopsy system on the mode of biopsy of MRI-only suspicious breast lesions. AJR Am J Roentgenol. 2010 Jun;194(6):1650–7. [PubMed: 20489109]

99.

Sequeiros RB, Reinikainen H, Sequeiros AM, et al. MR-guided breast biopsy and hook wire marking using a low-field (0.23 T) scanner with optical instrument tracking. Eur Radiol. 2007 Mar;17(3):813–9. [PubMed: 17021710]

100.

Slanetz PJ, Wu SP, Mendel JB. Percutaneous excision: a viable alternative to manage benign breast lesions. Can Assoc Radiol J. 2011 Nov;62(4):265–71. [PubMed: 20615659]

101.

Sung JS, Malak SF, Bajaj P, et al. Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology. 2011 Nov;261(2):414–20. [PubMed: 21900617]

102.

Thompson MO, Lipson J, Daniel B, et al. Why are patients noncompliant with follow-up recommendations after MRI-guided core needle biopsy of suspicious breast lesions? AJR Am J Roentgenol. 2013 Dec;201(6):1391–400. [PubMed: 24261382]

103.

Tozaki M, Yamashiro N, Sakamoto M, et al. Magnetic resonance-guided vacuum-assisted breast biopsy: results in 100 Japanese women. Jpn J Radiol. 2010 Aug;28(7):527–33. [PubMed: 20799018]

104.

Tozaki M, Yamashiro N, Suzuki T, et al. MR-guided vacuum-assisted breast biopsy: is it an essential technique? Breast Cancer. 2009;16(2):121–5. [PubMed: 18807122]

105.

van de Ven SM, Lin MC, Daniel BL, et al. Freehand MRI-guided preoperative needle localization of breast lesions after MRI-guided vacuum-assisted core needle biopsy without marker placement. J Magn Reson Imaging. 2010 Jul;32(1):101–9. [PubMed: 20575077]

106.

van den Bosch MA, Daniel BL, Pal S, et al. MRI-guided needle localization of suspicious breast lesions: results of a freehand technique. Eur Radiol. 2006 Aug;16(8):1811–7. [PubMed: 16683117]

107.

Wilhelm A, McDonough MD, DePeri ER. Malignancy rates of non-masslike enhancement on breast magnetic resonance imaging using American College of Radiology Breast Imaging Reporting and Data System descriptors. Breast J. 2012 Nov–Dec;18(6):523–6. [PubMed: 23009294]

108.

Wiratkapun C, Fusuwankaya E, Wibulpholprasert B, et al. Diagnostic accuracy of vacuum-assisted stereotactic core needle biopsy for breast lesions. J Med Assoc Thai. 2010 Sep;93(9):1058–64. [PubMed: 20873078]

109.

Zebic-Sinkovec M, Hertl K, Kadivec M, et al. Outcome of MRI-guided vacuum-assisted breast biopsy - initial experience at Institute of Oncology Ljubljana, Slovenia. Radiol Oncol. 2012 Jun;46(2):97–105. [PMC free article: PMC3472934] [PubMed: 23077445]

110.

Zografos G, Zagouri F, Sergentanis TN, et al. Vacuum-assisted breast biopsy in nonpalpable solid breast lesions without microcalcifications: the Greek experience. Diagn Interv Radiol. 2008;14(3):127–30. [PubMed: 18814132]

111.

Acheson MB, Patton RG, Howisey RL, et al. Three- to six-year followup for 379 benign image-guided large-core needle biopsies of nonpalpable breast abnormalities. J Am Coll Surg. 2002 Oct;195(4):462–6. [PubMed: 12375750]

112.

Agoff SN, Lawton TJ. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy? Am J Clin Pathol. 2004 Sep;122(3):440–3. [PubMed: 15362376]

113.

Arora N, Hill C, Hoda SA, et al. Clinicopathologic features of papillary lesions on core needle biopsy of the breast predictive of malignancy. Am J Surg. 2007 Oct;194(4):444–9. [PubMed: 17826053]

114.

Arpino G, Allred DC, Mohsin SK, et al. Lobular neoplasia on core-needle biopsy--clinical significance. Cancer. 2004 Jul 15;101(2):242–50. [PubMed: 15241819]

115.

Ashkenazi I, Ferrer K, Sekosan M, et al. Papillary lesions of the breast discovered on percutaneous large core and vacuum-assisted biopsies: reliability of clinical and pathological parameters in identifying benign lesions. Am J Surg. 2007 Aug;194(2):183–8. [PubMed: 17618801]

116.

Baer HJ, Collins LC, Connolly JL, et al. Lobule type and subsequent breast cancer risk: results from the Nurses’ Health Studies. Cancer. 2009 Apr 1;115(7):1404–11. [PMC free article: PMC2661011] [PubMed: 19170235]

117.

Bauer VP, Ditkoff BA, Schnabel F, et al. The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J. 2003 Jan–Feb;9(1):4–9. [PubMed: 12558663]

118.

Becker L, Trop I, David J, et al. Management of radial scars found at percutaneous breast biopsy. Can Assoc Radiol J. 2006 Apr;57(2):72–8. [PubMed: 16944680]

119.

Bedei L, Falcini F, Sanna PA, et al. Atypical ductal hyperplasia of the breast: the controversial management of a borderline lesion: experience of 47 cases diagnosed at vacuum-assisted biopsy. Breast. 2006 Apr;15(2):196–202. [PubMed: 16055333]

120.

Berg WA, Campassi CI, Ioffe OB. Cystic lesions of the breast: sonographic-pathologic correlation. Radiology. 2003 Apr;227(1):183–91. [PubMed: 12668745]

121.

Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology. 2001 Feb;218(2):503–9. [PubMed: 11161169]

122.

Bode MK, Rissanen T, Apaja-Sarkkinen M. Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes. Acta Radiol. 2007 Sep;48(7):708–13. [PubMed: 17728999]

123.

Bonnett M, Wallis T, Rossmann M, et al. Histopathologic analysis of atypical lesions in image-guided core breast biopsies. Mod Pathol. 2003 Feb;16(2):154–60. [PubMed: 12591968]

124.

Bonnett M, Wallis T, Rossmann M, et al. Histologic and radiographic analysis of ductal carcinoma in situ diagnosed using stereotactic incisional core breast biopsy. Mod Pathol. 2002 Feb;15(2):95–101. [PubMed: 11850537]

125.

Brem R, Tran K, Rapelyea J, et al. Percutaneous Biopsy of Papillary Lesions of the Breast: Accuracy of Pathologic Diagnosis. JOURNAL OF WOMENS IMAGING. 2005;7(4):157.

126.

Brem RF, Behrndt VS, Sanow L, et al. Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. AJR Am J Roentgenol. 1999 May;172(5):1405–7. [PubMed: 10227526]

127.

Brem RF, Lechner MC, Jackman RJ, et al. Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR Am J Roentgenol. 2008 Mar;190(3):637–41. [PubMed: 18287433]

128.

Brenner RJ, Jackman RJ, Parker SH, et al. Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary? AJR Am J Roentgenol. 2002 Nov;179(5):1179–84. [PubMed: 12388495]

129.

Buchbender S, Obenauer S, Mohrmann S, et al. Arterial spin labelling perfusion MRI of breast cancer using FAIR TrueFISP: initial results. Clin Radiol. 2013 Mar;68(3):e123–7. [PubMed: 23245275]

130.

Burbank F. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy. Radiology. 1997;202(3):843–7. [PubMed: 9051043]

131.

Carder PJ, Khan T, Burrows P, et al. Large volume “mammotome” biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast. J Clin Pathol. 2008 Aug;61(8):928–33. [PubMed: 18495791]

132.

Cawson JN, Malara F, Kavanagh A, et al. Fourteen-gauge needle core biopsy of mammographically evident radial scars: is excision necessary? Cancer. 2003 Jan 15;97(2):345–51. [PubMed: 12518358]

133.

Chrzan R, Rudnicka L, Popiela T Jr, et al. The problems with histopathological verification of breast microcalcification clusters in the stereotactic mammotome biopsy specimens. Pol J Pathol. 2006;57(3):133–5. [PubMed: 17219739]

134.

Cox D, Bradley S, England D. The significance of mammotome core biopsy specimens without radiographically identifiable microcalcification and their influence on surgical management--a retrospective review with histological correlation. Breast. 2006 Apr;15(2):210–8. [PubMed: 16081287]

135.

Crisi GM, Mandavilli S, Cronin E, et al. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am J Surg Pathol. 2003 Mar;27(3):325–33. [PubMed: 12604888]

136.

Darling ML, Smith DN, Lester SC, et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol. 2000 Nov;175(5):1341–6. [PubMed: 11044038]

137.

Das S, Sen S, Mukherjee A, et al. Risk factors of breast cancer among women in eastern India: a tertiary hospital based case control study. Asian Pac J Cancer Prev. 2012;13(10):4979–81. [PubMed: 23244094]

138.

Day AC. Pilot study on the effect of smoking one cigarette on physiological postural tremors. Agressologie. 1977;18 Spec No:9–18. [PubMed: 900365]

139.

de Mascarel I, Brouste V, Asad-Syed M, et al. All atypia diagnosed at stereotactic vacuum-assisted breast biopsy do not need surgical excision. Mod Pathol. 2011 Sep;24(9):1198–206. [PubMed: 21602816]

140.

Deschryver K, Radford DM, Schuh ME. Pathology of large-caliber stereotactic biopsies in nonpalpable breast lesions. Semin Diagn Pathol. 1999 Aug;16(3):224–34. [PubMed: 10490199]

141.

Destounis S, Hanson S, Morgan R, et al. Computer-aided detection of breast carcinoma in standard mammographic projections with digital mammography. Int J Comput Assist Radiol Surg. 2009 Jun;4(4):331–6. [PubMed: 20033580]

142.

Dillon MF, McDermott EW, Hill AD, et al. Predictive value of breast lesions of “uncertain malignant potential” and “suspicious for malignancy” determined by needle core biopsy. Ann Surg Oncol. 2007 Feb;14(2):704–11. [PubMed: 17151788]

143.

Dillon MF, McDermott EW, Quinn CM, et al. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only. J Surg Oncol. 2006 Jun 1;93(7):559–63. [PubMed: 16705731]

144.

Dillon MF, Quinn CM, McDermott EW, et al. Needle core biopsy in the diagnosis of phyllodes neoplasm. Surgery. 2006 Nov;140(5):779–84. [PubMed: 17084721]

145.

DiPiro PJ, Meyer JE, Denison CM, et al. Image-guided core breast biopsy of ductal carcinoma in situ presenting as a non-calcified abnormality. Eur J Radiol. 1999 Jun;30(3):231–6. [PubMed: 10452723]

146.

Dmytrasz K, Tartter PI, Mizrachy H, et al. The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J. 2003 Jan–Feb;9(1):10–2. [PubMed: 12558664]

147.

Doren E, Hulvat M, Norton J, et al. Predicting cancer on excision of atypical ductal hyperplasia. Am J Surg. 2008 Mar;195(3):358–61. discussion 61-2. [PubMed: 18206849]

148.

Douglas-Jones AG, Denson JL, Cox AC, et al. Radial scar lesions of the breast diagnosed by needle core biopsy: analysis of cases containing occult malignancy. J Clin Pathol. 2007 Mar;60(3):295–8. [PMC free article: PMC1860566] [PubMed: 16731590]

149.

Dupont WD, Breyer JP, Bradley KM, et al. Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk. Cancer. 2010 Jan 1;116(1):8–19. [PMC free article: PMC2807897] [PubMed: 19890961]

150.

Easley S, Abdul-Karim FW, Klein N, et al. Segregation of radiographic calcifications in stereotactic core biopsies of breast: is it necessary? Breast J. 2007 Sep–Oct;13(5):486–9. [PubMed: 17760670]

151.

Eby PR, Ochsner JE, DeMartini WB, et al. Is surgical excision necessary for focal atypical ductal hyperplasia found at stereotactic vacuum-assisted breast biopsy? Ann Surg Oncol. 2008 Nov;15(11):3232–8. [PubMed: 18696163]

152.

Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol. 2005 Apr;29(4):534–43. [PubMed: 15767810]

153.

Ely KA, Carter BA, Jensen RA, et al. Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol. 2001 Aug;25(8):1017–21. [PubMed: 11474285]

154.

Esserman LE, Lamea L, Tanev S, et al. Should the extent of lobular neoplasia on core biopsy influence the decision for excision? Breast J. 2007 Jan–Feb;13(1):55–61. [PubMed: 17214794]

155.

Forgeard C, Benchaib M, Guerin N, et al. Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients. Am J Surg. 2008 Sep;196(3):339–45. [PubMed: 18585676]

156.

Foster MC, Helvie MA, Gregory NE, et al. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology. 2004 Jun;231(3):813–9. [PubMed: 15105449]

157.

Foxcroft LM, Evans EB, Porter AJ. Difficulties in the pre-operative diagnosis of phyllodes tumours of the breast: a study of 84 cases. Breast. 2007 Feb;16(1):27–37. [PubMed: 16876413]

158.

Gadzala DE, Cederbom GJ, Bolton JS, et al. Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy. Ann Surg Oncol. 1997 Jun;4(4):283–6. [PubMed: 9181225]

159.

Gal-Gombos EC, Esserman LE, Recine MA, et al. Large-needle core biopsy in atypical intraductal epithelial hyperplasia including immunohistochemical expression of high molecular weight cytokeratin: analysis of results of a single institution. Breast J. 2002 Sep–Oct;8(5):269–74. [PubMed: 12199753]

160.

Gatek J, Vrana D, Melichar B, et al. Significance of the resection margin and risk factors for close or positive resection margin in patients undergoing breast-conserving surgery. J BUON. 2012 Jul–Sep;17(3):452–6. [PubMed: 23033280]

161.

Gendler LS, Feldman SM, Balassanian R, et al. Association of breast cancer with papillary lesions identified at percutaneous image-guided breast biopsy. Am J Surg. 2004 Oct;188(4):365–70. [PubMed: 15474427]

162.

Georgian-Smith D, Kricun B, McKee G, et al. The mammary hamartoma: appreciation of additional imaging characteristics. J Ultrasound Med. 2004 Oct;23(10):1267–73. [PubMed: 15448315]

163.

Grady I, Gorsuch H, Wilburn-Bailey S. Ultrasound-guided, vacuum-assisted, percutaneous excision of breast lesions: an accurate technique in the diagnosis of atypical ductal hyperplasia. J Am Coll Surg. 2005 Jul;201(1):14–7. [PubMed: 15978438]

164.

Harvey JM, Sterrett GF, Frost FA. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis. Pathology. 2002 Oct;34(5):410–6. [PubMed: 12408338]

165.

Harvey SC, Denison CM, Lester SC, et al. Fibrous nodules found at large-core needle biopsy of the breast: imaging features. Radiology. 1999 May;211(2):535–40. [PubMed: 10228539]

166.

Hoorntje LE, Schipper ME, Peeters PH, et al. The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol. 2003;10(7):748–53. [PubMed: 12900365]

167.

Houssami N, Ciatto S, Bilous M, et al. Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3). Br J Cancer. 2007 Apr 23;96(8):1253–7. [PMC free article: PMC2360144] [PubMed: 17438578]

168.

Huo L, Sneige N, Hunt KK, et al. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer. 2006 Oct 15;107(8):1760–8. [PubMed: 16977650]

169.

Hwang H, Barke LD, Mendelson EB, et al. Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol. 2008 Oct;21(10):1208–16. [PubMed: 18660792]

170.

Ivan D, Selinko V, Sahin AA, et al. Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy. Mod Pathol. 2004 Feb;17(2):165–71. [PubMed: 14631369]

171.

Jackman RJ, Birdwell RL, Ikeda DM. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision? Radiology. 2002 Aug;224(2):548–54. [PubMed: 12147855]

172.

Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology. 2001 Feb;218(2):497–502. [PubMed: 11161168]

173.

Jang M, Cho N, Moon WK, et al. Underestimation of atypical ductal hyperplasia at sonographically guided core biopsy of the breast. AJR Am J Roentgenol. 2008 Nov;191(5):1347–51. [PubMed: 18941067]

174.

Johnson JM, Dalton RR, Wester SM, et al. Histological correlation of microcalcifications in breast biopsy specimens. Arch Surg. 1999 Jul;134(7):712–5. discussion 5-6. [PubMed: 10401820]

175.

Karabakhtsian RG, Johnson R, Sumkin J, et al. The clinical significance of lobular neoplasia on breast core biopsy. Am J Surg Pathol. 2007 May;31(5):717–23. [PubMed: 17460455]

176.

Kil WH, Cho EY, Kim JH, et al. Is surgical excision necessary in benign papillary lesions initially diagnosed at core biopsy? Breast. 2008 Jun;17(3):258–62. [PubMed: 18054232]

177.

Kim MJ, Kim EK, Kwak JY, et al. Nonmalignant papillary lesions of the breast at US-guided directional vacuum-assisted removal: a preliminary report. Eur Radiol. 2008 Sep;18(9):1774–83. [PubMed: 18446345]

178.

Kim MY, Cho N, Yi A, et al. Sonoelastography in distinguishing benign from malignant complex breast mass and making the decision to biopsy. Korean J Radiol. 2013 Jul–Aug;14(4):559–67. [PMC free article: PMC3725349] [PubMed: 23901312]

179.

King TA, Cederbom GJ, Champaign JL, et al. A core breast biopsy diagnosis of invasive carcinoma allows for definitive surgical treatment planning. Am J Surg. 1998 Dec;176(6):497–501. [PubMed: 9926778]

180.

Kneeshaw PJ, Turnbull LW, Smith A, et al. Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. Eur J Surg Oncol. 2003 Feb;29(1):32–7. [PubMed: 12559074]

181.

Ko ES, Cho N, Cha JH, et al. Sonographically-guided 14-gauge core needle biopsy for papillary lesions of the breast. Korean J Radiol. 2007 May–Jun;8(3):206–11. [PMC free article: PMC2627411] [PubMed: 17554187]

182.

Komenaka IK, El-Tamer M, Pile-Spellman E, et al. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma. Arch Surg. 2003 Sep;138(9):987–90. [PubMed: 12963656]

183.

Kunju LP, Kleer CG. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised? Hum Pathol. 2007 Jan;38(1):35–41. [PubMed: 17095049]

184.

Lam WW, Chu WC, Tse GM, et al. Role of fine needle aspiration and tru cut biopsy in diagnosis of mucinous carcinoma of breast--from a radiologist’s perspective. Clin Imaging. 2006 Jan–Feb;30(1):6–10. [PubMed: 16377477]

185.

Lavoue V, Graesslin O, Classe JM, et al. Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision. Breast. 2007 Oct;16(5):533–9. [PubMed: 17629481]

186.

Lee CH, Carter D, Philpotts LE, et al. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology. 2000 Nov;217(2):466–70. [PubMed: 11058647]

187.

Leikola J, Heikkila P, Pamilo M, et al. Predicting invasion in patients with DCIS in the preoperative percutaneous biopsy. Acta Oncol. 2007;46(6):798–802. [PubMed: 17653903]

188.

Liberman L, Bracero N, Vuolo MA, et al. Percutaneous large-core biopsy of papillary breast lesions. AJR Am J Roentgenol. 1999 Feb;172(2):331–7. [PubMed: 9930777]

189.

Liberman L, Cohen MA, Dershaw DD, et al. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol. 1995 May;164(5):1111–3. [PubMed: 7717215]

190.

Liberman L, Dershaw D, Rosen P, et al. Stereotaxic core biopsy of impalpable spiculated breast masses. AJR Am J Roentgenol. 1995;165(3):551–4. [PubMed: 7645467]

191.

Liberman L, Drotman M, Morris EA, et al. Imaging-histologic discordance at percutaneous breast biopsy. Cancer. 2000 Dec 15;89(12):2538–46. [PubMed: 11135213]

192.

Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol. 1999 Aug;173(2):291–9. [PubMed: 10430122]

193.

Liberman L, Tornos C, Huzjan R, et al. Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy? AJR Am J Roentgenol. 2006 May;186(5):1328–34. [PubMed: 16632727]

194.

Lim CN, Ho BC, Bay BH, et al. Nuclear morphometry in columnar cell lesions of the breast: is it useful? J Clin Pathol. 2006 Dec;59(12):1283–6. [PMC free article: PMC1860532] [PubMed: 16603646]

195.

Lin PH, Clyde JC, Bates DM, et al. Accuracy of stereotactic core-needle breast biopsy in atypical ductal hyperplasia. Am J Surg. 1998 May;175(5):380–2. [PubMed: 9600282]

196.

Londero V, Zuiani C, Furlan A, et al. Role of ultrasound and sonographically guided core biopsy in the diagnostic evaluation of ductal carcinoma in situ (DCIS) of the breast. Radiol Med. 2007 Sep;112(6):863–76. [PubMed: 17891529]

197.

Londero V, Zuiani C, Linda A, et al. Lobular neoplasia: core needle breast biopsy underestimation of malignancy in relation to radiologic and pathologic features. Breast. 2008 Dec;17(6):623–30. [PubMed: 18619840]

198.

Lopez-Medina A, Cintora E, Mugica B, et al. Radial scars diagnosed at stereotactic core-needle biopsy: surgical biopsy findings. Eur Radiol. 2006 Aug;16(8):1803–10. [PubMed: 16708220]

199.

Lourenco AP, Mainiero MB, Lazarus E, et al. Stereotactic breast biopsy: comparison of histologic underestimation rates with 11- and 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol. 2007 Nov;189(5):W275–9. [PubMed: 17954625]

200.

Maganini RO, Klem DA, Huston BJ, et al. Upgrade rate of core biopsy-determined atypical ductal hyperplasia by open excisional biopsy. Am J Surg. 2001 Oct;182(4):355–8. [PubMed: 11720670]

201.

Makar AB, McMartin KE, Palese M, et al. Formate assay in body fluids: application in methanol poisoning. Biochem Med. 1975 Jun;13(2):117–26. [PubMed: 1]

202.

Martel M, Barron-Rodriguez P, Tolgay Ocal I, et al. Flat DIN 1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1,751 core biopsies performed over an 8-year period (1992–1999). Virchows Arch. 2007 Nov;451(5):883–91. [PubMed: 17786469]

203.

Masood S, Loya A, Khalbuss W. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions? Diagn Cytopathol. 2003 Jun;28(6):329–34. [PubMed: 12768640]

204.

McKian KP, Reynolds CA, Visscher DW, et al. Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol. 2009 Dec 10;27(35):5893–8. [PMC free article: PMC2793038] [PubMed: 19805686]

205.

Mendez I, Andreu FJ, Saez E, et al. Ductal carcinoma in situ and atypical ductal hyperplasia of the breast diagnosed at stereotactic core biopsy. Breast J. 2001 Jan–Feb;7(1):14–8. [PubMed: 11348410]

206.

Menon S, Porter GJ, Evans AJ, et al. The significance of lobular neoplasia on needle core biopsy of the breast. Virchows Arch. 2008 May;452(5):473–9. [PMC free article: PMC2329729] [PubMed: 18389278]

207.

Mercado CL, Hamele-Bena D, Oken SM, et al. Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology. 2006 Mar;238(3):801–8. [PubMed: 16424237]

208.

Mercado CL, Hamele-Bena D, Singer C, et al. Papillary lesions of the breast: evaluation with stereotactic directional vacuum-assisted biopsy. Radiology. 2001 Dec;221(3):650–5. [PubMed: 11719659]

209.

Middleton LP, Grant S, Stephens T, et al. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol. 2003 Feb;16(2):120–9. [PubMed: 12591964]

210.

Miller KL, Marks LB, Barrier RC Jr, et al. Increased sectioning of pathologic specimens with ductal carcinoma in situ of the breast: are there clinical consequences? Clin Breast Cancer. 2003 Aug;4(3):198–202. [PubMed: 14499013]

211.

Millos J, Costas-Rodriguez M, Lavilla I, et al. Multielemental determination in breast cancerous and non-cancerous biopsies by inductively coupled plasma-mass spectrometry following small volume microwave-assisted digestion. Anal Chim Acta. 2008 Aug 1;622(1–2):77–84. [PubMed: 18602537]

212.

Mitnick JS, Gianutsos R, Pollack AH, et al. Tubular carcinoma of the breast: sensitivity of diagnostic techniques and correlation with histopathology. AJR Am J Roentgenol. 1999 Feb;172(2):319–23. [PubMed: 9930775]

213.

Mitnick JS, Gianutsos R, Pollack AH, et al. Comparative Value of Mammography, Fine-Needle Aspiration Biopsy, and Core Biopsy in the Diagnosis of Invasive Lobular Carcinoma. Breast J. 1998;4(2):75–83.

214.

O’Hea B J, Tornos C. Mild ductal atypia after large-core needle biopsy of the breast: is surgical excision always necessary? Surgery. 2000 Oct;128(4):738–43. [PubMed: 11015109]

215.

Pan J, Dogan BE, Carkaci S, et al. Comparing performance of the CADstream and the DynaCAD breast MRI CAD systems : CADstream vs. DynaCAD in breast MRI. J Digit Imaging. 2013 Oct;26(5):971–6. [PMC free article: PMC3782607] [PubMed: 23589186]

216.

Philpotts LE, Lee CH, Horvath LJ, et al. Underestimation of breast cancer with II-gauge vacuum suction biopsy. AJR Am J Roentgenol. 2000 Oct;175(4):1047–50. [PubMed: 11000162]

217.

Philpotts LE, Shaheen NA, Jain KS, et al. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology. 2000 Sep;216(3):831–7. [PubMed: 10966718]

218.

Puglisi F, Zuiani C, Bazzocchi M, et al. Role of mammography, ultrasound and large core biopsy in the diagnostic evaluation of papillary breast lesions. Oncology. 2003;65(4):311–5. [PubMed: 14707450]

219.

Rao A, Parker S, Ratzer E, et al. Atypical ductal hyperplasia of the breast diagnosed by 11-gauge directional vacuum-assisted biopsy. Am J Surg. 2002 Dec;184(6):534–7. discussion 7. [PubMed: 12488158]

220.

Renshaw AA. Adequate histologic sampling of breast core needle biopsies. Arch Pathol Lab Med. 2001 Aug;125(8):1055–7. [PubMed: 11473457]

221.

Renshaw AA. Can mucinous lesions of the breast be reliably diagnosed by core needle biopsy? Am J Clin Pathol. 2002 Jul;118(1):82–4. [PubMed: 12109860]

222.

Renshaw AA, Cartagena N, Derhagopian RP, et al. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol. 2002 May;117(5):797–9. [PubMed: 12090431]

223.

Renshaw AA, Cartagena N, Schenkman RH, et al. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies. Am J Clin Pathol. 2001 Jul;116(1):92–6. [PubMed: 11447758]

224.

Renshaw AA, Derhagopian RP, Martinez P, et al. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Am J Clin Pathol. 2006 Aug;126(2):310–3. [PubMed: 16891208]

225.

Renshaw AA, Derhagopian RP, Tizol-Blanco DM, et al. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am J Clin Pathol. 2004 Aug;122(2):217–21. [PubMed: 15323138]

226.

Renshaw AA, Gould EW. Comparison of disagreement and amendment rates by tissue type and diagnosis: identifying cases for directed blinded review. Am J Clin Pathol. 2006 Nov;126(5):736–9. [PubMed: 17050070]

227.

Rizzo M, Lund MJ, Oprea G, et al. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy. Ann Surg Oncol. 2008 Apr;15(4):1040–7. [PubMed: 18204989]

228.

Gombos EC, Godinez J, Poppiti RJ. Significance of extent of lobular neoplasia on breast core biopsy. J Womens Imaging.

229.

Rosen EL, Bentley RC, Baker JA, et al. Imaging-guided core needle biopsy of papillary lesions of the breast. AJR Am J Roentgenol. 2002 Nov;179(5):1185–92. [PubMed: 12388496]

230.

Rosen EL, Soo MS, Bentley RC. Focal fibrosis: a common breast lesion diagnosed at imaging-guided core biopsy. AJR Am J Roentgenol. 1999 Dec;173(6):1657–62. [PubMed: 10584816]

231.

Rutstein LA, Johnson RR, Poller WR, et al. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Breast J. 2007 May–Jun;13(3):251–7. [PubMed: 17461899]

232.

Saxena A, Dhillon VS, Shahid M, et al. GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients. Exp Ther Med. 2012 Dec;4(6):1097–103. [PMC free article: PMC3494109] [PubMed: 23226781]

233.

Shepherd JA, Kerlikowske K, Ma L, et al. Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1473–82. [PMC free article: PMC3132306] [PubMed: 21610220]

234.

Shin HJ, Kim HH, Kim SM, et al. Papillary lesions of the breast diagnosed at percutaneous sonographically guided biopsy: comparison of sonographic features and biopsy methods. AJR Am J Roentgenol. 2008 Mar;190(3):630–6. [PubMed: 18287432]

235.

Shin SJ, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med. 2002 Jun;126(6):697–701. [PubMed: 12033958]

236.

Sie A, Bryan DC, Gaines V, et al. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device. Cancer. 2006 Sep 1;107(5):945–9. [PubMed: 16874817]

237.

Skandarajah AR, Field L, Yuen Larn Mou A, et al. Benign papilloma on core biopsy requires surgical excision. Ann Surg Oncol. 2008 Aug;15(8):2272–7. [PubMed: 18473143]

238.

Sklair-Levy M, Samuels TH, Catzavelos C, et al. Stromal fibrosis of the breast. AJR Am J Roentgenol. 2001 Sep;177(3):573–7. [PubMed: 11517049]

239.

Smetherman D, Dydynski P, Jackson P. Effect of breast core needle biopsy technique on detection of lobular intraepithelial neoplasia. Ochsner J. 2007 Fall;7(3):121–4. [PMC free article: PMC3096396] [PubMed: 21603526]

240.

Sneige N, Lim SC, Whitman GJ, et al. Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. Am J Clin Pathol. 2003 Feb;119(2):248–53. [PubMed: 12579995]

241.

Sohn V, Arthurs Z, Herbert G, et al. Atypical ductal hyperplasia: improved accuracy with the 11-gauge vacuum-assisted versus the 14-gauge core biopsy needle. Ann Surg Oncol. 2007 Sep;14(9):2497–501. [PubMed: 17564749]

242.

Sohn VY, Arthurs ZM, Kim FS, et al. Lobular neoplasia: is surgical excision warranted? Am Surg. 2008 Feb;74(2):172–7. [PubMed: 18306873]

243.

Sydnor MK, Wilson JD, Hijaz TA, et al. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology. 2007 Jan;242(1):58–62. [PubMed: 17090707]

244.

Tocino I, Garcia BM, Carter D. Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotaxic core needle biopsy. Ann Surg Oncol. 1996 Sep;3(5):483–8. [PubMed: 8876891]

245.

Tse GM, Law BK, Ma TK, et al. Hamartoma of the breast: a clinicopathological review. J Clin Pathol. 2002 Dec;55(12):951–4. [PMC free article: PMC1769817] [PubMed: 12461066]

246.

Valdes EK, Tartter PI, Genelus-Dominique E, et al. Significance of papillary lesions at percutaneous breast biopsy. Ann Surg Oncol. 2006 Apr;13(4):480–2. [PubMed: 16474908]

247.

Verkooijen HM, Hoorntje LE, Peeters PH. False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 consecutive cases of missed breast cancer. Cancer. 2004 Mar 1;100(5):1104–5. author reply 5–6. [PubMed: 14983508]

248.

Winchester DJ, Bernstein JR, Jeske JM, et al. Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy. Arch Surg. 2003 Jun;138(6):619–22. discussion 22-3. [PubMed: 12799332]

249.

Wiratkapun C, Wibulpholprasert B, Wongwaisayawan S, et al. Nondiagnostic core needle biopsy of the breast under imaging guidance: result of rebiopsy. J Med Assoc Thai. 2005 Mar;88(3):350–7. [PubMed: 15962643]

250.

Won B, Reynolds H, Lazaridis C, et al. Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: persistent underestimation of disease. AJR Am J Roentgenol. 1999;173(1):227–9. [PubMed: 10397131]

251.

Won B, Reynolds HE, Lazaridis CL, et al. Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: persistent underestimation of disease. AJR Am J Roentgenol. 1999 Jul;173(1):227–9. [PubMed: 10397131]

252.

Woolcott CG, SenGupta SK, Hanna WM, et al. Estrogen and progesterone receptor levels in nonneoplastic breast epithelium of breast cancer cases versus benign breast biopsy controls. BMC Cancer. 2008;8:130. [PMC free article: PMC2397427] [PubMed: 18466613]

253.

Worsham MJ, Raju U, Lu M, et al. Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat. 2009 Nov;118(1):1–7. [PMC free article: PMC3715322] [PubMed: 18836828]

254.

Xu HN, Tchou J, Li LZ. Redox imaging of human breast cancer core biopsies: a preliminary investigation. Acad Radiol. 2013 Jun;20(6):764–8. [PMC free article: PMC3791620] [PubMed: 23664401]

255.

Yeh IT, Dimitrov D, Otto P, et al. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med. 2003 Jan;127(1):49–54. [PubMed: 12521366]

256.

You JK, Kim EK, Kwak JY, et al. Focal fibrosis of the breast diagnosed by a sonographically guided core biopsy of nonpalpable lesions: imaging findings and clinical relevance. J Ultrasound Med. 2005 Oct;24(10):1377–84. [PubMed: 16179621]

257.

Youk JH, Gweon HM, Son EJ, et al. Three-dimensional shear-wave elastography for differentiating benign and malignant breast lesions: comparison with two-dimensional shear-wave elastography. Eur Radiol. 2013 Jun;23(6):1519–27. [PubMed: 23212276]

258.

Zagouri F, Sergentanis TN, Nonni A, et al. Vacuum-assisted breast biopsy: the value and limitations of cores with microcalcifications. Pathol Res Pract. 2007;203(8):563–6. [PubMed: 17611039]

259.

Zhao L, Freimanis R, Bergman S, et al. Biopsy needle technique and the accuracy of diagnosis of atypical ductal hyperplasia for mammographic abnormalities. Am Surg. 2003 Sep;69(9):757–62. discussion 62. [PubMed: 14509322]

260.

Zuiani C, Londero V, Bestagno A, et al. Proliferative high-risk lesions of the breast: contribution and limits of US-guided core biopsy. Radiol Med. 2005 Nov–Dec;110(5–6):589–602. [PubMed: 16437044]

261.

Adrales G, Turk P, Wallace T, et al. Is surgical excision necessary for atypical ductal hyperplasia of the breast diagnosed by Mammotome? Am J Surg. 2000 Oct;180(4):313–5. [PubMed: 11113443]

262.

Brem RF, Schoonjans JM, Goodman SN, et al. Nonpalpable Breast Cancer: Percutaneous Diagnosis with 11-and 8-gauge Stereotactic Vacuum-assisted Biopsy Devices 1. Radiology. 2001;219(3):793–6. [PubMed: 11376271]

263.

Burns RP, Brown JP, Roe SM, et al. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions. Ann Surg. 2000 Oct;232(4):542–8. [PMC free article: PMC1421186] [PubMed: 10998652]

264.

Caines JS, Chantziantoniou K, Wright BA, et al. Nova Scotia Breast Screening Program experience: use of needle core biopsy in the diagnosis of screening-detected abnormalities. Radiology. 1996 Jan;198(1):125–30. [PubMed: 8539363]

265.

Caines JS, McPhee MD, Konok GP, et al. Stereotaxic needle core biopsy of breast lesions using a regular mammographic table with an adaptable stereotaxic device. AJR Am J Roentgenol. 1994 Aug;163(2):317–21. [PubMed: 8037022]

266.

Cerwenka H, Hoff M, Rosanelli G, et al. Experience with a high speed biopsy gun in breast cancer diagnosis. Eur J Surg Oncol. 1997 Jun;23(3):206–7. [PubMed: 9236891]

267.

Chen X, Lehman CD, Dee KE. MRI-guided breast biopsy: clinical experience with 14-gauge stainless steel core biopsy needle. AJR Am J Roentgenol. 2004 Apr;182(4):1075–80. [PubMed: 15039191]

268.

Choo KS, Kwak HS, Tae Bae Y, et al. The value of a combination of wire localization and ultrasound-guided vacuum-assisted breast biopsy for clustered microcalcifications. Breast. 2008 Dec;17(6):611–6. [PubMed: 18653339]

269.

Cilotti A, Iacconi C, Marini C, et al. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications. Radiol Med. 2007 Mar;112(2):272–86. [PubMed: 17361370]

270.

Costantini R, Sardellone A, Marino C, et al. Vacuum-assisted core biopsy (Mammotome) for the diagnosis of non-palpable breast lesions: four-year experience in an Italian center. Tumori. 2005 Jul–Aug;91(4):351–4. [PubMed: 16277103]

271.

Crowe JP Jr, Rim A, Patrick RJ, et al. Does core needle breast biopsy accurately reflect breast pathology? Surgery. 2003 Oct;134(4):523–6. discussion 6-8. [PubMed: 14605609]

272.

Daniel BL, Birdwell RL, Butts K, et al. Freehand iMRI-guided large-gauge core needle biopsy: a new minimally invasive technique for diagnosis of enhancing breast lesions. J Magn Reson Imaging. 2001 Jun;13(6):896–902. [PubMed: 11382950]

273.

Dronkers DJ. Stereotaxic core biopsy of breast lesions. Radiology. 1992 Jun;183(3):631–4. [PubMed: 1584909]

274.

Evans AJ, Whitlock JP, Burrell HC, et al. A comparison of 14 and 12 gauge needles for core biopsy of suspicious mammographic calcification. Br J Radiol. 1999 Dec;72(864):1152–4. [PubMed: 10703470]

275.

Fures R, Bukovic D, Lez C, et al. Large-gauge needle biopsy in diagnosing malignant breast neoplasia. Coll Antropol. 2003 Jun;27(1):259–62. [PubMed: 12974154]

276.

Ghate SV, Rosen EL, Soo MS, et al. MRI-guided vacuum-assisted breast biopsy with a handheld portable biopsy system. AJR Am J Roentgenol. 2006 Jun;186(6):1733–6. [PubMed: 16714667]

277.

Giardina C, Guerrieri A, Ingravallo G, et al. Mammary stereotaxic core-biopsy by Mammotome: an alternative to frozen section examination. Pathologica. 2002;94(4):182–9. [PubMed: 12325416]

278.

Giardina C, Guerrieri AM, Ingravallo G, et al. [The stereotaxic core breast biopsy using the Mammotome: an alternative to intraoperative examination]. Pathologica. 2002 Aug;94(4):182–9. [PubMed: 12325416]

279.

Hirst C, Davis N. Core biopsy for microcalcifications in the breast. Aust N Z J Surg. 1997 Jun;67(6):320–4. [PubMed: 9193263]

280.

Hoorntje LE, Peeters PH, Borel Rinkes IH, et al. Stereotactic large core needle biopsy for all nonpalpable breast lesions? Breast Cancer Res Treat. 2002 May;73(2):177–82. [PubMed: 12088119]

281.

Israel PZ, Fine RE. Stereotactic needle biopsy for occult breast lesions: a minimally invasive alternative. Am Surg. 1995 Jan;61(1):87–91. [PubMed: 7832390]

282.

Jackman RJ, Nowels KW, Shepard MJ, et al. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology. 1994 Oct;193(1):91–5. [PubMed: 8090927]

283.

Joshi M, Duva-Frissora A, Padmanabhan R, et al. Atypical ductal hyperplasia in stereotactic breast biopsies: enhanced accuracy of diagnosis with the mammotome. Breast J. 2001 Jul–Aug;7(4):207–13. [PubMed: 11678796]

284.

Kikuchi M, Tsunoda-Shimizu H, Kawasaki T, et al. Indications for stereotactically-guided vacuum-assisted breast biopsy for patients with category 3 microcalcifications. Breast Cancer. 2007;14(3):285–91. [PubMed: 17690506]

285.

Kim MJ, Kim EK, Park SY, et al. Imaging-histologic discordance at sonographically guided percutaneous biopsy of breast lesions. Eur J Radiol. 2008 Jan;65(1):163–9. [PubMed: 17466478]

286.

Klar RM. National health insurance: the federal perspective. ASHA. 1975 Jun;17(6):388–91. [PubMed: 1137627]

287.

Klem D, Jacobs HK, Jorgensen R, et al. Stereotactic breast biopsy in a community hospital setting. Am Surg. 1999 Aug;65(8):737–40. discussion 40-1. [PubMed: 10432083]

288.

Kumaroswamy V, Liston J, Shaaban AM. Vacuum assisted stereotactic guided mammotome biopsies in the management of screen detected microcalcifications: experience of a large breast screening centre. J Clin Pathol. 2008 Jun;61(6):766–9. [PubMed: 18326021]

289.

Lee JM, Kaplan JB, Murray MP, et al. Complete excision of the MRI target lesion at MRI-guided vacuum-assisted biopsy of breast cancer. AJR Am J Roentgenol. 2008 Oct;191(4):1198–202. [PubMed: 18806165]

290.

Łuczyńska E, Kocurek A, Dyczek S, et al. Ultrasound-guided, vacuum-assisted biopsy in evaluation of breast lesions. NOWOTWORY. 2008;58

291.

Łuczyńska E, Skotnicki P, Kocurek A, et al. Vacuum mammotomy under ultrasound guidance. Polish Journal of Radiology. 2007;72(3):15–8.

292.

McCombs MM, Bassett LW, Jahan R, et al. Imaging-Guided Core Biopsy of the Breast. The Breast Journal. 1995;1(1):9–16.

293.

Mendez A, Cabanillas F, Echenique M, et al. Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice. Cancer. 2004 Feb 15;100(4):710–4. [PubMed: 14770425]

294.

Morrow M, Schmidt R, Cregger B, et al. Preoperative evaluation of abnormal mammographic findings to avoid unnecessary breast biopsies. Arch Surg. 1994 Oct;129(10):1091–6. [PubMed: 7944941]

295.

Newman MR, Frost FA, Sterrett GF, et al. Diagnosis of breast microcalcifications: a comparison of stereotactic FNA and core imprint cytology as adjuncts to core biopsy. Pathology. 2001 Nov;33(4):449–53. [PubMed: 11827411]

296.

Nisbet AP, Borthwick-Clarke A, Scott N. 11-gauge vacuum assisted directional biopsy of breast calcifications, using upright stereotactic guidance. Eur J Radiol. 2000 Dec;36(3):144–6. [PubMed: 11091014]

297.

Pillsbury SG Jr, Haugen JA, Roux S. Reliability of multimodal evaluation of abnormal screening mammogram results. Am J Obstet Gynecol. 1996 Jun;174(6):1683–6. discussion 6-7. [PubMed: 8678127]

298.

Rich PM, Michell MJ, Humphreys S, et al. Stereotactic 14G core biopsy of non-palpable breast cancer: what is the relationship between the number of core samples taken and the sensitivity for detection of malignancy? Clin Radiol. 1999 Jun;54(6):384–9. [PubMed: 10406340]

299.

Schneider E, Rohling KW, Schnall MD, et al. An apparatus for MR-guided breast lesion localization and core biopsy: Design and preliminary results. Journal of Magnetic Resonance Imaging. 2001;14(3):243–53. [PubMed: 11536401]

300.

Senn Bahls E, Dupont Lampert V, Oelschlegel C, et al. Multitarget stereotactic core-needle breast biopsy (MSBB)--an effective and safe diagnostic intervention for non-palpable breast lesions: a large prospective single institution study. Breast. 2006 Jun;15(3):339–46. [PubMed: 16488609]

301.

Seoudi H, Mortier J, Basile R, et al. Stereotactic core needle biopsy of nonpalpable breast lesions: initial experience with a promising technique. Arch Surg. 1998 Apr;133(4):366–72. [PubMed: 9565115]

302.

Shin JH, Han BK, Ko EY, et al. Probably benign breast masses diagnosed by sonography: is there a difference in the cancer rate according to palpability? AJR Am J Roentgenol. 2009 Apr;192(4):W187–91. [PubMed: 19304679]

303.

Smyczek-Gargya B, Krainick U, Muller-Schimpfle M, et al. Large-core needle biopsy for diagnosis and treatment of breast lesions. Arch Gynecol Obstet. 2002 Aug;266(4):198–200. [PubMed: 12192478]

304.

Soo MS, Baker JA, Rosen EL, et al. Sonographically guided biopsy of suspicious microcalcifications of the breast: a pilot study. AJR Am J Roentgenol. 2002 Apr;178(4):1007–15. [PubMed: 11906892]

305.

Taft R, Chao K, Dear P, et al. The role of core biopsy in the diagnosis of mammographically detected lesions. Aust N Z J Surg. 1996 Oct;66(10):664–7. [PubMed: 8855919]

306.

Taourel P, Hoa D, Chaveron C, et al. Stereotactic vacuum biopsy of calcifications with a handheld portable biopsy system: a validation study. Eur Radiol. 2008 Jul;18(7):1319–25. [PubMed: 18351352]

307.

Teh WL, Wilson AR, Evans AJ, et al. Ultrasound guided core biopsy of suspicious mammographic calcifications using high frequency and power Doppler ultrasound. Clin Radiol. 2000 May;55(5):390–4. [PubMed: 10816407]

308.

Vega A, Garijo F, Ortega E. Core needle aspiration biopsy of palpable breast masses. Acta Oncol. 1995;34(1):31–4. [PubMed: 7865233]

309.

Velanovich V, Lewis FR Jr, Nathanson SD, et al. Comparison of mammographically guided breast biopsy techniques. Ann Surg. 1999 May;229(5):625–30. discussion 30-3. [PMC free article: PMC1420806] [PubMed: 10235520]

310.

Wallace JE, Sayler C, McDowell NG, et al. The role of stereotactic biopsy in assessment of nonpalpable breast lesions. Am J Surg. 1996 May;171(5):471–3. [PubMed: 8651387]

311.

Wong T-T, Cheung PS, Ma MK, et al. Experience of stereotactic breast biopsy using the vacuum-assisted core needle biopsy device and the advanced breast biopsy instrumentation system in Hong Kong women. Asian Journal of Surgery. 2005;28(1):18–23. [PubMed: 15691792]

312.

Woodcock NP, Glaves I, Morgan DR, et al. Ultrasound-guided Tru-cut biopsy of the breast. Ann R Coll Surg Engl. 1998 Jul;80(4):253–6. [PMC free article: PMC2503103] [PubMed: 9771224]

313.

Zardawi IM. Fine needle aspiration cytology vs. core biopsy in a rural setting. Acta Cytol. 1998 Jul–Aug;42(4):883–7. [PubMed: 9684572]

314.

Zografos GC, Zagouri F, Sergentanis TN, et al. Is zero underestimation feasible? Extended Vacuum-Assisted Breast Biopsy in solid lesions - a blind study. World J Surg Oncol. 2007;5:53. [PMC free article: PMC1885798] [PubMed: 17501997]

315.

Zografos GC, Zagouri F, Sergentanis TN, et al. Pain during vacuum-assisted breast biopsy: are there any predictors? Breast. 2008 Dec;17(6):592–5. [PubMed: 18657974]

316.

Lifrange E, Dondelinger RF, Quatresooz P, et al. Stereotactic breast biopsy with an 8-gauge, directional, vacuum-assisted probe: initial experience. Eur Radiol. 2002 Sep;12(9):2180–7. [PubMed: 12195467]

317.

Abramovici G, Mainiero MB. Screening breast MR imaging: comparison of interpretation of baseline and annual follow-up studies. Radiology. 2011 Apr;259(1):85–91. [PubMed: 21285337]

318.

Acheson MB, Patton RG, Howisey RL, et al. Histologic correlation of image-guided core biopsy with excisional biopsy of nonpalpable breast lesions. Arch Surg. 1997 Aug;132(8):815–8. discussion 9-21. [PubMed: 9267263]

319.

Ahmed HG, Ali AS, Almobarak AO. Utility of fine-needle aspiration as a diagnostic technique in breast lumps. Diagn Cytopathol. 2009 Dec;37(12):881–4. [PubMed: 19760761]

320.

Andreu FJ, Saez A, Sentis M, et al. Breast core biopsy reporting categories--An internal validation in a series of 3054 consecutive lesions. Breast. 2007 Feb;16(1):94–101. [PubMed: 16982194]

321.

Aryal KR, Lengyel AJ, Purser N, et al. Nipple core biopsy for the deformed or scaling nipple. Breast. 2004 Aug;13(4):350–2. [PubMed: 15325673]

322.

Berner A, Davidson B, Sigstad E, et al. Fine-needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions. Diagn Cytopathol. 2003 Dec;29(6):344–8. [PubMed: 14648793]

323.

Bick U, Engelken F, Diederichs G, et al. MRI of the breast as part of the assessment in population-based mammography screening. Rofo. 2013 Sep;185(9):849–56. [PubMed: 23740312]

324.

Brancato B, Scialpi M, Pusiol T, et al. Needle core biopsy should replace fine needle aspiration cytology in ultrasound-guided sampling of breast lesions. Pathologica. 2011 Apr;103(2):52. [PubMed: 21797145]

325.

Brunner AH, Sagmeister T, Kremer J, et al. The accuracy of frozen section analysis in ultrasound- guided core needle biopsy of breast lesions. BMC Cancer. 2009;9:341. [PMC free article: PMC2759967] [PubMed: 19778424]

326.

Burak WE Jr, Owens KE, Tighe MB, et al. Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions. Arch Surg. 2000 Jun;135(6):700–3. [PubMed: 10843367]

327.

Carmichael AR, Berresford A, Sami A, et al. Imprint cytology of needle core-biopsy specimens of breast lesion: is it best of both worlds? Breast. 2004 Jun;13(3):232–4. [PubMed: 15177427]

328.

Cupido BD, Vawda F, Sabri A, et al. Evaluation and correlation of mammographically suspicious lesions with histopathology at Addington Hospital, Durban. S Afr Med J. 2013 Apr;103(4):251–4. [PubMed: 23547702]

329.

Duijm LE, Groenewoud JH, Roumen RM, et al. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer. Breast Cancer Res Treat. 2007 Nov;106(1):113–9. [PubMed: 17219049]

330.

Duncan JL 3rd, Cederbom GJ, Champaign JL, et al. Benign diagnosis by image-guided core-needle breast biopsy. Am Surg. 2000 Jan;66(1):5–9. discussion -10. [PubMed: 10651339]

331.

Fotou M, Oikonomou V, Zagouri F, et al. Imprint cytology on microcalcifications excised by vacuum-assisted breast biopsy: a rapid preliminary diagnosis. World J Surg Oncol. 2007;5:40. [PMC free article: PMC1876235] [PubMed: 17407604]

332.

Gebauer B, Bostanjoglo M, Moesta KT, et al. Magnetic resonance-guided biopsy of suspicious breast lesions with a handheld vacuum biopsy device. Acta Radiol. 2006 Nov;47(9):907–13. [PubMed: 17077039]

333.

Green RS, Mathew S. The contribution of cytologic imprints of stereotactically guided core needle biopsies of the breast in the management of patients with mammographic abnormalities. Breast J. 2001 Jul–Aug;7(4):214–8. [PubMed: 11678797]

334.

James JJ, Wilson AR, Evans AJ, et al. The use of a short-acting benzodiazepine to reduce the risk of syncopal episodes during upright stereotactic breast biopsy. Clin Radiol. 2005 Mar;60(3):394–6. [PubMed: 15710145]

335.

Joulaee A, Kalantari M, Kadivar M, et al. Trucut biopsy of breast lesions: the first step toward international standards in developing countries. Eur J Cancer. 2012 Mar;48(5):648–54. [PubMed: 22244803]

336.

Kam JK, Naidu P, Rose AK, et al. Five-year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancer. J Med Imaging Radiat Oncol. 2013 Aug;57(4):400–6. [PubMed: 23870334]

337.

Kang SS, Ko EY, Han BK, et al. Breast US in patients who had microcalcifications with low concern of malignancy on screening mammography. Eur J Radiol. 2008 Aug;67(2):285–91. [PubMed: 17703906]

338.

Kim MJ, Kim EK, Lee JY, et al. Breast lesions with imaging-histologic discordance during US-guided 14G automated core biopsy: can the directional vacuum-assisted removal replace the surgical excision? Initial findings. Eur Radiol. 2007 Sep;17(9):2376–83. [PubMed: 17361422]

339.

Kumaraswamy V, Carder PJ. Examination of breast needle core biopsy specimens performed for screen-detected microcalcification. J Clin Pathol. 2007 Jun;60(6):681–4. [PMC free article: PMC1955077] [PubMed: 16882700]

340.

Mak WS, Fong CY, Lui CY. Ultrasound-guided biopsy of solid breast lesions: Should fine-needle aspiration be replaced by core biopsy? Hong Kong. 2012;15(1):10–4.

341.

Mohr Z, Hirche C, Klein T, et al. Vacuum-assisted minimally invasive biopsy of soft-tissue tumors. J Bone Joint Surg Am. 2012 Jan 18;94(2):103–9. [PubMed: 22257995]

342.

Olaya W, Bae W, Wong J, et al. Accuracy and upgrade rates of percutaneous breast biopsy: the surgeon’s role. Am Surg. 2010 Oct;76(10):1084–7. [PubMed: 21105615]

343.

Parker SH, Klaus AJ, McWey PJ, et al. Sonographically guided directional vacuum-assisted breast biopsy using a handheld device. AJR Am J Roentgenol. 2001 Aug;177(2):405–8. [PubMed: 11461871]

344.

Peter D, Grunhagen J, Wenke R, et al. False-negative results after stereotactically guided vacuum biopsy. Eur Radiol. 2008 Jan;18(1):177–82. [PubMed: 17637996]

345.

Popiela TJ, Tabor J, Chrzan R, et al. Mammotome biopsy in the diagnostic management of non-palpable breast pathologies. Pol Przegl Radiol. 2006;71(3):48–56.

346.

Sakamoto N, Tozaki M, Higa K, et al. False-negative ultrasound-guided vacuum-assisted biopsy of the breast: difference with US-detected and MRI-detected lesions. Breast Cancer. 2010 Apr;17(2):110–7. [PubMed: 19434473]

347.

Sakamoto N, Tozaki M, Higa K, et al. Categorization of non-mass-like breast lesions detected by MRI. Breast Cancer. 2008;15(3):241–6. [PubMed: 18224381]

348.

Sarff M, Schmidt K, Vetto JT. Targeted breast cancer screening in women younger than 40: results from a statewide program. Am J Surg. 2008 May;195(5):626–30. discussion 30. [PubMed: 18374894]

349.

Schoonjans JM, Brem RF. Fourteen-gauge ultrasonographically guided large-core needle biopsy of breast masses. J Ultrasound Med. 2001 Sep;20(9):967–72. [PubMed: 11549157]

350.

Schur EA, Elmore JE, Onega T, et al. The impact of obesity on follow-up after an abnormal screening mammogram. Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):327–36. [PMC free article: PMC3275693] [PubMed: 22144503]

351.

Sigal-Zafrani B, Muller K, El Khoury C, et al. Vacuum-assisted large-core needle biopsy (VLNB) improves the management of patients with breast microcalcifications - analysis of 1009 cases. Eur J Surg Oncol. 2008 Apr;34(4):377–81. [PubMed: 17604937]

352.

Simon JR, Kalbhen CL, Cooper RA, et al. Accuracy and complication rates of US-guided vacuum-assisted core breast biopsy: initial results. Radiology. 2000 Jun;215(3):694–7. [PubMed: 10831686]

353.

Smith GE, Burrows P. Ultrasound diagnosis of fibroadenoma - is biopsy always necessary? Clin Radiol. 2008 May;63(5):511–5. discussion 6-7. [PubMed: 18374713]

354.

Sohn YM, Kim MJ, Kim EK, et al. Sonographic elastography combined with conventional sonography: how much is it helpful for diagnostic performance? J Ultrasound Med. 2009 Apr;28(4):413–20. [PubMed: 19321669]

355.

Sonmez G, Cuce F, Mutlu H, et al. Value of diffusion-weighted MRI in the differentiation of benign and malign breast lesions. Wien Klin Wochenschr. 2011 Nov;123(21–22):655–61. [PubMed: 21922210]

356.

Stijven S, Gielen E, Bevernage C, et al. Magnetic resonance imaging: value of diffusion-weighted imaging in differentiating benign from malignant breast lesions. Eur J Obstet Gynecol Reprod Biol. 2013 Feb;166(2):215–20. [PubMed: 23219320]

357.

Sung JS, Lee CH, Morris EA, et al. Screening breast MR imaging in women with a history of chest irradiation. Radiology. 2011 Apr;259(1):65–71. [PubMed: 21325032]

358.

Tabrizian P, Moezzi M, Menes TS. Synchronous benign-appearing calcifications in patients with ductal carcinoma in situ may not be benign. Breast Cancer. 2011 Oct;18(4):314–8. [PubMed: 20602184]

359.

Tadwalkar RV, Rapelyea JA, Torrente J, et al. Breast-specific gamma imaging as an adjunct modality for the diagnosis of invasive breast cancer with correlation to tumour size and grade. Br J Radiol. 2012 Jun;85(1014):e212–6. [PMC free article: PMC3474123] [PubMed: 21712429]

360.

Tozaki M. BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ. Breast Cancer. 2013 Jan;20(1):13–20. [PubMed: 22109641]

361.

Weigert JM, Bertrand ML, Lanzkowsky L, et al. Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique. AJR Am J Roentgenol. 2012 Jan;198(1):W69–75. [PubMed: 22194518]

362.

Weinstein SP, Hanna LG, Gatsonis C, et al. Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667. Radiology. 2010 Jun;255(3):731–7. [PMC free article: PMC2887932] [PubMed: 20501712]

363.

Whitlock JP, Evans AJ, Burrell HC, et al. Digital imaging improves upright stereotactic core biopsy of mammographic microcalcifications. Clin Radiol. 2000 May;55(5):374–7. [PubMed: 10816404]

364.

Whitworth PW. Intact Percutaneous Excision (IPEX) for Definitive Diagnosis of High-Risk Breast Lesions. Ann Surg Oncol. 2011 Oct;18(11):3095. [PubMed: 21904961]

365.

Wu YC, Chen DR, Kuo SJ. Personal experience of ultrasound-guided 14-gauge core biopsy of breast tumor. Eur J Surg Oncol. 2006 Sep;32(7):715–8. [PubMed: 16769196]

366.

Xu H, Rao M, Varghese T, et al. Axial-shear strain imaging for differentiating benign and malignant breast masses. Ultrasound Med Biol. 2010 Nov;36(11):1813–24. [PMC free article: PMC3033738] [PubMed: 20800948]

367.

Xu X, Gifford-Hollingsworth C, Sensenig R, et al. Breast tumor detection using piezoelectric fingers: first clinical report. J Am Coll Surg. 2013 Jun;216(6):1168–73. [PubMed: 23623223]

368.

Yi A, Cho N, Chang JM, et al. Sonoelastography for 1,786 non-palpable breast masses: diagnostic value in the decision to biopsy. Eur Radiol. 2012 May;22(5):1033–40. [PubMed: 22116557]

369.

Yoon JH, Jung HK, Lee JT, et al. Shear-wave elastography in the diagnosis of solid breast masses: what leads to false-negative or false-positive results? Eur Radiol. 2013 Sep;23(9):2432–40. [PubMed: 23673572]

370.

Yoon JH, Kim EK, Kwak JY, et al. Is US-guided core needle biopsy (CNB) enough in probably benign nodules with interval growth? Ultraschall Med. 2012 Dec;33(7):E145–50. [PubMed: 23023453]

371.

Yoon JH, Kim MJ, Moon HJ, et al. Subcategorization of ultrasonographic BI-RADS category 4: positive predictive value and clinical factors affecting it. Ultrasound Med Biol. 2011 May;37(5):693–9. [PubMed: 21458145]

372.

Youk JH, Kim EK, Kim MJ, et al. Performance of hand-held whole-breast ultrasound based on BI-RADS in women with mammographically negative dense breast. Eur Radiol. 2011 Apr;21(4):667–75. [PubMed: 20853108]

373.

A mammographic screening pilot project in Victoria 1988–1990. The Essendon Breast X-ray Program Collaborative Group. Med J Aust. 1992 Nov 16;157(10):670–3. [PubMed: 1435408]

374.

Hereditary breast and ovarian cancer syndrome. Gynecol Oncol. 2009 Apr;113(1):6–11. [PubMed: 19309638]

375.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. [cited 2013 June 25]. Available: http://www​.guideline.gov.

376.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: Use of tumor markers in clinical practice: quality requirements. [cited 2013 June 25]. Available: http://www​.guideline.gov.

377.

Abbas S, Miller G, Doyle T. Specimen Radiography Following Hook Wire Localization and Excision of Screen Detected Breast Abnormality. International Journal of Cancer Research. 2007;3(1):39–42.

378.

Abe H, Schmidt RA, Kulkarni K, et al. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients. Radiology. 2009 Jan;250(1):41–9. [PubMed: 18955508]

379.

Abrahamson PE, Dunlap LA, Amamoo MA, et al. Factors predicting successful needle-localized breast biopsy. Acad Radiol. 2003 Jun;10(6):601–6. [PubMed: 12809412]

380.

Abrahamsson A, Morad V, Saarinen NM, et al. Estradiol, tamoxifen, and flaxseed alter IL-1beta and IL-1Ra levels in normal human breast tissue in vivo. J Clin Endocrinol Metab. 2012 Nov;97(11):E2044–54. [PubMed: 22930784]

381.

Acosta JA, Greenlee JA, Gubler KD, et al. Surgical margins after needle-localization breast biopsy. Am J Surg. 1995 Dec;170(6):643–5. discussion 5-6. [PubMed: 7492018]

382.

Agodirin SO, Ojemakinde OM, Bello TO, et al. Ultrasound-guided wire localization of lesions detected on screening mammography in Osogbo, Nigeria and its impact on breast conservative surgery. Ann Afr Med. 2012 Apr–Jun;11(2):91–5. [PubMed: 22406668]

383.

Aitken RJ, MacDonald HL, Kirkpatrick AE, et al. Outcome of surgery for non-palpable mammographic abnormalities. Br J Surg. 1990 Jun;77(6):673–6. [PubMed: 2383738]

384.

Al Ayyan M, Bu Ali O, Al Sharri S, et al. Negative axillary ultrasonography with biopsy may predict non-involvement of the non-sentinel lymph nodes in operable breast cancer patients. Asia Pac J Clin Oncol. 2012 Nov 21 [PubMed: 23167952]

385.

Albert MP, Sachsse E, Coe NP, et al. Correlation between mammography and the pathology of nonpalpable breast lesions. J Surg Oncol. 1990 May;44(1):44–6. [PubMed: 2342374]

386.

Alexander HR, Candela FC, Dershaw DD, et al. Needle-localized mammographic lesions. Results and evolving treatment strategy. Arch Surg. 1990 Nov;125(11):1441–4. [PubMed: 2241554]

387.

Alhabshi SMI, Rahmat K, Abdul Halim N, et al. Semi-quantitative and qualitative assessment of breast ultrasound elastography in differentiating between malignant and benign lesions. Ultrasound Med Biol. 2013;39(4):568–78. [PubMed: 23384468]

388.

Al-Harethee W, Theodoropoulos G, Filippakis GM, et al. Complications of percutaneous stereotactic vacuum assisted breast biopsy system utilizing radio frequency. Eur J Radiol. 2013 Apr;82(4):623–6. [PubMed: 22227260]

389.

Alicioglu B, Yucesoy C. A simple method to decrease surgical trauma in wire localization procedures. Diagn Interv Radiol. 2008 Sep;14(3):131–2. [PubMed: 18814133]

390.

Al-Khawari H, Athyal R, Kovacs A, et al. Accuracy of the Fischer scoring system and the Breast Imaging Reporting and Data System in identification of malignant breast lesions. Ann Saudi Med. 2009 Jul–Aug;29(4):280–7. [PMC free article: PMC2841455] [PubMed: 19584584]

391.

Allen SD, Nerurkar A, Della Rovere GU. The breast lesion excision system (BLES): a novel technique in the diagnostic and therapeutic management of small indeterminate breast lesions? Eur Radiol. 2011 May;21(5):919–24. [PubMed: 21240608]

392.

Al-Thobhani AK, Raja’a YA, Noman TA, et al. Profile of breast lesions among women with positive biopsy findings in Yemen. East Mediterr Health J. 2006 Sep;12(5):599–604. [PubMed: 17333799]

393.

Amitkumar K, Srigayathri S, Praburaj AR, et al. Immunohistochemical analysis and correlation of p53, Ki-67 and PCNA in core needle Biopsy specimens of carcinoma breast. Res J Pharm, Biol Chem Sci. 2012;3(4):1446–58.

394.

Aoyama K, Kamio T, Hirano A, et al. Granular cell tumors: a report of six cases. World J Surg Oncol. 2012;10:204. [PMC free article: PMC3502223] [PubMed: 23021251]

395.

Arambula Cosio F, Lira Berra E, Hevia Montiel N, et al. Computer assisted biopsy of breast tumors. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:5995–8. [PubMed: 21097108]

396.

Armstrong K, Handorf EA, Chen J, et al. Breast cancer risk prediction and mammography biopsy decisions: a model-based study. Am J Prev Med. 2013 Jan;44(1):15–22. [PMC free article: PMC3527848] [PubMed: 23253645]

397.

Arora R, El Hameed AA, Al Ajrawi T, et al. The accuracy of abnormal cytology report in breast fine needle aspiration alone and in combination with clinical and imaging findings - a hospital based five year study in Kuwait. Gulf J Oncolog. 2008 Jul;(4):33–8. [PubMed: 20084773]

398.

Asadi M, Shobeiri H, Aliakbarian M, et al. Reproducibility of lymphoscintigraphy before and after excisional biopsy of primary breast lesions: a study using superficial peri-areolar injection of the radiotracer. Rev Esp Med Nucl Imagen Mol. 2013 May–Jun;32(3):152–5. [PubMed: 23044070]

399.

Ashraf M, Biswas J, Gupta S, et al. Determinants of wound infections for breast procedures: assessment of the risk of wound infection posed by an invasive procedure for subsequent operation. Int J Surg. 2009 Dec;7(6):543–6. [PubMed: 19748602]

400.

Asoglu O, Ozmen V, Karanlik H, et al. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy. Acta Chir Belg. 2005 May–Jun;105(3):291–6. [PubMed: 16018523]

401.

Ball CG, Butchart M, MacFarlane JK. Effect on biopsy technique of the breast imaging reporting and data system (BI-RADS) for nonpalpable mammographic abnormalities. Can J Surg. 2002 Aug;45(4):259–63. [PMC free article: PMC3684677] [PubMed: 12174979]

402.

Barbalaco Neto G, Rossetti C, Fonseca FL, et al. Ductal carcinoma in situ in core needle biopsies and its association with extensive in situ component in the surgical specimen. Int Arch Med. 2012;5(1):19. [PMC free article: PMC3432016] [PubMed: 22715888]

403.

Bassiouny RH, Youssef T, Hassan O. Diagnostic performance of breast MRI with and without the addition of quantitative diffusion weighted imaging. Egypt J Radiol Nucl Med. 2012;43(2):311–23.

404.

Bauer TL, Pandelidis SM, Rhoads JE Jr, et al. Mammographically detected carcinoma of the breast. Surg Gynecol Obstet. 1991 Dec;173(6):482–6. [PubMed: 1948608]

405.

Baute PB, Thibodeau ME, Newstead G. Improving the yield of biopsy for nonpalpable lesions of the breast. Surg Gynecol Obstet. 1992 Feb;174(2):93–6. [PubMed: 1734582]

406.

Baykara M, Özkan Z, Gül Y, et al. Effectiveness of the Triple Test and Its Alternatives for Breast Mass Evaluation.

407.

Bellantone R, Rossi S, Lombardi CP, et al. Excisional breast biopsy: when, why and how? Int Surg. 1995 Jan–Mar;80(1):75–8. [PubMed: 7657498]

408.

Bender JS, Magnuson TH, Smith-Meek MA, et al. Will stereotactic breast biopsy achieve results as good as current techniques? Am Surg. 1996 Aug;62(8):637–9. discussion 9-40. [PubMed: 8712560]

409.

Benedict S, Williams RD, Baron PL. Recalled anxiety: from discovery to diagnosis of a benign breast mass. Oncol Nurs Forum. 1994 Nov–Dec;21(10):1723–7. [PubMed: 7854934]

410.

Benedict S, Williams RD, Baron PL. The effect of benign breast biopsy on subsequent breast cancer detection practices. Oncol Nurs Forum. 1994 Oct;21(9):1467–75. [PubMed: 7816674]

411.

Benson SR, Harrison NJ, Lengyel J, et al. Combined image guidance excision of non-palpable breast lesions. Breast. 2004 Apr;13(2):110–4. [PubMed: 15019690]

412.

Berkey CS, Willett WC, Frazier AL, et al. Prospective study of adolescent alcohol consumption and risk of benign breast disease in young women. Pediatrics. 2010 May;125(5):e1081–7. [PMC free article: PMC3075610] [PubMed: 20385629]

413.

Berkey CS, Willett WC, Tamimi RM, et al. Dairy intakes in older girls and risk of benign breast disease in young women. Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):670–4. [PMC free article: PMC3617079] [PubMed: 23542805]

414.

Bianchini G, Qi Y, Alvarez RH, et al. Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers. J Clin Oncol. 2010 Oct 1;28(28):4316–23. [PubMed: 20805453]

415.

Bird D, Hart S. Early experience with needle localization and biopsy of mammographic lesions. Aust N Z J Surg. 1990 May;60(5):337–40. [PubMed: 2334355]

416.

Bluvol N, Kornecki A, Shaikh A, et al. Freehand versus guided breast biopsy: comparison of accuracy, needle motion, and biopsy time in a tissue model. AJR Am J Roentgenol. 2009 Jun;192(6):1720–5. [PubMed: 19457840]

417.

Bluvol N, Sheikh A, Kornecki A, et al. A needle guidance system for biopsy and therapy using two-dimensional ultrasound. Med Phys. 2008 Feb;35(2):617–28. [PubMed: 18383683]

418.

Bohndiek SE, Royle GJ, Speller RD. An active pixel sensor x-ray diffraction (APXRD) system for breast cancer diagnosis. Phys Med Biol. 2009 Jun 7;54(11):3513–27. [PubMed: 19443951]

419.

Bojia F, Demisse M, Dejane A, et al. Comparison of fine-needle aspiration cytology and excisional biopsy of breast lesions. East Afr Med J. 2001 May;78(5):226–8. [PubMed: 12002079]

420.

Bosch AM, Beets GL, Kessels AG, et al. A needle-localised open-breast biopsy for nonpalpable breast lesions should not be performed for diagnosis. Breast. 2004 Dec;13(6):476–82. [PubMed: 15563854]

421.

Bouton ME, Wilhelmson KL, Komenaka IK. Intraoperative ultrasound can facilitate the wire guided breast procedure for mammographic abnormalities. Am Surg. 2011 May;77(5):640–6. [PubMed: 21679601]

422.

Bowa K, Jewel J, Mudenda V. Fine needle aspiration cytology in the investigation of breast lumps at the University Teaching Hospital in Lusaka, Zambia. Trop Doct. 2008 Oct;38(4):245–7. [PubMed: 18820201]

423.

Brenner RJ. Lesions entirely removed during stereotactic biopsy: preoperative localization on the basis of mammographic landmarks and feasibility of freehand technique--initial experience. Radiology. 2000 Feb;214(2):585–90. [PubMed: 10671616]

424.

Brenner RJ, Pfaff JM. Mammographic changes after excisional breast biopsy for benign disease. AJR Am J Roentgenol. 1996 Oct;167(4):1047–52. [PubMed: 8819410]

425.

Brett J, Austoker J. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health Med. 2001 Dec;23(4):292–300. [PubMed: 11873891]

426.

Brett J, Austoker J, Ong G. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. J Public Health Med. 1998 Dec;20(4):396–403. [PubMed: 9923945]

427.

Budczies J, Weichert W, Noske A, et al. Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarrays. J Histochem Cytochem. 2011 Feb;59(2):146–57. [PMC free article: PMC3201135] [PubMed: 21339180]

428.

Burnside ES, Chhatwal J, Alagoz O. What is the optimal threshold at which to recommend breast biopsy? PLoS One. 2012;7(11):e48820. [PMC free article: PMC3492229] [PubMed: 23144986]

429.

Burrell H, Murphy C, Wilson A, et al. Wire localization biopsies of non-palpable breast lesions: the use of the Nottingham localization device. The Breast. 1997;6(2):79–83.

430.

Burrell HC, Pinder SE, Wilson AR, et al. The positive predictive value of mammographic signs: a review of 425 non-palpable breast lesions. Clin Radiol. 1996 Apr;51(4):277–81. [PubMed: 8617041]

431.

Carswell H. Minimally invasive FNAB versus surgical biopsy. Diagn Imaging (San Franc). 1991 Jun;13(6):97–104. [PubMed: 10149914]

432.

Castells X, Roman M, Romero A, et al. Breast cancer detection risk in screening mammography after a false-positive result. Cancer Epidemiol. 2013 Feb;37(1):85–90. [PubMed: 23142338]

433.

Caya JG. Breast Frozen Section Outcome in the Community Hospital Setting A Detailed Analysis of 932 Cases. International Journal of Surgical Pathology. 1995;2(3):215–9.

434.

Chadwick DR, Shorthouse AJ. Wire-directed localization biopsy of the breast: an audit of results and analysis of factors influencing therapeutic value in the treatment of breast cancer. Eur J Surg Oncol. 1997 Apr;23(2):128–33. [PubMed: 9158186]

435.

Chang CB, Lvoff NM, Leung JW, et al. Solitary dilated duct identified at mammography: outcomes analysis. AJR Am J Roentgenol. 2010 Feb;194(2):378–82. [PubMed: 20093599]

436.

Chen L, Abbey CK, Nosratieh A, et al. Anatomical complexity in breast parenchyma and its implications for optimal breast imaging strategies. Med Phys. 2012 Mar;39(3):1435–41. [PMC free article: PMC3298563] [PubMed: 22380376]

437.

Chimenti F, Vomero S. [Synthesis of N-substituted isoindolines]. Farmaco Sci. 1975 Nov;30(11):884–90. [PubMed: 251]

438.

Chinyama CN, Davies JD, Rayter Z, et al. Factors affecting surgical margin clearance in screen-detected breast cancer and the effect of cavity biopsies on residual disease. Eur J Surg Oncol. 1997 Apr;23(2):123–7. [PubMed: 9158185]

439.

Chlebowski RT, Anderson G, Manson JE, et al. Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy. J Clin Oncol. 2010 Jun 1;28(16):2690–7. [PMC free article: PMC2881849] [PubMed: 20439627]

440.

Ciatto S, Bonardi R, Ravaioli A, et al. Benign breast surgical biopsies: are they always justified? Tumori. 1998 Sep–Oct;84(5):521–4. [PubMed: 9862509]

441.

Cleverley JR, Jackson AR, Bateman AC. Pre-operative localization of breast microcalcification using high-frequency ultrasound. Clin Radiol. 1997 Dec;52(12):924–6. [PubMed: 9413966]

442.

Coady MS, Benson EA, Hartley MN. Provision and acceptability of day case breast biopsy: an audit of current practice. Ann R Coll Surg Engl. 1993 Jul;75(4):281–4. discussion 5. [PMC free article: PMC2497919] [PubMed: 8379634]

443.

Colbert ST, O’Hanlon DM, McDonnell C, et al. Analgesia in day case breast biopsy--the value of pre-emptive tenoxicam. Can J Anaesth. 1998 Mar;45(3):217–22. [PubMed: 9579258]

444.

Collins JC, Liao S, Wile AG. Surgical management of breast masses in pregnant women. J Reprod Med. 1995 Nov;40(11):785–8. [PubMed: 8592313]

445.

Cooper RA. Dual technique for preoperative localization of nonpalpable breast lesions. Can Assoc Radiol J. 1991 Dec;42(6):439–40. [PubMed: 1751909]

446.

Coskun G, Dogan L, Karaman N, et al. Value of sentinel lymph node biopsy in breast cancer patients with previous excisional biopsy. J Breast Cancer. 2012 Mar;15(1):87–90. [PMC free article: PMC3318180] [PubMed: 22493633]

447.

Cox CE, Reintgen DS, Nicosia SV, et al. Analysis of residual cancer after diagnostic breast biopsy: an argument for fine-needle aspiration cytology. Ann Surg Oncol. 1995 May;2(3):201–6. [PubMed: 7641015]

448.

Cox G, Didlake R, Powers C, et al. Choice of anesthetic technique for needle localized breast biopsy. Am Surg. 1991 Jul;57(7):414–8. [PubMed: 1647712]

449.

Crawford MD, Biankin AV, Rickard MT, et al. The operative management of screen-detected breast cancers. Aust N Z J Surg. 2000 Mar;70(3):168–73. [PubMed: 10765897]

450.

D’Alfonso TM, Liu YF, Chen Z, et al. SP3, a reliable alternative to HercepTest in determining HER-2/neu status in breast cancer patients. J Clin Pathol. 2013 May;66(5):409–14. [PubMed: 23386665]

451.

Davies AH, Cowan A, Jones P, et al. Ultrasound localization of screen detected impalpable breast tumours. J R Coll Surg Edinb. 1994 Dec;39(6):353–4. [PubMed: 7869290]

452.

Davies RJ, A’Hern RP, Parsons CA, et al. Mammographic accuracy and patient age: a study of 297 patients undergoing breast biopsy. Clin Radiol. 1993 Jan;47(1):23–5. [PubMed: 8280193]

453.

Day JC, Stone N. A subcutaneous Raman needle probe. Appl Spectrosc. 2013 Mar;67(3):349–54. [PubMed: 23452501]

454.

Dayal S, Murray J, Wilson K, et al. Imprint cytology from core biopsies increases the sensitivity of fine needle aspiration (FNA) in breast cancer patients. Magy Seb. 2011 Apr;64(2):59–62. [PubMed: 21504853]

455.

De Koning HJ, Fracheboud J, Boer R, et al. Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB). Int J Cancer. 1995 Mar 16;60(6):777–80. [PubMed: 7896444]

456.

Deane KA, Degner LF. Information needs, uncertainty, and anxiety in women who had a breast biopsy with benign outcome. Cancer Nurs. 1998 Apr;21(2):117–26. [PubMed: 9556938]

457.

Degnim AC, Miller J, Hoskin TL, et al. A prospective study of breast lymphedema: frequency, symptoms, and quality of life. Breast Cancer Res Treat. 2012 Aug;134(3):915–22. [PMC free article: PMC3924783] [PubMed: 22415476]

458.

della Rovere GQ, Benson JR, Morgan M, et al. Localization of impalpable breast lesions--a surgical approach. Eur J Surg Oncol. 1996 Oct;22(5):478–82. [PubMed: 8903489]

459.

Di Giorgio A, Alessi G, Arnone P, et al. Ultrasonographically guided excisional biopsy of non-palpable breast lesions. Br J Surg. 1996 Jan;83(1):103. [PubMed: 8653327]

460.

Diepstraten SC, Verkooijen HM, van Diest PJ, et al. Radiofrequency-assisted intact specimen biopsy of breast tumors: critical evaluation according to the IDEAL recommendations. Cancer Imaging. 2011;11:247–52. [PMC free article: PMC3266591] [PubMed: 22201702]

461.

Domanski AM, Monsef N, Domanski HA, et al. Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients. Cytopathology. 2013 Feb;24(1):21–5. [PubMed: 22783929]

462.

Dominguez WG, Nardi H, Montero H, et al. HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions. Exp Ther Med. 2010 Jul;1(4):597–602. [PMC free article: PMC3445870] [PubMed: 22993582]

463.

Dowlatshahi K, Jokich PM, Kluskens LF, et al. A prospective study of double diagnosis of nonpalpable lesions of the breast. Surg Gynecol Obstet. 1991 Feb;172(2):121–4. [PubMed: 1846452]

464.

Drosos Y, Kouloukoussa M, Ostvold AC, et al. NUCKS overexpression in breast cancer. Cancer Cell Int. 2009;9:19. [PMC free article: PMC2743642] [PubMed: 19664271]

465.

Du J, Wang L, Wan CF, et al. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging. Eur J Radiol. 2012 Dec;81(12):3890–9. [PubMed: 23062280]

466.

Dyess DL, Lorino CO, Grieco A, et al. Selective nonoperative management of solid breast masses. Am Surg. 1992 Jul;58(7):435–40. [PubMed: 1616189]

467.

Ebeed SA, Abd El-Moneim NA, Saad A, et al. Diagnostic and prognostic value of circulating tumor cells in female breast cancer patients. Alex J Med. 2012;48(3):197–206.

468.

Egyed Z, Pentek Z, Jaray B, et al. Radial scar-significant diagnostic challenge. Pathol Oncol Res. 2008 Jun;14(2):123–9. [PubMed: 18409019]

469.

Erguvan-Dogan B, Whitman GJ, Nguyen VA, et al. Specimen radiography in confirmation of MRI-guided needle localization and surgical excision of breast lesions. AJR Am J Roentgenol. 2006 Aug;187(2):339–44. [PubMed: 16861535]

470.

Estourgie SH, Valdes Olmos RA, Nieweg OE, et al. Excision biopsy of breast lesions changes the pattern of lymphatic drainage. Br J Surg. 2007 Sep;94(9):1088–91. [PubMed: 17514636]

471.

Ezer SS, Oguzkurt P, Ince E, et al. Surgical treatment of the solid breast masses in female adolescents. J Pediatr Adolesc Gynecol. 2013 Feb;26(1):31–5. [PubMed: 23158756]

472.

Fedoruk LM, Bojm MA, Bugis SP. Fine-wire localization for nonpalpable mammographic abnormalities. Can J Surg. 1995 Apr;38(2):173–7. [PubMed: 7728673]

473.

Feng XZ, Song YH, Zhang FX, et al. Diagnostic accuracy of fiberoptic ductoscopy plus in vivo iodine staining for intraductal proliferative lesions. Chin Med J (Engl). 2013 Aug;126(16):3124–9. [PubMed: 23981624]

474.

Feoli F, Ameye L, Van Eeckhout P, et al. Liquid-based cytology of the breast: pitfalls unrecognized before specific liquid-based cytology training - proposal for a modification of the diagnostic criteria. Acta Cytol. 2013;57(4):369–76. [PubMed: 23860126]

475.

Ferno M, Baldetorp B, Fallenius G, et al. Preoperative fine needle aspiration from human breast cancer is a valuable sampling material for progesterone receptor and cytometric DNA analysis. Acta Oncol. 1996;35(Suppl 8):19–25. [PubMed: 9073045]

476.

Ferreiro JA, Gisvold JJ, Bostwick DG. Accuracy of frozen-section diagnosis of mammographically directed breast biopsies. Results of 1,490 consecutive cases. Am J Surg Pathol. 1995 Nov;19(11):1267–71. [PubMed: 7573688]

477.

Flanagan JJ, Conry BG, Rubin G, et al. Short communication: Prospective assessment of a new graduated hookwire for the localization of impalpable breast lesions. Br J Radiol. 1996 Apr;69(820):341–3. [PubMed: 8665134]

478.

de Fleury EF, Fleury JC, Piato S, et al. New elastographic classification of breast lesions during and after compression. Diagn Interv Radiol. 2009 Jun;15(2):96–103. [PubMed: 19517379]

479.

Florentine BD, Kirsch D, Carroll-Johnson RM, et al. Conservative excision of wire-bracketed breast carcinomas: a community hospital’s experience. Breast J. 2004 Sep–Oct;10(5):398–404. [PubMed: 15327492]

480.

Franceschi D, Crowe J, Zollinger R, et al. Biopsy of the breast for mammographically detected lesions. Surg Gynecol Obstet. 1990 Dec;171(6):449–55. [PubMed: 2244276]

481.

Frank JL, Lynch K, Barrows G. Nipple smear cytology is of no value in the management of women with nipple discharge. Conn Med. 2010 Apr;74(4):207–10. [PubMed: 20441001]

482.

Frattini V, Ghisoni L, Teodoro A, et al. Clinical approach with optical imaging instrument. perspective analysis on 617 young females: Studio clinico mediante dinamica ottica mammaria per immagini. analisi prospettica in 617 donne con eta inferiore a 40 anni. Ital J Gynaecol Obstet. 2011;23(2–3):101–6.

483.

Fukutomi T, Yamamoto H, Nanasawa T, et al. Prognostic factors for local recurrence in breast conservation therapy: residual cancers after lumpectomy. Surg Today. 1993;23(5):402–6. [PubMed: 8324333]

484.

Garcia-Ortega MJ, Benito MA, Vahamonde EF, et al. Pretreatment axillary ultrasonography and core biopsy in patients with suspected breast cancer: diagnostic accuracy and impact on management. Eur J Radiol. 2011 Jul;79(1):64–72. [PubMed: 20047809]

485.

Garcia-Vilanova-Comas A, Fuster-Diana C, Cubells-Parrilla M, et al. Nicolau syndrome after lidocaine injection and cold application: a rare complication of breast core needle biopsy. Int J Dermatol. 2011 Jan;50(1):78–80. [PubMed: 21182507]

486.

Geelhoed GW, Barr HM, Curtis DJ, et al. Radiologic recommendation for breast biopsy on screening mammography reports. Am Surg. 1991 Jul;57(7):419–24. [PubMed: 2058848]

487.

Giacalone PL, Bourdon A, Trinh PD, et al. Radioguided occult lesion localization plus sentinel node biopsy (SNOLL) versus wire-guided localization plus sentinel node detection: a case control study of 129 unifocal pure invasive non-palpable breast cancers. Eur J Surg Oncol. 2012 Mar;38(3):222–9. [PubMed: 22231127]

488.

Giagounidis EM, Markus R, Josef L, et al. CT-guided preoperative needle localization of MRI-detected breast lesions. Eur J Radiol. 2001 Aug;39(2):100–3. [PubMed: 11522418]

489.

Goedde TA, Frykberg ER, Crump JM, et al. The impact of mammography on breast biopsy. Am Surg. 1992 Nov;58(11):661–6. [PubMed: 1485695]

490.

Goff JM, Molloy M, Debbas MT, et al. Long-term impact of previous breast biopsy on breast cancer screening modalities. J Surg Oncol. 1995 May;59(1):18–20. [PubMed: 7745971]

491.

Goldberg JA, Scott RN, Davidson PM, et al. Psychological morbidity in the first year after breast surgery. Eur J Surg Oncol. 1992 Aug;18(4):327–31. [PubMed: 1521623]

492.

Gossmann A, Bangard C, Warm M, et al. Real-time MR-guided wire localization of breast lesions by using an open 1.0-T imager: initial experience. Radiology. 2008 May;247(2):535–42. [PubMed: 18349317]

493.

Gouin F, Tournigand T, Moisan D, et al. [Preparation of the patient for reoperation]. Ann Anesthesiol Fr. 1975 Jul;16(4):237–40. [PubMed: 2040]

494.

Grannan KJ, Lamping K. Impact of method of anesthesia on the accuracy of needle-localized breast biopsies. Am J Surg. 1993 Feb;165(2):218–20. [PubMed: 8427399]

495.

Gray RJ, Salud C, Nguyen K, et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol. 2001 Oct;8(9):711–5. [PubMed: 11597011]

496.

Green B, Dowley A, Turnbull LS, et al. Impact of fine-needle aspiration cytology, ultrasonography and mammography on open biopsy rate in patients with benign breast disease. Br J Surg. 1995 Nov;82(11):1509–11. [PubMed: 8535805]

497.

Griffen MM, Welling RE. Needle-localized biopsy of the breast. Surg Gynecol Obstet. 1990 Feb;170(2):145–8. [PubMed: 2154039]

498.

Guarneri V, Barbieri E, Piacentini F, et al. Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis. Int J Biol Markers. 2010 Apr–Jun;25(2):104–11. [PubMed: 20544688]

499.

Gupta A, Subhas G, Dubay L, et al. Review of re-excision for narrow or positive margins of invasive and intraductal carcinoma. Am Surg. 2010 Jul;76(7):731–4. [PubMed: 20698380]

500.

Gwin JL Jr, King B, Hudson KB, et al. Interval mammography after needle localization biopsy of breast abnormalities that are pathologically benign. Am J Surg. 1995 Oct;170(4):323–6. [PubMed: 7573722]

501.

Hall JA, Murphy DC, Hall BR, et al. Open surgical biopsy for nonpalpable mammographic abnormalities: still an option compared with core needle biopsy. Am J Obstet Gynecol. 1998 Jun;178(6):1245–50. [PubMed: 9662308]

502.

Halladay JR, Yankaskas BC, Bowling JM, et al. Positive predictive value of mammography: comparison of interpretations of screening and diagnostic images by the same radiologist and by different radiologists. AJR Am J Roentgenol. 2010 Sep;195(3):782–5. [PMC free article: PMC4451561] [PubMed: 20729460]

503.

Hamby LS, McGrath PC, Stelling CB, et al. Management of mammographic indeterminate lesions. First place winner of the Conrad Jobst Award in the Gold Medal paper competition. Am Surg. 1993 Jan;59(1):4–8. [PubMed: 8386912]

504.

Hashemzadeh SH, Kumar PV, Malekpour N, et al. Diagnostic accuracy of fine needle aspiration cytology: Comparison of results in Tabriz Imam Khomeini Hospital and Shiraz University of Medical Sciences. Iran J Cancer Prev. 2009;2(3):133–6.

505.

Hasselgren PO, Hummel RP, Georgian-Smith D, et al. Breast biopsy with needle localization: accuracy of specimen x-ray and management of missed lesions. Surgery. 1993 Oct;114(4):836–40. discussion 40-2. [PubMed: 8211702]

506.

Haupt LM, Irving RE, Weinstein SR, et al. Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material. Mol Cell Probes. 2008 Apr;22(2):83–9. [PubMed: 17669621]

507.

Hewes JC, Imkampe A, Haji A, et al. Importance of routine cavity sampling in breast conservation surgery. Br J Surg. 2009 Jan;96(1):47–53. [PubMed: 19108003]

508.

Higgins G, Abdulkareen A, Loutfi A, et al. Productivity of needle localization to facilitate excision of nonpalpable, mammographically suspicious lesions. Can J Surg. 1991 Jun;34(3):287–9. [PubMed: 2054762]

509.

Hizukuri A, Nakayama R, Kashikura Y, et al. Computerized determination scheme for histological classification of breast mass using objective features corresponding to clinicians’ subjective impressions on ultrasonographic images. J Digit Imaging. 2013 Oct;26(5):958–70. [PMC free article: PMC3782602] [PubMed: 23546774]

510.

Homer MJ. Nonpalpable breast microcalcifications: frequency, management, and results of incisional biopsy. Radiology. 1992 Nov;185(2):411–3. [PubMed: 1410347]

511.

Hong JY, Kang YS, Kil HK. Anaesthesia for day case excisional breast biopsy: propofol-remifentanil compared with sevoflurane-nitrous oxide. Eur J Anaesthesiol. 2008 Jun;25(6):460–7. [PubMed: 18298873]

512.

Howe JR, Monsees B, Destouet J, et al. Needle localization breast biopsy: a model for multidisciplinary quality assurance. J Surg Oncol. 1995 Apr;58(4):233–9. [PubMed: 7723366]

513.

Hubbard R, Kerlikowske K, Buist D, et al. Evaluation of breast cancer screening strategies must be based on comparison of harms and benefits. AJR Am J Roentgenol. 2011 Oct;197(4):W793. author reply 4. [PubMed: 21940562]

514.

Hughes JH, Mason MC, Gray RJ, et al. A multi-site validation trial of radioactive seed localization as an alternative to wire localization. Breast J. 2008 Mar–Apr;14(2):153–7. [PubMed: 18248562]

515.

Iggo R, Rudewicz J, Monceau E, et al. Validation of a yeast functional assay for p53 mutations using clonal sequencing. J Pathol. 2013 Dec;231(4):441–8. [PubMed: 23897043]

516.

Irabor D, Okolo C. An audit of 149 consecutive breast biopsies in Ibadan, Nigeria. PAKISTAN JOURNAL OF MEDICAL SCIENCES. 2008;24(2):257.

517.

Jacquemier J, Spyratos F, Esterni B, et al. SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases. BMC Cancer. 2013;13:351. [PMC free article: PMC3729815] [PubMed: 23875536]

518.

Jardines L, Fowble B, Schultz D, et al. Factors associated with a positive reexcision after excisional biopsy for invasive breast cancer. Surgery. 1995 Nov;118(5):803–9. [PubMed: 7482265]

519.

Javid SH, Carlson JW, Garber JE, et al. Breast MRI wire-guided excisional biopsy: specimen size as compared to mammogram wire-guided excisional biopsy and implications for use. Ann Surg Oncol. 2007 Dec;14(12):3352–8. [PubMed: 17849165]

520.

Javid SH, Kirstein LJ, Rafferty E, et al. Outcome of multiple-wire localization for larger breast cancers: do multiple wires translate into additional imaging, biopsies, and recurrences? Am J Surg. 2009 Sep;198(3):368–72. [PubMed: 19716884]

521.

Jeter DD, Vest GR, Buday SJ. Mammographic guidewire localization of nonpalpable breast lesions. Am Surg. 1991 Jul;57(7):431–3. [PubMed: 1647713]

522.

Johnston JA, Clee CZ. Analysis of 308 localisation breast biopsies in a New Zealand hospital. Australas Radiol. 1991 May;35(2):148–51. [PubMed: 1930011]

523.

Johnston S, Trudeau M, Kaufman B, et al. Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy. J Clin Oncol. 2008 Mar 1;26(7):1066–72. [PubMed: 18212337]

524.

Johnstone AJ, John TG, Thompson AM, et al. PDS II (polydioxanone) is the monofilament suture of choice for subcuticular wound closure following breast biopsy. J R Coll Surg Edinb. 1992 Apr;37(2):94–6. [PubMed: 1377271]

525.

Johnstone AJ, Thompson AM, Charles M, et al. Wound compression pads are of no value after local anaesthetic breast biopsy. Ann R Coll Surg Engl. 1991 Sep;73(5):303–4. [PMC free article: PMC2499508] [PubMed: 1929132]

526.

Joo JD, In JH, Kim DW, et al. The comparison of sedation quality, side effect and recovery profiles on different dosage of remifentanil patient-controlled sedation during breast biopsy surgery. Korean J Anesthesiol. 2012 Nov;63(5):431–5. [PMC free article: PMC3506853] [PubMed: 23198037]

527.

Kaelin CM, Smith TJ, Homer MJ, et al. Safety, accuracy, and diagnostic yield of needle localization biopsy of the breast performed using local anesthesia. J Am Coll Surg. 1994 Sep;179(3):267–72. [PubMed: 8069420]

528.

Kalu ON, Chow C, Wheeler A, et al. The diagnostic value of nipple discharge cytology: breast imaging complements predictive value of nipple discharge cytology. J Surg Oncol. 2012 Sep 15;106(4):381–5. [PubMed: 22396104]

529.

Kanchwala SK, Bucky LP. Precision transverse rectus abdominis muscle flap breast reconstruction: a reliable technique for efficient preoperative planning. Ann Plast Surg. 2008 May;60(5):521–6. [PubMed: 18434826]

530.

Kanjer K, Tatic S, Neskovic-Konstantinovic Z, et al. Treatment response to preoperative anthracycline-based chemotherapy in locally advanced breast cancer: the relevance of proliferation and apoptosis rates. Pathol Oncol Res. 2013 Jul;19(3):577–88. [PubMed: 23526163]

531.

Kapp JM, Walker R, Haneuse S, et al. Are there racial/ethnic disparities among women younger than 40 undergoing mammography? Breast Cancer Res Treat. 2010 Nov;124(1):213–22. [PMC free article: PMC2927744] [PubMed: 20204501]

532.

Karp G, Abu-Ghanem S, Novack V, et al. Localization of PKCeta in cell membranes as a predictor for breast cancer response to treatment. Onkologie. 2012;35(5):260–6. [PubMed: 22868505]

533.

Kaviani A, Fateh M, Ataie-Fashtami L, et al. Comparison of carbon dioxide laser and scalpel for breast lumpectomy: a randomized controlled trial. Photomed Laser Surg. 2008 Jun;26(3):257–62. [PubMed: 18588441]

534.

Kearney TJ, Morrow M. Effect of reexcision on the success of breast-conserving surgery. Ann Surg Oncol. 1995 Jul;2(4):303–7. [PubMed: 7552618]

535.

Kelly P, Winslow EH. Needle wire localization for nonpalpable breast lesions: sensations, anxiety levels, and informational needs. Oncol Nurs Forum. 1996 May;23(4):639–45. [PubMed: 8735322]

536.

Kim J, Lee J, Chang E, et al. Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience. World J Surg. 2009 May;33(5):943–9. [PubMed: 19259728]

537.

Kim JA, Son EJ, Kim EK, et al. Postexcisional breast magnetic resonance imaging in patients with breast cancer: predictable findings of residual cancer. J Comput Assist Tomogr. 2009 Nov–Dec;33(6):940–5. [PubMed: 19940664]

538.

Kinsella MD, Nassar A, Siddiqui MT, et al. Estrogen receptor (ER), progesterone receptor (PR), and HER2 expression pre- and post- neoadjuvant chemotherapy in primary breast carcinoma: a single institutional experience. Int J Clin Exp Pathol. 2012;5(6):530–6. [PMC free article: PMC3430104] [PubMed: 22949935]

539.

Kishen R, Bartlett JM, Dixon JM, et al. Constructing tissue microarrays from core needle biopsies of breast cancers. Histopathology. 2011 Oct;59(4):794–6. [PubMed: 21906129]

540.

Klimberg VS, Westbrook KC, Korourian S. Use of touch preps for diagnosis and evaluation of surgical margins in breast cancer. Ann Surg Oncol. 1998 Apr–May;5(3):220–6. [PubMed: 9607622]

541.

Knutzen AM, Gisvold JJ. Likelihood of malignant disease for various categories of mammographically detected, nonpalpable breast lesions. Mayo Clin Proc. 1993 May;68(5):454–60. [PubMed: 8479209]

542.

Ko ES, Han H, Lee BH, et al. Sonographic changes after removing all benign breast masses with sonographically guided vacuum-assisted biopsy. Acta Radiol. 2009 Nov;50(9):968–74. [PubMed: 19863404]

543.

Kochli OR. Available stereotactic systems for breast biopsy. Recent Results Cancer Res. 2009;173:105–13. [PubMed: 19763450]

544.

Kombar OR, Fahmy DM, Brown MV, et al. Sonomammographic characteristics of invasive lobular carcinoma. Breast Cancer: Target Ther. 2012;4:115–24. [PMC free article: PMC3846710] [PubMed: 24367199]

545.

Kowal M, Filipczuk P, Obuchowicz A, et al. Computer-aided diagnosis of breast cancer based on fine needle biopsy microscopic images. Comput Biol Med. 2013 Oct 1;43(10):1563–72. [PubMed: 24034748]

546.

Kruger JM, Thomas M, Korn R, et al. Detection of truncated HER2 forms in formalin-fixed, paraffin-embedded breast cancer tissue captures heterogeneity and is not affected by HER2-targeted therapy. Am J Pathol. 2013 Aug;183(2):336–43. [PubMed: 23727348]

547.

Kumar N, Sayed S, Moloo Z, et al. Fine-needle aspiration in suspected inflammatory breast cancer: case series with emphasis on approach to specimen adequacy. Acta Cytol. 2011;55(3):239–44. [PubMed: 21525734]

548.

Kuo SJ. Evaluation of the CO2 laser in performance of breast surgery. Zhonghua Yi Xue Za Zhi (Taipei). 1994 May;53(5):288–92. [PubMed: 8039042]

549.

Kyle DJ, Harvey AG, Shih B, et al. Identification of molecular phenotypic descriptors of breast capsular contracture formation using informatics analysis of the whole genome transcriptome. Wound Repair Regen. 2013 Sep–Oct;21(5):762–9. [PubMed: 23941504]

550.

Lai YC, Huang YS, Wang DW, et al. Computer-aided diagnosis for 3-d power Doppler breast ultrasound. Ultrasound Med Biol. 2013 Apr;39(4):555–67. [PubMed: 23384464]

551.

Laird-Fick HS, Gardiner JC, Tokala H, et al. HER2 status in elderly women with breast cancer. Journal of geriatric oncology. 2013;4(4):362–7. [PubMed: 24472480]

552.

Landheer ML, Klinkenbijl JH, Pasker-de Jong PC, et al. Residual disease after excision of non-palpable breast tumours: analysis of tumour characteristics. Eur J Surg Oncol. 2004 Oct;30(8):824–8. [PubMed: 15336726]

553.

Landheer ML, Veltman J, van Eekeren R, et al. MRI-guided preoperative wire localization of nonpalpable breast lesions. Clin Imaging. 2006 Jul–Aug;30(4):229–33. [PubMed: 16814136]

554.

Langlois SL, Carter ML. Carbon localisation of impalpable mammographic abnormalities. Australas Radiol. 1991 Aug;35(3):237–41. [PubMed: 1763986]

555.

Lantsberg L, Kirshtein B, Koretz M, et al. Role of wire-guided breast biopsy for diagnosis of malignant nonpalpable mammographic lesions. World J Surg. 1999 Dec;23(12):1279–81. [PubMed: 10552121]

556.

Law MT, Bennett IC. Structured ultrasonography workshop for breast surgeons: is it an effective training tool? World J Surg. 2010 Mar;34(3):549–54. [PubMed: 20054545]

557.

Law NW, Johnson CD, Lamont PM, et al. Drainage or suture of the cavity after breast biopsy. Ann R Coll Surg Engl. 1990 Jan;72(1):11–3. [PMC free article: PMC2499066] [PubMed: 2405764]

558.

Lay SF, Crump JM, Frykberg ER, et al. Breast biopsy. Changing patterns during a five-year period. Am Surg. 1990 Feb;56(2):79–85. [PubMed: 2306056]

559.

Layfield LJ, Chrischilles EA, Cohen MB, et al. The palpable breast nodule. A cost-effectiveness analysis of alternate diagnostic approaches. Cancer. 1993 Sep 1;72(5):1642–51. [PubMed: 8348496]

560.

Lazarus E, Mainiero MB, Gareen IF. Effect of referring physician specialty and practice type on referral for image-guided breast biopsy. J Am Coll Radiol. 2005 Jun;2(6):488–93. [PubMed: 17411865]

561.

Lee AH, Hodi Z, Ellis IO. False-negative assessment of oestrogen receptor on needle core biopsy of invasive carcinoma of the breast. J Clin Pathol. 2008 Feb;61(2):239–40. [PubMed: 18223101]

562.

Lee CH, Carter D. Detecting residual tumor after excisional biopsy of impalpable breast carcinoma: efficacy of comparing preoperative mammograms with radiographs of the biopsy specimen. AJR Am J Roentgenol. 1995 Jan;164(1):81–6. [PubMed: 7998574]

563.

Lee EJ, Oh SM. The efficacy of stereotactic vacuum-assisted biopsy and needle localization vacuum-assisted biopsy for diagnosing breast microcalcification. J Breast Cancer. 2010;13(1):53–8.

564.

Lehr HA, Rochat C, Schaper C, et al. Mitotic figure counts are significantly overestimated in resection specimens of invasive breast carcinomas. Mod Pathol. 2013 Mar;26(3):336–42. [PubMed: 23041831]

565.

Lein BC, Alex WR, Zebley DM, et al. Results of needle localized breast biopsy in women under age 50. Am J Surg. 1996 Mar;171(3):356–9. [PubMed: 8615472]

566.

Leung TK, Huang PJ, Liang HH, et al. Retrospective Study of False-positive Breast Magnetic Resonance Images and Pathological Results in Taiwan. J Exp Clin Med. 2012;4(5):284–8.

567.

Liberman L, Mason G, Morris EA, et al. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol. 2006 Feb;186(2):426–30. [PubMed: 16423948]

568.

Linda A, Zuiani C, Londero V, et al. Magnetic resonance imaging of radial sclerosing lesions (radial scars) of the breast. Eur J Radiol. 2012 Nov;81(11):3201–7. [PubMed: 22386132]

569.

Liu X, Li L, Chen F, et al. An intraoperative localization technique for a postexcision specimen of nonpalpable breast calcifications: a pilot study. Am Surg. 2011 Nov;77(11):1467–71. [PubMed: 22196659]

570.

London SJ, Connolly JL, Schnitt SJ, et al. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992 Feb 19;267(7):941–4. [PubMed: 1734106]

571.

Lopes-Costa PV, dos Santos AR, da Silva BB. The effect of raloxifene on Bax protein expression in breast carcinomas of postmenopausal women. Diagn Cytopathol. 2012 Jul;40(7):570–4. [PubMed: 22707322]

572.

Lorenzen J, Finck-Wedel AK, Lisboa B, et al. Second opinion assessment in diagnostic mammography at a breast cancer centre. Geburtshilfe Frauenheilkd. 2012;72(8):734–9. [PMC free article: PMC4168327] [PubMed: 25258466]

573.

Loubeyre P, Bodmer A, Tille JC, et al. Concordance between core needle biopsy and surgical excision specimens for tumour hormone receptor profiling according to the 2011 St. Gallen Classification, in clinical practice. Breast J. 2013 Nov–Dec;19(6):605–10. [PubMed: 24165313]

574.

Loukas C, Kostopoulos S, Tanoglidi A, et al. Breast cancer characterization based on image classification of tissue sections visualized under low magnification. Comput Math Methods Med. 2013;2013:829461. [PMC free article: PMC3773385] [PubMed: 24069067]

575.

Lu P, Zhu XQ, Xu ZL, et al. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer. Surgery. 2009 Mar;145(3):286–93. [PubMed: 19231581]

576.

Luciani ML, Pediconi F, Telesca M, et al. Incidental enhancing lesions found on preoperative breast MRI: management and role of second-look ultrasound. Radiol Med. 2011 Sep;116(6):886–904. [PubMed: 21293943]

577.

Luini A, Sacchini V, Galimberti V, et al. Preoperative localization and surgical approach in 344 cases of non-palpable breast lesions. Eur J Surg Oncol. 1991 Oct;17(5):480–4. [PubMed: 1936294]

578.

Luo HJ, Chen X, Tu G, et al. Therapeutic application of ultrasound-guided 8-gauge Mammotome system in presumed benign breast lesions. Breast J. 2011 Sep–Oct;17(5):490–7. [PubMed: 21762243]

579.

Lyng MB, Laenkholm AV, Pallisgaard N, et al. Identification of genes for normalization of real-time RT-PCR data in breast carcinomas. BMC Cancer. 2008;8:20. [PMC free article: PMC2248196] [PubMed: 18211679]

580.

Ma K, Fenster A, Kornecki A, et al. A new lateral guidance device for stereotactic breast biopsy using an add-on unit to an upright mammography system. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:3653–6. [PubMed: 19163502]

581.

Madeira M, Mattar A, Logullo AF, et al. Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer. BMC Cancer. 2013;13:425. [PMC free article: PMC3851532] [PubMed: 24047421]

582.

Mallapragada VG, Sarkar N, Podder TK. Robotic system for tumor manipulation and ultrasound image guidance during breast biopsy. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:5589–92. [PubMed: 19163984]

583.

Mansour SM, Abolfotooh A. Does MRI help in the assessment of inflammatory breast disorders? The Egyptian Journal of Radiology and Nuclear Medicine. 2012;43(3):487–97.

584.

Markopoulos C, Kakisis J, Kouskos S, et al. Management of nonpalpable, mammographically detectable breast lesions. World J Surg. 1999 May;23(5):434–8. [PubMed: 10085389]

585.

Markopoulos C, Kouskos E, Revenas K, et al. Open surgical biopsy for nonpalpable breast lesions detected on screening mammography. Eur J Gynaecol Oncol. 2005;26(3):311–4. [PubMed: 15991535]

586.

Masroor I, Afzal S, Sakhawat S, et al. Negative predictive value of mammography and sonography in mastalgia with negative physical findings. J Pak Med Assoc. 2009 Sep;59(9):598–601. [PubMed: 19750852]

587.

Masroor I, Afzal S, Shafqat G, et al. Usefulness of hook wire localization biopsy under imaging guidance for nonpalpable breast lesions detected radiologically. Int J Womens Health. 2012;4:445–9. [PMC free article: PMC3469229] [PubMed: 23071414]

588.

Maxwell AJ. Ultrasound-guided vacuum-assisted excision of breast papillomas: review of 6-years experience. Clin Radiol. 2009 Aug;64(8):801–6. [PubMed: 19589419]

589.

Maxwell AJ, Pearson JM, Bishop HM. Crude open biopsy rates for benign screen detected lesions no longer reflect breast screening quality--time to change the standard. J Med Screen. 2002;9(2):83–5. [PubMed: 12133928]

590.

McCreery BR, Frankl G, Frost DB. An analysis of the results of mammographically guided biopsies of the breast. Surg Gynecol Obstet. 1991 Mar;172(3):223–6. [PubMed: 1847244]

591.

McGhan LJ, McKeever SC, Pockaj BA, et al. Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution. Ann Surg Oncol. 2011 Oct;18(11):3096–101. [PubMed: 21947587]

592.

McMahon MA, James JJ, Cornford EJ, et al. Does the insertion of a gel-based marker at stereotactic breast biopsy allow subsequent wire localizations to be carried out under ultrasound guidance? Clin Radiol. 2011 Sep;66(9):840–4. [PubMed: 21658688]

593.

McManus V, Desautels JE, Benediktsson H, et al. Enhancement of true-positive rates for nonpalpable carcinoma of the breast through mammographic selection. Surg Gynecol Obstet. 1992 Sep;175(3):212–8. [PubMed: 1514155]

594.

Medjhoul A, Canale S, Mathieu MC, et al. Breast lesion excision sample (BLES biopsy) combining stereotactic biopsy and radiofrequency: is it a safe and accurate procedure in case of BIRADS 4 and 5 breast lesions? Breast J. 2013 Nov–Dec;19(6):590–4. [PubMed: 24102869]

595.

Meeuwis C, Peters NH, Mali WP, et al. Targeting difficult accessible breast lesions: MRI-guided needle localization using a freehand technique in a 3.0 T closed bore magnet. Eur J Radiol. 2007 May;62(2):283–8. [PubMed: 17218074]

596.

Melanson GF, Otchy DP, Walters MJ, et al. The importance of stabilizing the specimen taken at needle localized biopsy of the breast for microcalcifications. Surg Gynecol Obstet. 1992 May;174(5):376–8. [PubMed: 1570614]

597.

Memis A, Ustun EE, Orguc S. Mammographic and ultrasonographic evaluation of breast after excisional biopsy. European journal of ultrasound. 1997;5(1):47–51.

598.

Menet E, Becette V, Briffod M. Cytologic diagnosis of lobular carcinoma of the breast: experience with 555 patients in the Rene Huguenin Cancer Center. Cancer. 2008 Apr 25;114(2):111–7. [PubMed: 18300231]

599.

Meng W, Zhang G, Wu C, et al. Preliminary results of acoustic radiation force impulse (ARFI) ultrasound imaging of breast lesions. Ultrasound Med Biol. 2011 Sep;37(9):1436–43. [PubMed: 21767903]

600.

Meyer JE, Eberlein TJ, Stomper PC, et al. Biopsy of occult breast lesions. Analysis of 1261 abnormalities. JAMA. 1990 May 2;263(17):2341–3. [PubMed: 2157903]

601.

Meyer JE, Kopans DB. Analysis of mammographically obvious carcinomas of the breast with benign results upon initial biopsy. Surg Gynecol Obstet. 1981 Oct;153(4):570–2. [PubMed: 6269239]

602.

Meyer JE, Smith DN, Kaelin C, et al. Surgical breast biopsy after wire localization: The impact of large core needle biopsy. JOURNAL OF WOMENS IMAGING. 2004;6(3):125–31.

603.

Miller RS, Adelman RW, Espinosa MH, et al. The early detection of nonpalpable breast carcinoma with needle localization. Experience with 500 patients in a community hospital. Am Surg. 1992 Mar;58(3):193–8. [PubMed: 1313665]

604.

Mok PM, Keepin Y. Stereotactic breast biopsies for lesions discovered on routine mammography: experience at the North Shore Hospital. N Z Med J. 2000 Jul 14;113(1113):273–4. [PubMed: 10935565]

605.

Mokbel K, Ahmed M, Nash A, et al. Re-excision operations in nonpalpable breast cancer. J Surg Oncol. 1995 Apr;58(4):225–8. discussion 9-32. [PubMed: 7723365]

606.

Monostori Z, Herman PG, Carmody DP, et al. Limitations in distinguishing malignant from benign lesions of the breast by systematic review of mammograms. Surg Gynecol Obstet. 1991 Dec;173(6):438–42. [PubMed: 1948599]

607.

Montgomery GH, Weltz CR, Seltz M, et al. Brief presurgery hypnosis reduces distress and pain in excisional breast biopsy patients. Int J Clin Exp Hypn. 2002 Jan;50(1):17–32. [PubMed: 11778705]

608.

Montrey JS, Levy JA, Brenner RJ. Wire fragments after needle localization. AJR Am J Roentgenol. 1996 Nov;167(5):1267–9. [PubMed: 8911193]

609.

Moreno M, Wiltgen JE, Bodanese B, et al. Radioguided breast surgery for occult lesion localization - correlation between two methods. J Exp Clin Cancer Res. 2008;27:29. [PMC free article: PMC2531080] [PubMed: 18706096]

610.

Morris EA, Liberman L, Dershaw DD, et al. Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol. 2002 May;178(5):1211–20. [PubMed: 11959734]

611.

Morris KT, Pommier RF, Vetto JT. Office-based wire-guided open breast biopsy under local anesthesia is accurate and cost effective. Am J Surg. 2000 May;179(5):422–5. [PubMed: 10930494]

612.

Mueller X, Amery A, Lallemand RC. Biopsy of mammographically-detected breast lesions in a district hospital. Eur J Surg Oncol. 1993 Oct;19(5):415–9. [PubMed: 8405476]

613.

Mujtaba S, Haroon S, Faridi N, et al. Correlation of human epidermal growth factor receptor 2 (HER-2/neu) receptor status with hormone receptors Oestrogen Receptor, Progesterone Receptor status and other prognostic markers in breast cancer: an experience at tertiary care hospital in Karachi. J Pak Med Assoc. 2013 Jul;63(7):854–8. [PubMed: 23901708]

614.

Murgo S, Wyshoff H, Faverly D, et al. Computed tomography-guided localization of breast lesions. Breast J. 2008 Mar–Apr;14(2):169–75. [PubMed: 18248560]

615.

Muslumanoglu M, Dolay K, Ozmen V, et al. Comparison of fine needle aspiration cytology and excisional biopsy in palpable breast cancers. Radiol Med. 1995 Mar;89(3):225–8. [PubMed: 7754112]

616.

Nair A, Jaleel S, Sathya V, et al. The role of freehand needle core biopsy in the diagnosis of isolated axillary lymphadenopathy. Breast. 2009 Jun;18(3):175–7. [PubMed: 19362840]

617.

Nassar A, Radhakrishnan A, Cabrero IA, et al. Intratumoral heterogeneity of immunohistochemical marker expression in breast carcinoma: a tissue microarray-based study. Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):433–41. [PubMed: 20485156]

618.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: Advanced breast cancer Diagnosis and treatment. [cited 2013 June 25]. Available: http://www​.guideline.gov.

619.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: Staging. Management of early breast cancer. [cited 2013 June 25]. Available: http://www​.guideline.gov.

620.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: Use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. [cited 2013 June 25]. Available: http://www​.guideline.gov.

621.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: General principles of care In: Management of early breast cancer. [cited 2013 June 25]. Available: http://www​.guideline.gov.

622.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: Breast cancer screening clinical practice guideline. [cited 2013 June 25]. Available: http://www​.guideline.gov.

623.

Nggada HA, Yawe KD, Abdulazeez J, et al. Breast cancer burden in Maiduguri, North eastern Nigeria. Breast J. 2008 May–Jun;14(3):284–6. [PubMed: 18476884]

624.

Niemann TH, Lucas JG, Marsh WL Jr. To freeze or not to freeze. A comparison of methods for the handling of breast biopsies with no palpable abnormality. Am J Clin Pathol. 1996 Aug;106(2):225–8. [PubMed: 8712178]

625.

Nishikawa RM, Pesce LL. Estimating sensitivity and specificity for technology assessment based on observer studies. Acad Radiol. 2013 Jul;20(7):825–30. [PubMed: 23660073]

626.

Ocal K, Dag A, Turkmenoglu O, et al. Radioguided occult lesion localization versus wire-guided localization for non-palpable breast lesions: randomized controlled trial. Clinics (Sao Paulo). 2011;66(6):1003–7. [PMC free article: PMC3129952] [PubMed: 21808866]

627.

O’Hanlon DM, Colbert ST, Keane PW, et al. Preemptive bupivacaine offers no advantages to postoperative wound infiltration in analgesia for outpatient breast biopsy. Am J Surg. 2000 Jul;180(1):29–32. [PubMed: 11036135]

628.

Ohi Y, Umekita Y, Rai Y, et al. Mucocele-like lesions of the breast: a long-term follow-up study. Diagn Pathol. 2011;6:29. [PMC free article: PMC3082220] [PubMed: 21466711]

629.

Ohlsson-Wilhelm BM, Wang G. Circulating killer cells in women undergoing needle-directed excisional breast biopsy. Eur J Histochem. 1994;38(Suppl 1):77–82. [PubMed: 8547715]

630.

Ohtake E, Asaga T, Inaba M. Sentinel lymphoscintigraphy in patients with breast cancer undergoing excisional biopsy. Ann Nucl Med. 2005 Dec;19(8):671–5. [PubMed: 16444992]

631.

Omranipour R, Alipour S, Hadji M, et al. Accuracy of estrogen and progesterone receptor assessment in core needle biopsy specimens of breast cancer. Iran Red Crescent Med J. 2013 Jun;15(6):515–8. [PMC free article: PMC3840840] [PubMed: 24349751]

632.

Opie H, Estes NC, Jewell WR, et al. Breast biopsy for nonpalpable lesions: a worthwhile endeavor? Am Surg. 1993 Aug;59(8):490–3. discussion 3-4. [PubMed: 8393310]

633.

Orel SG, Kay N, Reynolds C, et al. BI-RADS categorization as a predictor of malignancy. Radiology. 1999 Jun;211(3):845–50. [PubMed: 10352614]

634.

Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology. 1995 Jul;196(1):115–22. [PubMed: 7784554]

635.

Osako T, Iwase T, Akiyama F. Reply: Isolated tumour cells and micrometastases in intraductal breast cancer: a simple mechanical question in some cases. Br J Cancer. 2013 May 14;108(9):1921. [PMC free article: PMC3658517] [PubMed: 23538389]

636.

Owings DV, Hann L, Schnitt SJ. How thoroughly should needle localization breast biopsies be sampled for microscopic examination? A prospective mammographic/pathologic correlative study. Am J Surg Pathol. 1990 Jun;14(6):578–83. [PubMed: 2337206]

637.

Ozumba BC, Nzegwu MA, Anyikam A, et al. Breast disease in children and adolescents in eastern Nigeria--a five-year study. J Pediatr Adolesc Gynecol. 2009 Jun;22(3):169–72. [PubMed: 19539203]

638.

Palmedo H, Schomburg A, Grunwald F, et al. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med. 1996 Apr;37(4):626–30. [PubMed: 8691253]

639.

Palmer ML, Tsangaris TN. Breast biopsy in women 30 years old or less. Am J Surg. 1993 Jun;165(6):708–12. [PubMed: 8506971]

640.

Palmieri FM, DePeri ER, Mincey BA, et al. Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban population. Mayo Clin Proc. 2009 Apr;84(4):317–22. [PMC free article: PMC2665975] [PubMed: 19339648]

641.

Parlakgumus A, Karakoc D, Ozenc A. Nine years’ experience of needle localized breast biopsy in a university hospital: results and evaluation of the role of the surgeon in decision making. Acta Chir Belg. 2008 Sep–Oct;108(5):548–51. [PubMed: 19051464]

642.

Patchefsky AS, Potok J, Hoch WS, et al. Increased detection of occult breast carcinoma after more thorough histologic examination of breast biopsies. Am J Clin Pathol. 1973 Dec;60(6):799–804. [PubMed: 4357121]

643.

Paterson ML, Nathanson SD, Havstad S. Hematomas following excisional breast biopsies for invasive breast carcinoma: the influence of deep suture approximation of breast parenchyma. Am Surg. 1994 Nov;60(11):845–8. [PubMed: 7978679]

644.

Pathmanathan P, Gavaghan DJ, Whiteley JP, et al. Predicting tumor location by modeling the deformation of the breast. IEEE Trans Biomed Eng. 2008 Oct;55(10):2471–80. [PubMed: 18838373]

645.

Patton ML, Haith LR Jr, Goldman WT. An improved technique for needle localized biopsy of occult lesions of the breast. Surg Gynecol Obstet. 1993 Jan;176(1):25–9. [PubMed: 8381241]

646.

Pegolo E, Puppin C, Gerometta A, et al. One-step nucleic acid amplification (OSNA) for intraoperative evaluation of sentinel lymph node status in breast cancer: a comparative study between CK19 protein expression and CK19 mRNA level in primary tumors and lymph node metastasis. Virchows Arch. 2013 Jul;463(1):7–15. [PubMed: 23779101]

647.

Perdue P, Page D, Nellestein M, et al. Early detection of breast carcinoma: a comparison of palpable and nonpalpable lesions. Surgery. 1992 Jun;111(6):656–9. [PubMed: 1595061]

648.

Perdue PW, Galbo C, Ghosh BC. Stratification of palpable and nonpalpable breast cancer by method of detection and age. Ann Surg Oncol. 1995 Nov;2(6):512–5. [PubMed: 8591081]

649.

Perfetto F, Fiorentino F, Urbano F, et al. Adjunctive diagnostic value of MRI in the breast radial scar. Radiol Med. 2009 Aug;114(5):757–70. [PubMed: 19484584]

650.

Petit JY, Veronesi U, Rey P, et al. Nipple-sparing mastectomy: risk of nipple-areolar recurrences in a series of 579 cases. Breast Cancer Res Treat. 2009 Mar;114(1):97–101. [PubMed: 18360773]

651.

Petrik DW, McCready DR, Goel V, et al. The rate of breast-conserving surgery for early breast cancer is not influenced by the surgical strategy of excisional biopsy followed by the definitive procedure. Breast J. 2001 May–Jun;7(3):158–65. [PubMed: 11469928]

652.

Platt R, Zucker JR, Zaleznik DF, et al. Perioperative antibiotic prophylaxis and wound infection following breast surgery. J Antimicrob Chemother. 1993 Feb;31(Suppl B):43–8. [PubMed: 8449845]

653.

Popiela TJ, Kibil W, Herman-Sucharska I, et al. The use of magnetic resonance mammography in women at increased risk for developing breast cancer. Wideochir Inne Tech Malo Inwazyjne. 2013 Mar;8(1):55–62. [PMC free article: PMC3627154] [PubMed: 23630555]

654.

Purnell CA, Arnold RM. Retrospective analysis of communication with patients undergoing radiological breast biopsy. J Support Oncol. 2010 Nov–Dec;8(6):259–63. [PubMed: 21265393]

655.

Qi CJ, Ning YL, Zhu YL, et al. In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay. Arch Pharm Res. 2009 Dec;32(12):1737–42. [PubMed: 20162402]

656.

Raghavan K, Shah AK, Cosgrove JM. Intraoperative breast problem--focused sonography a valuable tool in the training of surgical residents. J Surg Educ. 2008 Sep–Oct;65(5):350–3. [PubMed: 18809164]

657.

Raju U. Mammographic Localization Biopsy for Ductal Carcinoma In Situ: A Simple Mapping Technique for Sampling and Size Estimation. Breast J. 2000 Nov;6(6):379–87. [PubMed: 11348396]

658.

Ramsey-Stewart G, Lauer CS. Use of a specimen-evaluation device for the diagnosis of impalpable breast lesions detected by mammography. Med J Aust. 1992 Feb 17;156(4):244–6. [PubMed: 1310796]

659.

Rao R, Lilley L, Andrews V, et al. Axillary staging by percutaneous biopsy: sensitivity of fine-needle aspiration versus core needle biopsy. Ann Surg Oncol. 2009 May;16(5):1170–5. [PubMed: 19263171]

660.

Rappaport W, Thompson S, Wong R, et al. Complications associated with needle localization biopsy of the breast. Surg Gynecol Obstet. 1991 Apr;172(4):303–6. [PubMed: 2006456]

661.

Raptopoulos V, Baum JK, Hochman M, et al. High resolution CT mammography of surgical biopsy specimens. J Comput Assist Tomogr. 1996 Mar–Apr;20(2):179–84. [PubMed: 8606220]

662.

Reeves MJ, Osuch JR, Pathak DR. Development of a clinical decision rule for triage of women with palpable breast masses. J Clin Epidemiol. 2003 Jul;56(7):636–45. [PubMed: 12921932]

663.

Reid SE Jr, Scanlon EF, Bernstein JR, et al. An alternative approach to nonpalpable breast biopsies. J Surg Oncol. 1990 Jun;44(2):93–6. [PubMed: 2162454]

664.

Rey JE, Gardner SM, Cushing RD. Determinants of surgical site infection after breast biopsy. Am J Infect Control. 2005 Mar;33(2):126–9. [PubMed: 15761414]

665.

Reynolds HE, Jackson VP, Musick BS. Preoperative needle localization in the breast: utility of local anesthesia. Radiology. 1993 May;187(2):503–5. [PubMed: 8475298]

666.

Ricci MD, Calvano Filho, Oliveira CM, Filho HR, et al. Analysis of the concordance rates between core needle biopsy and surgical excision in patients with breast cancer. Rev Assoc Med Bras. 2012 Sep–Oct;58(5):532–6. [PubMed: 23090222]

667.

Rickard MT, Lee W, Read JW, et al. Breast cancer diagnosis by screening mammography: early results of the Central Sydney Area Health Service Breast X-ray Programme. Med J Aust. 1991 Jan 21;154(2):126–31. [PubMed: 1986190]

668.

Rikabi A, Hussain S. Diagnostic usefulness of tru-cut biopsy in the diagnosis of breast lesions. Oman Med J. 2013 Mar;28(2):125–7. [PMC free article: PMC3628200] [PubMed: 23599882]

669.

Rimm DL, Stastny JF, Rimm EB, et al. Comparison of the costs of fine-needle aspiration and open surgical biopsy as methods for obtaining a pathologic diagnosis. Cancer. 1997 Feb 25;81(1):51–6. [PubMed: 9100542]

670.

Roses DF, Mitnick J, Harris MN, et al. The risk of carcinoma in wire localization biopsies for mammographically detected clustered microcalcifications. Surgery. 1991 Nov;110(5):877–86. [PubMed: 1658957]

671.

Rosner D, Lane WW, Penetrante R. Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy. Cancer. 1991 Mar 15;67(6):1498–503. [PubMed: 1848153]

672.

Rubin P, O’Hanlon D, Browell D, et al. Tumour bed biopsy detects the presence of multifocal disease in patients undergoing breast conservation therapy for primary breast carcinoma. Eur J Surg Oncol. 1996 Feb;22(1):23–6. [PubMed: 8846861]

673.

Ruckhaberle E, Karn T, Denkert C, et al. Predictive value of sphingosine kinase 1 expression in neoadjuvant treatment of breast cancer. J Cancer Res Clin Oncol. 2013 Oct;139(10):1681–9. [PubMed: 23955546]

674.

Saarela AO, Kiviniemi HO, Rissanen TJ, et al. Cosmetic results after wire-guided biopsy of benign breast lesions. J Am Coll Surg. 1998 Dec;187(6):610–5. [PubMed: 9849734]

675.

Sadeghi R, Forghani MN, Memar B, et al. Comparison of pre-operative lymphoscintigraphy with inter-operative gamma probe and dye technique regarding the number of detected sentinel lymph nodes. Hell J Nucl Med. 2009 Jan–Apr;12(1):30–2. [PubMed: 19330179]

676.

Sailors DM, Crabtree JD, Land RL, et al. Needle localization for nonpalpable breast lesions. Am Surg. 1994 Mar;60(3):186–9. [PubMed: 8116978]

677.

Sakakibara E, Kimachi S, Hashimoto K, et al. An aspiration material preparation system: application of a new liquid-based cytology technique for fine-needle aspiration of the breast. Acta Cytol. 2011;55(1):92–9. [PubMed: 21135528]

678.

Sanders LM, Lacz NL, Lara J. 16 year experience with aspiration of noncomplex breast cysts: cytology results with focus on positive cases. Breast J. 2012 Sep;18(5):443–52. [PubMed: 22845618]

679.

Sangoi A, Vose J, Atmodjo D, et al. A randomized controlled trial of the PEAK PlasmaBlade in open breast biopsy compared to scalpel and traditional electrosurgery. 2010. p. S186.

680.

Ann Surg Oncol. 233 SPRING ST, NEW YORK, NY 10013 USA: SPRINGER; 2010. A randomized controlled trial of the PEAK PlasmaBlade in open breast biopsy compared to scalpel and traditional electrosurgery. p. 17.

681.

Sari AA, Mobinizadeh M, Azadbakht M. A systematic review of the effects of diffuse optical imaging in breast diseases. Iran J Cancer Prev. 2013;6(1):44–51. [PMC free article: PMC4142904] [PubMed: 25250109]

682.

Sauer G, Schneiderhan-Marra N, Kazmaier C, et al. Prediction of nodal involvement in breast cancer based on multiparametric protein analyses from preoperative core needle biopsies of the primary lesion. Clin Cancer Res. 2008 Jun 1;14(11):3345–53. [PubMed: 18519762]

683.

Saunders G, Lakra Y, Libcke J. Comparison of needle aspiration cytologic diagnosis with excisional biopsy tissue diagnosis of palpable tumors of the breast in a community hospital. Surg Gynecol Obstet. 1991 Jun;172(6):437–40. [PubMed: 1852078]

684.

Saura C, Tseng L-M, Chan S, et al. Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer and Evaluation of βIII-Tubulin Expression as a Predictive Marker. Oncologist. 2013;18(7) [PMC free article: PMC3720631] [PubMed: 23853246]

685.

Scaperrotta G, Ferranti C, Costa C, et al. Role of sonoelastography in non-palpable breast lesions. Eur Radiol. 2008 Nov;18(11):2381–9. [PubMed: 18523780]

686.

Scheiden R, Sand J, Tanous AM, et al. Accuracy of frozen section diagnoses of breast lesions after introduction of a national programme in mammographic screening. Histopathology. 2001 Jul;39(1):74–84. [PubMed: 11454047]

687.

Schnur JB, Montgomery GH, Hallquist MN, et al. Anticipatory psychological distress in women scheduled for diagnostic and curative breast cancer surgery. Int J Behav Med. 2008 Jan–Mar;15(1):21–8. [PubMed: 18444017]

688.

Schwab FD, Burger H, Isenschmid M, et al. Suspicious axillary lymph nodes in patients with unremarkable imaging of the breast. Eur J Obstet Gynecol Reprod Biol. 2010 May;150(1):88–91. [PubMed: 20189710]

689.

Seah DS, Scott SM, Najita J, et al. Attitudes of patients with metastatic breast cancer toward research biopsies. Ann Oncol. 2013 Jul;24(7):1853–9. [PubMed: 23493137]

690.

Seltzer MH. Preoperative prediction of open breast biopsy results. Cancer. 1997 May 1;79(9):1822–7. [PubMed: 9129002]

691.

Sewell RF, Brenchley PE. Coupling of mono- and polyamino ligands to solid phases by nucleophilic attack on coupling groups that may be spontaneously hydrolysed. J Chromatogr. 1990 Jan 26;525(1):246–8. [PubMed: 2338446]

692.

Shaheen E, Van Ongeval C, Zanca F, et al. The simulation of 3D microcalcification clusters in 2D digital mammography and breast tomosynthesis. Med Phys. 2011 Dec;38(12):6659–71. [PubMed: 22149848]

693.

Shaikh A, Fatima S, Shaikh SM. Diagnostic value of needle-localization biopsy in the management of non-palpable breast lesions. Rawal Medical Journal. 2013;38(1):59–60.

694.

Sharma H, Alekseychuk A, Leskovsky P, et al. Determining similarity in histological images using graph-theoretic description and matching methods for content-based image retrieval in medical diagnostics. Diagn Pathol. 2012;7:134. [PMC free article: PMC3554463] [PubMed: 23035717]

695.

Sheikh HE, Abdulaziz NY. Intraoperative ultrasound localization of nonpalpable breast cancers: A valuable aid during breast-conserving surgery. The Egyptian Journal of Radiology and Nuclear Medicine. 2013;44(2):411–5.

696.

Shigekawa T, Ijichi N, Ikeda K, et al. FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer. Horm Cancer. 2011 Oct;2(5):286–97. [PMC free article: PMC10358050] [PubMed: 21901488]

697.

Shimauchi A, Jansen SA, Abe H, et al. Breast cancers not detected at MRI: review of false-negative lesions. AJR Am J Roentgenol. 2010 Jun;194(6):1674–9. [PubMed: 20489112]

698.

Shin HJ, Kim HH, Ko MS, et al. BI-RADS descriptors for mammographically detected microcalcifications verified by histopathology after needle-localized open breast biopsy. AJR Am J Roentgenol. 2010 Dec;195(6):1466–71. [PubMed: 21098211]

699.

Shroff JH, Lloyd LR, Schroder DM. Open breast biopsy. A critical analysis. Am Surg. 1991 Aug;57(8):481–5. [PubMed: 1928989]

700.

Singhal H, Potter C, Osborne MP. No effect of timing of biopsy in the menstrual cycle on incidence of bone marrow micrometastasis in patients with breast cancer. Ann Surg Oncol. 1997 Sep;4(6):503–5. [PubMed: 9309341]

701.

Skliris GP, Rowan BG, Al-Dhaheri M, et al. Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas. Breast Cancer Res Treat. 2009 Dec;118(3):443–53. [PMC free article: PMC3448371] [PubMed: 19104930]

702.

Skotnicki P, Łuczyńska E, Herman K, et al. USG-guided excision biopsy in case of ambiguous breast USG images. Polish Journal of Radiology. 2007;72(3):29–31.

703.

Skripenova S, Layfield LJ. Initial margin status for invasive ductal carcinoma of the breast and subsequent identification of carcinoma in reexcision specimens. Arch Pathol Lab Med. 2010 Jan;134(1):109–14. [PubMed: 20073613]

704.

Smith M, Zhai X, Harter R, et al. A novel MR-guided interventional device for 3D circumferential access to breast tissue. Med Phys. 2008 Aug;35(8):3779–86. [PMC free article: PMC2673646] [PubMed: 18777937]

705.

Snell MJ, Ostrow LB, DuBois JJ, et al. Needle-localized biopsy of occult breast lesions: an update. Mil Med. 1992 Feb;157(2):61–4. [PubMed: 1318524]

706.

Soluri A, Scopinaro F, De Vincentis G, et al. 99MTC [13LEU] bombesin and a new gamma camera, the imaging probe, are able to guide mammotome breast biopsy. Anticancer Res. 2003 May–Jun;23(3A):2139–42. [PubMed: 12894588]

707.

Son BK, Bong JG, Park SH, et al. Ductal carcinoma in situ and sentinel lymph node biopsy. J Breast Cancer. 2011 Dec;14(4):301–7. [PMC free article: PMC3268927] [PubMed: 22323917]

708.

SONUÇ MLSB-R, İÇİN K, DEĞERLERİ PÖ. POSITIVE PREDICTIVE VALUES OF THE SONOGRAPHIC BI-RADS FINAL ASSESSMENT CATEGORIES FOR BREAST LESIONS.

709.

Stein MA, Karlan MS. Calcifications in breast biopsy specimens: discrepancies in radiologic-pathologic identification. Radiology. 1991 Apr;179(1):111–4. [PubMed: 2006260]

710.

Stein T, Cosimo E, Yu X, et al. Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis. Am J Pathol. 2010 Nov;177(5):2323–33. [PMC free article: PMC2966791] [PubMed: 20847288]

711.

Steinberg JL, Trudeau ME, Ryder DE, et al. Combined fine-needle aspiration, physical examination and mammography in the diagnosis of palpable breast masses: their relation to outcome for women with primary breast cancer. Can J Surg. 1996 Aug;39(4):302–11. [PMC free article: PMC3950138] [PubMed: 8697321]

712.

Steri V, Farnedi A, Montinari E, et al. Fast track biopsy method: a rapid approach to preoperative diagnoses. Pathologica. 2010 Apr;102(2):41–5. [PubMed: 23596755]

713.

Tafra L, Guenther JM, Giuliano AE. Planned segmentectomy. A necessity for breast carcinoma. Arch Surg. 1993 Sep;128(9):1014–8. discussion 8-20. [PubMed: 8396387]

714.

Takagi K, Ishida T, Miki Y, et al. Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment. Br J Cancer. 2013 Jul 9;109(1):100–8. [PMC free article: PMC3708565] [PubMed: 23756858]

715.

Takhellambam YS, Lourembam SS, Sapam OS, et al. Comparison of Ultrasonography and Fine Needle Aspiration Cytology in the Diagnosis of Malignant Breast Lesions. 2013. [PMC free article: PMC3919308] [PubMed: 24551655]

716.

Tanaka K, Komoike Y, Egawa C, et al. Indeterminate calcification and clustered cystic lesions are strongly predictive of the presence of mucocele-like tumor of the breast: a report of six cases. Breast Cancer. 2009;16(1):77–82. [PubMed: 18478314]

717.

Tang J, Wang X, Wu YP, et al. Significance of methylene blue dye for localization biopsy of nonpalpable breast lesions. Ai Zheng. 2009 Jan;28(1):79–81. [PubMed: 19448424]

718.

Tang J, Xie XM, Wang X, et al. Radiocolloid in combination with methylene dye localization, rather than wire localization, is a preferred procedure for excisional biopsy of nonpalpable breast lesions. Ann Surg Oncol. 2011 Jan;18(1):109–13. [PubMed: 20680696]

719.

Tartter PI, Kaplan J, Bleiweiss I, et al. Lumpectomy margins, reexcision, and local recurrence of breast cancer. Am J Surg. 2000 Feb;179(2):81–5. [PubMed: 10773138]

720.

Taxin A, Tartter PI, Zappetti D. Breast cancer diagnosis by fine needle aspiration and excisional biopsy. Recurrence and survival. Acta Cytol. 1997 Mar–Apr;41(2):302–6. [PubMed: 9100758]

721.

Taylor L, Basro S, Apffelstaedt JP, et al. Time for a re-evaluation of mammography in the young? Results of an audit of mammography in women younger than 40 in a resource restricted environment. Breast Cancer Res Treat. 2011 Aug;129(1):99–106. [PubMed: 21698411]

722.

Tez S, Dener C, Koktener A, et al. The value of fine needle aspiration and cytologic examination of impalpable complicated breast cysts. Bratisl Lek Listy. 2008;109(9):387–90. [PubMed: 19040143]

723.

Tezuka K, Onoda N, Takashima T, et al. Clinical significance of intra-tumoral sinusoidal structures showing lympho-endothelial immunoreactivity in breast cancer. Oncol Rep. 2008 Jul;20(1):25–32. [PubMed: 18575714]

724.

Thomas PA, Vazquez MF, Waisman J. Comparison of fine-needle aspiration and frozen section of palpable mammary lesions. Mod Pathol. 1990 Sep;3(5):570–4. [PubMed: 2235982]

725.

Thomassin-Naggara I, Trop I, Chopier J, et al. Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization. Radiology. 2011 Oct;261(1):69–9. [PubMed: 21771958]

726.

Thompson WR, Bowen JR, Dorman BA, et al. Mammographic localization and biopsy of nonpalpable breast lesions. A 5-year study. Arch Surg. 1991 Jun;126(6):730–3. discussion 3-4. [PubMed: 1645516]

727.

Thurley P, Evans A, Hamilton L, et al. Patient satisfaction and efficacy of vacuum-assisted excision biopsy of fibroadenomas. Clin Radiol. 2009 Apr;64(4):381–5. [PubMed: 19264182]

728.

Tisi P, Langham-Brown J, Jackson A, et al. Localization biopsy for impalpable breast lesions in a district general hospital. Eur J Surg Oncol. 1994 Apr;20(2):115–7. [PubMed: 8181574]

729.

Torres-Tabanera M, Alonso-Bartolome P, Vega-Bolivar A, et al. Percutaneous microductectomy with a directional vacuum-assisted system guided by ultrasonography for the treatment of breast discharge: experience in 63 cases. Acta Radiol. 2008 Apr;49(3):271–6. [PubMed: 18365813]

730.

Troxel DB. Medicolegal aspects of error in pathology. Arch Pathol Lab Med. 2006 May;130(5):617–9. [PubMed: 16683874]

731.

Tsai YM, Hsu HM, Chen CJ, et al. Association of estrogen receptor, progesterone receptor and HER2 following neoadjuvant systemic treatment in breast cancer patients undergoing surgery. Ir J Med Sci. 2014 Mar;183(1):71–5. [PubMed: 23757214]

732.

Ueno E, Aiyoshi Y, Imamura A, et al. Ultrasonically guided biopsy of nonpalpable lesions of the breast by the spot method. Surg Gynecol Obstet. 1990 Feb;170(2):153–5. [PubMed: 2405524]

733.

Uhercik M, Kybic J, Liebgott H, et al. Model fitting using RANSAC for surgical tool localization in 3-D ultrasound images. IEEE Trans Biomed Eng. 2010 Aug;57(8):1907–16. [PubMed: 20483680]

734.

van Breest Smallenburg V, Duijm LE, Voogd AC, et al. Lower sensitivity of screening mammography after previous benign breast surgery. Int J Cancer. 2012 Jan 1;130(1):122–8. [PubMed: 21328339]

735.

van Vlymen JM, Sa Rego MM, White PF. Benzodiazepine premedication: can it improve outcome in patients undergoing breast biopsy procedures? Anesthesiology. 1999 Mar;90(3):740–7. [PubMed: 10078675]

736.

Venter A, Rosca E, Mutiu G, et al. The value of ultrasounds exam correlated with frozen section diagnosis in the breast tumors. Rom J Morphol Embryol. 2010;51(4):745–50. [PubMed: 21103636]

737.

Verkooijen HM, Peeters PH, Pijnappel RM, et al. Diagnostic accuracy of needle-localized open breast biopsy for impalpable breast disease. Br J Surg. 2000 Mar;87(3):344–7. [PubMed: 10718805]

738.

Volynskaya Z, Haka AS, Bechtel KL, et al. Diagnosing breast cancer using diffuse reflectance spectroscopy and intrinsic fluorescence spectroscopy. J Biomed Opt. 2008 Mar–Apr;13(2):024012. [PubMed: 18465975]

739.

Wachter DL, Fasching PA, Haeberle L, et al. Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients. Arch Gynecol Obstet. 2013 Feb;287(2):337–44. [PubMed: 22955249]

740.

Wahner-Roedler DL, Hruska CB, O’Connor MK, et al. Molecular breast imaging for women presenting with a history of non-reproducible bloody nipple discharge and negative findings on routine imaging studies: A pilot study. J Surg Radiol. 2011;2(1):92–9.

741.

Wakefield SE, Powis SJ. Benign breast surgery: is there a need for outpatient follow-up? Ann R Coll Surg Engl. 1995 Nov;77(6):457–9. [PMC free article: PMC2502462] [PubMed: 8540668]

742.

Wang HY, Jiang YX, Zhu QL, et al. Differentiation of benign and malignant breast lesions: a comparison between automatically generated breast volume scans and handheld ultrasound examinations. Eur J Radiol. 2012 Nov;81(11):3190–200. [PubMed: 22386134]

743.

Wang J, Chang KJ, Chen CY, et al. Evaluation of the diagnostic performance of infrared imaging of the breast: a preliminary study. Biomed Eng Online. 2010;9:3. [PMC free article: PMC2818658] [PubMed: 20055999]

744.

Wang J, Xu B, Yuan P, et al. TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy. Breast Cancer Res Treat. 2012 Sep;135(2):531–7. [PubMed: 22864769]

745.

Wang T, Wang K, Yao Q, et al. Prospective study on combination of electrical impedance scanning and ultrasound in estimating risk of development of breast cancer in young women. Cancer Invest. 2010 Mar;28(3):295–303. [PubMed: 19857040]

746.

Wang X, Lederman D, Tan J, et al. Computerized detection of breast tissue asymmetry depicted on bilateral mammograms: a preliminary study of breast risk stratification. Acad Radiol. 2010 Oct;17(10):1234–41. [PMC free article: PMC2939253] [PubMed: 20619697]

747.

Wang ZL, Liu G, Li JL, et al. Sonographically guided percutaneous excision of clinically benign breast masses. J Clin Ultrasound. 2011 Jan;39(1):1–5. [PubMed: 20957735]

748.

Warren HW, Griffith CD, McLean L, et al. Should breast biopsy cavities be drained? Ann R Coll Surg Engl. 1994 Jan;76(1):39–41. [PMC free article: PMC2502159] [PubMed: 8117018]

749.

Weaver M. Breast cancer in nonpalpable lesions: can mammographic parenchymal pattern improve the predictive value of biopsy? Am Surg. 1992 Nov;58(11):692–4. [PubMed: 1485702]

750.

Weise LM, Bruder M, Eibach S, et al. Efficacy and safety of local versus general anesthesia in stereotactic biopsies: a matched-pairs cohort study. J Neurosurg Anesthesiol. 2013 Apr;25(2):148–53. [PubMed: 23103527]

751.

Weyant M, Carroccio A, Tartter PI, et al. Determinants of success with spot localization biopsy of the breast. J Am Coll Surg. 1995 Dec;181(6):521–4. [PubMed: 7582226]

752.

Wiksell H, Schassburger KU, Janicijevic M, et al. Prevention of tumour cell dissemination in diagnostic needle procedures. Br J Cancer. 2010 Nov 23;103(11):1706–9. [PMC free article: PMC2994228] [PubMed: 21045831]

753.

Wilkinson J, Appleton CM, Margenthaler JA. Utility of breast MRI for evaluation of residual disease following excisional biopsy. J Surg Res. 2011 Oct;170(2):233–9. [PubMed: 21550064]

754.

Wilson R, Kavia S. Comparison of large-core vacuum-assisted breast biopsy and excision systems. Recent Results Cancer Res. 2009;173:23–41. [PubMed: 19763447]

755.

Wiratkapun C, Bunyapaiboonsri W, Wibulpolprasert B, et al. Biopsy rate and positive predictive value for breast cancer in BI-RADS category 4 breast lesions. J Med Assoc Thai. 2010 Jul;93(7):830–7. [PubMed: 20649064]

756.

Woodward S, Daly CP, Patterson SK, et al. Ensuring excision of intraductal lesions: marker placement at time of ductography. Acad Radiol. 2010 Nov;17(11):1444–8. [PubMed: 20650666]

757.

Wulfkuhle JD, Berg D, Wolff C, et al. Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping. Clin Cancer Res. 2012 Dec 1;18(23):6426–35. [PMC free article: PMC5581198] [PubMed: 23045247]

758.

Xiong J, Yu D, Wei N, et al. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J. 2010 Apr;277(7):1684–94. [PubMed: 20180843]

759.

Yang JH, Lee WS, Kim SW, et al. Effect of core-needle biopsy vs fine-needle aspiration on pathologic measurement of tumor size in breast cancer. Arch Surg. 2005 Feb;140(2):125–8. [PubMed: 15723992]

760.

Yang WT, Whitman GJ, Johnson MM, et al. Needle localization for excisional biopsy of breast lesions: comparison of effect of use of full-field digital versus screen-film mammographic guidance on procedure time. Radiology. 2004 Apr;231(1):277–81. [PubMed: 15068954]

761.

Yararbas U, Argon AM, Yeniay L, et al. Problematic aspects of sentinel lymph node biopsy and its relation to previous excisional biopsy in breast cancer. Clin Nucl Med. 2009 Dec;34(12):854–8. [PubMed: 20139816]

762.

Yom CK, Han W, Kim SW, et al. Clinical significance of annexin A1 expression in breast cancer. J Breast Cancer. 2011 Dec;14(4):262–8. [PMC free article: PMC3268921] [PubMed: 22323911]

763.

Yom CK, Moon BI, Choe KJ, et al. Long-term results after excision of breast mass using a vacuum-assisted biopsy device. ANZ J Surg. 2009 Nov;79(11):794–8. [PubMed: 20078528]

764.

Yoshinaga Y, Enomoto Y, Fujimitsu R, et al. Image and pathological changes after radiofrequency ablation of invasive breast cancer: a pilot study of nonsurgical therapy of early breast cancer. World J Surg. 2013 Feb;37(2):356–63. [PubMed: 23052813]

765.

You SS, Jiang YX, Zhu QL, et al. US-guided diffused optical tomography: a promising functional imaging technique in breast lesions. Eur Radiol. 2010 Feb;20(2):309–17. [PubMed: 19707770]

766.

Youk JH, Son EJ, Kim JA, et al. Scoring system based on BI-RADS lexicon to predict probability of malignancy in suspicious microcalcifications. Ann Surg Oncol. 2012 May;19(5):1491–8. [PubMed: 22173328]

767.

Zhi W, Gu X, Qin J, et al. Solid breast lesions: clinical experience with US-guided diffuse optical tomography combined with conventional US. Radiology. 2012 Nov;265(2):371–8. [PubMed: 23012460]

768.

Zhu Q, You S, Jiang Y, et al. Detecting angiogenesis in breast tumors: comparison of color Doppler flow imaging with ultrasound-guided diffuse optical tomography. Ultrasound Med Biol. 2011 Jun;37(6):862–9. [PubMed: 21531497]

769.

Zografos GC, Zagouri F, Sergentanis TN, et al. Excisional breast biopsy under local anesthesia: stress-related neuroendocrine, metabolic and immune reactions during the procedure. In Vivo. 2009 Jul–Aug;23(4):649–52. [PubMed: 19567403]

770.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: ACR Appropriateness Criteria® palpable breast masses. [cited 2013 June 25]. Available: http://www​.guideline.gov.

771.

Albarracin CT, Nguyen CV, Whitman GJ, et al. Identifying patients with atypical ductal hyperplasia diagnosed at core-needle biopsy who are at low risk of malignancy. Radiology. 2010 Dec;257(3):893–4. author reply 984. [PubMed: 21084420]

772.

Amir E, Bedard PL, Ocana A, et al. Benefits and harms of detecting clinically occult breast cancer. J Natl Cancer Inst. 2012 Oct 17;104(20):1542–7. [PubMed: 22988040]

773.

Bond M, Pavey T, Welch K, et al. Psychological consequences of false-positive screening mammograms in the UK. Evid Based Med. 2013 Apr;18(2):54–61. [PubMed: 22859786]

774.

Bowman K, Munoz A, Mahvi DM, et al. Lobular neoplasia diagnosed at core biopsy does not mandate surgical excision. J Surg Res. 2007 Oct;142(2):275–80. [PubMed: 17662303]

775.

Brant W. Percutaneous core biopsy of the breast. West J Med. 1996 Jul–Aug;165(1–2):52–3. [PMC free article: PMC1307541] [PubMed: 8855685]

776.

Carkaci S, Santiago L, Adrada BE, et al. Screening for breast cancer with sonography. Semin Roentgenol. 2011 Oct;46(4):285–91. [PubMed: 22035671]

777.

Cohen Y, Gekhtman D, Strano S. Mammography-sonography concordance. AJR Am J Roentgenol. 2011 Sep;197(3):765. author reply 6. [PubMed: 21862823]

778.

Cooney CS, Khouri NF, Tsangaris TN. The role of breast MRI in the management of patients with breast disease. Adv Surg. 2008;42:299–312. [PubMed: 18953825]

779.

Cusumano P, Polkowski WP, Liu H, et al. Percutaneous tissue acquisition: a treatment for breast cancer? Vacuum-assisted biopsy devices are not indicated for extended tissue removal. Eur J Cancer Prev. 2008 Aug;17(4):323–30. [PubMed: 18562956]

780.

Damron TA. Vacuum-assisted biopsy is useful for breast tissue, but how useful is it for soft-tissue tumors in orthopaedics? Commentary on an article by Zarah Mohr, MD, et al.: “Vacuum-assisted minimally invasive biopsy of soft-tissue tumors” J Bone Joint Surg Am. 2012 Jan 18;94(2):e11. [PubMed: 22258008]

781.

Dershaw DD. Stereotaxic breast biopsy. Semin Ultrasound CT MR. 1996 Oct;17(5):444–59. [PubMed: 8896110]

782.

Eby PR, Lehman CD. Magnetic resonance imaging--guided breast interventions. Top Magn Reson Imaging. 2008 Jun;19(3):151–62. [PubMed: 18941395]

783.

Giordano L, Giorgi D, Ventura L, et al. Time trends of process and impact indicators in Italian breast screening programmes 1999–2009. Epidemiol Prev. 2011 Sep–Dec;35(5–6 Suppl 5):28–38. [PubMed: 22166348]

784.

Haid A, Knauer M, Dunzinger S, et al. Intra-operative sonography: a valuable aid during breast-conserving surgery for occult breast cancer. Ann Surg Oncol. 2007 Nov;14(11):3090–101. [PubMed: 17593330]

785.

Hashimoto BE. New sonographic breast technologies. Semin Roentgenol. 2011 Oct;46(4):292–301. [PubMed: 22035672]

786.

Kaiser WA, Pfleiderer SO, Baltzer PA. MRI-guided interventions of the breast. J Magn Reson Imaging. 2008 Feb;27(2):347–55. [PubMed: 18219688]

787.

Karamouzis MV, Likaki-Karatza E, Ravazoula P, et al. Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors. Int J Cancer. 2002 Nov 1;102(1):86–90. [PubMed: 12353238]

788.

Kettritz U. Modern concepts of ductal carcinoma in situ (DCIS) and its diagnosis through percutaneous biopsy. Eur Radiol. 2008 Feb;18(2):343–50. [PubMed: 17899107]

789.

King V, Dershaw DD. Combining MRI with mammography: a more effective approach to breast cancer detection. Expert Rev Anticancer Ther. 2011 Aug;11(8):1155–8. [PubMed: 21916568]

790.

Kluttig A, Trocchi P, Heinig A, et al. Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS). BMC Cancer. 2007;7:100. [PMC free article: PMC1913923] [PubMed: 17570833]

791.

Kontos M, Felekouras E, Fentiman IS. Radiofrequency ablation in the treatment of primary breast cancer: no surgical redundancies yet. Int J Clin Pract. 2008 May;62(5):816–20. [PubMed: 18412934]

792.

Kopans DB. Review of stereotaxic large-core needle biopsy and surgical biopsy results in nonpalpable breast lesions. Radiology. 1993 Dec;189(3):665–6. [PubMed: 8234687]

793.

Kopans DB. Caution on core. Radiology. 1994 Nov;193(2):325–6. discussion 6-8. [PubMed: 7972737]

794.

Krupinski EA, Borders M, Fitzpatrick K. Processing stereotactic breast biopsy specimens: impact of specimen radiography system on workflow. Breast J. 2013 Jul–Aug;19(4):455–6. [PubMed: 23701431]

795.

Marshall D, Laberge JM, Firetag B, et al. The changing face of percutaneous image-guided biopsy: molecular profiling and genomic analysis in current practice. J Vasc Interv Radiol. 2013 Aug;24(8):1094–103. [PubMed: 23806383]

796.

Masood S. Reproducibility of breast biopsy. Eur J Radiol. 2012 Sep;81(Suppl 1):S95–6. [PubMed: 23083620]

797.

Masood S, Vass L, Ibarra JA Jr, et al. Breast pathology guideline implementation in low- and middle-income countries. Cancer. 2008 Oct 15;113(8 Suppl):2297–304. [PubMed: 18837021]

798.

Mattheis J. Breast-cancer screening. N Engl J Med. 2012 Jan 12;366(2):190–1. author reply 1-2. [PubMed: 22236238]

799.

Molleran V. Postbiopsy management. Semin Roentgenol. 2011 Jan;46(1):40–50. [PubMed: 21134527]

800.

Monticciolo DL. Postbiopsy confirmation of MR-detected lesions biopsied using ultrasound. AJR Am J Roentgenol. 2012 Jun;198(6):W618–20. [PubMed: 22623580]

801.

Morris EA, Kuhl CK, Lehman CD. Ensuring high-quality breast MR imaging technique and interpretation. Radiology. 2013 Mar;266(3):996–7. [PubMed: 23431233]

802.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: Diagnosis of breast disease. [cited 2013 June 25]. Available: http://www​.guideline.gov.

803.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: Breast cancer In: Suspected cancer in primary care: guidelines for investigation, referral and reducing ethnic disparities. [cited 2013 June 25]. Available: http://www​.guideline.gov.

804.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: ACR Appropriateness Criteria® nonpalpable mammographic findings (excluding calcifications). [cited 2013 June 25]. Available: http://www​.guideline.gov.

805.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: Gynaecological cancer In: Suspected cancer in primary care: guidelines for investigation, referral and reducing ethnic disparities. [cited 2013 June 25]. Available: http://www​.guideline.gov.

806.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: ACR Appropriateness Criteria® breast microcalcifications - initial diagnostic workup. [cited 2013 June 25]. Available: http://www​.guideline.gov.

807.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: Early and locally advanced breast cancer Diagnosis and treatment. [cited 2013 June 25]. Available: http://www​.guideline.gov.

808.

Nields MW. Cost-effectiveness of image-guided core needle biopsy versus surgery in diagnosing breast cancer. Acad Radiol. 1996 Apr;3(Suppl 1):S138–40. [PubMed: 8796544]

809.

Orel S. Who should have breast magnetic resonance imaging evaluation? J Clin Oncol. 2008 Feb 10;26(5):703–11. [PubMed: 18258977]

810.

Park JM, Yang L, Laroia A, et al. Missed and/or misinterpreted lesions in breast ultrasound: reasons and solutions. Can Assoc Radiol J. 2011 Feb;62(1):41–9. [PubMed: 20947291]

811.

Sardanelli F, Giuseppetti GM, Canavese G, et al. Indications for breast magnetic resonance imaging. Consensus document “Attualita in senologia”, Florence 2007. Radiol Med. 2008 Dec;113(8):1085–95. [PubMed: 18953635]

812.

Schousboe JT, Kerlikowske K, Loh A, et al. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011 Jul 5;155(1):10–20. [PMC free article: PMC3759993] [PubMed: 21727289]

813.

Schulz-Wendtl R. The vacora biopsy system. Recent Results Cancer Res. 2009;173:97–103. [PubMed: 19763449]

814.

Sedgwick EL. Ultrasound-guided breast biopsy. Ultrasound Cln. 2011;6(3):327–33.

815.

Sung JS, Lee CH, Morris EA, et al. Patient follow-up after concordant histologically benign imaging-guided biopsy of MRI-detected lesions. AJR Am J Roentgenol. 2012 Jun;198(6):1464–9. [PubMed: 22623564]

816.

Trop I, Labelle M, David J, et al. Second-look targeted studies after breast magnetic resonance imaging: practical tips to improve lesion identification. Curr Probl Diagn Radiol. 2010 Sep–Oct;39(5):200–11. [PubMed: 20674767]

817.

Tsang YY, Yau KK, Tang CN. Vacuum-assisted excision for benign breast lesions. Surgical Practice. 2013;17(3):129.

818.

Tse GM, Tan PH, Cheung HS, et al. Intermediate to highly suspicious calcification in breast lesions: a radio-pathologic correlation. Breast Cancer Res Treat. 2008 Jul;110(1):1–7. [PubMed: 17674189]

819.

Tse GM, Tan PH, Lui PC, et al. Spindle cell lesions of the breast--the pathologic differential diagnosis. Breast Cancer Res Treat. 2008 May;109(2):199–207. [PubMed: 17636400]

820.

Uematsu T. Screening and diagnosis of breast cancer in augmented women. Breast Cancer. 2008;15(2):159–64. [PubMed: 18293060]

821.

Verkooijen HM. Needle core biopsy for screen detected breast lesions: time to raise the bar? Eur J Cancer. 2008 Nov;44(17):2540–1. [PubMed: 18930652]

822.

Vogel VG. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer. Menopause. 2008 Jul–Aug;15(4 Suppl):782–9. [PubMed: 18596599]

823.

Warner E. Breast Surveillance of Patients with BRCA1 and BRCA2 Mutations. Current Breast Cancer Reports. 2013;5(3):255–61.

824.

Perez S, Néron S, Séguin C, Holcroft C, Lisbona A, Rosberger Z. The effect of a hypnotic intervention on anxiety and psychological distress in the breast biopsy suite: A pilot study. [conference abstract]

825.

Zagouri F, Sergentanis TN, Zografos GC. Vacuum-assisted breast biopsy: A role also on palpable lesions? Med Hypotheses. 2008;70(1):198–9. [PubMed: 17582694]

826.

[Update on current care guidelines: breast cancer diagnostics and screening]. Duodecim. 2010;126(10):1183–5. [PubMed: 20597348]

827.

Aksoy F, Gundes E, Vatansev C, et al. Surgical treatment of phyllodes tumors of the breast: A single center experience: Memenin fillodes tumorlerinde cerrahi tedavi: Tek merkez deneyimi. J Breast Health. 2013;9(2):52–6.

828.

Ding J.-H, Peng W.-J, Jiang Z.-X, Liu G.-Y, Ji Y.-J, Zheng X.-J, Hu D.-T, Wu J, Chang C, Zeng W. The first round imaging screening of breast cancer in Shanghai community: Primary results in 8234 patients. Chin J Radiol. 2013

829.

Apesteguia L, Ovelar A, Dominguez-Cunchillos F, et al. [Radiofrequency ablation of breast carcinomas: preliminary results of a clinical trial]. Radiologia. 2009 Nov–Dec;51(6):591–600. [PubMed: 19913265]

830.

Aulmann S. [Ductal and lobular preneoplasia: role in breast cancer development]. Pathologe. 2011 Nov;32(Suppl 2):316–20. [PubMed: 21915665]

831.

Bak M, Konyar E, Schneider F, et al. The “gray zone” in fine-needle aspiration cytology of the organized mammography screening. Cytohistological correlation: A “szurke zona” az emlorak mammografias szervezett szureseben. Citologiai-hisztologiai tanulmany. Orvosi Hetil. 2011;152(8):292–5. [PubMed: 21310698]

832.

Barreto AS, Mendes MF, Thuler LC. [Evaluation of a strategy adopted to expand adherence to breast cancer screening in Brazilian Northeast]. Rev Bras Ginecol Obstet. 2012 Feb;34(2):86–91. [PubMed: 22437768]

833.

Bellolio JE, Guzman GP, Orellana CJ, et al. [Diagnostic value of frozen section biopsy during surgery for breast lesions or neoplasms]. Rev Med Chil. 2009 Sep;137(9):1173–8. [PubMed: 20011957]

834.

Bettencourt H, Amendoeira I. Are core-needle biopsies representative of breast carcinomas?: Serao as microbiopsias representativas nos carcinomas da mama? Arq Med. 2012;26(4):145–8.

835.

Bilkova A, Janik V, Bendova M, et al. Computed tomography laser mamography (CTLM) - New imaging method in mammadiagnostics: Computed tomography laser mammography (CTLM) - Nova vysetrovaci metoda v mamarni diagnostice. Ceska Radiol. 2009;63(1):69–75.

836.

Bokun ZV, Bokun R, Tatomirovic Z. [Determination of infiltrative ductal breast carcinoma differentiation grade in biopsy imprints]. Vojnosanit Pregl. 2009 Jul;66(7):527–33. [PubMed: 19678576]

837.

Bouchlaka A, Ben Abdallah M, Ben Aissa R, et al. [Results and evaluation of 3 years of a large scale mammography program in the Ariana area of Tunisia]. Tunis Med. 2009 Jul;87(7):438–42. [PubMed: 20063676]

838.

Bouhafa T, Masbah O, Bekkouch I, et al. [Phyllodes tumors of the breast: analysis of 53 patients]. Cancer Radiother. 2009 Apr;13(2):85–91. [PubMed: 19119040]

839.

Brouwer OR, Donker M, Woerdeman LA, et al. [Local recurrence after skin-sparing mastectomy]. Ned Tijdschr Geneeskd. 2012;156(31):A4692. [PubMed: 22853767]

840.

Chaveron C, Bachelle F, Fauquet I, et al. [Clip migration after stereotactic macrobiopsy and presurgical localization: technical considerations and tricks]. J Radiol. 2009 Jan;90(1 Pt 1):31–6. [PubMed: 19182711]

841.

Contreras-Melendez L, Piottante-Becker A, Contreras-Seitz M, et al. The Chilean experience of variability in the assessment of HER2 status using immunohistochemistry: Variabilidad en la determinacion del estado de HER2 por inmunohistoquimica en Chile. Revista Esp Patol. 2013;46(1):33–9.

842.

Daubner D, Friedrich K, Spieth S. [Lactating adenoma of the breast - differential diagnosis in pregnancy and during breast feeding]. Rofo. 2012 Oct;184(10):934–5. [PubMed: 22744327]

843.

de Lara CT, Fournier M, Macgrogan G. Ganglions sentinelles et carcinome canalaire in situ. Oncologie. 2013;15(6):331–5.

844.

de Souza E, de Souza LF, Batista Mda C, et al. [Breast biopsy performed by the helicoid biopsy technique: an experimental study]. Rev Bras Ginecol Obstet. 2010 Dec;32(12):597–601. [PubMed: 21484028]

845.

Ding Jianhui eaSCwwbcsrotfrotiaR-. Shanghai Community 8234 women with breast cancer screening results of the first round of the image analysis.

846.

Dumay-Levesque T, Lemery S, Dauplat MM, et al. [Evaluation of stereotactic core biopsies of the breast with the 10-gauge Vacora(R) biopsy device: a review of 541 procedures]. J Radiol. 2011 Mar;92(3):226–35. [PubMed: 21501761]

847.

Engvad B, Laenkholm AV, Schwartz W, et al. [Fine needle aspiration cytology of mammography screening]. Ugeskr Laeger. 2009 Aug 17;171(34):2379–82. [PubMed: 19732519]

848.

Fischer T, Grigoryev M, Bossenz S, et al. [Sonographic detection of microcalcifications - potential of new method]. Ultraschall Med. 2012 Aug;33(4):357–65. [PubMed: 22322544]

849.

Fischer U, Schwethelm L, Baum FT, et al. [Effort, accuracy and histology of MR-guided vacuum biopsy of suspicious breast lesions--retrospective evaluation after 389 interventions]. Rofo. 2009 Aug;181(8):774–81. [PubMed: 19582655]

850.

Fouche CJ, Tabareau F, Michenet P, et al. [Specimen radiography assessment of surgical margins status in subclinical breast carcinoma: a diagnostic study]. J Gynecol Obstet Biol Reprod (Paris). 2011 Jun;40(4):314–22. [PubMed: 21349659]

851.

Frankel PP, Esteves VF, Thuler LC, et al. [Diagnostic accuracy of the fine needle aspiration cytology and core needle biopsy as a diagnostic method for breast lesions]. Rev Bras Ginecol Obstet. 2011 Mar;33(3):139–43. [PubMed: 21829998]

852.

Frikha M, Yaiche O, Elloumi F, et al. [Results of a pilot study for breast cancer screening by mammography in Sfax region, Tunisia]. J Gynecol Obstet Biol Reprod (Paris). 2013 May;42(3):252–61. [PubMed: 23478043]

853.

Tunon de Lara C, Fournier M, Macgrogan G. Sentinel lymph nodes and ductal carcinoma in situ: Ganglions sentinelles et carcinome canalaire in situ. Oncologie.

854.

Gomi N, Iwase T, Akiyama F. [VAB (vacuum-assisted breast biopsy system)]. Nihon Rinsho. 2012 Sep;70(Suppl 7):302–5. [PubMed: 23350410]

855.

Gong J, Yao Y, Tang J, et al. Impact of preoperative chemotherapy on expression of hormone receptor and drug-resistant related proteins in breast cancer tissue. Chin. J. Clin Oncol. 2012;39(23):1896–8.

856.

Hahn M, Fischbach E, Fehm T, et al. [Are breast biopsies adequately funded? A process cost & revenue analysis]. Rofo. 2011 Apr;183(4):347–57. [PubMed: 21113867]

857.

He YJ, Li JF, Wang TF, et al. [Diagnostic value and health economic evaluation of ultrasound-combined fine-needle aspiration cytology in primary breast cancer]. Zhonghua Yi Xue Za Zhi. 2012 Dec 11;92(46):3288–90. [PubMed: 23328516]

858.

Heineke A, Bendel M, Tronnier M, et al. [Grouped papules on the left chest wall]. J Dtsch Dermatol Ges. 2010 Sep;8(9):715–7. [PubMed: 20821831]

859.

Horak M, Barta J, Andryskova H, et al. Breast biopsy guided by magnetic resonance - First experiences: Biopsie prsu se zamerenim cile na magneticke rezonanci - Prvni zkusenosti. Ceska Radiol. 2009;63(1):56–60.

860.

Jiang H, Fu J, Zhang F, et al. Value of steel wire implantation with prone table stereotactic digital mammography in the detection of microcalcification of the breast. Chin. J. Clin Oncol. 2010;37(1):1–4.

861.

Jing Z, Yu-xin J, Qing-li Z, et al. Impact of lesion size on the detection rate of non-palpable breast malignant lesions. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011 Apr;33(2):136–41. [PubMed: 21529439]

862.

Kanayev SV, Novikov SN, Semiglazov VF, et al. The role of scintimammography and ultrasound in diagnosis of early (less than 10 mm) breast cancer. Vopr Onkol. 2011;57(5):622–6. [PubMed: 22238933]

863.

Khlifi A, Ziadi S, Trimeche M, et al. Clinicopathological study of breast lobular carcinoma in Central Tunisia: A report of 74 cases: Etude clinicopathologique des carcinomes lobulaires du sein dans le Centre tunisien: a propos de 74 cas. J. Afr Cancer. 2011;3(3):155–62.

864.

Kosa C, Garami Z, Dinya T, et al. [Predictive factors of invasion with initial diagnosis of ductal carcinoma in situ based on core biopsy]. Magy Seb. 2012 Aug;65(4):218–21. [PubMed: 22940391]

865.

Kuipers IM, Oostenbroek RJ, Storm RK, et al. [Suppose a mammary carcinoma is absent from the surgical specimen]. Ned Tijdschr Geneeskd. 2009;153:A3. [PubMed: 19900338]

866.

ZaL-YaZaR-ZaZaC-WaLaJaaWa L. Quantitative dynamic contrast enhanced MR in the prediction of response in breast cancer patients undergoing neoadjuvant chemotherapy. Chin J Radiol.

867.

Langhans L, Vejborg TS, Vejborg I, et al. [Marking of non-palpable changes in breast tissue]. Ugeskr Laeger. 2012 Aug 20;174(34):1891–4. [PubMed: 22909568]

868.

Li TY, Yu ZY, Wang LX, et al. Value of ultrasound-guided Mammotome rotation system in diagnosis and treatment of breast lesions. Chin. J. Cancer Prev Treat. 2010;17(24):2060–1.

869.

Li Y, Tong XS, Mu WM, et al. [Evaluation of the value of ultrasound-guided core needle biopsy in the diagnosis of breast lesions]. Zhonghua Zhong Liu Za Zhi. 2010 Jun;32(6):470–1. [PubMed: 20819494]

870.

Liu M, Chen W, Li XR, et al. [Study on diagnostic accuracy of ultrasound-guided core needle breast biopsy]. Zhonghua Bing Li Xue Za Zhi. 2010 Nov;39(11):739–42. [PubMed: 21215163]

871.

Lobato Miguélez J, Moreno Domingo J, Martinez Urruzola J, et al. Riesgo de invasión en carcinoma in situ de mama diagnosticado por biopsia percutánea: estudio retrospectivo. Clínica e Investigación en Ginecología y Obstetricia. 2013

872.

Ma WY, Zhang P, Zhang BL, et al. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer]. Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):770–4. [PubMed: 23291072]

873.

Manych M. MR-detected lesions of the breast - When should a specific sonography follow?: MR-Lsionen der Brust - Wann Sollte Eine Gezielte Sonografie Folgen? RoFo Fortschr. Geb. Rontgenstr Bildgebenden Verfahren. 2010;182(4):305.

874.

MAO F, PAN B, SUN Q, et al. Diagnosis and treatment of neuroendocrine breast cancer: A retrospective analysis of ten cases and review of the literature. TUMOR. 2013;33(2):171–6.

875.

Martins EC, Soares A, Guimaraes CM, et al. [Ultrasound guided core biopsy for breast lesions using 16G needle]. Rev Col Bras Cir. 2009 Aug;36(4):312–5. [PubMed: 20076920]

876.

Mercier-Vogel L, Couson F, Kohlik M, et al. [Impact of breast MRI and PET-CT in breast cancer staging]. Rev Med Suisse. 2010 May 26;6(250):1076–8. 80. [PubMed: 20564867]

877.

Mohajeri G, Khezreh H, Kushki AM, et al. Evaluation of fine needle aspiration versus core needle biopsy for breast cancer detection. J Isfahan Med Sch. 2012;30(174)

878.

Monter SEP, Gómez ACA, Chávez VG, et al. Abordaje quirúrgico de nódulos mamarios durante el embarazo• Ginecol Obstet Mex. 2009;77(4):191–8. [PubMed: 19496511]

879.

Neira P, Aguirre B, Taub T, et al. [Breast MRI--histologic correlation for ductal carcinoma in situ]. Radiologia. 2009 Jul–Aug;51(4):396–402. [PubMed: 19406443]

880.

Nicolas F, Voltzenlogel MC, Lavoue V, et al. [Pleomorphic lobular intraepithelial neoplasia: clinical, histological and prognostic study of nine cases]. J Gynecol Obstet Biol Reprod (Paris). 2013 Apr;42(2):130–6. [PubMed: 23265671]

881.

Obermann EC, Eppenberger-Castori S, Tapia C. [Assessment of proliferation: core biopsy or resection specimen? Discrepancies in breast cancer with low and high proliferation]. Pathologe. 2012 May;33(3):245–50. [PubMed: 22576598]

882.

Ouldamer L, Body G, Arbion F, et al. [Mucocele-like lesions of the breast: management after diagnosis on ultrasound guided core biopsy or stereotactic vacuum-assisted biopsy]. Gynecol Obstet Fertil. 2010 Jul–Aug;38(7–8):455–9. [PubMed: 20605510]

883.

Peres A, Becette V, Guinebretiere JM, et al. [The lesions of flat epithelial atypia diagnosed on breast biopsy]. Gynecol Obstet Fertil. 2011 Oct;39(10):579–85. [PubMed: 21924938]

884.

Perez Monter SE, Arteaga Gomez AC, Gorbea Chavez V, et al. [Surgical approach of breast nodules during pregnancy]. Ginecol Obstet Mex. 2009 Apr;77(4):189–96. [PubMed: 19496511]

885.

Perlet C, Schneider P, Amaya B, et al. MR-Guided vacuum biopsy of 206 contrast-enhancing breast lesions. Rofo. 2002 Jan;174(1):88–95. [PubMed: 11793291]

886.

Plaza Loma S, Rodriguez de Diego Y, Gonzalez Blanco I, et al. Stereotactic vacuum-assisted breast biopsy. Correlation with surgical excisional biopsy: Biopsia mamaria asistida por vacio y guiada por estereotaxia. Correlacion con la biopsia quirurgica. Prog. Obstet Ginecol. 2012;55(2):66–70.

887.

Prutki M, Stern-Padovan R, Jakic-Razumovic J, et al. [Ultrasound guided breast biopsy--a retrospective study and literature review]. Lijec Vjesn. 2012 Sep–Oct;134(9–10):270–5. [PubMed: 23297511]

888.

Qin NS, Wang XY, Wu CX, et al. Correlation of tumor vessel morphologic features with clinical and pathological characteristics of breast cancer on dynamic contrast enhanced MRI. Chin. J. Med Imaging Technol. 2009;25(2):244–7.

889.

Ren AH, Zhang XP, Li J, et al. Dynamic contrast-enhanced breast MRI for patients with BI-RADS 3-5 microcalcifications detected by digital mammography. Chin. J. Med Imaging Technol. 2009;25(1):89–92.

890.

Ricart Selma V, Camps Herrero J, Martinez Rubio C, et al. [Diabetic mastopathy: clinical presentation, imaging and histologic findings, and treatment]. Radiologia. 2011 Jul–Aug;53(4):349–54. [PubMed: 21530989]

891.

Ruvalcaba Limon E, Espejo Fonseca R, Bautista Pina V, et al. [Radiological control intraoperatory of a surgical piece in non palpable breast lesions]. Ginecol Obstet Mex. 2009 Sep;77(9):407–18. [PubMed: 19899430]

892.

Salem A, Debabria H, Mehiri S, et al. [Retrospective results of ultrasonographically-guided biopsy the breast cancer screening program of the Ariana area of Tunisia]. Tunis Med. 2009 Jul;87(7):463–70. [PubMed: 20063681]

893.

Schulz-Wendtland R, Adamietz B, Meier-Meitinger M, et al. Ultrasound-guided core cut biopsy: 15 years’ follow-up: Sonografisch gezielte Stanzbiopsie: 15 Jahre Follow-up. Geburtshilfe Frauenheilkd. 2010;70(6):478–82.

894.

Semiglazov VV, Semiglazov VF, Ermchenkova AM. [Minimal breast carcinomas]. Vopr Onkol. 2011;57(6):702–6. [PubMed: 22416384]

895.

Shi SH, Deng YC, Li XJ. Ultrasound-guided mammotome biopsy in diagnosis and management of single intraductal breast papilloma. J. Pract Oncol. 2012;27(4):390–2.

896.

Siegmann KC, Moron HU, Baur A, et al. [Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI]. Rofo. 2009 Jun;181(6):556–63. [PubMed: 19452398]

897.

Stoblen F, Landt S, Koninger A, et al. [Detection of microcalcifications by high-resolution B-mode sonography in patients with BI-RADS 4a lesions]. Gynakol Geburtshilfliche Rundsch. 2009;49(4):292–8. [PubMed: 20530944]

898.

Su KL, Xu HB, Hu ZJ, et al. [Vacuum-assisted biopsy and wire localization for the diagnosis of non-palpable breast lesions]. Zhonghua Zhong Liu Za Zhi. 2010 Jun;32(6):472–5. [PubMed: 20819495]

899.

Traore B, Eric Douanla D, Diallo Y, et al. Problems in the management of breast cancers diagnosed post-surgery in the unit of surgical oncology, teaching hospital Donka, Conakry (Guinea): Problematique de la prise en charge des cancers du sein de << diagnostic postoperatoire >> a l’unite de chirurgie oncologique, CHU de Donka, Conakry (Guinee). J. Afr. Cancer. 2010;2(3):140–5.

900.

Uehara M. [Breast surgery and biopsy in anticoagulated patients]. Nihon Rinsho. 2012 Sep;70(Suppl 7):706–9. [PubMed: 23350490]

901.

Uhara M, Matsuda K, Shimojyo Y, et al. [Comparison of two HER-2 FISH kits on formalin-fixed paraffin-embedded tissues: signal detection and simple procedure]. Rinsho Byori. 2010 Jan;58(1):25–9. [PubMed: 20169940]

902.

Utzschneider S, Weber P, Fottner A, et al. [Prognosis-adapted surgical management of bone metastases]. Orthopade. 2009 Apr;38(4):308, 10–12, 14–5. [PubMed: 19296081]

903.

Wang Q, Zhu CX, Zhang AQ, et al. Clinical and pathological analysis of breast cancer with false-negative mammogram. Chin. J. Cancer Prev Treat. 2009;16(2):138–40.

904.

LaJ-CaFaX-LaZaW-MaaZa X-J. Analysis of 278 breast biopsy cases guided by mammography. Cancer Res Clin.

905.

Xu J, Wang Q, Xia J, et al. Primary efficacy of physical examination combined with ultragraphy and complemented with mammography for breast cancer screening in 280 thousand Chinese women. European Journal of Cancer. 2013;49:S322–S3.

906.

Juan Xu, et al. Complement the X-ray and ultrasonic examination mammography for breast cancer screening mode preliminary application evaluation. Chinese Journal of Cancer. 2013

907.

Yan L, Qiang S, Wei-Xuan Z. Role of fine needle aspiration cytology in surgical treatment of breast cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011 Feb;33(1):80–2. [PubMed: 21375944]

908.

Ye JM, Xu L, Wang DM, et al. [Prospective study on the role of MRI and B ultrasonography in evaluating the tumor response to neoadjuvant chemotherapy in breast cancer]. Zhonghua Wai Ke Za Zhi. 2009 Mar 1;47(5):349–52. [PubMed: 19595011]

909.

Yin CF, Zhao HJ, Gao WR. Diagnostic value of three-dimensional stereotactic localization for nonpalpable breast lesions. Chin. J. Med Imaging Technol. 2010;26(8):1492–4.

910.

Yin HF, Wang YH, Qin XQ, et al. [Effect of neoadjuvant chemotherapy on histologic grade and expression of biological markers in breast cancer]. Zhonghua Zhong Liu Za Zhi. 2009 Nov;31(11):858–62. [PubMed: 20137353]

911.

Zhang Y, Tang Y, Bai L, et al. Clinical significance of ultrasound and needle biopsy in diagnosis of breast cancer with liver metastasis. Chin. J. Cancer Prev Treat. 2010;17(2):142–4.

912.

Zhao HJ, Yin CF, Zhao AL. Comparison of two-dimensional and three-dimensional X-ray guided wire localization breast biopsy. Chin. J. Intervent Imaging Ther. 2011;8(4):307–9.

913.

Zhao JH, Ding J, Xu SB, et al. Comparison of diagnosis value between 18F-FDG PET/CT and MRI in breast cancer. J. Jilin Univ. Med Ed. 2011;37(4):746–9.

914.

Zhou YJ, Ying M, He YJ, et al. [Analysis of associations between molecular subtypes and responses to neoadjuvant chemotherapy in primary breast cancer patients]. Zhonghua Yi Xue Za Zhi. 2013 Jun 11;93(22):1711–5. [PubMed: 24124677]

915.

Abbas H, Imran S, Waris NA, et al. Importance of physical examination in early detection of lump in breast in women of different age groups. J Ayub Med Coll Abbottabad. 2010 Apr–Jun;22(2):79–82. [PubMed: 21702273]

916.

Abdel-Hadi M, Abdel-Hamid GF, Abdel-Razek N, et al. Should fine-needle aspiration cytology be the first choice diagnostic modality for assessment of all nonpalpable breast lesions? The experience of a breast cancer screening center in Alexandria, Egypt. Diagn Cytopathol. 2010 Dec;38(12):880–9. [PubMed: 20049973]

917.

Adamietz BR, Kahmann L, Fasching PA, et al. Differentiation between phyllodes tumor and fibroadenoma using real-time elastography. Ultraschall Med. 2011 Dec;32(Suppl 2):E75–9. [PubMed: 22194044]

918.

Adibelli ZH, Ergenc R, Oztekin O, et al. Observer Variability of the Breast Imaging Reporting and Data System (BI-RADS) Lexicon for Mammography. Breast Care (Basel). 2010 Mar;5(1):11–6. [PMC free article: PMC3357160] [PubMed: 22619635]

919.

Adler DD, Riba MB, Eggly S. Breaking bad news in the breast imaging setting. Acad Radiol. 2009 Feb;16(2):130–5. [PubMed: 19124097]

920.

Aellig A, Maillard M, Phavorin A, et al. The energy metabolism of the leukocyte. VIII. The determination of the concentration of the coenzymes NAD, NADH, NADP and NADPH in polymorphonuclear leukocytes at rest and after incubation by enzymatic cycling. Enzyme. 1977;22(3):196–206. [PubMed: 16746]

921.

Al-Attar MA, Michell MJ, Ralleigh G, et al. The impact of image guided needle biopsy on the outcome of mammographically detected indeterminate microcalcification. Breast. 2006 Oct;15(5):635–9. [PubMed: 16488148]

922.

Albert US, Duda V, Hadji P, et al. Imprint cytology of core needle biopsy specimens of breast lesions. A rapid approach to detecting malignancies, with comparison of cytologic and histopathologic analyses of 173 cases. Acta Cytol. 2000 Jan–Feb;44(1):57–62. [PubMed: 10667161]

923.

Al-Hallaq HA, Mell LK, Bradley JA, et al. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer. 2008 Nov 1;113(9):2408–14. [PubMed: 18823018]

924.

Al-Harethee WA, Kalles V, Papapanagiotou I, et al. Thermal damage of the specimen during breast biopsy with the use of the Breast Lesion Excision System: does it affect diagnosis? Breast Cancer. 2013 Mar 16 [PubMed: 23504263]

925.

Alimoglu E, Bayraktar SD, Bozkurt S, et al. Follow-up versus tissue diagnosis in BI-RADS category 3 solid breast lesions at US: a cost-consequence analysis. Diagn Interv Radiol. 2012 Jan–Feb;18(1):3–10. [PubMed: 21997885]

926.

Al-Rikabi A, Husain S. Increasing prevalence of breast cancer among Saudi patients attending a tertiary referral hospital: a retrospective epidemiologic study. Croat Med J. 2012 Jun;53(3):239–43. [PMC free article: PMC3370407] [PubMed: 22661137]

927.

Al-Sobhi SS, Helvie MA, Pass HA, et al. Extent of lumpectomy for breast cancer after diagnosis by stereotactic core versus wire localization biopsy. Ann Surg Oncol. 1999;6(4):330–5. [PubMed: 10379852]

928.

Anania G, Bazzocchi M, di Loreto C, et al. Percutaneous large core needle biopsy versus surgical biopsy in the diagnosis of breast lesions. Int Surg. 1997 Jan–Mar;82(1):52–5. [PubMed: 9189803]

929.

Andersen SB, Vejborg I, von Euler-Chelpin M. Participation behaviour following a false positive test in the Copenhagen mammography screening programme. Acta Oncol. 2008;47(4):550–5. [PubMed: 18465321]

930.

Andreu FJ, Sentis M, Castaner E, et al. The impact of stereotactic large-core needle biopsy in the treatment of patients with nonpalpable breast lesions: a study of diagnostic accuracy in 510 consecutive cases. Eur Radiol. 1998;8(8):1468–74. [PubMed: 9853239]

931.

Arentz C, Baxter K, Boneti C, et al. Ten-year experience with hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann Surg Oncol. 2010 Oct;17(Suppl 3):378–83. [PubMed: 20853061]

932.

Ariyarathenam AV, Currie R, Cooper MJ, et al. Impact of age extension to include 47–49 year old women on the workload of the surgical department of a single Breast Cancer Screening Unit--The first non-randomized experience in UK. Int J Surg. 2013;11(7):535–7. [PubMed: 23684821]

933.

Arleo EK, Dashevsky BZ, Reichman M, et al. Screening mammography for women in their 40s: a retrospective study of the potential impact of the U.S. Preventive Service Task Force’s 2009 breast cancer screening recommendations. AJR Am J Roentgenol. 2013 Dec;201(6):1401–6. [PubMed: 24261383]

934.

Arora N, Martins D, Ruggerio D, et al. Effectiveness of a noninvasive digital infrared thermal imaging system in the detection of breast cancer. Am J Surg. 2008 Oct;196(4):523–6. [PubMed: 18809055]

935.

Arrangoiz R, Garand S, Slomski C, et al. What is the diagnostic accuracy of hypocellular fine needle aspiration of the breast in the context of an otherwise negative triple screen. Int J Oncol. 2009;6(1)

936.

Ashbeck EL, Rosenberg RD, Stauber PM, et al. Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):467–72. [PubMed: 17337650]

937.

Aslam HM, Saleem S, Shaikh HA, et al. Clinico- pathological profile of patients with breast diseases. Diagn Pathol. 2013;8:77. [PMC free article: PMC3655823] [PubMed: 23659667]

938.

Awad FM. Role of supersonic shear wave imaging quantitative elastography (SSI) in differentiating benign and malignant solid breast masses. The Egyptian Journal of Radiology and Nuclear Medicine. 2013;44(3):681–5.

939.

Ballesio L, Maggi C, Savelli S, et al. Role of breast magnetic resonance imaging (MRI) in patients with unilateral nipple discharge: preliminary study. Radiol Med. 2008 Mar;113(2):249–64. [PubMed: 18386126]

940.

Ballo MS, Sneige N. Can core needle biopsy replace fine-needle aspiration cytology in the diagnosis of palpable breast carcinoma. A comparative study of 124 women. Cancer. 1996 Aug 15;78(4):773–7. [PubMed: 8756371]

941.

Baltzer PA, Yang F, Dietzel M, et al. Sensitivity and specificity of unilateral edema on T2w-TSE sequences in MR-Mammography considering 974 histologically verified lesions. Breast J. 2010 May–Jun;16(3):233–9. [PubMed: 20565468]

942.

Barman I, Dingari NC, Saha A, et al. Application of Raman spectroscopy to identify microcalcifications and underlying breast lesions at stereotactic core needle biopsy. Cancer Res. 2013 Jun 1;73(11):3206–15. [PMC free article: PMC3754785] [PubMed: 23729641]

943.

Barr RG. Real-time ultrasound elasticity of the breast: initial clinical results. Ultrasound Q. 2010 Jun;26(2):61–6. [PubMed: 20498561]

944.

Barr RG, Lackey AE. The utility of the“ bull’s-eye” artifact on breast elasticity imaging in reducing breast lesion biopsy rate. Ultrasound Q. 2011;27(3):151–5. [PubMed: 21873851]

945.

Barra Ade A, Gobbi H, de LRCA, et al. A comparision of aspiration cytology and core needle biopsy according to tumor size of suspicious breast lesions. Diagn Cytopathol. 2008 Jan;36(1):26–31. [PubMed: 18064684]

946.

Battaglia TA, Howard MB, Kavanah M, et al. The addition of internists to a breast health program. Breast J. 2012 Jan–Feb;18(1):58–64. [PubMed: 22098389]

947.

Beattie A. Detecting breast cancer in a general practice - Like finding needles in a haystack? Aust Fam Physician. 2009 Dec;38(12):1003–6. [PubMed: 20369155]

948.

Beckmann KR, Farshid G, Roder DM, et al. Impact of hormone replacement therapy use on mammographic screening outcomes. Cancer Causes Control. 2013 Jul;24(7):1417–26. [PubMed: 23649232]

949.

Bent CK, Bassett LW, D’Orsi CJ, et al. The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories. AJR Am J Roentgenol. 2010 May;194(5):1378–83. [PubMed: 20410428]

950.

Berg WA, Jaeger B, Campassi C, et al. Predictive value of specimen radiography for core needle biopsy of noncalcified breast masses. AJR Am J Roentgenol. 1998 Dec;171(6):1671–8. [PubMed: 9843311]

951.

Berna JD, Nieves FJ, Romero T, et al. A multimodality approach to the diagnosis of breast hamartomas with atypical mammographic appearance. Breast J. 2001 Jan–Feb;7(1):2–7. [PubMed: 11348408]

952.

Berna-Serna JD, Torres-Ales C, Berna-Mestre JD, et al. Role of Galactography in the Early Diagnosis of Breast Cancer. Breast Care. 2013;8(2):122–6. [PMC free article: PMC3683945] [PubMed: 24419050]

953.

Berube M, Curpen B, Ugolini P, et al. Level of suspicion of a mammographic lesion: use of features defined by BI-RADS lexicon and correlation with large-core breast biopsy. Can Assoc Radiol J. 1998 Aug;49(4):223–8. [PubMed: 9709675]

954.

Bianchi S, Caini S, Renne G, et al. Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy. Breast. 2011 Jun;20(3):264–70. [PubMed: 21208804]

955.

Bleznak AD, Magaram D. Surgical biopsy techniques for mammographically detected abnormalities. The Breast Journal. 1998;4(6):426–9.

956.

Boba M, Koltun U, Bobek-Billewicz B, et al. False-negative results of breast core needle biopsies - retrospective analysis of 988 biopsies. Pol J Radiol. 2011 Jan;76(1):25–9. [PMC free article: PMC3389906] [PubMed: 22802813]

957.

Bodai BI, Boyd B, Brown L, et al. Total cost comparison of 2 biopsy methods for nonpalpable breast lesions. Am J Manag Care. 2001 May;7(5):527–38. [PubMed: 11388132]

958.

Bonifacino A, Petrocelli V, Pisani T, et al. Accuracy rates of US-guided vacuum-assisted breast biopsy. Anticancer Res. 2005 May–Jun;25(3c):2465–70. [PubMed: 16080477]

959.

Bowers GJ, Getz JB, Roettger RH, et al. Nonpalpable breast lesions: association of mammographic abnormalities with diagnosis after needle-directed biopsy. South Med J. 1993 Jul;86(7):748–52. [PubMed: 8391719]

960.

Brem RF, Floerke AC, Rapelyea JA, et al. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology. 2008 Jun;247(3):651–7. [PubMed: 18487533]

961.

Brenner RJ, Sickles EA. Surveillance mammography and stereotactic core breast biopsy for probably benign lesions: a cost comparison analysis. Acad Radiol. 1997 Jun;4(6):419–25. [PubMed: 9189199]

962.

Breslin TM, Caughran J, Pettinga J, et al. Improving breast cancer care through a regional quality collaborative. Surgery. 2011 Oct;150(4):635–42. [PubMed: 22000174]

963.

Britton P, McCann J. Needle biopsy in the NHS breast screening programme 1996/97: how much and how accurate? The Breast. 1999;8(1):5–11.

964.

Brown ML, Houn F, Sickles EA, et al. Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. AJR Am J Roentgenol. 1995 Dec;165(6):1373–7. [PubMed: 7484568]

965.

Buijs-van der Woude T, Verkooijen HM, Pijnappel RM, et al. Cost comparison between stereotactic large-core-needle biopsy versus surgical excision biopsy in The Netherlands. Eur J Cancer. 2001 Sep;37(14):1736–45. [PubMed: 11549426]

966.

Bulte JP, Polman L, Schlooz-Vries M, et al. One-day core needle biopsy in a breast clinic: 4 years experience. Breast Cancer Res Treat. 2013 Jan;137(2):609–16. [PubMed: 23239152]

967.

Bundred SM, Zhou J, Whiteside S, et al. Impact of full-field digital mammography on pre-operative diagnosis and surgical treatment of mammographic microcalcification. Breast Cancer Res Treat. 2014 Jan;143(2):359–66. [PubMed: 24318468]

968.

Burbank F. Stereotactic breast biopsy: comparison of 14- and 11-gauge Mammotome probe performance and complication rates. Am Surg. 1997 Nov;63(11):988–95. [PubMed: 9358788]

969.

Burbank F, Forcier N. Tissue marking clip for stereotactic breast biopsy: initial placement accuracy, long-term stability, and usefulness as a guide for wire localization. Radiology. 1997 Nov;205(2):407–15. [PubMed: 9356621]

970.

Burbank F, Parker SH, Fogarty TJ. Stereotactic breast biopsy: improved tissue harvesting with the Mammotome. Am Surg. 1996 Sep;62(9):738–44. [PubMed: 8751765]

971.

Burnside ES, Rubin DL, Fine JP, et al. Bayesian network to predict breast cancer risk of mammographic microcalcifications and reduce number of benign biopsy results: initial experience. Radiology. 2006 Sep;240(3):666–73. [PubMed: 16926323]

972.

Caines JS, Schaller GH, Iles SE, et al. Ten years of breast screening in the Nova Scotia Breast Screening Program, 1991–2001. experience: use of an adaptable stereotactic device in the diagnosis of screening-detected abnormalities. Can Assoc Radiol J. 2005 Apr;56(2):82–93. [PubMed: 15957275]

973.

Calhoun K, Giuliano A, Brenner RJ. Intraoperative loss of core biopsy clips: clinical implications. AJR Am J Roentgenol. 2008 Mar;190(3):W196–200. [PubMed: 18287412]

974.

Candelaria R, Fornage BD. Second-look US examination of MR-detected breast lesions. J Clin Ultrasound. 2011 Mar–Apr;39(3):115–21. [PubMed: 21387324]

975.

Cangiarella J, Gross J, Symmans WF, et al. The incidence of positive margins with breast conserving therapy following mammotome biopsy for microcalcification. J Surg Oncol. 2000 Aug;74(4):263–6. [PubMed: 10962457]

976.

Cangiarella J, Mercado CL, Symmans WF, et al. Stereotaxic aspiration biopsy in the evaluation of mammographically detected clustered microcalcification. Cancer. 1998 Aug 25;84(4):226–30. [PubMed: 9723597]

977.

Cangiarella JF, Waisman J, Weg N, et al. The Use of Stereotaxic Core Biopsy and Stereotaxic Aspiration Biopsy as Diagnostic Tools in the Evaluation of Mammary Calcification. Breast J. 2000 Nov;6(6):366–72. [PubMed: 11348394]

978.

Carbonaro LA, Verardi N, Di Leo G, et al. Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement. Invest Radiol. 2010 Mar;45(3):114–20. [PubMed: 20065856]

979.

Carney PA, Parikh J, Sickles EA, et al. Diagnostic mammography: identifying minimally acceptable interpretive performance criteria. Radiology. 2013 May;267(2):359–67. [PMC free article: PMC3632803] [PubMed: 23297329]

980.

Carty NJ, Ravichandran D, Carter C, et al. Randomized comparison of fine-needle aspiration cytology and Biopty-Cut needle biopsy after unsatisfactory initial cytology of discrete breast lesions. Br J Surg. 1994 Sep;81(9):1313–4. [PubMed: 7953396]

981.

Chan KKK, Lui CY, Chu T, et al. Stratifying risk for malignancy using microcalcification descriptors from the breast imaging reporting and data system 4th edition: Experience in a single centre in Hong Kong. J HK Coll Radiol. 2009;11(4):149–53.

982.

Chang JM, Moon WK, Cho N, et al. Breast mass evaluation: factors influencing the quality of US elastography. Radiology. 2011 Apr;259(1):59–64. [PubMed: 21330569]

983.

Chang JM, Moon WK, Cho N, et al. Breast cancers initially detected by hand-held ultrasound: detection performance of radiologists using automated breast ultrasound data. Acta Radiol. 2011 Feb 1;52(1):8–14. [PubMed: 21498319]

984.

Chang JM, Moon WK, Cho N, et al. Radiologists’ performance in the detection of benign and malignant masses with 3D automated breast ultrasound (ABUS). Eur J Radiol. 2011 Apr;78(1):99–103. [PubMed: 21330080]

985.

Chang JM, Moon WK, Cho N, et al. Clinical application of shear wave elastography (SWE) in the diagnosis of benign and malignant breast diseases. Breast Cancer Res Treat. 2011 Aug;129(1):89–97. [PubMed: 21681447]

986.

Chare MJ, Flowers CI, O’Brien CJ, et al. Image-guided core biopsy in patients with breast disease. Br J Surg. 1996 Oct;83(10):1415–6. [PubMed: 8944459]

987.

Chasteen ND, White LK, Campbell RF. Metal site conformational states of vanadyl(IV) human serotransferrin complexes. Biochemistry. 1977 Feb 8;16(3):363–5. [PubMed: 13814]

988.

Cheng J, Qiu S, Raju U, et al. Benign breast disease heterogeneity: association with histopathology, age, and ethnicity. Breast Cancer Res Treat. 2008 Sep;111(2):289–96. [PMC free article: PMC3707617] [PubMed: 17917807]

989.

Cheng YC, Wu NY, Ko JS, et al. Breast cancers detected by breast MRI screening and ultrasound in asymptomatic Asian women: 8 years of experience in Taiwan. Oncology. 2012;82(2):98–107. [PubMed: 22328009]

990.

Cheung KL, Wong AW, Parker H, et al. Pathological features of primary breast cancer in the elderly based on needle core biopsies--a large series from a single centre. Crit Rev Oncol Hematol. 2008 Sep;67(3):263–7. [PubMed: 18524618]

991.

Cheung YC, Wan YL, Chen SC, et al. Sonographic evaluation of mammographically detected microcalcifications without a mass prior to stereotactic core needle biopsy. J Clin Ultrasound. 2002 Jul–Aug;30(6):323–31. [PubMed: 12116093]

992.

Chlebowski RT, Anderson G, Pettinger M, et al. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Arch Intern Med. 2008 Feb 25;168(4):370–7. quiz 45. [PubMed: 18299491]

993.

Cho N, Moon WK. Digital mammography-guided skin marking for sonographically guided biopsy of suspicious microcalcifications. AJR Am J Roentgenol. 2009 Mar;192(3):W132–6. [PubMed: 19234241]

994.

Cho N, Moon WK, Cha JH, et al. Ultrasound-guided vacuum-assisted biopsy of microcalcifications detected at screening mammography. Acta Radiol. 2009 Jul;50(6):602–9. [PubMed: 19449232]

995.

Cho N, Moon WK, Cha JH, et al. Sonographically guided core biopsy of the breast: comparison of 14-gauge automated gun and 11-gauge directional vacuum-assisted biopsy methods. Korean J Radiol. 2005 Apr–Jun;6(2):102–9. [PMC free article: PMC2686400] [PubMed: 15968149]

996.

Cho N, Moon WK, Chang JM, et al. Aliasing artifact depicted on ultrasound (US)-elastography for breast cystic lesions mimicking solid masses. Acta Radiol. 2011 Feb 1;52(1):3–7. [PubMed: 21498318]

997.

Chu TY, Lui CY, Hung WK, et al. Localisation of occult breast lesion: a comparative analysis of hookwire and radioguided procedures. Hong Kong Med J. 2010 Oct;16(5):367–72. [PubMed: 20890001]

998.

Chuo CB, Corder AP. Core biopsy vs fine needle aspiration cytology in a symptomatic breast clinic. Eur J Surg Oncol. 2003 May;29(4):374–8. [PubMed: 12711292]

999.

Ciatto S, Del Turco MR, Marrazzo A, et al. Time trends of benign/malignant breast biopsy ratios a multicenter Italian study. Tumori. 1996 Jul–Aug;82(4):325–8. [PubMed: 8890964]

1000.

Clarke D, Sudhakaran N, Gateley CA. Replace fine needle aspiration cytology with automated core biopsy in the triple assessment of breast cancer. Ann R Coll Surg Engl. 2001 Mar;83(2):110–2. [PMC free article: PMC2503348] [PubMed: 11320918]

1001.

Clarke-Pearson EM, Jacobson AF, Boolbol SK, et al. Quality assurance initiative at one institution for minimally invasive breast biopsy as the initial diagnostic technique. J Am Coll Surg. 2009 Jan;208(1):75–8. [PubMed: 19228506]

1002.

Clifford EJ, De Vol EB, Pockaj BA, et al. Early results from a novel quality outcomes program: the American Society Of Breast Surgeons’ Mastery of Breast Surgery. Ann Surg Oncol. 2010 Oct;17(Suppl 3):233–41. [PubMed: 20853039]

1003.

Coldman AJ, Phillips N. False-positive screening mammograms and biopsies among women participating in a Canadian provincial breast screening program. Can J Public Health. 2012 Nov–Dec;103(6):e420–4. [PMC free article: PMC6975198] [PubMed: 23618020]

1004.

Cole EB, Toledano AY, Lundqvist M, et al. Comparison of radiologist performance with photon-counting full-field digital mammography to conventional full-field digital mammography. Acad Radiol. 2012 Aug;19(8):916–22. [PubMed: 22537503]

1005.

Corn CC. Review of 125 SiteSelect stereotactic large-core breast biopsy procedures. Breast J. 2003 May–Jun;9(3):147–52. [PubMed: 12752621]

1006.

Cornea V, Jaffer S, Bleiweiss IJ, et al. Adequate histologic sampling of breast magnetic resonance imaging-guided core needle biopsy. Arch Pathol Lab Med. 2009 Dec;133(12):1961–4. [PubMed: 19961252]

1007.

Corsetti V, Houssami N, Ferrari A, et al. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer. 2008 Mar;44(4):539–44. [PubMed: 18267357]

1008.

Crotch-Harvey M, Loughran C. Combined stereotactic wide-core needle biopsy and fine-needle aspiration cytology in the assessment of impalpable mammographic abnormalities detected in a breast-screening programme. The Breast. 1996;5(1):48–9.

1009.

Crowe JP Jr, Rim A, Patrick R, et al. A prospective review of the decline of excisional breast biopsy. Am J Surg. 2002 Oct;184(4):353–5. [PubMed: 12383901]

1010.

Crump SR, Shipp MP, McCray GG, et al. Abnormal mammogram follow-up: do community lay health advocates make a difference? Health Promot Pract. 2008 Apr;9(2):140–8. [PubMed: 18340089]

1011.

Cui Y, Page DL, Lane DS, et al. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study. Breast Cancer Res Treat. 2009 Mar;114(1):113–20. [PubMed: 18360772]

1012.

Dahlstrom JE, Sutton S, Jain S. Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions. Histopathology. 1996 Jun;28(6):537–41. [PubMed: 8803597]

1013.

Dahlstrom JE, Sutton S, Jain S. Histologic-radiologic correlation of mammographically detected microcalcification in stereotactic core biopsies. Am J Surg Pathol. 1998 Feb;22(2):256–9. [PubMed: 9500229]

1014.

Daly CP, Bailey JE, Klein KA, et al. Complicated breast cysts on sonography: is aspiration necessary to exclude malignancy? Acad Radiol. 2008 May;15(5):610–7. [PubMed: 18423318]

1015.

Damascelli B, Frigerio LF, Lanocita R, et al. Stereotactic excisional breast biopsy performed by interventional radiologists using the advanced breast biopsy instrumentation system. Br J Radiol. 1998 Oct;71(850):1003–11. [PubMed: 10211058]

1016.

Damascelli B, Frigerio LF, Patelli G, et al. Stereotactic breast biopsy: en bloc excision of microcalcifications with a large-bore cannula device. AJR Am J Roentgenol. 1999 Oct;173(4):895–900. [PubMed: 10511143]

1017.

D’Angelo PC, Galliano DE, Rosemurgy AS. Stereotactic excisional breast biopsies utilizing the advanced breast biopsy instrumentation system. Am J Surg. 1997 Sep;174(3):297–302. [PubMed: 9324141]

1018.

Demir F, Donmez YC, Ozsaker E, et al. Patients’ lived experiences of excisional breast biopsy: a phenomenological study. J Clin Nurs. 2008 Mar;17(6):744–51. [PubMed: 18279277]

1019.

Dennison G, Anand R, Makar SH, et al. A prospective study of the use of fine-needle aspiration cytology and core biopsy in the diagnosis of breast cancer. Breast J. 2003 Nov–Dec;9(6):491–3. [PubMed: 14616944]

1020.

Denton ER, Ryan S, Beaconfield T, et al. Image-guided breast biopsy: analysis of pain and discomfort related to technique. Breast. 1999 Oct;8(5):257–60. [PubMed: 14965740]

1021.

Dershaw DD, Morris EA, Liberman L, et al. Nondiagnostic stereotaxic core breast biopsy: results of rebiopsy. Radiology. 1996 Feb;198(2):323–5. [PubMed: 8596825]

1022.

Destounis S, Arieno A, Morgan R, et al. Clinical experience with elasticity imaging in a community-based breast center. J Ultrasound Med. 2013 Feb;32(2):297–302. [PubMed: 23341386]

1023.

Destounis S, Skolny MN, Morgan R, et al. Rates of pathological underestimation for 9 and 12 gauge breast needle core biopsies at surgical excision. Breast Cancer. 2011 Jan;18(1):42–50. [PubMed: 20204553]

1024.

Deurloo EE, Gilhuijs KG, Kool LJS, et al. Displacement of breast tissue and needle deviations during stereotactic procedures. Invest Radiol. 2001;36(6):347–53. [PubMed: 11410756]

1025.

Deutscher SL, Dickerson M, Gui G, et al. Carbohydrate antigens in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy. BMC Cancer. 2010;10:519. [PMC free article: PMC2958935] [PubMed: 20920311]

1026.

Devia A, Murray KA, Nelson EW. Stereotactic core needle biopsy and the workup of mammographic breast lesions. Arch Surg. 1997 May;132(5):512–5. discussion 5-7. [PubMed: 9161394]

1027.

Dietzel M, Baltzer PA, Vag T, et al. The necrosis sign in magnetic resonance-mammography: diagnostic accuracy in 1,084 histologically verified breast lesions. Breast J. 2010 Nov–Dec;16(6):603–8. [PubMed: 21070437]

1028.

Dillon MF, Maguire AA, McDermott EW, et al. Needle core biopsy characteristics identify patients at risk of compromised margins in breast conservation surgery. Mod Pathol. 2008 Jan;21(1):39–45. [PubMed: 17948023]

1029.

Dittus K, Geller B, Weaver DL, et al. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI. J Gen Intern Med. 2013 Nov;28(11):1454–62. [PMC free article: PMC3797353] [PubMed: 23760741]

1030.

Docktor BJ, MacGregor JH, Burrowes PW. Ultrasonographic findings 6 months after 11-gauge vacuum-assisted large-core breast biopsy. Can Assoc Radiol J. 2004 Jun;55(3):151–6. [PubMed: 15237775]

1031.

Donaldson LA, Cliff A, Gardiner L, et al. Surgeon-controlled ultrasound-guided core biopsies in the breast--a prospective study and a new use for surgeons in the clinic. Eur J Surg Oncol. 2003 Mar;29(2):139–42. [PubMed: 12633556]

1032.

Doridot V, Meunier M, El Khoury C, et al. Stereotactic radioguided surgery by siteSelect for subclinical mammographic lesions. Ann Surg Oncol. 2005 Feb;12(2):181–8. [PubMed: 15827800]

1033.

D’Orsi CJ, Getty DJ, Pickett RM, et al. Stereoscopic digital mammography: improved specificity and reduced rate of recall in a prospective clinical trial. Radiology. 2013 Jan;266(1):81–8. [PubMed: 23150865]

1034.

Dowlatshahi K, Yaremko ML, Kluskens LF, et al. Nonpalpable breast lesions: findings of stereotaxic needle-core biopsy and fine-needle aspiration cytology. Radiology. 1991 Dec;181(3):745–50. [PubMed: 1947091]

1035.

Doyle AJ, King AR, Miller MV, et al. Implementation of image-guided large-core needle biopsy of the breast on a limited budget. Australas Radiol. 1998 Aug;42(3):199–203. [PubMed: 9727241]

1036.

Doyle JM, O’Doherty A, Coffey L, et al. Can the radiologist accurately predict the adequacy of sampling when performing ultrasound-guided core biopsy of BI-RADS category 4 and 5 lesions detected on screening mammography? Clin Radiol. 2005 Sep;60(9):999–1005. [PubMed: 16124982]

1037.

Duijm LE, Groenewoud JH, de Koning HJ, et al. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography. Eur J Cancer. 2009 Mar;45(5):774–81. [PubMed: 19046632]

1038.

Duijm LE, Groenewoud JH, Fracheboud J, et al. Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000–2005. Eur Radiol. 2008 Nov;18(11):2390–7. [PubMed: 18491102]

1039.

Duijm LE, Louwman MW, Groenewoud JH, et al. Inter-observer variability in mammography screening and effect of type and number of readers on screening outcome. Br J Cancer. 2009 Mar 24;100(6):901–7. [PMC free article: PMC2661777] [PubMed: 19259088]

1040.

Dunning K, Liedtke E, Toedter L, et al. Outpatient surgery centers draw cases away from hospitals, impact resident training volume. J Surg Educ. 2008 Nov–Dec;65(6):460–4. [PubMed: 19059178]

1041.

Florentine BD, Cobb CJ, Frankel K, Greaves T, Martin SE. Core needle biopsy: A useful adjunct to fine-needle aspiration in select patients with palpable breast lesions. Cancer. [PubMed: 9100539]

1042.

El Khouli RH, Macura KJ, Barker PB, et al. MRI-guided vacuum-assisted breast biopsy: a phantom and patient evaluation of targeting accuracy. J Magn Reson Imaging. 2009 Aug;30(2):424–9. [PMC free article: PMC2735014] [PubMed: 19629977]

1043.

El Khoury M, Mesurolle B, Omeroglu A, et al. Values of pathological analysis of lost tissue fragments in the vacuum canister during a vacuum-assisted stereotactic biopsy of the breast. Br J Radiol. 2013 May;86(1025):20120270. [PMC free article: PMC3635795] [PubMed: 23520227]

1044.

Elkum NB, Myles JD, Kumar P. Analyzing biological rhythms in clinical trials. Contemp Clin Trials. 2008 Sep;29(5):720–6. [PubMed: 18571991]

1045.

El-Sayed ME, Rakha EA, Reed J, et al. Audit of performance of needle core biopsy diagnoses of screen detected breast lesions. Eur J Cancer. 2008 Nov;44(17):2580–6. [PubMed: 18632261]

1046.

Elter M, Schulz-Wendtland R, Wittenberg T. The prediction of breast cancer biopsy outcomes using two CAD approaches that both emphasize an intelligible decision process. Med Phys. 2007 Nov;34(11):4164–72. [PubMed: 18072480]

1047.

Ertas G, Gulcur HO, Tunaci M, et al. A preliminary study on computerized lesion localization in MR mammography using 3D nMITR maps, multilayer cellular neural networks, and fuzzy c-partitioning. Med Phys. 2008 Jan;35(1):195–205. [PubMed: 18293575]

1048.

Eser M, Kaptanoglu L, Kement M, et al. A Challenging entity in the differential diagnosis of breast cancer: A retrospective analysis of 17 cases with granulomatous lobular mastitis: Meme kanserinin ayirici tanisinda zor bir durum: Granulomatoz lobuler mastitli 17 olgunun retrospektif analizi. J Breast Health. 2013;9(2):69–75.

1049.

Evans A, Whelehan P, Thomson K, et al. Differentiating benign from malignant solid breast masses: value of shear wave elastography according to lesion stiffness combined with greyscale ultrasound according to BI-RADS classification. Br J Cancer. 2012 Jul 10;107(2):224–9. [PMC free article: PMC3394981] [PubMed: 22691969]

1050.

Evans A, Whelehan P, Thomson K, et al. Quantitative shear wave ultrasound elastography: initial experience in solid breast masses. Breast Cancer Res. 2010;12(6):R104. [PMC free article: PMC3046449] [PubMed: 21122101]

1051.

Evans LA. Feasibility of family member presence in the OR during breast biopsy procedures. AORN J. 2008 Oct;88(4):568–86. [PubMed: 18928960]

1052.

Fahy BN, Bold RJ, Schneider PD, et al. Cost-benefit analysis of biopsy methods for suspicious mammographic lesions; discussion 994-5. Arch Surg. 2001 Sep;136(9):990–4. [PubMed: 11529819]

1053.

Fajardo LL. Cost-effectiveness of stereotaxic breast core needle biopsy. Acad Radiol. 1996 Apr;3(Suppl 1):S21–3. [PubMed: 8796501]

1054.

Fajardo LL, Bird RE, Herman CR, et al. Placement of endovascular embolization microcoils to localize the site of breast lesions removed at stereotactic core biopsy. Radiology. 1998 Jan;206(1):275–8. [PubMed: 9423683]

1055.

Farshid G, Pieterse S. Core imprint cytology of screen-detected breast lesions is predictive of the histologic results. Cancer. 2006 Jun 25;108(3):150–6. [PubMed: 16634070]

1056.

Farshid G, Rush G. The use of fine-needle aspiration cytology and core biopsy in the assessment of highly suspicious mammographic microcalcifications: analysis of outcome for 182 lesions detected in the setting of a population-based breast cancer screening program. Cancer. 2003 Dec 25;99(6):357–64. [PubMed: 14681944]

1057.

Faulkner K, McCormack S, Bennison K. A retrospective analysis of digital stereotaxis in breast screening. Br J Radiol. 2007 Jul;80(955):563–8. [PubMed: 17621605]

1058.

Feeley L, Kiernan D, Mooney T, et al. Digital mammography in a screening programme and its implications for pathology: a comparative study. J Clin Pathol. 2011 Mar;64(3):215–9. [PubMed: 21177749]

1059.

Fenton JJ, Xing G, Elmore JG, et al. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees. Ann Intern Med. 2013 Apr 16;158(8):580–7. [PMC free article: PMC3772716] [PubMed: 23588746]

1060.

Feoli F, Paesmans M, Van Eeckhout P. Fine needle aspiration cytology of the breast: impact of experience on accuracy, using standardized cytologic criteria. Acta Cytol. 2008 Mar–Apr;52(2):145–51. [PubMed: 18499986]

1061.

Ferguson J, Chamberlain P, Cramer HM, et al. ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: a comparison study with formalin-fixed cell blocks and surgical biopsies. Diagn Cytopathol. 2013 Jul;41(7):575–81. [PubMed: 22807465]

1062.

Ferzli GS, Hurwitz JB, Puza T, et al. Advanced breast cancer biopsy instrumentation: a critique. J Am Coll Surg. 1997 Aug;185(2):145–51. [PubMed: 9249081]

1063.

Ferzli GS, Puza T, Vanvorst-Bilotti S, et al. Breast Biopsies with ABBI(R): Experience with 183 Attempted Biopsies. Breast J. 1999 Jan;5(1):26–8. [PubMed: 11348252]

1064.

Fiaschetti V, Salimbeni C, Gaspari E, et al. The role of second-look ultrasound of BIRADS-3 mammary lesions detected by breast MR imaging. Eur J Radiol. 2012 Nov;81(11):3178–84. [PubMed: 22417393]

1065.

Fine RE, Boyd BA. Stereotactic breast biopsy: a practical approach. Am Surg. 1996 Feb;62(2):96–102. [PubMed: 8554199]

1066.

Fine RE, Boyd BA, Whitworth PW, et al. Percutaneous removal of benign breast masses using a vacuum-assisted hand-held device with ultrasound guidance. Am J Surg. 2002 Oct;184(4):332–6. [PubMed: 12383895]

1067.

Fine RE, Israel PZ, Walker LC, et al. A prospective study of the removal rate of imaged breast lesions by an 11-gauge vacuum-assisted biopsy probe system. Am J Surg. 2001 Oct;182(4):335–40. [PubMed: 11720666]

1068.

Fitzpatrick P, Fleming P, O’Neill S, et al. False-positive mammographic screening: factors influencing re-attendance over a decade of screening. J Med Screen. 2011;18(1):30–3. [PubMed: 21536814]

1069.

Fleury EF, Rinaldi JF, Piato S, et al. Appearance of breast masses on sonoelastography with special focus on the diagnosis of fibroadenomas. Eur Radiol. 2009 Jun;19(6):1337–46. [PubMed: 19159934]

1070.

Fornasa F, Pinali L, Gasparini A, et al. Diffusion-weighted magnetic resonance imaging in focal breast lesions: analysis of 78 cases with pathological correlation. Radiol Med. 2011 Mar;116(2):264–75. [PubMed: 21076884]

1071.

Fournier LS, Vanel D, Athanasiou A, et al. Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels. Eur J Radiol. 2009 Jan;69(1):43–9. [PubMed: 18829193]

1072.

Frayne J, Sterrett GF, Harvey J, et al. Stereotactic 14 gauge core-biopsy of the breast: results from 101 patients. Aust N Z J Surg. 1996 Sep;66(9):585–91. [PubMed: 8859155]

1073.

Freeman S. One-stop clinic can diagnose suspect lesions in a day. Oncol Rep. 2010;(SEPTEMBER–OCTOBER):14–5.

1074.

Friedlander LC, Roth SO, Gavenonis SC. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology. 2011 Nov;261(2):421–7. [PubMed: 21900618]

1075.

Fu CY, Hsu HH, Yu JC, et al. Influence of age on PPV of sonographic BI-RADS categories 3, 4, and 5. Ultraschall Med. 2011 Jan;32(Suppl 1):S8–13. [PubMed: 20603785]

1076.

Gajdos C, Levy M, Herman Z, et al. Complete removal of nonpalpable breast malignancies with a stereotactic percutaneous vacuum-assisted biopsy instrument. J Am Coll Surg. 1999 Sep;189(3):237–40. [PubMed: 10472922]

1077.

Gala I, Fisher P, Hermann GA. Usefulness of Telfa pads in the histologic assessment of stereotactic-guided breast biopsy specimens. Mod Pathol. 1999 May;12(5):553–7. [PubMed: 10349996]

1078.

Gallagher R, Schafer G, Redick M, et al. Microcalcifications of the breast: a mammographic-histologic correlation study using a newly designed Path/Rad Tissue Tray. Ann Diagn Pathol. 2012 Jun;16(3):196–201. [PubMed: 22225905]

1079.

Gan FY, Wettlaufer JR, Lundell AL. Breast imaging in a military setting: a comparison with civilian breast imaging. Mil Med. 2004 May;169(5):361–7. [PubMed: 15186000]

1080.

Geller BM, Oppenheimer RG, Mickey RM, et al. Patient perceptions of breast biopsy procedures for screen-detected lesions. Am J Obstet Gynecol. 2004 Apr;190(4):1063–9. [PubMed: 15118643]

1081.

Gentry CL, Henry CA. Stereotactic Percutaneous Breast Biopsy: A Comparative Analysis Between Surgeon and Radiologist. Breast J. 1999 Mar;5(2):101–4. [PubMed: 11348267]

1082.

Ghosh K, Melton LJ 3rd, Suman VJ, et al. Breast biopsy utilization: a population-based study. Arch Intern Med. 2005 Jul 25;165(14):1593–8. [PubMed: 16043676]

1083.

Giordano L, Giorgi D, Piccini P, et al. Time trends of process and impact indicators in Italian breast screening programmes: 1998–2007. Epidemiol Prev. 2009 May–Jun;33(3 Suppl 2):29–39. [PubMed: 19776485]

1084.

Giordano L, Giorgi D, Piccini P, et al. Time trends of process and impact indicators in Italian breast screening programmes--1996–2005. Epidemiol Prev. 2008 Mar–Apr;32(2 Suppl 1):23–36. [PubMed: 18770993]

1085.

Giordano L, Giorgi D, Ventura L, et al. Time trends of process and impact indicators in Italian breast screening programmes: 1998–2008. Epidemiol Prev. 2010 Sep–Dec;34(5–6 Suppl 4):27–34. [PubMed: 21220835]

1086.

Girardi V, Tonegutti M, Ciatto S, et al. Breast ultrasound in 22,131 asymptomatic women with negative mammography. Breast. 2013 Oct;22(5):806–9. [PubMed: 23558244]

1087.

Gittleman MA. Single-step ultrasound localization of breast lesions and lumpectomy procedure. Am J Surg. 2003 Oct;186(4):386–90. [PubMed: 14553856]

1088.

Goldman LE, Walker R, Hubbard R, et al. Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women. Med Care. 2013 Apr;51(4):307–14. [PMC free article: PMC3966312] [PubMed: 23358386]

1089.

Goldman LE, Walker R, Miglioretti DL, et al. Facility characteristics do not explain higher false-positive rates in diagnostic mammography at facilities serving vulnerable women. Med Care. 2012 Mar;50(3):210–6. [PMC free article: PMC3422679] [PubMed: 22186768]

1090.

Golub RM, Bennett CL, Stinson T, et al. Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. Journal of clinical oncology. 2004;22(12):2430–7. [PubMed: 15197205]

1091.

Goodman KA, Birdwell RL, Ikeda DM. Compliance with recommended follow-up after percutaneous breast core biopsy. AJR Am J Roentgenol. 1998 Jan;170(1):89–92. [PubMed: 9423606]

1092.

Gray RE, Benson GW, Lustig DD. Stereotactic breast biopsy: experience in a community setting. J Miss State Med Assoc. 1999 Jan;40(1):3–7. [PubMed: 9919043]

1093.

Grimes MM, Karageorge LS, Hogge JP. Does exhaustive search for microcalcifications improve diagnostic yield in stereotactic core needle breast biopsies? Mod Pathol. 2001 Apr;14(4):350–3. [PubMed: 11301352]

1094.

Groenewoud JH, Pijnappel RM, van den Akker-Van Marle ME, et al. Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy. Br J Cancer. 2004 Jan 26;90(2):383–92. [PMC free article: PMC2409541] [PubMed: 14735181]

1095.

Gruber S, Debski BK, Pinker K, et al. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions. Radiology. 2011 Dec;261(3):752–61. [PubMed: 21998046]

1096.

Gufler H, Wagner S, Franke FE. The interior structure of breast microcalcifications assessed with micro computed tomography. Acta Radiol. 2011 Jul 1;52(6):592–6. [PubMed: 21498282]

1097.

Gumus H, Gumus M, Devalia H, et al. Causes of failure in removing calcium in microcalcification-only lesions using 11-gauge stereotactic vacuum-assisted breast biopsy. Diagn Interv Radiol. 2012 Jul–Aug;18(4):354–9. [PubMed: 22477646]

1098.

Gumus H, Gumus M, Mills P, et al. Clinically palpable breast abnormalities with normal imaging: is clinically guided biopsy still required? Clin Radiol. 2012 May;67(5):437–40. [PubMed: 22119297]

1099.

Gumus H, Mills P, Fish D, et al. Breast microcalcification: diagnostic value of calcified and non-calcified cores on specimen radiographs. Breast J. 2013 Mar–Apr;19(2):156–61. [PubMed: 23294155]

1100.

Gur D, Wallace LP, Klym AH, et al. Trends in recall, biopsy, and positive biopsy rates for screening mammography in an academic practice. Radiology. 2005 May;235(2):396–401. [PubMed: 15770039]

1101.

Gurel K, Karabay O, Gurel S, et al. Does prebiopsy, nonsterile ultrasonography gel affect biopsy-site asepsis? Cardiovasc Intervent Radiol. 2008 Jan–Feb;31(1):131–4. [PubMed: 17978849]

1102.

Gutwein LG, Ang DN, Liu H, et al. Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions. Am J Surg. 2011 Aug;202(2):127–32. [PubMed: 21295284]

1103.

Gweon HM, Youk JH, Son EJ, et al. Visually assessed colour overlay features in shear-wave elastography for breast masses: quantification and diagnostic performance. Eur Radiol. 2013 Mar;23(3):658–63. [PubMed: 22976918]

1104.

Haj M, Kniaz D, Eitan A, et al. Three years of experience with advanced breast biopsy instrumentation (ABBI). Breast J. 2002 Sep–Oct;8(5):275–80. [PubMed: 12199754]

1105.

Hamilton LJ, Cornford EJ, Maxwell AJ. A survey of current UK practice regarding the biopsy of clinically and radiologically benign breast masses in young women. Clin Radiol. 2011 Aug;66(8):738–41. [PubMed: 21513922]

1106.

Hann LE, Liberman L, Dershaw DD, et al. Mammography immediately after stereotaxic breast biopsy: is it necessary? AJR Am J Roentgenol. 1995 Jul;165(1):59–62. [PubMed: 7785633]

1107.

Hanna WC, Demyttenaere SV, Ferri LE, et al. The use of stereotactic excisional biopsy in the management of invasive breast cancer. World J Surg. 2005 Nov;29(11):1490–4. discussion 5-6. [PubMed: 16240063]

1108.

Harlow SP, Krag DN, Ames SE, et al. Intraoperative ultrasound localization to guide surgical excision of nonpalpable breast carcinoma. J Am Coll Surg. 1999 Sep;189(3):241–6. [PubMed: 10472923]

1109.

Harman SM, Gucciardo F, Heward CB, et al. Discrimination of breast cancer by anti-malignin antibody serum test in women undergoing biopsy. Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2310–5. [PubMed: 16214910]

1110.

Harvey JA, Nicholson BT, Lorusso AP, et al. Short-term follow-up of palpable breast lesions with benign imaging features: evaluation of 375 lesions in 320 women. AJR Am J Roentgenol. 2009 Dec;193(6):1723–30. [PubMed: 19933671]

1111.

Hassan HHM, Mahmoud Zahran MH, El-Prince Hassan H, et al. Diffusion magnetic resonance imaging of breast lesions: Initial experience at Alexandria University. Alexandria Journal of Medicine. 2013;49(3):265–72.

1112.

Hatada T, Ishii H, Ichii S, et al. Diagnostic value of ultrasound-guided fine-needle aspiration biopsy, core-needle biopsy, and evaluation of combined use in the diagnosis of breast lesions. J Am Coll Surg. 2000 Mar;190(3):299–303. [PubMed: 10703854]

1113.

Hayes BD, Brodie C, O’Doherty A, et al. High-grade histologic features of DCIS are associated with R5 rather than R3 calcifications in breast screening mammography. Breast J. 2013 May–Jun;19(3):319–24. [PubMed: 23600490]

1114.

Hemmer JM, Kelder JC, van Heesewijk HP. Stereotactic large-core needle breast biopsy: analysis of pain and discomfort related to the biopsy procedure. Eur Radiol. 2008 Feb;18(2):351–4. [PMC free article: PMC2668619] [PubMed: 17909818]

1115.

Henderson LM, Hubbard RA, Onega TL, et al. Assessing health care use and cost consequences of a new screening modality: the case of digital mammography. Med Care. 2012 Dec;50(12):1045–52. [PMC free article: PMC3650634] [PubMed: 22922432]

1116.

Heywang-Koebrunner S, Bock K, Heindel W, et al. Mammography Screening–as of 2013. Geburtshilfe und Frauenheilkunde. 2013;73(10):1007–16. [PMC free article: PMC3862045] [PubMed: 24771889]

1117.

Hille H, Vetter M, Hackeloer BJ. The accuracy of BI-RADS classification of breast ultrasound as a first-line imaging method. Ultraschall Med. 2012 Apr;33(2):160–3. [PubMed: 21877320]

1118.

Hillhouse RA, Norvill KA, Buchanan SW, et al. Analysis of malignancy detected by needle-localized breast biopsy. J Am Osteopath Assoc. 1996 Jul;96(7):398–400. [PubMed: 8758871]

1119.

Hillner BE, Bear HD, Fajardo LL. Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model. Acad Radiol. 1996 Apr;3(4):351–60. [PubMed: 8796686]

1120.

Hoffmann J. Analysis of surgical and diagnostic quality at a specialist breast unit. The Breast. 2006;15(4):490–7. [PubMed: 16343904]

1121.

Hofvind S, Ponti A, Patnick J, et al. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen. 2012;19(Suppl 1):57–66. [PubMed: 22972811]

1122.

Holloway CM, Gagliardi AR. Percutaneous needle biopsy for breast diagnosis: how do surgeons decide? Ann Surg Oncol. 2009 Jun;16(6):1629–36. [PubMed: 19357925]

1123.

Holloway CM, Saskin R, Paszat L. Geographic variation and physician specialization in the use of percutaneous biopsy for breast cancer diagnosis. Can J Surg. 2008 Dec;51(6):453–63. [PMC free article: PMC2592581] [PubMed: 19057734]

1124.

Homesh NA, Issa MA, El-Sofiani HA. The diagnostic accuracy of fine needle aspiration cytology versus core needle biopsy for palpable breast lump(s). Saudi Med J. 2005 Jan;26(1):42–6. [PubMed: 15756351]

1125.

Hooley RJ, Greenberg KL, Stackhouse RM, et al. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology. 2012 Oct;265(1):59–69. [PubMed: 22723501]

1126.

Hoorntje LE, Peeters PH, Mali WP, et al. Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions? Breast Cancer Res Treat. 2004 Jul;86(2):165–70. [PubMed: 15319568]

1127.

Hrung JM, Langlotz CP, Orel SG, et al. Cost-effectiveness of MR imaging and core-needle biopsy in the preoperative work-up of suspicious breast lesions. Radiology. 1999 Oct;213(1):39–49. [PubMed: 10540638]

1128.

Hsu HH, Yu JC, Lee HS, et al. Complex cystic lesions of the breast on ultrasonography: feature analysis and BI-RADS assessment. Eur J Radiol. 2011 Jul;79(1):73–9. [PubMed: 20116191]

1129.

Hubbard RA, Kerlikowske K, Flowers CI, et al. Cumulative Probability of False-Positive Recall or Biopsy Recommendation After 10 Years of Screening Mammography: A Cohort Study. Ann Intern Med. 2011;155(8):481–92. [PMC free article: PMC3209800] [PubMed: 22007042]

1130.

Hubbard RA, Zhu W, Horblyuk R, et al. Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography. Breast Cancer Res Treat. 2013 Apr;138(3):879–87. [PMC free article: PMC3640408] [PubMed: 23471650]

1131.

Hubbard RA, Zhu W, Onega TL, et al. Effects of digital mammography uptake on downstream breast-related care among older women. Med Care. 2012 Dec;50(12):1053–9. [PMC free article: PMC3494765] [PubMed: 23132199]

1132.

Hung WK, Lam HS, Lau Y, et al. Diagnostic accuracy of vacuum-assisted biopsy device for image-detected breast lesions. ANZ J Surg. 2001 Aug;71(8):457–60. [PubMed: 11504288]

1133.

Hunter TB, Roberts CC, Hunt KR, et al. Occurrence of fibroadenomas in postmenopausal women referred for breast biopsy. J Am Geriatr Soc. 1996 Jan;44(1):61–4. [PubMed: 8537592]

1134.

Ibrahim AE, Bateman AC, Theaker JM, et al. The role and histological classification of needle core biopsy in comparison with fine needle aspiration cytology in the preoperative assessment of impalpable breast lesions. J Clin Pathol. 2001 Feb;54(2):121–5. [PMC free article: PMC1731351] [PubMed: 11215280]

1135.

Idowu MO, Hardy LB, Souers RJ, et al. Pathologic diagnostic correlation with breast imaging findings: a College of American Pathologists Q-Probes study of 48 institutions. Arch Pathol Lab Med. 2012 Jan;136(1):53–60. [PubMed: 22208488]

1136.

Ikeda K, Ogawa Y, Takii M, et al. A role for elastography in the diagnosis of breast lesions by measuring the maximum fat lesion ratio (max-FLR) by tissue Doppler imaging. Breast Cancer. 2012 Jan;19(1):71–6. [PubMed: 21567172]

1137.

Insausti LP, Alberro JA, Regueira FM, et al. An experience with the Advanced Breast Biopsy Instrumentation (ABBI) system in the management of non-palpable breast lesions. Eur Radiol. 2002 Jul;12(7):1703–10. [PubMed: 12111061]

1138.

Iwatani T, Matsuda A, Kawabata H, et al. Predictive factors for psychological distress related to diagnosis of breast cancer. Psychooncology. 2013 Mar;22(3):523–9. [PubMed: 23577351]

1139.

Jackman RJ, Marzoni FA Jr. Needle-localized breast biopsy: why do we fail? Radiology. 1997 Sep;204(3):677–84. [PubMed: 9280243]

1140.

Jackman RJ, Marzoni FA Jr. Stereotactic histologic biopsy with patients prone: technical feasibility in 98% of mammographically detected lesions. AJR Am J Roentgenol. 2003 Mar;180(3):785–94. [PubMed: 12591697]

1141.

Jackman RJ, Rodriguez-Soto J. Breast microcalcifications: retrieval failure at prone stereotactic core and vacuum breast biopsy--frequency, causes, and outcome. Radiology. 2006 Apr;239(1):61–70. [PubMed: 16567483]

1142.

Jacobs IA, Chevinsky AH, Diehl W, et al. Advanced breast biopsy instrumentation (ABBI) and management of nonpalpable breast abnormalities: a community hospital experience. Breast. 2001 Oct;10(5):421–6. [PubMed: 14965618]

1143.

Jacobs TW, Silverman JF, Schroeder B, et al. Accuracy of touch imprint cytology of image-directed breast core needle biopsies. Acta Cytol. 1999 Mar–Apr;43(2):169–74. [PubMed: 10097705]

1144.

Jaffer S, Bleiweiss IJ, Nagi C. Incidental intraductal papillomas (<2 mm) of the breast diagnosed on needle core biopsy do not need to be excised. Breast J. 2013 Mar–Apr;19(2):130–3. [PubMed: 23336823]

1145.

Jan WA, Zada N, Samieulla, et al. Comparison of FNAC and core biopsy for evaluating breast lumps. Med Forum Mon. 2002;13(12):26–8.

1146.

Jara-Lazaro AR, Tan PH. Comparing digital and optical microscopy diagnoses of breast and prostate core biopsies. Pathology. 2012 Jan;44(1):46–8. [PubMed: 22157691]

1147.

Jensen A, Rank F, Dyreborg U, et al. Performance of combined clinical mammography and needle biopsy: a nationwide study from Denmark. APMIS. 2006 Dec;114(12):884–92. [PubMed: 17207089]

1148.

Johnson KS, Baker JA, Lee SS, et al. Cancelation of MRI guided breast biopsies for suspicious breast lesions identified at 3.0 T MRI: reasons, rates, and outcomes. Acad Radiol. 2013 May;20(5):569–75. [PubMed: 23473719]

1149.

Jones L, Lott MF, Calder CJ, et al. Imprint cytology from ultrasound-guided core biopsies: accurate and immediate diagnosis in a one-stop breast clinic. Clin Radiol. 2004 Oct;59(10):903–8. [PubMed: 15451349]

1150.

Jung HJ, Hahn SY, Choi HY, et al. Breast sonographic elastography using an advanced breast tissue-specific imaging preset: initial clinical results. J Ultrasound Med. 2012 Feb;31(2):273–80. [PubMed: 22298871]

1151.

Kaiser CG, Reich C, Wasser K, et al. Economic aspects of MR-mammography in dense breasts. Eur J Radiol. 2012 Sep;81(Suppl 1):S69–71. [PubMed: 23083609]

1152.

Kaplan SS, Collado-Mesa F, Ekens J, et al. Palpable solid breast masses with probably benign sonographic features: can biopsy be avoided? Breast J. 2013 Mar–Apr;19(2):212–4. [PubMed: 23316805]

1153.

Kasahara Y, Kawai M, Tsuji I, et al. Harms of screening mammography for breast cancer in Japanese women. Breast Cancer. 2013 Oct;20(4):310–5. [PubMed: 22282164]

1154.

Kass R, Henry-Tillman RS, Nurko J, et al. Touch preparation of breast core needle specimens is a new method for same-day diagnosis. Am J Surg. 2003 Dec;186(6):737–41. discussion 42. [PubMed: 14672788]

1155.

Kass R, Kumar G, Klimberg VS, et al. Clip migration in stereotactic biopsy. Am J Surg. 2002 Oct;184(4):325–31. [PubMed: 12383894]

1156.

Kaufman HJ, Witherspoon LE, Gwin JL Jr, et al. Stereotactic breast biopsy: a study of first core samples. Am Surg. 2001 Jun;67(6):572–5. discussion 5-6. [PubMed: 11409806]

1157.

Kawasaki T, Mochizuki K, Yamauchi H, et al. High prevalence of neuroendocrine carcinoma in breast lesions detected by the clinical symptom of bloody nipple discharge. Breast. 2012 Oct;21(5):652–6. [PubMed: 22397895]

1158.

Kaye MD, Vicinanza-Adami CA, Sullivan ML. Mammographic findings after stereotaxic biopsy of the breast performed with large-core needles. Radiology. 1994 Jul;192(1):149–51. [PubMed: 8208927]

1159.

Kelaher M, Cawson J, Miller J, et al. Use of breast cancer screening and treatment services by Australian women aged 25–44 years following Kylie Minogue’s breast cancer diagnosis. Int J Epidemiol. 2008 Dec;37(6):1326–32. [PubMed: 18515324]

1160.

Kelley WE, Bailey R, Bertelsen C, et al. Stereotactic automated surgical biopsy using the ABBI biopsy device: a multicenter study. The Breast Journal. 1998;4(5):302–6.

1161.

Kennedy G, Markert M, Alexander JR, et al. Predictive value of BI-RADS classification for breast imaging in women under age 50. Breast Cancer Res Treat. 2011 Dec;130(3):819–23. [PubMed: 21748292]

1162.

Kessler R, Sutcliffe JB, Bell L, et al. Negative predictive value of breast-specific gamma imaging in low suspicion breast lesions: a potential means for reducing benign biopsies. Breast J. 2011 May–Jun;17(3):319–21. [PubMed: 21492299]

1163.

Khanna AK, Singh MR, Khanna S, et al. Fine needle aspiration cytology, imprint cytology and tru-cut needle biopsy in breast lumps: a comparative evaluation. J Indian Med Assoc. 1991 Jul;89(7):192–5. [PubMed: 1940411]

1164.

Kiaer HW, Laenkholm AV, Nielsen BB, et al. Classical pathological variables recorded in the Danish Breast Cancer Cooperative Group’s register 1978–2006. Acta Oncol. 2008;47(4):778–83. [PubMed: 18465348]

1165.

Kibil W, Hodorowicz-Zaniewska D, Popiela TJ, et al. Mammotome biopsy in diagnosing and treatment of intraductal papilloma of the breast. Polish Journal of Surgery. 2013;85(4):210–5. [PubMed: 23640929]

1166.

Kim BS. Usefulness of breast-specific gamma imaging as an adjunct modality in breast cancer patients with dense breast: a comparative study with MRI. Ann Nucl Med. 2012 Feb;26(2):131–7. [PubMed: 22006539]

1167.

Kim C, Yoon C, Park JH, et al. Evaluation of ultrasound synthetic aperture imaging using bidirectional pixel-based focusing: preliminary phantom and in vivo breast study. IEEE Trans Biomed Eng. 2013 Oct;60(10):2716–24. [PubMed: 23686939]

1168.

Kim MJ, Kim JY, Youn JH, et al. US-guided diffuse optical tomography for breast lesions: the reliability of clinical experience. Eur Radiol. 2011 Jul;21(7):1353–63. [PubMed: 21274716]

1169.

Kim SJ, Chang JM, Cho N, et al. Outcome of breast lesions detected at screening ultrasonography. Eur J Radiol. 2012 Nov;81(11):3229–33. [PubMed: 22591758]

1170.

Kim WH, Chang JM, Moon WK, et al. Intraductal mass on breast ultrasound: final outcomes and predictors of malignancy. AJR Am J Roentgenol. 2013 Apr;200(4):932–7. [PubMed: 23521472]

1171.

Kim YW, Kim SK, Youn HJ, et al. The clinical utility of automated breast volume scanner: a pilot study of 139 cases. J Breast Cancer. 2013 Sep;16(3):329–34. [PMC free article: PMC3800730] [PubMed: 24155763]

1172.

Klein RL, Mook JA, Euhus DM, et al. Evaluation of a hydrogel based breast biopsy marker (HydroMARK(R)) as an alternative to wire and radioactive seed localization for non-palpable breast lesions. J Surg Oncol. 2012 May;105(6):591–4. [PubMed: 22095610]

1173.

Klevesath MB, Godwin RJ, Bannon R, et al. Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions. Eur J Surg Oncol. 2005 Jun;31(5):490–4. [PubMed: 15922884]

1174.

Ko ES, Choi HY, Kim RB, et al. Application of sonoelastography: comparison of performance between mass and non-mass lesion. Eur J Radiol. 2012 Apr;81(4):731–6. [PubMed: 21306848]

1175.

Kontos M, Wilson R, Fentiman I. Digital infrared thermal imaging (DITI) of breast lesions: sensitivity and specificity of detection of primary breast cancers. Clin Radiol. 2011 Jun;66(6):536–9. [PubMed: 21377664]

1176.

Kooistra B, Wauters C, Strobbe L. Indeterminate breast fine-needle aspiration: repeat aspiration or core needle biopsy? Ann Surg Oncol. 2009 Feb;16(2):281–4. [PubMed: 19050965]

1177.

Koskela A, Berg M, Sudah M, et al. Learning curve for add-on stereotactic core needle breast biopsy. Acta Radiol. 2006 Jun;47(5):454–60. [PubMed: 16796305]

1178.

Kotsianos-Hermle D, Hiltawsky KM, Wirth S, et al. Analysis of 107 breast lesions with automated 3D ultrasound and comparison with mammography and manual ultrasound. Eur J Radiol. 2009 Jul;71(1):109–15. [PubMed: 18468829]

1179.

Krainick-Strobel U, Flugel B, Hahn M, et al. Complete resection of benign breast lesions with an ultrasound-guided vacuum biopsy system with a median follow-up of 13 months: Komplettresektion benigner Mammabefunde mittels ultraschallgefuhrter grosslumiger Vakuumbiopsie: Medianes Follow-up von 13 Monaten. Tumor Diagn Ther. 2010;31(6):338–42.

1180.

Kruger BM, Burrowes P, MacGregor JH. Accuracy of marker clip placement after mammotome breast biopsy. Can Assoc Radiol J. 2002 Jun;53(3):137–40. [PubMed: 12101533]

1181.

Kuhl CK, Morakkabati N, Leutner CC, et al. MR imaging--guided large-core (14-gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology. 2001 Jul;220(1):31–9. [PubMed: 11425969]

1182.

Kumm TR, Szabunio MM. Elastography for the characterization of breast lesions: initial clinical experience. Cancer Control. 2010 Jul;17(3):156–61. [PubMed: 20664512]

1183.

Kuo YL, Chang TW. Can concurrent core biopsy and fine needle aspiration biopsy improve the false negative rate of sonographically detectable breast lesions? BMC Cancer. 2010;10:371. [PMC free article: PMC2914704] [PubMed: 20637074]

1184.

Lacquement MA, Mitchell D, Hollingsworth AB. Positive predictive value of the Breast Imaging Reporting and Data System. J Am Coll Surg. 1999 Jul;189(1):34–40. [PubMed: 10401738]

1185.

Lamm RL, Jackman RJ. Mammographic abnormalities caused by percutaneous stereotactic biopsy of histologically benign lesions evident on follow-up mammograms. AJR Am J Roentgenol. 2000 Mar;174(3):753–6. [PubMed: 10701620]

1186.

Lang EV, Berbaum KS, Lutgendorf SK. Large-core breast biopsy: abnormal salivary cortisol profiles associated with uncertainty of diagnosis. Radiology. 2009 Mar;250(3):631–7. [PubMed: 19244038]

1187.

Lannin DR, Ponn T, Andrejeva L, et al. Should all breast cancers be diagnosed by needle biopsy? Am J Surg. 2006 Oct;192(4):450–4. [PubMed: 16978947]

1188.

LaRaja RD, Saber AA, Sickles A. Early experience in the use of the Advanced Breast Biopsy Instrumentation: a report of one hundred twenty-seven patients. Surgery. 1999 Apr;125(4):380–4. [PubMed: 10216528]

1189.

Larrieux G, Cupp JA, Liao J, et al. Effect of introducing hematoma ultrasound-guided lumpectomy in a surgical practice. J Am Coll Surg. 2012 Aug;215(2):237–43. [PMC free article: PMC4437196] [PubMed: 22632911]

1190.

Larson BT, Erdman AG, Tsekos NV, et al. Design of an MRI-compatible robotic stereotactic device for minimally invasive interventions in the breast. J Biomech Eng. 2004 Aug;126(4):458–65. [PubMed: 15543863]

1191.

Laudico A, Redaniel MT, Mirasol-Lumague MR, et al. Epidemiology and clinicopathology of breast cancer in metro Manila and Rizal Province, Philippines. Asian Pac J Cancer Prev. 2009 Jan–Mar;10(1):167–72. [PubMed: 19469648]

1192.

Layfield LJ, Factor RE, Jarboe EA. Clinician compliance with laboratory regulations requiring submission of relevant clinical data: A one year retrospective analysis. Pathol Res Pract. 2012 Nov 15;208(11):668–71. [PubMed: 22999368]

1193.

LeCarpentier GL, Roubidoux MA, Fowlkes JB, et al. Suspicious breast lesions: assessment of 3D Doppler US indexes for classification in a test population and fourfold cross-validation scheme. Radiology. 2008 Nov;249(2):463–70. [PMC free article: PMC2657861] [PubMed: 18936310]

1194.

Leconte I, Abraham C, Galant C, et al. Fibroadenoma: can fine needle aspiration biopsy avoid short term follow-up? Diagn Interv Imaging. 2012 Oct;93(10):750–6. [PubMed: 22999986]

1195.

Lee A, Chang J, Lim W, et al. Effectiveness of breast-specific gamma imaging (BSGI) for breast cancer in Korea: a comparative study. Breast J. 2012 Sep;18(5):453–8. [PubMed: 22897514]

1196.

Lee AH, Villena Salinas NM, Hodi Z, et al. The value of examination of multiple levels of mammary needle core biopsy specimens taken for investigation of lesions other than calcification. J Clin Pathol. 2012 Dec;65(12):1097–9. [PubMed: 22918889]

1197.

Lee CI, Wells CJ, Bassett LW. Cost minimization analysis of ultrasound-guided diagnostic evaluation of probably benign breast lesions. Breast J. 2013 Jan–Feb;19(1):41–8. [PubMed: 23186174]

1198.

Lee EJ, Jung HK, Ko KH, et al. Diagnostic performances of shear wave elastography: which parameter to use in differential diagnosis of solid breast masses? Eur Radiol. 2013 Jul;23(7):1803–11. [PubMed: 23423637]

1199.

Lee HJ, Kim EK, Kim MJ, et al. Observer variability of Breast Imaging Reporting and Data System (BI-RADS) for breast ultrasound. Eur J Radiol. 2008 Feb;65(2):293–8. [PubMed: 17531417]

1200.

Lee JH, Fulp W, Wells KJ, et al. Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL. PLoS One. 2013;8(9):e74542. [PMC free article: PMC3774725] [PubMed: 24066145]

1201.

Lee SH, Chang JM, Kim WH, et al. Differentiation of benign from malignant solid breast masses: comparison of two-dimensional and three-dimensional shear-wave elastography. Eur Radiol. 2013 Apr;23(4):1015–26. [PubMed: 23085867]

1202.

Lefkowitz RJ. Identification of adenylate cyclase-coupled beta-adrenergic receptors with radiolabeled beta-adrenergic antagonists. Biochem Pharmacol. 1975 Sep 15;24(18):1651–8. [PubMed: 11]

1203.

Lehman CD, Shook JE. Position of clip placement after vacuum-assisted breast biopsy: is a unilateral two-view postbiopsy mammogram necessary? Breast J. 2003 Jul–Aug;9(4):272–6. [PubMed: 12846859]

1204.

Leifland K, Lagerstedt U, Svane G. Comparison of stereotactic fine needle aspiration cytology and core needle biopsy in 522 non-palpable breast lesions. Acta Radiol. 2003 Jul;44(4):387–91. [PubMed: 12846688]

1205.

Leifland K, Lundquist H, Lagerstedt U, et al. Comparison of preoperative simultaneous stereotactic fine needle aspiration biopsy and stereotactic core needle biopsy in ductal carcinoma in situ of the breast. Acta Radiol. 2003 Mar;44(2):213–7. [PubMed: 12694110]

1206.

Leong LC, Sim LS, Lee YS, et al. A prospective study to compare the diagnostic performance of breast elastography versus conventional breast ultrasound. Clin Radiol. 2010 Nov;65(11):887–94. [PubMed: 20933643]

1207.

Leucht W, Leucht D, Kiesel L. Sonographic demonstration and evaluation of microcalcifications in the breast. Breast disease. 1992;5(2):105–23.

1208.

Levin DC, Parker L, Schwartz GF, et al. Percutaneous needle vs surgical breast biopsy: previous allegations of overuse of surgery are in error. J Am Coll Radiol. 2012 Feb;9(2):137–40. [PubMed: 22305700]

1209.

Li M, Song Y, Cho N, et al. An HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsy. PLoS One. 2011;6(10):e25563. [PMC free article: PMC3196497] [PubMed: 22028780]

1210.

Liao MN, Chen PL, Chen MF, et al. Effect of supportive care on the anxiety of women with suspected breast cancer. J Adv Nurs. 2010 Jan;66(1):49–59. [PubMed: 19968726]

1211.

Liao MN, Chen PL, Chen MF, et al. Supportive care for Taiwanese women with suspected breast cancer during the diagnostic period: effect on healthcare and support needs. Oncol Nurs Forum. 2009 Sep;36(5):585–92. [PubMed: 19726399]

1212.

Liberman L, Benton CL, Dershaw DD, et al. Learning curve for stereotactic breast biopsy: how many cases are enough? AJR Am J Roentgenol. 2001 Mar;176(3):721–7. [PubMed: 11222213]

1213.

Liberman L, Dershaw DD, Morris EA, et al. Clip placement after stereotactic vacuum-assisted breast biopsy. Radiology. 1997 Nov;205(2):417–22. [PubMed: 9356622]

1214.

Liberman L, Dershaw DD, Rosen PP, et al. Stereotaxic 14-gauge breast biopsy: how many core biopsy specimens are needed? Radiology. 1994 Sep;192(3):793–5. [PubMed: 8058949]

1215.

Liberman L, Dershaw DD, Rosen PP, et al. Percutaneous removal of malignant mammographic lesions at stereotactic vacuum-assisted biopsy. Radiology. 1998 Mar;206(3):711–5. [PubMed: 9494489]

1216.

Liberman L, Dershaw DD, Rosen PP, et al. Core needle biopsy of synchronous ipsilateral breast lesions: impact on treatment. AJR Am J Roentgenol. 1996 Jun;166(6):1429–32. [PubMed: 8633457]

1217.

Liberman L, Evans WP 3rd, Dershaw DD, et al. Radiography of microcalcifications in stereotaxic mammary core biopsy specimens. Radiology. 1994 Jan;190(1):223–5. [PubMed: 8259409]

1218.

Liberman L, Goodstine SL, Dershaw DD, et al. One operation after percutaneous diagnosis of nonpalpable breast cancer: frequency and associated factors. AJR Am J Roentgenol. 2002 Mar;178(3):673–9. [PubMed: 11856696]

1219.

Liberman L, Hann LE, Dershaw DD, et al. Mammographic findings after stereotactic 14-gauge vacuum biopsy. Radiology. 1997 May;203(2):343–7. [PubMed: 9114086]

1220.

Liberman L, Smolkin JH, Dershaw DD, et al. Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. Radiology. 1998 Jul;208(1):251–60. [PubMed: 9646821]

1221.

Lieske B, Ravichandran D, Wright D. Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma. Br J Cancer. 2006 Jul 3;95(1):62–6. [PMC free article: PMC2360502] [PubMed: 16755293]

1222.

Lieu D. Cytopathologist-performed ultrasound-guided fine-needle aspiration and core-needle biopsy: a prospective study of 500 consecutive cases. Diagn Cytopathol. 2008 May;36(5):317–24. [PubMed: 18418854]

1223.

Lifrange E, Dondelinger RF, Foidart JM, et al. Percutaneous stereotactic en bloc excision of nonpalpable breast carcinoma: a step in the direction of supraconservative surgery. Breast. 2002 Dec;11(6):501–8. [PubMed: 14965717]

1224.

Lifrange E, Dondelinger RF, Fridman V, et al. En bloc excision of nonpalpable breast lesions using the advanced breast biopsy instrumentation system: an alternative to needle guided surgery? Eur Radiol. 2001;11(5):796–801. [PubMed: 11372610]

1225.

Lifrange E, Kridelka F, Colin C. Stereotaxic needle-core biopsy and fine-needle aspiration biopsy in the diagnosis of nonpalpable breast lesions: controversies and future prospects. Eur J Radiol. 1997 Jan;24(1):39–47. [PubMed: 9056148]

1226.

Linda A, Zuiani C, Londero V, et al. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size. Breast. 2008 Feb;17(1):51–7. [PubMed: 17709249]

1227.

Lindfors KK, O’Connor J, Acredolo CR, et al. Short-interval follow-up mammography versus immediate core biopsy of benign breast lesions: assessment of patient stress. AJR Am J Roentgenol. 1998 Jul;171(1):55–8. [PubMed: 9648763]

1228.

Lister D, Evans AJ, Burrell HC, et al. The accuracy of breast ultrasound in the evaluation of clinically benign discrete, symptomatic breast lumps. Clin Radiol. 1998 Jul;53(7):490–2. [PubMed: 9714387]

1229.

Liu X, Inciardi M, Bradley JP, et al. Microcalcifications of the breast: size matters! A mammographic-histologic correlation study. Pathologica. 2007 Feb;99(1):5–10. [PubMed: 17566305]

1230.

Lo GG, Ai V, Chan JK, et al. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T. J Comput Assist Tomogr. 2009 Jan–Feb;33(1):63–9. [PubMed: 19188787]

1231.

Logan-Young W, Dawson AE, Wilbur DC, et al. The cost-effectiveness of fine-needle aspiration cytology and 14-gauge core needle biopsy compared with open surgical biopsy in the diagnosis of breast carcinoma. Cancer. 1998 May 15;82(10):1867–73. [PubMed: 9587118]

1232.

Lovrics PJ, Gordon M, Cornacchi SD, et al. Practice patterns and perceptions of margin status for breast conserving surgery for breast carcinoma: National Survey of Canadian General Surgeons. Breast. 2012 Dec;21(6):730–4. [PubMed: 22901975]

1233.

Lyon D, Walter J, Munro CL, et al. Challenges in interpreting cytokine biomarkers in biobehavioral research: a breast cancer exemplar. Biol Res Nurs. 2011 Jan;13(1):25–31. [PMC free article: PMC3966622] [PubMed: 21199813]

1234.

Mack LA, Dabbs K, Temple WJ. Synoptic operative record for point of care outcomes: a leap forward in knowledge translation. Eur J Surg Oncol. 2010 Sep;36(Suppl 1):S44–9. [PubMed: 20609548]

1235.

Madabhushi A, Agner S, Basavanhally A, et al. Computer-aided prognosis: predicting patient and disease outcome via quantitative fusion of multi-scale, multi-modal data. Comput Med Imaging Graph. 2011 Oct–Dec;35(7–8):506–14. [PubMed: 21333490]

1236.

Mahoney MC. Initial clinical experience with a new MRI vacuum-assisted breast biopsy device. J Magn Reson Imaging. 2008 Oct;28(4):900–5. [PubMed: 18821610]

1237.

Mainiero MB, Koelliker SL, Lazarus E, et al. Ultrasound-guided large-core needle biopsy of the breast. JOURNAL OF WOMENS IMAGING. 2002;4(2):52–7.

1238.

Majek O, Danes J, Skovajsova M, et al. Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme. BMC Public Health. 2011;11:288. [PMC free article: PMC3112123] [PubMed: 21554747]

1239.

Manfrin E, Mariotto R, Remo A, et al. Is there still a role for fine-needle aspiration cytology in breast cancer screening? Experience of the Verona Mammographic Breast Cancer Screening Program with real-time integrated radiopathologic activity (1999–2004). Cancer. 2008 Apr 25;114(2):74–82. [PubMed: 18306357]

1240.

Mann RM. The effectiveness of MR imaging in the assessment of invasive lobular carcinoma of the breast. Magn Reson Imaging Clin N Am. 2010 May;18(2):259–76. ix. [PubMed: 20494311]

1241.

Mansour SM, Omar OS. Elastography ultrasound and questionable breast lesions: does it count? Eur J Radiol. 2012 Nov;81(11):3234–44. [PubMed: 22591761]

1242.

March DE, Walker MT, Bur M, et al. Touch-preparation cytologic examination of breast core biopsy specimens: accuracy in predicting benign or malignant core histologic results. Acad Radiol. 1999 Jun;6(6):333–8. [PubMed: 10376063]

1243.

Margolin FR, Kaufman L, Denny SR, et al. Metallic marker placement after stereotactic core biopsy of breast calcifications: comparison of two clips and deployment techniques. AJR Am J Roentgenol. 2003 Dec;181(6):1685–90. [PubMed: 14627597]

1244.

Margolin FR, Kaufman L, Jacobs RP, et al. Stereotactic core breast biopsy of malignant calcifications: diagnostic yield of cores with and cores without calcifications on specimen radiographs. Radiology. 2004 Oct;233(1):251–4. [PubMed: 15333764]

1245.

Marti WR, Zuber M, Oertli D, et al. Advanced breast biopsy instrumentation for the evaluation of impalpable lesions: a reliable diagnostic tool with little therapeutic potential. European Journal of Surgery. 2001;167(1):15–8. [PubMed: 11213814]

1246.

Masood S, Antley CM, Mooney EE, et al. A Comparison of Accuracy Rates Between Open Biopsy, Cutting-Needle Biopsy, and Fine-Needle Aspiration Biopsy of the Breast: A 3-Year Experience. The Breast Journal. 1998;4(1):3–8.

1247.

Masood S, Feng D, Tutuncuoglu O, et al. Diagnostic value of imprint cytology during image-guided core biopsy in improving breast health care. Ann Clin Lab Sci. 2011 Fall;41(1):8–13. [PubMed: 21325248]

1248.

Masroor I. Effectiveness of assigning BI-RADS category-3 to breast lesion with respect to follow-up. J Coll Physicians Surg Pak. 2008 Apr;18(4):209–12. [PubMed: 18474152]

1249.

Matthews BD, Williams GB. Initial experience with the advanced breast biopsy instrumentation system. Am J Surg. 1999 Feb;177(2):97–101. [PubMed: 10204548]

1250.

Mazouni C, Sneige N, Rouzier R, et al. A nomogram to predict for malignant diagnosis of BI-RADS Category 4 breast lesions. J Surg Oncol. 2010 Sep 1;102(3):220–4. [PubMed: 20740578]

1251.

Mazzini RC, Elias S, Nazario AC, et al. Prevalence of c-myc expression in breast lesions associated with microcalcifications detected by routine mammography. Sao Paulo Med J. 2009 May;127(2):66–70. [PubMed: 19597680]

1252.

McKee MD, Cropp MD, Hyland A, et al. Provider case volume and outcome in the evaluation and treatment of patients with mammogram-detected breast carcinoma. Cancer. 2002 Aug 15;95(4):704–12. [PubMed: 12209712]

1253.

Meloni GB, Dessole S, Becchere MP, et al. Ultrasound-guided mammotome vacuum biopsy for the diagnosis of impalpable breast lesions. Ultrasound Obstet Gynecol. 2001 Nov;18(5):520–4. [PubMed: 11844176]

1254.

Melotti MK, Berg WA. Core needle breast biopsy in patients undergoing anticoagulation therapy: preliminary results. AJR Am J Roentgenol. 2000 Jan;174(1):245–9. [PubMed: 10628487]

1255.

Mendez A, Cabanillas F, Echenique M, et al. Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB). Ann Oncol. 2004 Mar;15(3):450–4. [PubMed: 14998847]

1256.

Menes TS, Kerlikowske K, Jaffer S, et al. Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium. Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2822–8. [PMC free article: PMC2920735] [PubMed: 19900937]

1257.

Mercado CL, Guth AA, Toth HK, et al. Sonographically guided marker placement for confirmation of removal of mammographically occult lesions after localization. AJR Am J Roentgenol. 2008 Oct;191(4):1216–9. [PubMed: 18806168]

1258.

Mesurolle B, Bining HJ, El Khoury M, et al. Contribution of tissue harmonic imaging and frequency compound imaging in interventional breast sonography. J Ultrasound Med. 2006 Jul;25(7):845–55. [PubMed: 16798895]

1259.

Meyer JE, Smith DN, DiPiro PJ, et al. Stereotactic breast biopsy of clustered microcalcifications with a directional, vacuum-assisted device. Radiology. 1997 Aug;204(2):575–6. [PubMed: 9240556]

1260.

Milenkovic J, Hertl K, Kosir A, et al. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions. Artif Intell Med. 2013 Jun;58(2):101–14. [PubMed: 23548472]

1261.

Moon HJ, Kim EK, Kwak JY, et al. Interval growth of probably benign breast lesions on follow-up ultrasound: how can these be managed? Eur Radiol. 2011 May;21(5):908–18. [PubMed: 21113596]

1262.

Moon HJ, Kim MJ, Kwak JY, et al. Probably benign breast lesions on ultrasonography: a retrospective review of ultrasonographic features and clinical factors affecting the BI-RADS categorization. Acta Radiol. 2010 May;51(4):375–82. [PubMed: 20350247]

1263.

Moon HJ, Kim MJ, Kwak JY, et al. Malignant lesions initially categorized as probably benign breast lesions: retrospective review of ultrasonographic, clinical and pathologic characteristics. Ultrasound Med Biol. 2010 Apr;36(4):551–9. [PubMed: 20350681]

1264.

Moon JH, Kim HH, Shin HJ, et al. Supplemental use of optical diffusion breast imaging for differentiation between benign and malignant breast lesions. AJR Am J Roentgenol. 2011 Sep;197(3):732–9. [PubMed: 21862818]

1265.

Moon WK, Huang CS, Shen WC, et al. Analysis of elastographic and B-mode features at sonoelastography for breast tumor classification. Ultrasound Med Biol. 2009 Nov;35(11):1794–802. [PubMed: 19767139]

1266.

Moore SG, Shenoy PJ, Fanucchi L, et al. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population. BMC Health Serv Res. 2009;9:9. [PMC free article: PMC2630922] [PubMed: 19144138]

1267.

Moritz JD, Luftner-Nagel S, Westerhof JP, et al. A comparison of conventional mammographic magnification, ultra high magnification and industrial magnification radiography in the radiographic detection of microcalcifications within core biopsies of the breast. Br J Radiol. 1997 Nov;70(839):1099–103. [PubMed: 9536898]

1268.

Moritz JD, Mertens C, Westerhof JP, et al. Role of high magnification specimen radiography in surgical and core biopsies of the breast. Br J Radiol. 2000 Nov;73(875):1170–7. [PubMed: 11144794]

1269.

Morrogh M, Morris EA, Liberman L, et al. MRI identifies otherwise occult disease in select patients with Paget disease of the nipple. J Am Coll Surg. 2008 Feb;206(2):316–21. [PubMed: 18222386]

1270.

Morrogh M, Park A, Elkin EB, et al. Lessons learned from 416 cases of nipple discharge of the breast. Am J Surg. 2010 Jul;200(1):73–80. [PubMed: 20079481]

1271.

Morrow M, Venta L, Stinson T, et al. Prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients. Ann Surg. 2001 Apr;233(4):537–41. [PMC free article: PMC1421283] [PubMed: 11303136]

1272.

Mouton JP, Apffelstaedt J, Baatjes K. Surgical mammography reporting in a limited resource environment. World J Surg. 2010 Nov;34(11):2530–6. [PubMed: 20577769]

1273.

Moy L, Elias K, Patel V, et al. Is breast MRI helpful in the evaluation of inconclusive mammographic findings? AJR Am J Roentgenol. 2009 Oct;193(4):986–93. [PubMed: 19770320]

1274.

Moy L, Noz ME, Maguire GQ Jr, et al. Role of fusion of prone FDG-PET and magnetic resonance imaging of the breasts in the evaluation of breast cancer. Breast J. 2010 Jul–Aug;16(4):369–76. [PubMed: 20443788]

1275.

Moyle P, Sonoda L, Britton P, et al. Incidental breast lesions detected on CT: what is their significance? Br J Radiol. 2010 Mar;83(987):233–40. [PMC free article: PMC3473543] [PubMed: 19546179]

1276.

Mullen DJ, Eisen RN, Newman RD, et al. The use of carbon marking after stereotactic large-core-needle breast biopsy. Radiology. 2001 Jan;218(1):255–60. [PubMed: 11152811]

1277.

Nakhleh RE, Grimm EE, Idowu MO, et al. Laboratory compliance with the American Society of Clinical Oncology/college of American Pathologists guidelines for human epidermal growth factor receptor 2 testing: a College of American Pathologists survey of 757 laboratories. Arch Pathol Lab Med. 2010 May;134(5):728–34. [PubMed: 20441503]

1278.

National Guideline Clearinghouse (NGC). National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Guideline summary: Cancer in children and young people In: Suspected cancer in primary care: guidelines for investigation, referral and reducing ethnic disparities. [cited 2013 June 25]. Available: http://www​.guideline.gov.

1279.

Neary M, Lowery AJ, O’Conghaile A, et al. NCCP breast cancer referral guidelines--are breast cancer patients prioritised? Ir Med J. 2011 Feb;104(2):39–41. [PubMed: 21465872]

1280.

Nederend J, Duijm LE, Louwman MW, et al. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands. Eur J Cancer. 2014 Jan;50(1):31–9. [PubMed: 24275518]

1281.

Nederend J, Duijm LE, Louwman MW, et al. Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study. Ann Oncol. 2012 Dec;23(12):3098–103. [PubMed: 22745215]

1282.

Ng AK, Garber JE, Diller LR, et al. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol. 2013 Jun 20;31(18):2282–8. [PubMed: 23610104]

1283.

Ng CH, Lee KT, Taib NA, et al. Experience with hookwire localisation excision biopsy at a medical centre in Malaysia. Singapore Med J. 2010 Apr;51(4):306–10. [PubMed: 20505908]

1284.

Ngotho J, Githaiga J, Kaisha W. Palpable discrete breast masses in young women: two of the components of the modified triple test may be adequate. S Afr J Surg. 2013 May;51(2):58–60. [PubMed: 23725894]

1285.

Nguansangiam S, Jesdapatarakul S, Tangjitgamol S. Accuracy of fine needle aspiration cytology from breast masses in Thailand. Asian Pac J Cancer Prev. 2009 Oct–Dec;10(4):623–6. [PubMed: 19827882]

1286.

Nizri E, Schneebaum S, Klausner JM, et al. Current management practice of breast borderline lesions--need for further research and guidelines. Am J Surg. 2012 Jun;203(6):721–5. [PubMed: 22153085]

1287.

Noroozian M, Hadjiiski L, Rahnama-Moghadam S, et al. Digital breast tomosynthesis is comparable to mammographic spot views for mass characterization. Radiology. 2012 Jan;262(1):61–8. [PMC free article: PMC3244671] [PubMed: 21998048]

1288.

Nurko J, Mancino AT, Whitacre E, et al. Surgical benefits conveyed by biopsy site marking system using ultrasound localization. Am J Surg. 2005 Oct;190(4):618–22. [PubMed: 16164935]

1289.

O’Flynn EA, Currie RJ, Mohammed K, et al. Pre-operative factors indicating risk of multiple operations versus a single operation in women undergoing surgery for screen detected breast cancer. Breast. 2013 Feb;22(1):78–82. [PubMed: 22789490]

1290.

Ogura A, Hayakawa K, Yoshida S, et al. Use of dynamic phase subtraction (DPS) map in dynamic contrast-enhanced MRI of the breast. J Comput Assist Tomogr. 2011 Nov–Dec;35(6):749–52. [PubMed: 22082548]

1291.

Ohene-Yeboah M. Breast pain in Ghanaian women: clinical, ultrasonographic, mammographic and histological findings in 1612 consecutive patients. West Afr J Med. 2008 Jan;27(1):20–3. [PubMed: 18689298]

1292.

Oikonomou V, Fotou M, Zagouri F, et al. Imprint cytology of vacuum-assisted breast biopsy specimens: a rapid diagnostic tool in non-palpable solid lesions. Cytopathology. 2008 Oct;19(5):311–5. [PubMed: 17953690]

1293.

Okazaki H, Tsujimoto F, Maeda I, et al. Radiologic-pathological correlation of punctate hyperechoic foci by ultrasound in stereotactic vacuum-assisted breast biopsy samples. Jpn J Radiol. 2009 Dec;27(10):438–43. [PubMed: 20035416]

1294.

Okines AF, Thompson LC, Cunningham D, et al. Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial. Ann Oncol. 2013 May;24(5):1253–61. [PubMed: 23233651]

1295.

Olaya W, Bae W, Wong J, et al. Are percutaneous biopsy rates a reasonable quality measure in breast cancer management? Ann Surg Oncol. 2010 Oct;17(Suppl 3):268–72. [PubMed: 20853045]

1296.

O’Leary R, Hawkins K, Beazley JC, et al. Agreement between preoperative core needle biopsy and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained. J Clin Pathol. 2004 Feb;57(2):193–5. [PMC free article: PMC1770204] [PubMed: 14747449]

1297.

Oliveira TM, Brasileiro Sant’Anna TK, Mauad FM, et al. Breast imaging: is the sonographic descriptor of orientation valid for magnetic resonance imaging? J Magn Reson Imaging. 2012 Dec;36(6):1383–8. [PubMed: 22911937]

1298.

Olsen ML, Morton MJ, Stan DL, et al. Is there a role for magnetic resonance imaging in diagnosing palpable breast masses when mammogram and ultrasound are negative? J Womens Health (Larchmt). 2012 Nov;21(11):1149–54. [PMC free article: PMC3698622] [PubMed: 23046046]

1299.

O’Meara ES, Zhu W, Hubbard RA, et al. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013 Nov 15;119(22):3959–67. [PMC free article: PMC3935985] [PubMed: 24037812]

1300.

Ooi GJ, Fox J, Siu K, et al. Fourier transform infrared imaging and small angle x-ray scattering as a combined biomolecular approach to diagnosis of breast cancer. Med Phys. 2008 May;35(5):2151–61. [PubMed: 18561690]

1301.

Oster NV, Carney PA, Allison KH, et al. Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS). BMC Womens Health. 2013;13:3. [PMC free article: PMC3610240] [PubMed: 23379630]

1302.

Ozulker T, Ozulker F, Ozpacaci T, et al. The efficacy of (99m)Tc-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with X-rays mammography, ultrasonography and magnetic resonance imaging. Hell J Nucl Med. 2010 May–Aug;13(2):144–9. [PubMed: 20808988]

1303.

Pacheco JM, Gao F, Bumb C, et al. Racial differences in outcomes of triple-negative breast cancer. Breast Cancer Res Treat. 2013 Feb;138(1):281–9. [PMC free article: PMC4537526] [PubMed: 23400579]

1304.

Pagni F, Bosisio FM, Salvioni D, et al. Application of the British National Health Service Breast Cancer Screening Programme classification in 226 breast core needle biopsies: correlation with resected specimens. Ann Diagn Pathol. 2012 Apr;16(2):112–8. [PubMed: 22056037]

1305.

Park YM, Kim EK, Lee JH, et al. Palpable breast masses with probably benign morphology at sonography: can biopsy be deferred? Acta Radiol. 2008 Dec;49(10):1104–11. [PubMed: 18855166]

1306.

Parker SJ, Wheaton M, Wallis MG, et al. Why should diagnostic benign breast biopsies weight less than twenty grams? Ann R Coll Surg Engl. 2001 Mar;83(2):113–6. [PMC free article: PMC2503347] [PubMed: 11320919]

1307.

Partridge SC, DeMartini WB, Kurland BF, et al. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol. 2009 Dec;193(6):1716–22. [PubMed: 19933670]

1308.

Pegolo E, Pandolfi M, Di Loreto C. Implementation of a microwave-assisted tissue-processing system and an automated embedding system for breast needle core biopsy samples: morphology, immunohistochemistry, and FISH evaluation. Appl Immunohistochem Mol Morphol. 2013 Jul;21(4):362–70. [PubMed: 23060302]

1309.

Pelletier M, Knauper B, Loiselle CG, et al. Moderators of psychological recovery from benign cancer screening results. Curr Oncol. 2012 Jun;19(3):e191–200. [PMC free article: PMC3364780] [PubMed: 22670109]

1310.

Perelman VS, Colapinto ND, Lee S, et al. Experience with the advanced breast biopsy instrumentation system. Can J Surg. 2000 Dec;43(6):437–41. [PMC free article: PMC3695199] [PubMed: 11129832]

1311.

Perez-Stable EJ, Afable-Munsuz A, Kaplan CP, et al. Factors influencing time to diagnosis after abnormal mammography in diverse women. J Womens Health (Larchmt). 2013 Feb;22(2):159–66. [PMC free article: PMC3573728] [PubMed: 23350859]

1312.

Pezner RD, Lorant JA, Terz J, et al. Wound-healing complications following biopsy of the irradiated breast. Arch Surg. 1992 Mar;127(3):321–4. [PubMed: 1550480]

1313.

Philpotts LE, Lee CH, Horvath LJ, et al. Canceled stereotactic core-needle biopsy of the breast: analysis of 89 cases. Radiology. 1997 Nov;205(2):423–8. [PubMed: 9356623]

1314.

Philpotts LE, Shaheen NA, Carter D, et al. Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. AJR Am J Roentgenol. 1999 Mar;172(3):683–7. [PubMed: 10063860]

1315.

Pijnappel RM, van Dalen A, Borel Rinkes IH, et al. The diagnostic accuracy of core biopsy in palpable and non-palpable breast lesions. Eur J Radiol. 1997 Feb;24(2):120–3. [PubMed: 9097053]

1316.

Pilgrim S, Ravichandran D. Fine needle aspiration cytology as an adjunct to core biopsy in the assessment of symptomatic breast carcinoma. The Breast. 2005;14(5):411–4. [PubMed: 16216746]

1317.

Piron CA, Causer P, Jong R, et al. A hybrid breast biopsy system combining ultrasound and MRI. IEEE Trans Med Imaging. 2003 Sep;22(9):1100–10. [PubMed: 12956265]

1318.

Pocock B, Taback B, Klein L, et al. Preoperative needle biopsy as a potential quality measure in breast cancer surgery. Ann Surg Oncol. 2009 May;16(5):1108–11. [PubMed: 18953610]

1319.

Pogacnik A, Strojan Flezar M, Rener M. Ultrasonographically and stereotactically guided fine-needle aspiration cytology of non-palpable breast lesions: cyto-histological correlation. Cytopathology. 2008 Oct;19(5):303–10. [PubMed: 17944953]

1320.

Poole GH, Willsher PC, Pinder SE, et al. Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytology. Aust N Z J Surg. 1996 Sep;66(9):592–4. [PubMed: 8859156]

1321.

Portincasa G, Lucci E, Navarra GG, et al. Initial experience with breast biopsy utilizing the Advanced Breast Biopsy Instrumentation (ABBI). J Surg Oncol. 2000;74(3):201–3. [PubMed: 10951417]

1322.

Povoski SP, Jimenez RE. A comprehensive evaluation of the 8-gauge vacuum-assisted Mammotome® system for ultrasound-guided diagnostic biopsy and selective excision of breast lesions. World journal of surgical oncology. 2007;5(1):83. [PMC free article: PMC1988825] [PubMed: 17663769]

1323.

Prat X, Sittek H, Grosse A, et al. European quadricentric evaluation of a breast MR biopsy and localization device: technical improvements based on phase-I evaluation. Eur Radiol. 2002 Jul;12(7):1720–7. [PubMed: 12111063]

1324.

Price J, Chen SW. Screening for breast cancer with MRI: recent experience from the Australian Capital Territory. J Med Imaging Radiat Oncol. 2009 Feb;53(1):69–80. [PubMed: 19453531]

1325.

Prieto-Granada C, Setia N, Otis CN. Lymph node extramedullary hematopoiesis in breast cancer patients receiving neoadjuvant therapy: a potential diagnostic pitfall. Int J Surg Pathol. 2013 Jun;21(3):264–6. [PubMed: 23493877]

1326.

Pritchard MG, Townend JN, Lester WA, et al. Management of patients taking antiplatelet or anticoagulant medication requiring invasive breast procedures: United Kingdom survey of radiologists’ and surgeons’ current practice. Clin Radiol. 2008 Mar;63(3):305–11. [PubMed: 18275871]

1327.

Provatopoulou X, Gounaris A, Kalogera E, et al. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease. BMC Cancer. 2009;9:390. [PMC free article: PMC2775750] [PubMed: 19889214]

1328.

Pruthi S, Shmidt E, Sherman MM, et al. Promoting a breast cancer screening clinic for underserved women: a community collaboration. Ethn Dis. 2010 Autumn;20(4):463–6. [PubMed: 21305838]

1329.

Psooy BJ, Schreuer D, Borgaonkar J, et al. Patient navigation: improving timeliness in the diagnosis of breast abnormalities. Can Assoc Radiol J. 2004 Jun;55(3):145–50. [PubMed: 15237774]

1330.

Qazi DES, Mohayuddin N. Role of fine needle aspiration cytology and core biopsy in the diagnosis of breast lumps. J Postgrad med Inst. 2005;19(1):67–70.

1331.

Qi J, Ye Z. CTLM as an adjunct to mammography in the diagnosis of patients with dense breast. Clin Imaging. 2013 Mar–Apr;37(2):289–94. [PubMed: 23465981]

1332.

Qin W, Gui G, Zhang K, et al. Proteins and carbohydrates in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy. BMC Cancer. 2012;12:52. [PMC free article: PMC3337322] [PubMed: 22296682]

1333.

Qureshi NA, Beresford A, Sami S, et al. Imprint cytology of needle core-biopsy specimens of breast lesions: is it a useful adjunt to rapid assessment breast clinics? Breast. 2007 Feb;16(1):81–5. [PubMed: 16952454]

1334.

Raj V, Sivashanmugam T, Gupta S, et al. Influence of imaging on touch imprint cytology of breast lesions. Cancer Epidemiol. 2010 Aug;34(4):457–60. [PubMed: 20537609]

1335.

Rebner M, Chesbrough R, Gregory N. Initial experience with the advanced breast biopsy instrumentation device. AJR Am J Roentgenol. 1999 Jul;173(1):221–6. [PubMed: 10397130]

1336.

Regini E, Bagnera S, Tota D, et al. Role of sonoelastography in characterising breast nodules. Preliminary experience with 120 lesions. Radiol Med. 2010 Jun;115(4):551–62. [PubMed: 20177990]

1337.

Renshaw AA. Minimal (< or =0.1 cm) invasive carcinoma in breast core needle biopsies. Incidence, sampling, associated findings, and follow-up. Arch Pathol Lab Med. 2004 Sep;128(9):996–9. [PubMed: 15335264]

1338.

Reynolds HE. Marker clip placement following directional, vacuum-assisted breast biopsy. Am Surg. 1999 Jan;65(1):59–60. [PubMed: 9915534]

1339.

Rhodes DJ, Hruska CB, Phillips SW, et al. Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts. Radiology. 2011 Jan;258(1):106–18. [PubMed: 21045179]

1340.

Riedl CC, Pfarl G, Memarsadeghi M, et al. Lesion miss rates and false-negative rates for 1115 consecutive cases of stereotactically guided needle-localized open breast biopsy with long-term follow-up. Radiology. 2005 Dec;237(3):847–53. [PubMed: 16237133]

1341.

Robbins J, Jeffries D, Roubidoux M, et al. Accuracy of diagnostic mammography and breast ultrasound during pregnancy and lactation. AJR Am J Roentgenol. 2011 Mar;196(3):716–22. [PubMed: 21343518]

1342.

Roe SM, Mathews JA, Burns RP, et al. Stereotactic and ultrasound core needle breast biopsy performed by surgeons. Am J Surg. 1997 Dec;174(6):699–703. discussion -4. [PubMed: 9409600]

1343.

Roman M, Hubbard RA, Sebuodegard S, et al. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: Updated results. Cancer. 2013 Nov 15;119(22):3952–8. [PubMed: 23963877]

1344.

Romero C, Varela C, Munoz E, et al. Impact on breast cancer diagnosis in a multidisciplinary unit after the incorporation of mammography digitalization and computer-aided detection systems. AJR Am J Roentgenol. 2011 Dec;197(6):1492–7. [PubMed: 22109307]

1345.

Rominger MB, Sax EV, Figiel JH, et al. Occurrence and Positive Predictive Value of Additional Nonmass Findings for Risk Stratification of Breast Microcalcifications in Mammography. Can Assoc Radiol J. 2013 Jan 5 [PubMed: 23298860]

1346.

Rose A, Collins JP, Neerhut P, et al. Carbon localisation of impalpable breast lesions. Breast. 2003 Aug;12(4):264–9. [PubMed: 14659311]

1347.

Rosen EL, Baker JA, Soo MS. Accuracy of a collagen-plug biopsy site marking device deployed after stereotactic core needle breast biopsy. AJR Am J Roentgenol. 2003 Nov;181(5):1295–9. [PubMed: 14573422]

1348.

Rosen EL, Vo TT. Metallic clip deployment during stereotactic breast biopsy: retrospective analysis. Radiology. 2001 Feb;218(2):510–6. [PubMed: 11161170]

1349.

Rotten D, Levaillant JM, Leridon H, et al. Ultrasonographically guided fine needle aspiration cytology and core-needle biopsy in the diagnosis of breast tumors. Eur J Obstet Gynecol Reprod Biol. 1993 May;49(3):175–86. [PubMed: 8405632]

1350.

Ruano R, Ramos M, Garcia-Talavera JR, et al. Staging the axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer. Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1299–304. [PubMed: 18274744]

1351.

Rubin E, Dempsey PJ, Pile NS, et al. Needle-localization biopsy of the breast: impact of a selective core needle biopsy program on yield. Radiology. 1995 Jun;195(3):627–31. [PubMed: 7753985]

1352.

Rulli A, Lauro A, Bisacci C, et al. Non-palpable breast lesion-biopsy by ABBI® system. A diagnostic tool. CHIRURGIA-TORINO. 2005;18(4):175.

1353.

Saad Z, Vincent M, Bramwell V, et al. Timing of surgery influences survival in receptor-negative as well as receptor-positive breast cancer. Eur J Cancer. 1994;30A(9):1348–52. [PubMed: 7999424]

1354.

Sadler GP, McGee S, Dallimore NS, et al. Role of fine-needle aspiration cytology and needle-core biopsy in the diagnosis of lobular carcinoma of the breast. Br J Surg. 1994 Sep;81(9):1315–7. [PubMed: 7953397]

1355.

Saha A, Barman I, Dingari NC, et al. Precision of Raman spectroscopy measurements in detection of microcalcifications in breast needle biopsies. Anal Chem. 2012 Aug 7;84(15):6715–22. [PMC free article: PMC3424275] [PubMed: 22746329]

1356.

Sahiner B, Chan HP, Hadjiiski LM, et al. Multi-modality CADx: ROC study of the effect on radiologists’ accuracy in characterizing breast masses on mammograms and 3D ultrasound images. Acad Radiol. 2009 Jul;16(7):810–8. [PMC free article: PMC2722036] [PubMed: 19375953]

1357.

Sakuma T, Mimura A, Tanigawa N, et al. Rapid on-site cytologic examination of 1500 breast lesions using the modified Shorr’s stain. Breast Cancer. 2013 Jun 4 [PubMed: 23733595]

1358.

Sanchez Gomez S, Torres Tabanera M, Vega Bolivar A, et al. Impact of a CAD system in a screen-film mammography screening program: a prospective study. Eur J Radiol. 2011 Dec;80(3):e317–21. [PubMed: 20863639]

1359.

Sanders MA, Roland L, Sahoo S. Clinical implications of subcategorizing BI-RADS 4 breast lesions associated with microcalcification: a radiology-pathology correlation study. Breast J. 2010 Jan–Feb;16(1):28–31. [PubMed: 19929890]

1360.

Satchithananda K, Fernando RA, Ralleigh G, et al. An audit of pain/discomfort experienced during image-guided breast biopsy procedures. Breast J. 2005 Nov–Dec;11(6):398–402. [PubMed: 16297083]

1361.

Sauter ER, Davis W, Qin W, et al. Identification of a beta-casein-like peptide in breast nipple aspirate fluid that is associated with breast cancer. Biomark Med. 2009 Oct;3(5):577–88. [PMC free article: PMC3377166] [PubMed: 20477526]

1362.

Sauven P, Bishop H, Patnick J, et al. The National Health Service Breast Screening Programme and British Association of Surgical Oncology audit of quality assurance in breast screening 1996–2001. Br J Surg. 2003 Jan;90(1):82–7. [PubMed: 12520580]

1363.

Sayed S, Moloo Z, Bird P, et al. Breast cancer diagnosis in a resource poor environment through a collaborative multidisciplinary approach: the Kenyan experience. J Clin Pathol. 2013 Apr;66(4):307–11. [PubMed: 23378268]

1364.

Scaranelo AM, Crystal P, Bukhanov K, et al. Sensitivity of a direct computer-aided detection system in full-field digital mammography for detection of microcalcifications not associated with mass or architectural distortion. Can Assoc Radiol J. 2010 Jun;61(3):162–9. [PubMed: 20137883]

1365.

Schabel MC, Morrell GR, Oh KY, et al. Pharmacokinetic mapping for lesion classification in dynamic breast MRI. J Magn Reson Imaging. 2010 Jun;31(6):1371–8. [PMC free article: PMC4657573] [PubMed: 20512889]

1366.

Schaefer FK, Eden I, Schaefer PJ, et al. Factors associated with one step surgery in case of non-palpable breast cancer. Eur J Radiol. 2007 Dec;64(3):426–31. [PubMed: 17386990]

1367.

Schaefer FK, Heer I, Schaefer PJ, et al. Breast ultrasound elastography--results of 193 breast lesions in a prospective study with histopathologic correlation. Eur J Radiol. 2011 Mar;77(3):450–6. [PubMed: 19773141]

1368.

Schaub NP, Jones KJ, Nyalwidhe JO, et al. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients. J Am Coll Surg. 2009 May;208(5):970–8. discussion 8-80. [PubMed: 19476873]

1369.

Schiffhauer LM, Boger JN, Bonfiglio TA, et al. Confocal microscopy of unfixed breast needle core biopsies: a comparison to fixed and stained sections. BMC Cancer. 2009;9:265. [PMC free article: PMC3087331] [PubMed: 19650910]

1370.

Schiller DE, Le LW, Cho BC, et al. Factors associated with negative margins of lumpectomy specimen: potential use in selecting patients for intraoperative radiotherapy. Ann Surg Oncol. 2008 Mar;15(3):833–42. [PubMed: 18163174]

1371.

Schneider J, Lucas R, Tejerina A. Predicting complete removal of impalpable breast carcinomas using stereotactic radiologically guided surgery. Br J Surg. 2005 May;92(5):563–4. [PubMed: 15739212]

1372.

Schneider P, Piper S, Schmitz CH, et al. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions. Rofo. 2011 Oct;183(10):956–63. [PubMed: 21972043]

1373.

Schnur JB, Bovbjerg DH, David D, et al. Hypnosis decreases presurgical distress in excisional breast biopsy patients. Anesth Analg. 2008 Feb;106(2):440–4. table of contents. [PubMed: 18227298]

1374.

Schonberg MA, Silliman RA, Marcantonio ER. Weighing the benefits and burdens of mammography screening among women age 80 years or older. J Clin Oncol. 2009 Apr 10;27(11):1774–80. [PMC free article: PMC2668704] [PubMed: 19255318]

1375.

Schwartz JC, Rishi M, Christy CJ, et al. What do breast surgeons do? Am J Surg. 2009 Oct;198(4):544–6. [PubMed: 19800465]

1376.

Schwartzberg BS, Goates JJ, Keeler SA, et al. Use of advanced breast biopsy instrumentation while performing stereotactic breast biopsies: review of 150 consecutive biopsies. J Am Coll Surg. 2000 Jul;191(1):9–15. [PubMed: 10898178]

1377.

Seigneurin A, Exbrayat C, Labarere J, et al. Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive cases. Breast Cancer Res Treat. 2011 May;127(1):221–8. [PubMed: 20809364]

1378.

Seow JH, Metcalf C, Wylie E. Nipple discharge in a screening programme: imaging findings with pathological correlation. J Med Imaging Radiat Oncol. 2011 Dec;55(6):577–86. [PubMed: 22141605]

1379.

Setz-Pels W, Duijm LE, Coebergh JW, et al. Re-attendance after false-positive screening mammography: a population-based study in the Netherlands. Br J Cancer. 2013 Oct 15;109(8):2044–50. [PMC free article: PMC3798969] [PubMed: 24052045]

1380.

Setz-Pels W, Duijm LE, Louwman MW, et al. Characteristics and screening outcome of women referred twice at screening mammography. Eur Radiol. 2012 Dec;22(12):2624–32. [PubMed: 22696156]

1381.

Shaaban MA, Aly AEAK. Real-time ultrasound elastography: Does it improve B-mode ultrasound characterization of solid breast lesions? Egypt. J. Radiol. Nucl Med. 2012;43(2):301–9.

1382.

Shabaik AS, Cox CE, Clark RA, et al. Imprint cytology of needle-localized breast lesions. Acta Cytol. 1993 Jan–Feb;37(1):10–5. [PubMed: 8434486]

1383.

Shafqat G, Agha A, Masror I, et al. Dynamic contrast enhanced MRI breast for lesion detection and characterization with histopathological co relation: preliminary experience at tertiary care hospital. J Pak Med Assoc. 2011 Mar;61(3):252–5. [PubMed: 21465939]

1384.

Shannon J, Douglas-Jones AG, Dallimore NS. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? J Clin Pathol. 2001 Oct;54(10):762–5. [PMC free article: PMC1731291] [PubMed: 11577122]

1385.

Sharifi S, Peterson MK, Baum JK, et al. Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol. 1999 Oct;12(10):941–5. [PubMed: 10530557]

1386.

Sheth D, Wesen CA, Schroder D, et al. The advanced breast biopsy instrumentation (ABBI) experience at a community hospital. Am Surg. 1999 Aug;65(8):726–9. discussion 9-30. [PubMed: 10432081]

1387.

Shields MW, Smith RS, Bardwil MF, et al. Is needle-directed breast biopsy overused? West J Med. 1994 Mar;160(3):229–31. [PMC free article: PMC1022385] [PubMed: 8191754]

1388.

Shin HJ, Sneige N, Staerkel GA. Utility of punch biopsy for lesions that are hard to aspirate by conventional fine-needle aspiration. Cancer. 1999 Jun 25;87(3):149–54. [PubMed: 10385446]

1389.

Shin S, Schneider HB, Cole FJ, et al. Follow-Up Recommendations for Benign Breast Biopsies. Breast J. 2006;12(5):413–7. [PubMed: 16958957]

1390.

Shirley SE, Mitchell DI, Soares DP, et al. Clinicopathologic features of breast disease in Jamaica: findings of the Jamaican Breast Disease Study, 2000–2002. West Indian Med J. 2008 Mar;57(2):90–4. [PubMed: 19565948]

1391.

Siegal E, Angelakis E, Morris P, et al. Breast molecular imaging: a retrospective review of one institutions experience with this modality and analysis of its potential role in breast imaging decision making. Breast J. 2012 Mar–Apr;18(2):111–7. [PubMed: 22300043]

1392.

Simpson WL Jr, Hermann G, Rausch DR, et al. Ultrasound detection of nonpalpable mammographically occult malignancy. Can Assoc Radiol J. 2008 Apr;59(2):70–6. [PubMed: 18533395]

1393.

Skaane P, Gullien R, Bjorndal H, et al. Digital breast tomosynthesis (DBT): initial experience in a clinical setting. Acta Radiol. 2012 Jun 1;53(5):524–9. [PubMed: 22593120]

1394.

Slanetz PJ, Giardino AA, McCarthy KA, et al. Previous breast biopsy for benign disease rarely complicates or alters interpretation on screening mammography. AJR Am J Roentgenol. 1998 Jun;170(6):1539–41. [PubMed: 9609170]

1395.

Smathers RL. Advanced breast biopsy instrumentation device: percentages of lesion and surrounding tissue removed. AJR Am J Roentgenol. 2000 Sep;175(3):801–3. [PubMed: 10954470]

1396.

Sneige N, Tulbah A. Accuracy of cytologic diagnoses made from touch imprints of image-guided needle biopsy specimens of nonpalpable breast abnormalities. Diagn Cytopathol. 2000 Jul;23(1):29–34. [PubMed: 10907929]

1397.

Soares JS, Barman I, Dingari NC, et al. Diagnostic power of diffuse reflectance spectroscopy for targeted detection of breast lesions with microcalcifications. Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):471–6. [PMC free article: PMC3545788] [PubMed: 23267090]

1398.

Somerville P, Seifert PJ, Destounis SV, et al. Anticoagulation and bleeding risk after core needle biopsy. AJR Am J Roentgenol. 2008 Oct;191(4):1194–7. [PubMed: 18806164]

1399.

Soo MS, Kliewer MA, Ghate S, et al. Stereotactic breast biopsy of noncalcified lesions: a cost-minimization analysis comparing 14-gauge multipass automated core biopsy to 14-and 11-gauge vacuum-assisted biopsy. Clin Imaging. 2005;29(1):26–33. [PubMed: 15859015]

1400.

Staren ED, O’Neill TP. Ultrasound-guided needle biopsy of the breast. Surgery. 1999 Oct;126(4):629–34. discussion 34-5. [PubMed: 10520908]

1401.

Stojadinovic A, Nissan A, Shriver CD, et al. Electrical impedance scanning as a new breast cancer risk stratification tool for young women. J Surg Oncol. 2008;97(2):112–20. [PubMed: 18050282]

1402.

Stolier AJ, Rupley DG. The impact of image-directed core biopsy on the practice of breast surgery: a new algorithm for a changing technology. Am Surg. 1997 Sep;63(9):827–30. [PubMed: 9290531]

1403.

Stomper PC, Budnick RM, Stewart CC. Breast stereotactic core biopsy washings: abundant cell samples from clinically occult lesions for flow cytometric DNA analysis. Invest Radiol. 1998 Jan;33(1):51–5. [PubMed: 9438510]

1404.

Stomper PC, Cholewinski SP, Penetrante RB, et al. Atypical hyperplasia: frequency and mammographic and pathologic relationships in excisional biopsies guided with mammography and clinical examination. Radiology. 1993 Dec;189(3):667–71. [PubMed: 8234688]

1405.

Su MYL. Early-stage invasive breast cancers: Potential role of optical tomography with US localization in assisting diagnosis: Zhu Q, Hegde PU, Ricci a Jr, et al (Univ of Connecticut, Storrs; Univ of Connecticut Health Ctr, Farmington; Hartford Hosp, CT; et al) Radiology 256:367–378, 2010. Breast Dis. 2011;22(2):151–2. [PMC free article: PMC2909434] [PubMed: 20571122]

1406.

Sun W, Li A, Abreo F, et al. Comparison of fine-needle aspiration cytology and core biopsy for diagnosis of breast cancer. Diagn Cytopathol. 2001 Jun;24(6):421–5. [PubMed: 11391825]

1407.

Suzuki K, Shiraishi A, Arakawa A. Analysis of stereotactic vacuum-assisted breast biopsy for patients with segmental calcifications. Jpn J Radiol. 2009 Dec;27(10):450–4. [PubMed: 20035418]

1408.

Svahn TM, Chakraborty DP, Ikeda D, et al. Breast tomosynthesis and digital mammography: a comparison of diagnostic accuracy. Br J Radiol. 2012 Nov;85(1019):e1074–82. [PMC free article: PMC3500806] [PubMed: 22674710]

1409.

Swan JS, Ying J, Stahl J, et al. Initial development of the Temporary Utilities Index: a multiattribute system for classifying the functional health impact of diagnostic testing. Qual Life Res. 2010 Apr;19(3):401–12. [PubMed: 20084464]

1410.

Symmans WF, Weg N, Gross J, et al. A prospective comparison of stereotaxic fine-needle aspiration versus stereotaxic core needle biopsy for the diagnosis of mammographic abnormalities. Cancer. 1999 Mar 1;85(5):1119–32. [PubMed: 10091797]

1411.

Takei J, Tsunoda-Shimizu H, Kikuchi M, et al. Clinical implications of architectural distortion visualized by breast ultrasonography. Breast Cancer. 2009;16(2):132–5. [PubMed: 19048193]

1412.

Tan SM, Behranwala KA, Trott PA, et al. A retrospective study comparing the individual modalities of triple assessment in the pre-operative diagnosis of invasive lobular breast carcinoma. Eur J Surg Oncol. 2002 Apr;28(3):203–8. [PubMed: 11944950]

1413.

Taskin F, Koseoglu K, Unsal A, et al. Sclerosing adenosis of the breast: radiologic appearance and efficiency of core needle biopsy. Diagn Interv Radiol. 2011 Dec;17(4):311–6. [PubMed: 21328197]

1414.

Taylor K, O’Keeffe S, Britton PD, et al. Ultrasound elastography as an adjuvant to conventional ultrasound in the preoperative assessment of axillary lymph nodes in suspected breast cancer: a pilot study. Clin Radiol. 2011 Nov;66(11):1064–71. [PubMed: 21835398]

1415.

Thomassin-Naggara I, Jalaguier-Coudray A, Chopier J, et al. Current opinion on clip placement after breast biopsy: a survey of practising radiologists in France and Quebec. Clin Radiol. 2013 Jul;68(7):e378–83. [PubMed: 23522486]

1416.

Tice JA, O’Meara ES, Weaver DL, et al. Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst. 2013 Jul 17;105(14):1043–9. [PMC free article: PMC3714021] [PubMed: 23744877]

1417.

Tran DQ, Wilkerson DK, Namm J, et al. Needle-localized breast biopsy for mammographic abnormalities: a community hospital experience. Am Surg. 1999 Mar;65(3):283–8. [PubMed: 10075310]

1418.

Tsang FH, Lo JJ, Wong JL, et al. Application of image-guided biopsy for impalpable breast lesions in Chinese women. ANZ J Surg. 2003 Jan–Feb;73(1–2):23–5. [PubMed: 12534733]

1419.

Tudorica LA, Oh KY, Roy N, et al. A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings. Magn Reson Imaging. 2012 Nov;30(9):1257–67. [PMC free article: PMC3466402] [PubMed: 22770687]

1420.

Turner AJ, Hick PE. Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines. Biochem Pharmacol. 1975 Sep 15;24(18):1731–3. [PubMed: 16]

1421.

Uematsu T, Kasami M. Core wash cytology of breast lesions by ultrasonographically guided core needle biopsy. Breast Cancer Res Treat. 2008 May;109(2):251–3. [PubMed: 17616804]

1422.

Uematsu T, Kasami M, Takahashi K, et al. Clip placement after an 11-gauge vacuum-assisted stereotactic breast biopsy: correlation between breast thickness and clip movement. Breast Cancer. 2012 Jan;19(1):30–6. [PubMed: 21274668]

1423.

Ukwenya AY, Yusufu LM, Nmadu PT, et al. Delayed treatment of symptomatic breast cancer: the experience from Kaduna, Nigeria. S Afr J Surg. 2008 Nov;46(4):106–10. [PubMed: 19051953]

1424.

Utzon-Frank N, Vejborg I, von Euler-Chelpin M, et al. Balancing sensitivity and specificity: sixteen year’s of experience from the mammography screening programme in Copenhagen, Denmark. Cancer Epidemiol. 2011 Oct;35(5):393–8. [PubMed: 21239242]

1425.

Vargas HI, Vargas MP, Gonzalez K, et al. Percutaneous excisional biopsy of palpable breast masses under ultrasound visualization. Breast J. 2006 Sep–Oct;12(5 Suppl 2):S218–22. [PubMed: 16959005]

1426.

Verardi N, Di Leo G, Carbonaro LA, et al. Contrast-enhanced MR imaging of the breast: association between asymmetric increased breast vascularity and ipsilateral cancer in a consecutive series of 197 patients. Radiol Med. 2013 Mar;118(2):239–50. [PubMed: 22872456]

1427.

Verenhitach BD, Elias S, Patrocinio AC, et al. Evaluation of the clinical efficacy of minimally invasive procedures for breast cancer screening at a teaching hospital. J Clin Pathol. 2011 Oct;64(10):858–61. [PubMed: 21666140]

1428.

Verkooijen HM, Buskens E, Peeters PH, et al. Diagnosing non-palpable breast disease: short-term impact on quality of life of large-core needle biopsy versus open breast biopsy. Surg Oncol. 2002 May;10(4):177–81. [PubMed: 12020672]

1429.

Verkooijen HM, Peeters PH, Borel Rinkes IH, et al. Risk factors for cancellation of stereotactic large core needle biopsy on a prone biopsy table. Br J Radiol. 2001 Nov;74(887):1007–12. [PubMed: 11709465]

1430.

Verkooijen HM, Peterse JL, Schipper ME, et al. Interobserver variability between general and expert pathologists during the histopathological assessment of large-core needle and open biopsies of non-palpable breast lesions. Eur J Cancer. 2003 Oct;39(15):2187–91. [PubMed: 14522377]

1431.

Verschuur-Maes AH, van Gils CH, van den Bosch MA, et al. Digital mammography: more microcalcifications, more columnar cell lesions without atypia. Mod Pathol. 2011 Sep;24(9):1191–7. [PubMed: 21572405]

1432.

Vimpeli SM, Saarenmaa I, Huhtala H, et al. Large-core needle biopsy versus fine-needle aspiration biopsy in solid breast lesions: comparison of costs and diagnostic value. Acta Radiol. 2008 Oct;49(8):863–9. [PubMed: 18618302]

1433.

Wai CJ, Al-Mubarak G, Homer MJ, et al. A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy. Ann Surg Oncol. 2013 Mar;20(3):850–5. [PubMed: 23104707]

1434.

Waldherr C, Cerny P, Altermatt HJ, et al. Value of one-view breast tomosynthesis versus two-view mammography in diagnostic workup of women with clinical signs and symptoms and in women recalled from screening. AJR Am J Roentgenol. 2013 Jan;200(1):226–31. [PubMed: 23255766]

1435.

Wang S, Delproposto Z, Wang H, et al. Differentiation of breast cancer from fibroadenoma with dual-echo dynamic contrast-enhanced MRI. PLoS One. 2013;8(7):e67731. [PMC free article: PMC3699626] [PubMed: 23844077]

1436.

Watanabe S. [Mammographic detection of early breast cancer]. Gan No Rinsho. 1988 Aug;34(10):1378–87. [PubMed: 3172495]

1437.

Watermann DO, Einert A, Ehritt-Braun C, et al. Experience with the Advanced Breast Biopsy Instrumentation (ABBI) system. Anticancer Res. 2002 Sep–Oct;22(5):3067–70. [PubMed: 12530044]

1438.

Wauters CA, Sanders-Eras CT, Kooistra BW, et al. Modified core wash cytology procedure for the immediate diagnosis of core needle biopsies of breast lesions. Cancer. 2009 Oct 25;117(5):333–7. [PubMed: 19739241]

1439.

Wauters CA, Sanders-Eras MC, de Kievit-van der Heijden IM, et al. Modified core wash cytology (CWC), an asset in the diagnostic work-up of breast lesions. Eur J Surg Oncol. 2010 Oct;36(10):957–62. [PubMed: 20708371]

1440.

Weigel S, Biesheuvel C, Berkemeyer S, et al. Digital mammography screening: how many breast cancers are additionally detected by bilateral ultrasound examination during assessment? Eur Radiol. 2013 Mar;23(3):684–91. [PubMed: 23052645]

1441.

Weigert J, Steenbergen S. The connecticut experiment: the role of ultrasound in the screening of women with dense breasts. Breast J. 2012 Nov–Dec;18(6):517–22. [PubMed: 23009208]

1442.

Weismann CF, Forstner R, Prokop E, et al. Three-dimensional targeting: a new three-dimensional ultrasound technique to evaluate needle position during breast biopsy. Ultrasound Obstet Gynecol. 2000 Sep;16(4):359–64. [PubMed: 11169313]

1443.

Westenend PJ, Sever AR, Beekman-De Volder HJ, et al. A comparison of aspiration cytology and core needle biopsy in the evaluation of breast lesions. Cancer. 2001 Apr 25;93(2):146–50. [PubMed: 11309781]

1444.

Whang IY. Power Doppler needle-induced fremitus for breast localization. Arch Gynecol Obstet. 2008 Oct;278(4):337–40. [PubMed: 18283477]

1445.

Williams MB, Judy PG, Gunn S, et al. Dual-modality breast tomosynthesis. Radiology. 2010 Apr;255(1):191–8. [PMC free article: PMC2843832] [PubMed: 20308457]

1446.

Wishart GC, Campisi M, Boswell M, et al. The accuracy of digital infrared imaging for breast cancer detection in women undergoing breast biopsy. Eur J Surg Oncol. 2010 Jun;36(6):535–40. [PubMed: 20452740]

1447.

Wishart GC, Campisi MS, Chapman D, et al. O-83 Digital infrared imaging for breast cancer detection in younger women undergoing breast biopsy. EJC Supplements. 2010;8(6):31–2. Language: English. Entry Date: 20110304. Revision Date: 20120817. Publication Type: journal article.

1448.

Witek-Janusek L, Gabram S, Mathews HL. Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy. Psychoneuroendocrinology. 2007 Jan;32(1):22–35. [PMC free article: PMC3937868] [PubMed: 17092654]

1449.

Witt A, Yavuz D, Walchetseder C, et al. Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery. Obstet Gynecol. 2003 Apr;101(4):745–50. [PubMed: 12681880]

1450.

Wong SL, Edwards MJ, Chao C, et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol. 2002 Apr;9(3):272–7. [PubMed: 11923134]

1451.

Woods RW, Oliphant L, Shinki K, et al. Validation of results from knowledge discovery: mass density as a predictor of breast cancer. J Digit Imaging. 2010 Oct;23(5):554–61. [PMC free article: PMC2950275] [PubMed: 19760292]

1452.

Woods RW, Sisney GS, Salkowski LR, et al. The mammographic density of a mass is a significant predictor of breast cancer. Radiology. 2011 Feb;258(2):417–25. [PMC free article: PMC3029888] [PubMed: 21177388]

1453.

Woon DT, Serpell JW. Preoperative core biopsy of soft tissue tumours facilitates their surgical management: a 10-year update. ANZ J Surg. 2008 Nov;78(11):977–81. [PubMed: 18959696]

1454.

Wu X, Chen G, Lu J, et al. Label-free detection of breast masses using multiphoton microscopy. PLoS One. 2013;8(6):e65933. [PMC free article: PMC3675049] [PubMed: 23755295]

1455.

Xie HB, Salhadar A, Haara A, et al. How stereotactic core-needle biopsy affected breast fine-needle aspiration utilization: an 11-year institutional review. Diagn Cytopathol. 2004 Aug;31(2):106–10. [PubMed: 15282722]

1456.

Yang JH, Lee SD, Nam SJ. Diagnostic utility of ABBI®(Advanced Breast Biopsy Instrumentation) for nonpalpable breast lesions in Korea. The breast journal. 2000;6(4):257–62. [PubMed: 11348375]

1457.

Yau EJ, Gutierrez RL, DeMartini WB, et al. The utility of breast MRI as a problem-solving tool. Breast J. 2011 May–Jun;17(3):273–80. [PubMed: 21477168]

1458.

Yazici B, Sever AR, Mills P, et al. Scar formation after stereotactic vacuum-assisted core biopsy of benign breast lesions. Clin Radiol. 2006 Jul;61(7):619–24. [PubMed: 16784949]

1459.

Yener NA, Midi A, Cubuk R, et al. Palpable lesions as a diagnostic tool in patients with thoracic pathology. Diagn Cytopathol. 2013 Jan;41(1):28–34. [PubMed: 21681977]

1460.

Ying X, Lin Y, Xia X, et al. A comparison of mammography and ultrasound in women with breast disease: a receiver operating characteristic analysis. Breast J. 2012 Mar–Apr;18(2):130–8. [PubMed: 22356352]

1461.

Yong WS, Chia KH, Poh WT, et al. A comparison of trucut biopsy with fine needle aspiration cytology in the diagnosis of breast cancer. Singapore Med J. 1999 Sep;40(9):587–9. [PubMed: 10628249]

1462.

Yoon JH, Kim MH, Kim EK, et al. Interobserver variability of ultrasound elastography: how it affects the diagnosis of breast lesions. AJR Am J Roentgenol. 2011 Mar;196(3):730–6. [PubMed: 21343520]

1463.

Youk JH, Gweon HM, Son EJ, et al. Diagnostic value of commercially available shear-wave elastography for breast cancers: integration into BI-RADS classification with subcategories of category 4. Eur Radiol. 2013 Oct;23(10):2695–704. [PubMed: 23652850]

1464.

Zagouri F, Sergentanis TN, Gounaris A, et al. Pain in different methods of breast biopsy: emphasis on vacuum-assisted breast biopsy. Breast. 2008 Feb;17(1):71–5. [PubMed: 17869106]

1465.

Zagouri F, Sergentanis TN, Zografos GC. Lesions too close to the chest wall: a relative contraindication for vacuum-assisted breast biopsy. AJR Am J Roentgenol. 2008 Apr;190(4):W270. [PubMed: 18356420]

1466.

Zahid Z, Ibrahim Z, Bilal S, et al. Comparison of diagnostic accuracy of film-Screen mammography and ultrasound in breast masses. Pak. J. Med Health Sci. 2011;5(3):433–5.

1467.

Zanca F, Chakraborty DP, Van Ongeval C, et al. An improved method for simulating microcalcifications in digital mammograms. Med Phys. 2008 Sep;35(9):4012–8. [PMC free article: PMC2673659] [PubMed: 18841852]

1468.

Zheng B, Lederman D, Sumkin JH, et al. A preliminary evaluation of multi-probe resonance-frequency electrical impedance based measurements of the breast. Acad Radiol. 2011 Feb;18(2):220–9. [PMC free article: PMC3021623] [PubMed: 21126888]

1469.

Zheng B, Zuley ML, Sumkin JH, et al. Detection of breast abnormalities using a prototype resonance electrical impedance spectroscopy system: a preliminary study. Med Phys. 2008 Jul;35(7):3041–8. [PMC free article: PMC2673557] [PubMed: 18697526]

1470.

Zhou J, Zhan W, Chang C, et al. Role of acoustic shear wave velocity measurement in characterization of breast lesions. J Ultrasound Med. 2013 Feb;32(2):285–94. [PubMed: 23341385]

1471.

Zhu C, Burnside ES, Sisney GA, et al. Fluorescence spectroscopy: an adjunct diagnostic tool to image-guided core needle biopsy of the breast. IEEE Trans Biomed Eng. 2009 Oct;56(10):2518–28. [PMC free article: PMC2791790] [PubMed: 19272976]

1472.

Zhu J, Kurihara Y, Kanemaki Y, et al. Diagnostic accuracy of high-resolution MRI using a microscopy coil for patients with presumed DCIS following mammography screening. J Magn Reson Imaging. 2007 Jan;25(1):96–103. [PubMed: 17154376]

1473.

Zhu Q, Hegde PU, Ricci A Jr, et al. Early-stage invasive breast cancers: potential role of optical tomography with US localization in assisting diagnosis. Radiology. 2010 Aug;256(2):367–78. [PMC free article: PMC2909434] [PubMed: 20571122]

1474.

Zimmermann CJ, Sheffield KM, Duncan CB, et al. Time trends and geographic variation in use of minimally invasive breast biopsy. J Am Coll Surg. 2013 Apr;216(4):814–24. discussion 24-7. [PMC free article: PMC3608736] [PubMed: 23376029]

1475.

Zimmermann N, Ohlinger R. Diagnostic value of palpation, mammography, and ultrasonography in the diagnosis of fibroadenoma: impact of breast density, patient age, ultrasonographic size, and palpability. Ultraschall Med. 2012 Dec;33(7):E151–7. [PubMed: 21667430]

1476.

Zografos G, Koulocheri D, Liakou P, et al. Novel technology of multimodal ultrasound tomography detects breast lesions. Eur Radiol. 2013 Mar;23(3):673–83. [PubMed: 22983317]

1477.

Zografos GC, Zagouri F, Sergentanis TN, et al. Cytokine dysregulation during vacuum-assisted breast biopsy: early phase of a complex phenomenon. Isr Med Assoc J. 2008 Mar;10(3):246. [PubMed: 18494247]

1478.

Zonderland H, Hermans J, Van De Vijver M, et al. Triple diagnostic approach versus ultrasound-guided 18 gauge core biopsy in suspicious breast masses. The Breast. 1998;7(3):168–72.

1479.

Zonderland HM, van de Vijver MJ, Visser M. [Breast lesion diagnosis: integrating pathology and radiology]. Ned Tijdschr Geneeskd. 2011;155(18):A2967. [PubMed: 21466724]

1480.

Abbate F, Bacigalupo L, Latronico A, et al. Ultrasound-guided vacuum assisted breast biopsy in the assessment of C3 breast lesions by ultrasound-guided fine needle aspiration cytology: results and costs in comparison with surgery. Breast. 2009 Apr;18(2):73–7. [PubMed: 19342236]

1481.

Abbate F, Cassano E, Menna S, et al. Ultrasound-guided vacuum-assisted breast biopsy: Use at the European Institute of Oncology in 2010. J Ultrasound. 2011 Dec;14(4):177–81. [PMC free article: PMC3558107] [PubMed: 23397003]

1482.

Abbott AM, Portschy PR, Lee C, et al. Prospective multicenter trial evaluating balloon-catheter partial-breast irradiation for ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):494–8. [PubMed: 24074922]

1483.

Abdsaleh S, Warnberg F, Azavedo E, et al. Comparison of core needle biopsy and surgical specimens in malignant breast lesions regarding histological features and hormone receptor expression. Histopathology. 2008 May;52(6):773–5. [PubMed: 18393972]

1484.

Acs G, Paragh G, Chuang ST, et al. The presence of micropapillary features and retraction artifact in core needle biopsy material predicts lymph node metastasis in breast carcinoma. Am J Surg Pathol. 2009 Feb;33(2):202–10. [PubMed: 18987549]

1485.

Adkisson CD, Vallow LA, Kowalchik K, et al. Patient age and preoperative breast MRI in women with breast cancer: biopsy and surgical implications. Ann Surg Oncol. 2011 Jun;18(6):1678–83. [PubMed: 21207171]

1486.

Adler DD, Light RJ, Granstrom P, et al. Follow-up of benign results of stereotactic core breast biopsy. Acad Radiol. 2000 Apr;7(4):248–53. [PubMed: 10766097]

1487.

Aftab K, Idrees R. Nipple adenoma of breast: a masquerader of malignancy. J Coll Physicians Surg Pak. 2010 Jul;20(7):472–4. [PubMed: 20642949]

1488.

Aftab ML, Rashid A, Aslam M, et al. Clinical value of sure cut biopsy in breast masses. Pak. J. Med Health Sci. 2010;4(1):46–8.

1489.

Agarwal T, Patel B, Rajan P, et al. Core biopsy versus FNAC for palpable breast cancers. Is image guidance necessary? Eur J Cancer. 2003 Jan;39(1):52–6. [PubMed: 12504658]

1490.

Ahmad A, Bano U, Gondal M, et al. Her-2/neu gene overexpression in breast carcinoma and its association with clinicopathological characteristics of the disease. J Coll Physicians Surg Pak. 2009 May;19(5):297–9. [PubMed: 19409162]

1491.

Ahmadiyeh N, Stoleru MA, Raza S, et al. Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome. Ann Surg Oncol. 2009 Aug;16(8):2264–9. [PubMed: 19484312]

1492.

Akagi T, Kinoshita T, Shien T, et al. Clinical and pathological features of intracystic papillary carcinoma of the breast. Surg Today. 2009;39(1):5–8. [PubMed: 19132460]

1493.

Akbulut M, Zekioglu O, Kapkac M, et al. Fine needle aspiration cytology of glycogen-rich clear cell carcinoma of the breast: review of 37 cases with histologic correlation. Acta Cytol. 2008 Jan–Feb;52(1):65–71. [PubMed: 18323277]

1494.

Al Hassan T, Delli Fraine P, El-Khoury M, et al. Accuracy of percutaneous core needle biopsy in diagnosing papillary breast lesions and potential impact of sonographic features on their management. J Clin Ultrasound. 2013 Jan;41(1):1–9. [PubMed: 22987609]

1495.

Al Sarakbi W, Salhab M, Thomas V, et al. Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer? Int Semin Surg Oncol. 2005 Aug 22;2:15. [PMC free article: PMC1198246] [PubMed: 16115314]

1496.

Al-Janabi S, Huisman A, Willems SM, et al. Digital slide images for primary diagnostics in breast pathology: a feasibility study. Hum Pathol. 2012 Dec;43(12):2318–25. [PubMed: 22901465]

1497.

Al-Khawari HA, Al-Manfouhi HA, Madda JP, et al. Radiologic features of granulomatous mastitis. Breast J. 2011 Nov–Dec;17(6):645–50. [PubMed: 21929558]

1498.

Allen LR, Lago-Toro CE, Hughes JH, et al. Is there a role for MRI in the preoperative assessment of patients with DCIS? Ann Surg Oncol. 2010 Sep;17(9):2395–400. [PubMed: 20217259]

1499.

Allison KH, Eby PR, Kohr J, et al. Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade. Hum Pathol. 2011 Jan;42(1):41–50. [PubMed: 20970167]

1500.

Amir E, Miller N, Geddie W, et al. Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer. J Clin Oncol. 2012 Feb 20;30(6):587–92. [PMC free article: PMC5015424] [PubMed: 22124102]

1501.

Ancona A, Capodieci M, Galiano A, et al. Vacuum-assisted biopsy diagnosis of atypical ductal hyperplasia and patient management. Radiol Med. 2011 Mar;116(2):276–91. [PubMed: 21225358]

1502.

Andacoglu O, Kanbour-Shakir A, Teh YC, et al. Rationale of excisional biopsy after the diagnosis of benign radial scar on core biopsy: a single institutional outcome analysis. Am J Clin Oncol. 2013 Feb;36(1):7–11. [PubMed: 22134516]

1503.

Andrade VP, Gobbi H. Accuracy of typing and grading invasive mammary carcinomas on core needle biopsy compared with the excisional specimen. Virchows Arch. 2004 Dec;445(6):597–602. [PubMed: 15480766]

1504.

Andrews-Tang D, Diamond AB, Rogers L, et al. Diabetic Mastopathy: Adjunctive Use of Ultrasound and Utility of Core Biopsy in Diagnosis. Breast J. 2000 May;6(3):183–8. [PubMed: 11348362]

1505.

Andrykowski MA, Carpenter JS, Studts JL, et al. Psychological impact of benign breast biopsy: a longitudinal, comparative study. Health Psychol. 2002 Sep;21(5):485–94. [PubMed: 12211516]

1506.

Ansari B, Boughey JC, Adamczyk DL, et al. Should axillary ultrasound be used in patients with a preoperative diagnosis of ductal carcinoma in situ? Am J Surg. 2012 Sep;204(3):290–3. [PubMed: 22749764]

1507.

Apple SK. Variability in gross and microscopic pathology reporting in excisional biopsies of breast cancer tissue. Breast J. 2006 Mar–Apr;12(2):145–9. [PubMed: 16509839]

1508.

Apple SK, Lowe AC, Rao PN, et al. Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer. Mod Pathol. 2009 Sep;22(9):1151–9. [PubMed: 19483670]

1509.

Arazi-Kleinman T, Causer PA, Nofech-Mozes S, et al. Is ductal carcinoma in situ with “possible invasion” more predictive of invasive carcinoma than pure ductal carcinoma in situ? Can Assoc Radiol J. 2012 May;63(2):146–52. [PubMed: 21561735]

1510.

Arnedos M, Nerurkar A, Osin P, et al. Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Ann Oncol. 2009 Dec;20(12):1948–52. [PubMed: 19570962]

1511.

Arnould L, Roger P, Macgrogan G, et al. Accuracy of HER2 status determination on breast core-needle biopsies (immunohistochemistry, FISH, CISH and SISH vs FISH). Mod Pathol. 2012 May;25(5):675–82. [PubMed: 22222637]

1512.

Aroner SA, Collins LC, Schnitt SJ, et al. Columnar cell lesions and subsequent breast cancer risk: a nested case-control study. Breast Cancer Res. 2010;12(4):R61. [PMC free article: PMC2949654] [PubMed: 20691043]

1513.

Arora S, Menes TS, Moung C, et al. Atypical ductal hyperplasia at margin of breast biopsy--is re-excision indicated? Ann Surg Oncol. 2008 Mar;15(3):843–7. [PubMed: 17987337]

1514.

Arora S, Moezzi M, Kim U, et al. Is surgical excision necessary for atypical ductal hyperplasia diagnosed with 8 gauge stereotactic biopsy? Breast J. 2009 Nov–Dec;15(6):673–4. [PubMed: 19686226]

1515.

Aruga T, Suzuki E, Saji S, et al. A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer. Oncol Rep. 2009 Aug;22(2):273–8. [PubMed: 19578766]

1516.

Athanassiou E, Sioutopoulou D, Vamvakopoulos N, et al. The fat content of small primary breast cancer interferes with radiofrequency-induced thermal ablation. Eur Surg Res. 2009;42(1):54–8. [PubMed: 18987475]

1517.

Badoual C, Maruani A, Ghorra C, et al. Pathological prognostic factors of invasive breast carcinoma in ultrasound-guided large core biopsies-correlation with subsequent surgical excisions. Breast. 2005 Feb;14(1):22–7. [PubMed: 15695077]

1518.

Bae MS, Moon WK, Cho N, et al. Patient age and tumor size determine the cancer yield of preoperative bilateral breast MRI in women with ductal carcinoma in situ. AJR Am J Roentgenol. 2013 Sep;201(3):684–91. [PubMed: 23971464]

1519.

Baek SE, Kim MJ, Kim EK, et al. Effect of clinical information on diagnostic performance in breast sonography. J Ultrasound Med. 2009 Oct;28(10):1349–56. [PubMed: 19778881]

1520.

Baez E, Huber A, Vetter M, et al. Minimal invasive complete excision of benign breast tumors using a three-dimensional ultrasound-guided mammotome vacuum device. Ultrasound Obstet Gynecol. 2003 Mar;21(3):267–72. [PubMed: 12666222]

1521.

Bagaria SP, Shamonki J, Kinnaird M, et al. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma? Ann Surg Oncol. 2011 Jul;18(7):1845–51. [PubMed: 21287281]

1522.

Bagnall MJ, Evans AJ, Wilson AR, et al. When have mammographic calcifications been adequately sampled at needle core biopsy? Clin Radiol. 2000 Jul;55(7):548–53. [PubMed: 10924380]

1523.

Bagnall MJ, Evans AJ, Wilson AR, et al. Predicting invasion in mammographically detected microcalcification. Clin Radiol. 2001 Oct;56(10):828–32. [PubMed: 11895299]

1524.

Bai HX, Motwani SB, Higgins SA, et al. Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes? Int J Clin Oncol. 2013 Jun 19 [PubMed: 23780727]

1525.

Bani MR, Lux MP, Heusinger K, et al. Factors correlating with reexcision after breast-conserving therapy. Eur J Surg Oncol. 2009 Jan;35(1):32–7. [PubMed: 18539425]

1526.

Barr FE, Degnim AC, Hartmann LC, et al. Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer. Cancer Prev Res (Phila). 2011 Mar;4(3):435–44. [PMC free article: PMC3049965] [PubMed: 21209395]

1527.

Barry WT, Kernagis DN, Dressman HK, et al. Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome. J Clin Oncol. 2010 May 1;28(13):2198–206. [PMC free article: PMC2860437] [PubMed: 20368555]

1528.

Bathen TF, Geurts B, Sitter B, et al. Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery. PLoS One. 2013;8(4):e61578. [PMC free article: PMC3629170] [PubMed: 23613877]

1529.

Bauer TL, Pandelidis SM, Rhoads JE Jr. Five-year survival of 100 women with carcinoma of the breast diagnosed by screening mammography and needle-localization biopsy. J Am Coll Surg. 1994 May;178(5):427–30. [PubMed: 8167877]

1530.

Becker AK, Gordon PB, Harrison DA, et al. Flat ductal intraepithelial neoplasia 1A diagnosed at stereotactic core needle biopsy: is excisional biopsy indicated? AJR Am J Roentgenol. 2013 Mar;200(3):682–8. [PubMed: 23436863]

1531.

Begum SM, Jara-Lazaro AR, Thike AA, et al. Mucin extravasation in breast core biopsies--clinical significance and outcome correlation. Histopathology. 2009 Nov;55(5):609–17. [PubMed: 19912367]

1532.

Bendifallah S, Chabbert-Buffet N, Maurin N, et al. Predictive factors for breast cancer in patients diagnosed with ductal intraepithelial neoplasia, grade 1B. Anticancer Res. 2012 Aug;32(8):3571–9. [PubMed: 22843948]

1533.

Bendifallah S, Defert S, Chabbert-Buffet N, et al. Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperplasia diagnosed by an 11-gauge vacuum-assisted biopsy device: an external validation study. Eur J Cancer. 2012 Jan;48(1):30–6. [PubMed: 22100905]

1534.

Bennett LE, Ghate SV, Bentley R, et al. Is surgical excision of core biopsy proven benign papillomas of the breast necessary? Acad Radiol. 2010 May;17(5):553–7. [PubMed: 20223685]

1535.

Berg JC, Visscher DW, Vierkant RA, et al. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat. 2008 Mar;108(2):167–74. [PubMed: 18297395]

1536.

Berg WA, Madsen KS, Schilling K, et al. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology. 2011 Jan;258(1):59–72. [PMC free article: PMC3009380] [PubMed: 21076089]

1537.

Bernard JR Jr, Vallow LA, DePeri ER, et al. In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: the mayo clinic in Florida experience. Breast J. 2010 Mar–Apr;16(2):118–26. [PubMed: 20136645]

1538.

Bianchi S, Bendinelli B, Castellano I, et al. Morphological parameters of lobular in situ neoplasia in stereotactic 11-gauge vacuum-assisted needle core biopsy do not predict the presence of malignancy on subsequent surgical excision. Histopathology. 2013 Jul;63(1):83–95. [PubMed: 23692123]

1539.

Bianchi S, Caini S, Cattani MG, et al. Diagnostic concordance in reporting breast needle core biopsies using the B classification-A panel in Italy. Pathol Oncol Res. 2009 Dec;15(4):725–32. [PubMed: 19449173]

1540.

Bianchi S, Giannotti E, Vanzi E, et al. Radial scar without associated atypical epithelial proliferation on image-guided 14-gauge needle core biopsy: analysis of 49 cases from a single-centre and review of the literature. Breast. 2012 Apr;21(2):159–64. [PubMed: 21944431]

1541.

Biggar MA, Kerr KM, Erzetich LM, et al. Columnar cell change with atypia (flat epithelial atypia) on breast core biopsy-outcomes following open excision. Breast J. 2012 Nov–Dec;18(6):578–81. [PubMed: 23078374]

1542.

Bode MK, Rissanen T. Imaging findings and accuracy of core needle biopsy in mucinous carcinoma of the breast. Acta Radiol. 2011 Mar 1;52(2):128–33. [PubMed: 21498339]

1543.

Bode MK, Rissanen T, Apaja-Sarkkinen M. Ultrasonography-guided core needle biopsy in differential diagnosis of papillary breast tumors. Acta Radiol. 2009 Sep;50(7):722–9. [PubMed: 19488890]

1544.

Bodian CA, lattes R, Perzin KH. The epidemiology of gross cystic disease of the breast confirmed by biopsy or by aspiration of cyst fluid. Cancer Detect Prev. 1992;16(1):7–15. [PubMed: 1551140]

1545.

Bohling SD, Allison KH. Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target. Mod Pathol. 2008 Dec;21(12):1527–32. [PubMed: 18820666]

1546.

Bonanni B, Puntoni M, Cazzaniga M, et al. Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial. J Clin Oncol. 2012 Jul 20;30(21):2593–600. [PubMed: 22564993]

1547.

Bonnas C, Specht K, Spleiss O, et al. Effects of cold ischemia and inflammatory tumor microenvironment on detection of PI3K/AKT and MAPK pathway activation patterns in clinical cancer samples. Int J Cancer. 2012 Oct 1;131(7):1621–32. [PubMed: 22213219]

1548.

Bonnefoi H, Piccart M, Bogaerts J, et al. TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial. Lancet Oncol. 2011 Jun;12(6):527–39. [PMC free article: PMC4172919] [PubMed: 21570352]

1549.

Borecky N, Rickard M. Preoperative diagnosis of carcinoma within fibroadenoma on screening mammograms. J Med Imaging Radiat Oncol. 2008 Feb;52(1):64–7. [PubMed: 18373829]

1550.

Boughey JC, Hartmann LC, Anderson SS, et al. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. J Clin Oncol. 2010 Aug 1;28(22):3591–6. [PMC free article: PMC2917314] [PubMed: 20606088]

1551.

Boulos FI, Dupont WD, Simpson JF, et al. Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study. Cancer. 2008 Nov 1;113(9):2415–21. [PMC free article: PMC3121952] [PubMed: 18816618]

1552.

Bowman E, Oprea G, Okoli J, et al. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients. Breast J. 2012 May–Jun;18(3):242–7. [PMC free article: PMC3658111] [PubMed: 22583194]

1553.

Braun M, Fountoulakis M, Papadopoulou A, et al. Down-regulation of microfilamental network-associated proteins in leukocytes of breast cancer patients: potential application to predictive diagnosis. Cancer Genomics Proteomics. 2009 Jan–Feb;6(1):31–40. [PubMed: 19451088]

1554.

Brem RF, Ioffe M, Rapelyea JA, et al. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. AJR Am J Roentgenol. 2009 Feb;192(2):379–83. [PubMed: 19155397]

1555.

Brem RF, Shahan C, Rapleyea JA, et al. Detection of occult foci of breast cancer using breast-specific gamma imaging in women with one mammographic or clinically suspicious breast lesion. Acad Radiol. 2010 Jun;17(6):735–43. [PubMed: 20457416]

1556.

Brennan SB, Corben A, Liberman L, et al. Papilloma diagnosed at MRI-guided vacuum-assisted breast biopsy: is surgical excision still warranted? AJR Am J Roentgenol. 2012 Oct;199(4):W512–9. [PubMed: 22997402]

1557.

Brkljacic B, Cikara I, Ivanac G, et al. Ultrasound-guided bipolar radiofrequency ablation of breast cancer in inoperable patients: a pilot study. Ultraschall Med. 2010 Apr;31(2):156–62. [PubMed: 19941254]

1558.

Browne EP, Punska EC, Lenington S, et al. Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy. Epigenetics. 2011 Dec;6(12):1425–35. [PubMed: 22139572]

1559.

Bukhari MH, Akhtar ZM. Comparison of accuracy of diagnostic modalities for evaluation of breast cancer with review of literature. Diagn Cytopathol. 2009 Jun;37(6):416–24. [PubMed: 19217034]

1560.

Bundred NJ, Cramer A, Morris J, et al. Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial. Clin Cancer Res. 2010 Mar 1;16(5):1605–12. [PubMed: 20179229]

1561.

Bunting DM, Steel JR, Holgate CS, et al. Long term follow-up and risk of breast cancer after a radial scar or complex sclerosing lesion has been identified in a benign open breast biopsy. Eur J Surg Oncol. 2011 Aug;37(8):709–13. [PubMed: 21684716]

1562.

Burbank F. Mammographic findings after 14-gauge automated needle and 14-gauge directional, vacuum-assisted stereotactic breast biopsies. Radiology. 1997 Jul;204(1):153–6. [PubMed: 9205238]

1563.

Burge CN, Chang HR, Apple SK. Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens? Breast. 2006 Apr;15(2):167–72. [PubMed: 16095904]

1564.

Cahill RA, Walsh D, Landers RJ, et al. Preoperative profiling of symptomatic breast cancer by diagnostic core biopsy. Ann Surg Oncol. 2006 Jan;13(1):45–51. [PubMed: 16378157]

1565.

Calvo-Plaza I, Ugidos L, Miro C, et al. Retrospective study assessing the role of MRI in the diagnostic procedures for early breast carcinoma: a correlation of new foci in the MRI with tumor pathological features. Clin Transl Oncol. 2013 Mar;15(3):205–10. [PubMed: 22872518]

1566.

Campbell I, Royle G, Coddington R, et al. Management of screen-detected breast cancer: audit of the first 100 cases in the Southampton and Salisbury breast screening programme. Ann R Coll Surg Engl. 1993 Jan;75(1):13–7. [PMC free article: PMC2497746] [PubMed: 8422137]

1567.

Cangiarella J, Guth A, Axelrod D, et al. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. Arch Pathol Lab Med. 2008 Jun;132(6):979–83. [PubMed: 18517282]

1568.

Carder PJ, Liston JC. Will the spectrum of lesions prompting a “B3” breast core biopsy increase the benign biopsy rate? J Clin Pathol. 2003 Feb;56(2):133–8. [PMC free article: PMC1769892] [PubMed: 12560393]

1569.

Carder PJ, Shaaban A, Alizadeh Y, et al. Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis. Histopathology. 2010 Sep;57(3):472–8. [PubMed: 20727019]

1570.

Carkaci S, Lane DL, Gilcrease MZ, et al. Do all mucocele-like lesions of the breast require surgery? Clin Imaging. 2011 Mar–Apr;35(2):94–101. [PubMed: 21377046]

1571.

Carson W, Sanchez-Forgach E, Stomper P, et al. Lobular carcinoma in situ: observation without surgery as an appropriate therapy. Ann Surg Oncol. 1994 Mar;1(2):141–6. [PubMed: 7834439]

1572.

Cassano E, Urban LA, Pizzamiglio M, et al. Ultrasound-guided vacuum-assisted core breast biopsy: experience with 406 cases. Breast Cancer Res Treat. 2007 Mar;102(1):103–10. [PubMed: 16838109]

1573.

Catteau X, Simon P, Noel JC. Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy. Pathol Res Pract. 2012 Apr 15;208(4):217–20. [PubMed: 22445178]

1574.

Caughran JL, Vicini FA, Kestin LL, et al. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy. Ann Surg Oncol. 2009 Nov;16(11):3020–7. [PubMed: 19636632]

1575.

Cavaliere A, Sidoni A, Scheibel M, et al. Biopathologic profile of breast cancer core biopsy: is it always a valid method? Cancer Lett. 2005 Jan 31;218(1):117–21. [PubMed: 15639347]

1576.

Cermik TF, Mavi A, Basu S, et al. Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer. Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):475–83. [PubMed: 17957366]

1577.

Chae BJ, Lee A, Song BJ, et al. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy. World J Surg Oncol. 2009;7:77. [PMC free article: PMC2771003] [PubMed: 19852801]

1578.

Chagpar AB, Martin RC 2nd, Hagendoorn LJ, et al. Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique. Am J Surg. 2004 Oct;188(4):399–402. [PubMed: 15474434]

1579.

Chagpar AB, Scoggins CR, Sahoo S, et al. Biopsy type does not influence sentinel lymph node status. Am J Surg. 2005 Oct;190(4):551–6. [PubMed: 16164918]

1580.

Chambon M, Orsetti B, Berthe ML, et al. Prognostic significance of TRIM24/TIF-1alpha gene expression in breast cancer. Am J Pathol. 2011 Apr;178(4):1461–9. [PMC free article: PMC3128458] [PubMed: 21435435]

1581.

Chan MY, Lim S. Predictors of invasive breast cancer in ductal carcinoma in situ initially diagnosed by core biopsy. Asian J Surg. 2010 Apr;33(2):76–82. [PubMed: 21029943]

1582.

Chang JM, Han W, Moon WK, et al. Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision. Ann Surg Oncol. 2011 Sep;18(9):2506–14. [PubMed: 21369740]

1583.

Chang JM, Moon WK, Cho N, et al. Risk of carcinoma after subsequent excision of benign papilloma initially diagnosed with an ultrasound (US)-guided 14-gauge core needle biopsy: a prospective observational study. Eur Radiol. 2010 May;20(5):1093–100. [PubMed: 19890638]

1584.

Charles M, Edge SB, Winston JS, et al. Effect of stereotactic core needle biopsy on pathologic measurement of tumor size of T1 invasive breast carcinomas presenting as mammographic masses. Cancer. 2003 May 1;97(9):2137–41. [PubMed: 12712464]

1585.

Charlot M, Seldin DC, O’Hara C, et al. Localized amyloidosis of the breast: a case series. Amyloid. 2011 Jun;18(2):72–5. [PubMed: 21501022]

1586.

Chen J, Yao Q, Li D, et al. Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study. BMC Cancer. 2013 May 21;13(1):248. [PMC free article: PMC3664086] [PubMed: 23693018]

1587.

Chen X, Sun L, Mao Y, et al. Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer. BMC Cancer. 2013;13:390. [PMC free article: PMC3765132] [PubMed: 23957561]

1588.

Cheng TY, Chen CM, Lee MY, et al. Risk factors associated with conversion from nonmalignant to malignant diagnosis after surgical excision of breast papillary lesions. Ann Surg Oncol. 2009 Dec;16(12):3375–9. [PubMed: 19641969]

1589.

Cherrington BD, Mohanan S, Diep AN, et al. Comparative analysis of peptidylarginine deiminase-2 expression in canine, feline and human mammary tumours. J Comp Pathol. 2012 Aug–Oct;147(2–3):139–46. [PubMed: 22520816]

1590.

Cheung YC, Wan YL, Lo YF, et al. Preoperative magnetic resonance imaging evaluation for breast cancers after sonographically guided core-needle biopsy: a comparison study. Ann Surg Oncol. 2004 Aug;11(8):756–61. [PubMed: 15289239]

1591.

Chiesa J, Ferrer C, Arnould C, et al. Autocrine proliferative effects of hGH are maintained in primary cultures of human mammary carcinoma cells. J Clin Endocrinol Metab. 2011 Sep;96(9):E1418–26. [PubMed: 21733992]

1592.

Chin-Lenn L, Mack LA, Temple W, et al. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy. Ann Surg Oncol. 2014 Jan;21(1):66–73. [PubMed: 24046105]

1593.

Chintamani, Tandon M, Mishra A, et al. Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer--a prospective study. World J Surg Oncol. 2011;9:19. [PMC free article: PMC3041688] [PubMed: 21396137]

1594.

Chivukula M, Bhargava R, Brufsky A, et al. Clinical importance of HER2 immunohistologic heterogeneous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) cases. Mod Pathol. 2008 Apr;21(4):363–8. [PubMed: 18246053]

1595.

Chivukula M, Bhargava R, Tseng G, et al. Clinicopathologic implications of “flat epithelial atypia” in core needle biopsy specimens of the breast. Am J Clin Pathol. 2009 Jun;131(6):802–8. [PubMed: 19461086]

1596.

Chivukula M, Haynik DM, Brufsky A, et al. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol. 2008 Nov;32(11):1721–6. [PubMed: 18769331]

1597.

Chivukula M, Striebel JM, Ersahin C, et al. Evaluation of morphologic features to identify “basal-like phenotype” on core needle biopsies of breast. Appl Immunohistochem Mol Morphol. 2008 Oct;16(5):411–6. [PubMed: 18542031]

1598.

Cho N, Moon WK, Chang JM, et al. Ultrasonography-guided vacuum-assisted biopsy of microcalcifications: Comparison of the diagnostic yield of calcified cores and non-calcified cores on specimen radiographs. Acta Radiol. 2010 Mar;51(2):123–7. [PubMed: 19912076]

1599.

Cho N, Moon WK, Chang JM, et al. Sonoelastographic lesion stiffness: preoperative predictor of the presence of an invasive focus in nonpalpable DCIS diagnosed at US-guided needle biopsy. Eur Radiol. 2011 Aug;21(8):1618–27. [PubMed: 21400103]

1600.

Choi J, Koo JS. Comparative study of histological features between core needle biopsy and surgical excision in phyllodes tumor. Pathol Int. 2012 Feb;62(2):120–6. [PubMed: 22243782]

1601.

Choi JS, Baek HM, Kim S, et al. HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors. PLoS One. 2012;7(12):e51712. [PMC free article: PMC3522710] [PubMed: 23272149]

1602.

Choi YJ, Ko EY, Kook S. Diagnosis of pseudoangiomatous stromal hyperplasia of the breast: ultrasonography findings and different biopsy methods. Yonsei Med J. 2008 Oct 31;49(5):757–64. [PMC free article: PMC2615356] [PubMed: 18972596]

1603.

Choi YJ, Shin YD, Kang YH, et al. The Effects of Preoperative (18)F-FDG PET/CT in Breast Cancer Patients in Comparison to the Conventional Imaging Study. J Breast Cancer. 2012 Dec;15(4):441–8. [PMC free article: PMC3542853] [PubMed: 23346174]

1604.

Chung J, Son EJ, Kim JA, et al. Giant phyllodes tumors of the breast: imaging findings with clinicopathological correlation in 14 cases. Clin Imaging. 2011 Mar–Apr;35(2):102–7. [PubMed: 21377047]

1605.

Chuthapisith S, Bean BE, Cowley G, et al. Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy. Eur J Cancer. 2009 May;45(7):1274–81. [PubMed: 19171478]

1606.

Ciatto S, Houssami N. Breast imaging and needle biopsy in women with clinically evident breast cancer: does combined imaging change overall diagnostic sensitivity? Breast. 2007 Aug;16(4):382–6. [PubMed: 17350262]

1607.

Ciocchetti JM, Joy N, Staller S, et al. The effect of magnetic resonance imaging in the workup of breast cancer. Am J Surg. 2009 Dec;198(6):824–8. [PubMed: 19969136]

1608.

Clark CJ, Wechter D. Morphea of the breast--an uncommon cause of breast erythema. Am J Surg. 2010 Jul;200(1):173–6. [PubMed: 20637350]

1609.

Coffey JP, Hill JC. Breast sentinel node imaging with low-dose SPECT/CT. Nucl Med Commun. 2010 Feb;31(2):107–11. [PubMed: 19966597]

1610.

Colleoni M, Viale G, Zahrieh D, et al. Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy. Ann Oncol. 2008 Mar;19(3):465–72. [PubMed: 17986623]

1611.

Collins LC, Wang Y, Connolly JL, et al. Potential role of tissue microarrays for the study of biomarker expression in benign breast disease and normal breast tissue. Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):438–41. [PMC free article: PMC2783452] [PubMed: 19363445]

1612.

Connor CS, Tawfik OW, Joyce AJ, et al. A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimens. Am J Surg. 2002 Oct;184(4):322–4. [PubMed: 12383893]

1613.

Corben AD, Abi-Raad R, Popa I, et al. Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application. Arch Pathol Lab Med. 2013 Aug;137(8):1074–82. [PubMed: 23899063]

1614.

Cote ML, Ruterbusch JJ, Alosh B, et al. Benign breast disease and the risk of subsequent breast cancer in African American women. Cancer Prev Res (Phila). 2012 Dec;5(12):1375–80. [PMC free article: PMC3518609] [PubMed: 23087047]

1615.

Crowe JP, Patrick RJ, Rim A. The importance of preoperative breast MRI for patients newly diagnosed with breast cancer. Breast J. 2009 Jan–Feb;15(1):52–60. [PubMed: 19141134]

1616.

Cyr AE, Novack D, Trinkaus K, et al. Are we overtreating papillomas diagnosed on core needle biopsy? Ann Surg Oncol. 2011 Apr;18(4):946–51. [PMC free article: PMC3980447] [PubMed: 21046266]

1617.

da Silva BB, dos Santos AR, Pires CG, et al. Effect of raloxifene on vascular endothelial growth factor expression in breast carcinomas of postmenopausal women. Cell Prolif. 2009 Aug;42(4):506–10. [PMC free article: PMC6496576] [PubMed: 19489979]

1618.

Daidone MG, Orefice S, Mastore M, et al. Comparing core needle to surgical biopsies in breast cancer for cell kinetic and ploidy studies. Breast Cancer Res Treat. 1991 Sep;19(1):33–7. [PubMed: 1756265]

1619.

D’Alfonso T, Liu YF, Monni S, et al. Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed. Am J Surg Pathol. 2010 Apr;34(4):575–81. [PubMed: 20216378]

1620.

D’Alfonso TM, Wang K, Chiu YL, et al. Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the radiographic target. Arch Pathol Lab Med. 2013 Jul;137(7):927–35. [PubMed: 23808465]

1621.

Darvishian F, Singh B, Simsir A, et al. Atypia on breast core needle biopsies: reproducibility and significance. Ann Clin Lab Sci. 2009 Summer;39(3):270–6. [PubMed: 19667411]

1622.

Dayton A, Soot L, Wolf R, et al. Light-guided lumpectomy: first clinical experience. J Biophotonics. 2011 Oct;4(10):752–8. [PubMed: 21956998]

1623.

de Beca FF, Rasteiro C, Correia A, et al. Improved malignancy prediction by B3 breast lesions subclassification. Ann Diagn Pathol. 2013 Oct;17(5):434–6. [PubMed: 23773891]

1624.

de Cremoux P, Martin EC, Vincent-Salomon A, et al. Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185(HER2/neu) protein expression in breast cancer drill biopsies. Int J Cancer. 1999 Oct 8;83(2):157–61. [PubMed: 10471520]

1625.

De Felice C, Cipolla V, Stagnitti A, et al. The impact of presurgical magnetic resonance in early breast cancer: an observational study. Eur J Gynaecol Oncol. 2012;33(2):193–9. [PubMed: 22611962]

1626.

Dede DS, Gumuskaya B, Guler G, et al. Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel. J BUO N. 2013 Jan–Mar;18(1):57–63. [PubMed: 23613389]

1627.

DeMartini WB, Hanna L, Gatsonis C, et al. Evaluation of tissue sampling methods used for MRI-detected contralateral breast lesions in the American College of Radiology Imaging Network 6667 trial. AJR Am J Roentgenol. 2012 Sep;199(3):W386–91. [PMC free article: PMC3703204] [PubMed: 22915431]

1628.

Dennis MA, Parker S, Kaske TI, et al. Incidental treatment of nipple discharge caused by benign intraductal papilloma through diagnostic Mammotome biopsy. AJR Am J Roentgenol. 2000 May;174(5):1263–8. [PubMed: 10789774]

1629.

Deshaies I, Provencher L, Jacob S, et al. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy. Breast. 2011 Feb;20(1):50–5. [PubMed: 20619647]

1630.

Destounis SV, Murphy PF, Seifert PJ, et al. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility. AJR Am J Roentgenol. 2012 Feb;198(2):281–7. [PubMed: 22268169]

1631.

Dey P, Logasundaram R, Joshi K. Artificial neural network in diagnosis of lobular carcinoma of breast in fine-needle aspiration cytology. Diagn Cytopathol. 2013 Feb;41(2):102–6. [PubMed: 21987420]

1632.

Di Loreto C, Puglisi F, Rimondi G, et al. Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas. Eur J Cancer. 1996 Sep;32A(10):1693–700. [PubMed: 8983276]

1633.

Di Saverio S, Catena F, Santini D, et al. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Breast Cancer Res Treat. 2008 Jun;109(3):405–16. [PubMed: 17687650]

1634.

Diepstraten SC, van de Ven SM, Pijnappel RM, et al. Development and evaluation of a prediction model for underestimated invasive breast cancer in women with ductal carcinoma in situ at stereotactic large core needle biopsy. PLoS One. 2013;8(10):e77826. [PMC free article: PMC3795649] [PubMed: 24147085]

1635.

Dogan L, Gulcelik MA, Yuksel M, et al. Wire-guided localization biopsy to determine surgical margin status in patients with non-palpable suspicious breast lesions. Asian Pac J Cancer Prev. 2012;13(10):4989–92. [PubMed: 23244096]

1636.

Domeyer PJ, Sergentanis TN, Zagouri F, et al. Health-related quality of life in vacuum-assisted breast biopsy: short-term effects, long-term effects and predictors. Health Qual Life Outcomes. 2010;8:11. [PMC free article: PMC2835677] [PubMed: 20102642]

1637.

Domingo L, Romero A, Blanch J, et al. Clinical and radiological features of breast tumors according to history of false-positive results in mammography screening. Cancer Epidemiol. 2013 Oct;37(5):660–5. [PubMed: 23962702]

1638.

Dominici L, Liao GS, Brock J, et al. Large needle core biopsy of atypical ductal hyperplasia: results of surgical excision. Breast J. 2012 Sep;18(5):506–8. [PubMed: 22897750]

1639.

dos Santos LG, da Silva BB. The effect of raloxifene on telomerase expression in breast carcinoma samples from postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):165–7. [PubMed: 21741149]

1640.

Douglas-Jones AG, Collett N, Morgan JM, et al. Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma. J Clin Pathol. 2001 Dec;54(12):951–5. [PMC free article: PMC1731334] [PubMed: 11729216]

1641.

Doyle B, Al-Mudhaffer M, Kennedy MM, et al. Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified? J Clin Pathol. 2009 Jun;62(6):534–8. [PubMed: 19190009]

1642.

Dragun AE, Jenrette JM, Ackerman SJ, et al. Mammographic surveillance after MammoSite breast brachytherapy: analysis of architectural patterns and additional interventions. Am J Clin Oncol. 2007 Dec;30(6):574–9. [PubMed: 18091050]

1643.

Drev P, Grazio SF, Bracko M. Tissue microarrays for routine diagnostic assessment of HER2 status in breast carcinoma. Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):179–84. [PubMed: 18227723]

1644.

Dudley DJ, Drake J, Quinlan J, et al. Beneficial effects of a combined navigator/promotora approach for Hispanic women diagnosed with breast abnormalities. Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1639–44. [PMC free article: PMC3469583] [PubMed: 23045538]

1645.

Dunbier AK, Anderson H, Ghazoui Z, et al. Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. J Clin Oncol. 2010 Mar 1;28(7):1161–7. [PMC free article: PMC2834467] [PubMed: 20124184]

1646.

Dundar MM, Badve S, Bilgin G, et al. Computerized classification of intraductal breast lesions using histopathological images. IEEE Trans Biomed Eng. 2011 Jul;58(7):1977–84. [PMC free article: PMC3328096] [PubMed: 21296703]

1647.

Dutra I, Nassif H, Page D, et al. Integrating machine learning and physician knowledge to improve the accuracy of breast biopsy. AMIA Annu Symp Proc. 2011;2011:349–55. [PMC free article: PMC3243183] [PubMed: 22195087]

1648.

Eby PR, Calhoun KE, Kurland BF, et al. Preoperative and intraoperative sonographic visibility of collagen-based breast biopsy marker clips. Acad Radiol. 2010 Mar;17(3):340–7. [PubMed: 20042350]

1649.

Eby PR, Ochsner JE, DeMartini WB, et al. Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge. AJR Am J Roentgenol. 2009 Jan;192(1):229–34. [PubMed: 19098204]

1650.

Edeiken-Monroe BS, Monroe DP, Monroe BJ, et al. Metastases to intramammary lymph nodes in patients with breast cancer: sonographic findings. J Clin Ultrasound. 2008 Jun;36(5):279–85. [PubMed: 18366093]

1651.

Edelweiss M, Corben AD, Liberman L, et al. Focal extravasated mucin in breast core needle biopsies: is surgical excision always necessary? Breast J. 2013 May–Jun;19(3):302–9. [PubMed: 23534893]

1652.

Edwards HD, Oakley F, Koyama T, et al. The impact of tumor size in breast needle biopsy material on final pathologic size and tumor stage: a detailed analysis of 222 consecutive cases. Am J Surg Pathol. 2013 May;37(5):739–44. [PubMed: 23552386]

1653.

Ekmekcioglu O, Aliyev A, Yilmaz S, et al. Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma. Nucl Med Commun. 2013 Nov;34(11):1055–67. [PubMed: 24025919]

1654.

El-Sayed ME, Rakha EA, Reed J, et al. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology. 2008 Dec;53(6):650–7. [PubMed: 19076681]

1655.

El-Shinawi M, Abdelwahab SF, Sobhy M, et al. Capturing and characterizing immune cells from breast tumor microenvironment: an innovative surgical approach. Ann Surg Oncol. 2010 Oct;17(10):2677–84. [PMC free article: PMC3402355] [PubMed: 20333554]

1656.

El-Sibai MF, Cohen C, Nassar A, et al. Predictive markers in primary breast cancer compared with lymph node and bloodspread metastases. Int J Physiol Pathophysiol Pharmacol. 2009;1(1):57–63. [PMC free article: PMC3040940] [PubMed: 21383878]

1657.

El-Tamer M, Axiotis C, Kim E, et al. Accurate prediction of the amount of in situ tumor in palpable breast cancers by core needle biopsy: implications for neoadjuvant therapy. Ann Surg Oncol. 1999 Jul–Aug;6(5):461–6. [PubMed: 10458684]

1658.

Erggelet J, Grosse R, Holzhausen H, et al. Correlation of human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR) expression as predicted by core biopsy with the immunohistochemical results of surgical breast cancer specimens. Breast Care. 2007;2(2):94–8.

1659.

Erozgen F, Ersoy YE, Akaydin M, et al. Corticosteroid treatment and timing of surgery in idiopathic granulomatous mastitis confusing with breast carcinoma. Breast Cancer Res Treat. 2010 Sep;123(2):447–52. [PubMed: 20625813]

1660.

Fan XC, Nemoto T, Blatto K, et al. Impact of presurgical breast magnetic resonance imaging (MRI) on surgical planning - a retrospective analysis from a private radiology group. Breast J. 2013 Mar–Apr;19(2):134–41. [PubMed: 23294216]

1661.

Fancellu A, Soro D, Castiglia P, et al. Usefulness of magnetic resonance in patients with invasive cancer eligible for breast conservation: a comparative study. Clin Breast Cancer. 2014 Apr;14(2):114–21. [PubMed: 24321101]

1662.

Farshid G, Downey P, Gill P, et al. Assessment of 1183 screen-detected, category 3B, circumscribed masses by cytology and core biopsy with long-term follow up data. Br J Cancer. 2008 Apr 8;98(7):1182–90. [PMC free article: PMC2359648] [PubMed: 18382460]

1663.

Farshid G, Walker A, Battersby G, et al. Predictors of malignancy in screen-detected breast masses with indeterminate/equivocal (grade 3) imaging features. Breast. 2011 Feb;20(1):56–61. [PubMed: 20691591]

1664.

Fatakdawala H, Xu J, Basavanhally A, et al. Expectation-maximization-driven geodesic active contour with overlap resolution (EMaGACOR): application to lymphocyte segmentation on breast cancer histopathology. IEEE Trans Biomed Eng. 2010 Jul;57(7):1676–89. [PubMed: 20172780]

1665.

Fedewa SA, Edge SB, Stewart AK, et al. Race and ethnicity are associated with delays in breast cancer treatment (2003–2006). J Health Care Poor Underserved. 2011 Feb;22(1):128–41. [PubMed: 21317511]

1666.

Feldman SM, Krag DN, McNally RK, et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg. 1999 Mar;188(3):248–54. [PubMed: 10065813]

1667.

Ferreira M, Albarracin CT, Resetkova E. Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases. Mod Pathol. 2008 Feb;21(2):201–7. [PubMed: 18084246]

1668.

Fillion MM, Black EA, Hudson KB, et al. The effect of multiple wire localization in breast conservation. Am Surg. 2012 May;78(5):519–22. [PubMed: 22546121]

1669.

Fine RE, Staren ED. Percutaneous radiofrequency-assisted excision of fibroadenomas. Am J Surg. 2006 Oct;192(4):545–7. [PubMed: 16978972]

1670.

Flegg KM, Flaherty JJ, Bicknell AM, et al. Surgical outcomes of borderline breast lesions detected by needle biopsy in a breast screening program. World J Surg Oncol. 2010;8:78. [PMC free article: PMC2945347] [PubMed: 20822548]

1671.

Forghani MN, Memar B, Jangjoo A, et al. The effect of excisional biopsy on the accuracy of sentinel lymph node mapping in early stage breast cancer: comparison with core needle biopsy. Am Surg. 2010 Nov;76(11):1232–5. [PubMed: 21140690]

1672.

Friedman PD, Sanders LM, Menendez C, et al. Retrieval of lost microcalcifications during stereotactic vacuum-assisted core biopsy. AJR Am J Roentgenol. 2003 Jan;180(1):275–80. [PubMed: 12490519]

1673.

Fu CY, Chen TW, Hong ZJ, et al. Papillary breast lesions diagnosed by core biopsy require complete excision. Eur J Surg Oncol. 2012 Nov;38(11):1029–35. [PubMed: 22959140]

1674.

Fuehrer N, Hartmann L, Degnim A, et al. Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients. Arch Pathol Lab Med. 2012 Feb;136(2):179–82. [PMC free article: PMC3964588] [PubMed: 22288965]

1675.

Gadre SA, Perkins GH, Sahin AA, et al. Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion. Histopathology. 2008 Nov;53(5):545–53. [PubMed: 18983463]

1676.

Gao F, Carter G, Tseng G, et al. Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies. Am J Clin Pathol. 2010 May;133(5):767–71. [PubMed: 20395524]

1677.

Garcia-Manero M, Olartecoechea B, Royo P. Different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience. Eur J Obstet Gynecol Reprod Biol. 2010 Dec;153(2):185–7. [PubMed: 20702018]

1678.

Garg S, Mohan H, Bal A, et al. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions. Diagn Cytopathol. 2007 Nov;35(11):681–9. [PubMed: 17924407]

1679.

Garwood ER, Kumar AS, Baehner FL, et al. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat. 2010 Jan;119(1):137–44. [PMC free article: PMC4087110] [PubMed: 19728082]

1680.

Gautier N, Lalonde L, Tran-Thanh D, et al. Chronic granulomatous mastitis: Imaging, pathology and management. Eur J Radiol. 2013 Apr;82(4):e165–75. [PubMed: 23200627]

1681.

Gazic B, Pizem J, Bracko M, et al. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients. Cytopathology. 2008 Oct;19(5):294–302. [PubMed: 18070112]

1682.

Gemignani ML, Patil S, Seshan VE, et al. Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer. J Nucl Med. 2013 Oct;54(10):1697–702. [PMC free article: PMC4404505] [PubMed: 23970364]

1683.

Gerloff A, Dittmer A, Oerlecke I, et al. Protein expression of the Ets transcription factor Elf-1 in breast cancer cells is negatively correlated with histological grading, but not with clinical outcome. Oncol Rep. 2011 Nov;26(5):1121–5. [PubMed: 21811762]

1684.

Germano S, Kennedy S, Rani S, et al. MAGE-D4B is a novel marker of poor prognosis and potential therapeutic target involved in breast cancer tumorigenesis. Int J Cancer. 2012 May 1;130(9):1991–2002. [PubMed: 21618523]

1685.

Gill HK, Ioffe OB, Berg WA. When is a diagnosis of sclerosing adenosis acceptable at core biopsy? Radiology. 2003 Jul;228(1):50–7. [PubMed: 12738875]

1686.

Giskeodegard GF, Lundgren S, Sitter B, et al. Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers. NMR Biomed. 2012 Nov;25(11):1271–9. [PubMed: 22407957]

1687.

Glazebrook KN, Reynolds C, Smith RL, et al. Adenoid cystic carcinoma of the breast. AJR Am J Roentgenol. 2010 May;194(5):1391–6. [PubMed: 20410430]

1688.

Go EM, Chan SK, Vong JS, et al. Predictors of invasion in needle core biopsies of the breast with ductal carcinoma in situ. Mod Pathol. 2010 May;23(5):737–42. [PubMed: 20081814]

1689.

Gobbi H, Tse G, Page DL, et al. Reactive spindle cell nodules of the breast after core biopsy or fine-needle aspiration. Am J Clin Pathol. 2000 Feb;113(2):288–94. [PubMed: 10664632]

1690.

Godinez J, Gombos EC, Chikarmane SA, et al. Breast MRI in the evaluation of eligibility for accelerated partial breast irradiation. AJR Am J Roentgenol. 2008 Jul;191(1):272–7. [PubMed: 18562758]

1691.

Golshan M, Fung BB, Wiley E, et al. Prediction of breast cancer size by ultrasound, mammography and core biopsy. Breast. 2004 Aug;13(4):265–71. [PubMed: 15325659]

1692.

Goto M, Yuen S, Akazawa K, et al. The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy. Eur Radiol. 2012 Jun;22(6):1255–64. [PubMed: 22205445]

1693.

Gould DJ, Salmans JA, Lassinger BK, et al. Factors associated with phyllodes tumor of the breast after core needle biopsy identifies fibroepithelial neoplasm. J Surg Res. 2012 Nov;178(1):299–303. [PubMed: 22524977]

1694.

Govindarajulu S, Narreddy S, Shere MH, et al. Preoperative mammotome biopsy of ducts beneath the nipple areola complex. Eur J Surg Oncol. 2006 May;32(4):410–2. [PubMed: 16516432]

1695.

Grady I, Gorsuch-Rafferty H, Hadley P. Preoperative staging with magnetic resonance imaging, with confirmatory biopsy, improves surgical outcomes in women with breast cancer without increasing rates of mastectomy. Breast J. 2012 May–Jun;18(3):214–8. [PubMed: 22487017]

1696.

Graesslin O, Antoine M, Chopier J, et al. Histology after lumpectomy in women with epithelial atypia on stereotactic vacuum-assisted breast biopsy. Eur J Surg Oncol. 2010 Feb;36(2):170–5. [PubMed: 19811884]

1697.

Greco FA, Spigel DR, Yardley DA, et al. Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction. Oncologist. 2010;15(5):500–6. [PMC free article: PMC3227979] [PubMed: 20427384]

1698.

Green S, Khalkhali I, Azizollahi E, et al. Excisional biopsy of borderline lesions after large bore vacuum-assisted core needle biopsy- is it necessary? Am Surg. 2011 Oct;77(10):1358–60. [PubMed: 22127088]

1699.

Greer LT, Rosman M, Mylander WC, et al. Does breast tumor heterogeneity necessitate further immunohistochemical staining on surgical specimens? J Am Coll Surg. 2013 Feb;216(2):239–51. [PubMed: 23141136]

1700.

Greif F, Sharon E, Shechtman I, et al. Carcinoma within solitary ductal papilloma of the breast. Eur J Surg Oncol. 2010 Apr;36(4):384–6. [PubMed: 19646841]

1701.

Gresik CM, Godellas C, Aranha GV, et al. Pseudoangiomatous stromal hyperplasia of the breast: a contemporary approach to its clinical and radiologic features and ideal management. Surgery. 2010 Oct;148(4):752–7. discussion 7-8. [PubMed: 20708765]

1702.

Grin A, O’Malley FP, Mulligan AM. Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy. Am J Surg Pathol. 2009 Nov;33(11):1615–23. [PubMed: 19675450]

1703.

Groheux D, Giacchetti S, Moretti JL, et al. Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer. Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):426–35. [PubMed: 21057787]

1704.

Gunalp B, Ince S, Karacalioglu AO, et al. Clinical impact of (18)F-FDG PET/CT on initial staging and therapy planning for breast cancer. Exp Ther Med. 2012 Oct;4(4):693–8. [PMC free article: PMC3501408] [PubMed: 23170128]

1705.

Gutierrez RL, DeMartini WB, Silbergeld JJ, et al. High cancer yield and positive predictive value: outcomes at a center routinely using preoperative breast MRI for staging. AJR Am J Roentgenol. 2011 Jan;196(1):W93–9. [PubMed: 21178040]

1706.

Hahn M, Okamgba S, Scheler P, et al. Vacuum-assisted breast biopsy: a comparison of 11-gauge and 8-gauge needles in benign breast disease. World J Surg Oncol. 2008;6:51. [PMC free article: PMC2405782] [PubMed: 18489771]

1707.

Haigh PI, Hansen NM, Qi K, et al. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol. 2000 Jan–Feb;7(1):21–7. [PubMed: 10674444]

1708.

Haj M, Loberant N, Salamon V, et al. Membranous fat necrosis of the breast: diagnosis by minimally invasive technique. Breast J. 2004 Nov–Dec;10(6):504–8. [PubMed: 15569206]

1709.

Han JS, Molberg KH, Sarode V. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases. Breast J. 2011 May–Jun;17(3):223–9. [PubMed: 21545433]

1710.

Hanley C, Kessaram R. Quality of diagnosis and surgical management of breast lesions in a community hospital: room for improvement? Can J Surg. 2006 Jun;49(3):185–92. [PMC free article: PMC3207602] [PubMed: 16749979]

1711.

Hanley KZ, Birdsong GG, Cohen C, et al. Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas: comparison on cell block, needle-core, and tissue block preparations. Cancer. 2009 Aug 25;117(4):279–88. [PubMed: 19551847]

1712.

Harada S, Mick R, Roses RE, et al. The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease. J Surg Oncol. 2011 Oct;104(5):458–65. [PMC free article: PMC3168675] [PubMed: 21557226]

1713.

Haraldsdottir KH, Ivarsson K, Gotberg S, et al. Interstitial laser thermotherapy (ILT) of breast cancer. Eur J Surg Oncol. 2008 Jul;34(7):739–45. [PubMed: 18291614]

1714.

Hargaden GC, Yeh ED, Georgian-Smith D, et al. Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia. AJR Am J Roentgenol. 2008 Aug;191(2):359–63. [PubMed: 18647902]

1715.

Harris GC, Denley HE, Pinder SE, et al. Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma. Am J Surg Pathol. 2003 Jan;27(1):11–5. [PubMed: 12502923]

1716.

Harrison RL, Britton P, Warren R, et al. Can we be sure about a radiological diagnosis of fat necrosis of the breast? Clin Radiol. 2000 Feb;55(2):119–23. [PubMed: 10657157]

1717.

Hasebe T, Tamura N, Iwasaki M, et al. Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy. Mod Pathol. 2010 Apr;23(4):581–92. [PubMed: 20118911]

1718.

Hayes BD, O’Doherty A, Quinn CM. Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience. J Clin Pathol. 2009 Dec;62(12):1136–40. [PubMed: 19946101]

1719.

Hedayati E, Schedin A, Nyman H, et al. The effects of breast cancer diagnosis and surgery on cognitive functions. Acta Oncol. 2011 Oct;50(7):1027–36. [PubMed: 21554027]

1720.

Heudel P, Cimarelli S, Montella A, et al. Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors. Int J Clin Oncol. 2010 Dec;15(6):588–93. [PubMed: 20809217]

1721.

Hiraike H, Wada-Hiraike O, Nakagawa S, et al. Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer. Exp Ther Med. 2011 Nov;2(6):1105–9. [PMC free article: PMC3440794] [PubMed: 22977628]

1722.

Hoang JK, Hill P, Cawson JN. Can mammographic findings help discriminate between atypical ductal hyperplasia and ductal carcinoma in situ after needle core biopsy? Breast. 2008 Jun;17(3):282–8. [PubMed: 18063369]

1723.

Holley SO, Appleton CM, Farria DM, et al. Pathologic outcomes of nonmalignant papillary breast lesions diagnosed at imaging-guided core needle biopsy. Radiology. 2012 Nov;265(2):379–84. [PubMed: 22952379]

1724.

Hollingsworth AB, Stough RG. Multicentric and contralateral invasive tumors identified with pre-op MRI in patients newly diagnosed with ductal carcinoma in situ of the breast. Breast J. 2012 Sep;18(5):420–7. [PubMed: 22804792]

1725.

Holmes DR, Silverstein MJ. A minimally invasive breast biopsy clinic: an innovative way to teach breast fellows how to perform breast ultrasound and ultrasound-guided breast procedures. Am J Surg. 2006 Oct;192(4):439–43. [PubMed: 16978945]

1726.

Hong ZJ, Chu CH, Fan HL, et al. Factors predictive of breast cancer in open biopsy in cases with atypical ductal hyperplasia diagnosed by ultrasound-guided core needle biopsy. Eur J Surg Oncol. 2011 Sep;37(9):758–64. [PubMed: 21764539]

1727.

Horiguchi K, Toi M, Horiguchi S, et al. Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients. J Med Dent Sci. 2010 Jun;57(2):165–75. [PubMed: 21073135]

1728.

Horimoto Y, Tokuda E, Arakawa A, et al. Significance of HER2 protein examination in ductal carcinoma in situ. J Surg Res. 2011 May 15;167(2):e205–10. [PubMed: 20018297]

1729.

Houssami N, Ambrogetti D, Marinovich ML, et al. Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy. Ann Surg Oncol. 2011 May;18(5):1364–71. [PubMed: 21107741]

1730.

Houssami N, Ciatto S, Ellis I, et al. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer. 2007 Feb 1;109(3):487–95. [PubMed: 17186530]

1731.

Hovanessian Larsen LJ, Peyvandi B, Klipfel N, et al. Granulomatous lobular mastitis: imaging, diagnosis, and treatment. AJR Am J Roentgenol. 2009 Aug;193(2):574–81. [PubMed: 19620458]

1732.

Hsu HH, Yu JC, Hsu GC, et al. Atypical ductal hyperplasia of the breast diagnosed by ultrasonographically guided core needle biopsy. Ultraschall Med. 2012 Oct;33(5):447–54. [PubMed: 22161618]

1733.

Huang CH, Veillard A, Roux L, et al. Time-efficient sparse analysis of histopathological whole slide images. Comput Med Imaging Graph. 2011 Oct–Dec;35(7–8):579–91. [PubMed: 21145705]

1734.

Huang O, Chen C, Wu J, et al. Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months. BMC Cancer. 2009;9:375. [PMC free article: PMC2770573] [PubMed: 19845944]

1735.

Huang YT, Cheung YC, Lo YF, et al. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy. Acta Radiol. 2011 Dec 1;52(10):1064–8. [PubMed: 21969708]

1736.

Hukkinen K, Kivisaari L, Heikkila PS, et al. Unsuccessful preoperative biopsies, fine needle aspiration cytology or core needle biopsy, lead to increased costs in the diagnostic workup in breast cancer. Acta Oncol. 2008;47(6):1037–45. [PubMed: 18607862]

1737.

Hung WK, Ying M, Chan M, et al. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ. Breast Cancer. 2010 Oct;17(4):276–80. [PubMed: 19756924]

1738.

Hunt RJ, Steel JR, Porter GJ, et al. Lesions of uncertain malignant potential (B3) on core biopsy in the NHS Breast Screening Programme: is the screening round relevant? Ann R Coll Surg Engl. 2012 Mar;94(2):108–11. [PMC free article: PMC3954131] [PubMed: 22391380]

1739.

Ibrahim N, Bessissow A, Lalonde L, et al. Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia? AJR Am J Roentgenol. 2012 Feb;198(2):288–91. [PubMed: 22268170]

1740.

Ilic I, Randelovic P, Ilic R, et al. An approach to malignant mammary phyllodes tumors detection. Vojnosanit Pregl. 2009 Apr;66(4):277–82. [PubMed: 19441158]

1741.

Ingegnoli A, d’Aloia C, Frattaruolo A, et al. Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate. Breast J. 2010 Jan–Feb;16(1):55–9. [PubMed: 19825003]

1742.

Inoue S, Inoue M, Kawasaki T, et al. Six cases showing radial scar/complex sclerosing lesions of the breast detected by breast cancer screening. Breast Cancer. 2008;15(3):247–51. [PubMed: 18311480]

1743.

Inui H, Watatani M, Hashimoto Y, et al. Hematoma-directed and ultrasound-guided breast-conserving surgery for nonpalpable breast cancer after Mammotome biopsy. Surg Today. 2008;38(3):279–82. [PubMed: 18307007]

1744.

Irfan K, Brem RF. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy. Breast J. 2002 Jul–Aug;8(4):230–3. [PubMed: 12100116]

1745.

Itakura K, Lessing J, Sakata T, et al. The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ. Clin Breast Cancer. 2011 Mar;11(1):33–8. [PMC free article: PMC4508001] [PubMed: 21421520]

1746.

Jackman RJ, Burbank F, Parker SH, et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology. 1997 Aug;204(2):485–8. [PubMed: 9240540]

1747.

Jackman RJ, Marzoni FA Jr, Nowels KW. Percutaneous removal of benign mammographic lesions: comparison of automated large-core and directional vacuum-assisted stereotactic biopsy techniques. AJR Am J Roentgenol. 1998 Nov;171(5):1325–30. [PubMed: 9798873]

1748.

Jaffer S, Bleiweiss IJ, Nagi CS. Benign mucocele-like lesions of the breast: revisited. Mod Pathol. 2011 May;24(5):683–7. [PubMed: 21240257]

1749.

Jaffer S, Nagi C, Bleiweiss IJ. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy. Cancer. 2009 Jul 1;115(13):2837–43. [PubMed: 19402174]

1750.

Jaka RC, Zaveri SS, Somashekhar SP, et al. Value of frozen section and primary tumor factors in determining sentinel lymph node spread in early breast carcinoma. Indian J Surg Oncol. 2010 Jan;1(1):27–36. [PMC free article: PMC3420992] [PubMed: 22930615]

1751.

Jakate K, De Brot M, Goldberg F, et al. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses. Am J Surg Pathol. 2012 Apr;36(4):544–51. [PubMed: 22314186]

1752.

James TA, Mace JL, Virnig BA, et al. Preoperative needle biopsy improves the quality of breast cancer surgery. J Am Coll Surg. 2012 Oct;215(4):562–8. [PubMed: 22726895]

1753.

Jimenez RE, Bongers S, Bouwman D, et al. Clinicopathologic significance of ductal carcinoma in situ in breast core needle biopsies with invasive cancer. Am J Surg Pathol. 2000 Jan;24(1):123–8. [PubMed: 10632496]

1754.

Jones RJ, Young O, Renshaw L, et al. Src inhibitors in early breast cancer: a methodology, feasibility and variability study. Breast Cancer Res Treat. 2009 Mar;114(2):211–21. [PubMed: 18409068]

1755.

Jorgensen TJ, Helzlsouer KJ, Clipp SC, et al. DNA repair gene variants associated with benign breast disease in high cancer risk women. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):346–50. [PMC free article: PMC3428042] [PubMed: 19124519]

1756.

Jung SY, Kang HS, Kwon Y, et al. Risk factors for malignancy in benign papillomas of the breast on core needle biopsy. World J Surg. 2010 Feb;34(2):261–5. [PubMed: 19997916]

1757.

Kadivar M, Monabati A, Joulaee A, et al. Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women. Pathol Oncol Res. 2011 Sep;17(3):489–92. [PubMed: 21207256]

1758.

Kalles V, Zografos GC, Provatopoulou X, et al. Circulating levels of endothelin-1 (ET-1) and its precursor (Big ET-1) in breast cancer early diagnosis. Tumour Biol. 2012 Aug;33(4):1231–6. [PubMed: 22415226]

1759.

Kaneko S, Gerasimova T, Butler WM, et al. The use of FISH on breast core needle samples for the presurgical assessment of HER-2 oncogene status. Exp Mol Pathol. 2002 Aug;73(1):61–6. [PubMed: 12127055]

1760.

Kaya H, Ragazzini T, Aribal E, et al. Her-2/neu gene amplification compared with HER-2/neu protein overexpression on ultrasound guided core-needle biopsy specimens of breast carcinoma. Pathol Oncol Res. 2001;7(4):279–83. [PubMed: 11882907]

1761.

Keto JL, Kirstein L, Sanchez DP, et al. MRI versus breast-specific gamma imaging (BSGI) in newly diagnosed ductal cell carcinoma-in-situ: a prospective head-to-head trial. Ann Surg Oncol. 2012 Jan;19(1):249–52. [PubMed: 21739318]

1762.

Khoumais NA, Scaranelo AM, Moshonov H, et al. Incidence of breast cancer in patients with pure flat epithelial atypia diagnosed at core-needle biopsy of the breast. Ann Surg Oncol. 2013 Jan;20(1):133–8. [PubMed: 23064777]

1763.

Khoury T, Zakharia Y, Tan W, et al. Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsy. Breast J. 2011 Mar–Apr;17(2):180–6. [PubMed: 21306471]

1764.

Khout H, Mohiuddin MK, Veeratterapillay R, et al. Breast cancer mimicking fibroadenomas in postmenopausal women. Int J Surg. 2011;9(1):2–4. [PubMed: 20804869]

1765.

Kibil W, Hodorowicz-Zaniewska D, Popiela TJ, et al. Vacuum-assisted core biopsy in diagnosis and treatment of intraductal papillomas. Clin Breast Cancer. 2013 Apr;13(2):129–32. [PubMed: 23127339]

1766.

Killelea BK, Gillego A, Kirstein LJ, et al. George Peters Award: How does breast-specific gamma imaging affect the management of patients with newly diagnosed breast cancer? Am J Surg. 2009 Oct;198(4):470–4. [PubMed: 19800450]

1767.

Killelea BK, Grube BJ, Rishi M, et al. Is the use of preoperative breast MRI predictive of mastectomy? World J Surg Oncol. 2013;11:154. [PMC free article: PMC3716627] [PubMed: 23849218]

1768.

Kim BS, Moon BI, Cha ES. A comparative study of breast-specific gamma imaging with the conventional imaging modality in breast cancer patients with dense breasts. Ann Nucl Med. 2012 Dec;26(10):823–9. [PubMed: 22922890]

1769.

Kim HS, Seok JH, Cha ES, et al. Significance of nipple enhancement of Paget’s disease in contrast enhanced breast MRI. Arch Gynecol Obstet. 2010 Aug;282(2):157–62. [PubMed: 19838723]

1770.

Kim J, Han W, Go EY, et al. Validation of a scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia using an ultrasound-guided core needle biopsy. J Breast Cancer. 2012 Dec;15(4):407–11. [PMC free article: PMC3542848] [PubMed: 23346169]

1771.

Kim J, Han W, Lee JW, et al. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Breast. 2012 Oct;21(5):641–5. [PubMed: 22749854]

1772.

Kim MJ, Kim EK, Kwak JY, et al. Sonographic surveillance for the detection of contralateral metachronous breast cancer in an Asian population. AJR Am J Roentgenol. 2009 Jan;192(1):221–8. [PubMed: 19098203]

1773.

Kim MJ, Kim SI, Youk JH, et al. The diagnosis of non-malignant papillary lesions of the breast: comparison of ultrasound-guided automated gun biopsy and vacuum-assisted removal. Clin Radiol. 2011 Jun;66(6):530–5. [PubMed: 21353213]

1774.

Kim SM, Kim HH, Kang DK, et al. Mucocele-like tumors of the breast as cystic lesions: sonographic-pathologic correlation. AJR Am J Roentgenol. 2011 Jun;196(6):1424–30. [PubMed: 21606308]

1775.

Kim T, Jung EA, Song JY, et al. Prevalence of the CTNNB1 mutation genotype in surgically resected fibromatosis of the breast. Histopathology. 2012 Jan;60(2):347–56. [PubMed: 22211293]

1776.

Kimmick GG, Cirrincione C, Duggan DB, et al. Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944). Breast Cancer Res Treat. 2009 Feb;113(3):479–90. [PMC free article: PMC4217205] [PubMed: 18306034]

1777.

Kinoshita T, Iwamoto E, Tsuda H, et al. Radiofrequency ablation as local therapy for early breast carcinomas. Breast Cancer. 2011 Jan;18(1):10–7. [PubMed: 20072824]

1778.

Klimberg VS, Boneti C, Adkins LL, et al. Feasibility of percutaneous excision followed by ablation for local control in breast cancer. Ann Surg Oncol. 2011 Oct;18(11):3079–87. [PMC free article: PMC3280094] [PubMed: 21904959]

1779.

Ko E, Han W, Lee JW, et al. Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy. Breast Cancer Res Treat. 2008 Nov;112(1):189–95. [PubMed: 18060577]

1780.

Ko EY, Bae YA, Kim MJ, et al. Factors affecting the efficacy of ultrasound-guided vacuum-assisted percutaneous excision for removal of benign breast lesions. J Ultrasound Med. 2008 Jan;27(1):65–73. [PubMed: 18096732]

1781.

Koh C, Nelson JM, Cook PF. Evaluation of a patient navigation program. Clin J Oncol Nurs. 2011 Feb;15(1):41–8. [PubMed: 21278040]

1782.

Kohr JR, Eby PR, Allison KH, et al. Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications. Radiology. 2010 Jun;255(3):723–30. [PubMed: 20173103]

1783.

Kok KY, Telisinghe PU. Granulomatous mastitis: presentation, treatment and outcome in 43 patients. Surgeon. 2010 Aug;8(4):197–201. [PubMed: 20569938]

1784.

Koo JS, Han K, Kim MJ, et al. Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy? Breast Cancer Res Treat. 2013 Feb;137(3):797–806. [PubMed: 23292118]

1785.

Koo JS, Jung W. Xanthogranulomatous mastitis: clinicopathology and pathological implications. Pathol Int. 2009 Apr;59(4):234–40. [PubMed: 19351366]

1786.

Koo JS, Kim MJ, Kim EK, et al. Factors in the breast core needle biopsies of atypical ductal hyperplasia that can predict carcinoma in the subsequent surgical excision specimens. J Breast Cancer. 2010;13(2):132–7.

1787.

Koo JS, Kim MJ, Kim EK, et al. Comparison of immunohistochemical staining in breast papillary neoplasms of cytokeratin 5/6 and p63 in core needle biopsies and surgical excisions. Appl Immunohistochem Mol Morphol. 2012 Mar;20(2):108–15. [PubMed: 22553810]

1788.

Kostopoulos S, Glotsos D, Cavouras D, et al. Computer-based association of the texture of expressed estrogen receptor nuclei with histologic grade using immunohistochemically-stained breast carcinomas. Anal Quant Cytol Histol. 2009 Aug;31(4):187–96. [PubMed: 19736866]

1789.

Krainick-Strobel U, Huber B, Majer I, et al. Complete extirpation of benign breast lesions with an ultrasound-guided vacuum biopsy system. Ultrasound in obstetrics & gynecology. 2007;29(3):342–6. [PubMed: 17167817]

1790.

Kremer ME, Downs-Holmes C, Novak RD, et al. Neglecting to screen women between the ages of 40 and 49 years with mammography: what is the impact on breast cancer diagnosis? AJR Am J Roentgenol. 2012 May;198(5):1218–22. [PubMed: 22528917]

1791.

Kryvenko ON, Chitale DA, VanEgmond EM, et al. Angiolipoma of the female breast: clinicomorphological correlation of 52 cases. Int J Surg Pathol. 2011 Feb;19(1):35–43. [PubMed: 21087987]

1792.

Kundu UR, Guo M, Landon G, et al. Fine-needle aspiration cytology of sclerosing adenosis of the breast: a retrospective review of cytologic features in conjunction with corresponding histologic features and radiologic findings. Am J Clin Pathol. 2012 Jul;138(1):96–102. [PubMed: 22706864]

1793.

Kunju LP, Cookingham C, Toy KA, et al. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development. Mod Pathol. 2011 Jun;24(6):786–93. [PMC free article: PMC3106137] [PubMed: 21399615]

1794.

Kurita T, Tsuchiya S, Watarai Y, et al. Roles of fine-needle aspiration and core needle biopsy in the diagnosis of breast cancer. Breast Cancer. 2012 Jan;19(1):23–9. [PubMed: 21298376]

1795.

Kurniawan ED, Rose A, Mou A, et al. Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ. Arch Surg. 2010 Nov;145(11):1098–104. [PubMed: 21079099]

1796.

Kurniawan ED, Wong MH, Windle I, et al. Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Ann Surg Oncol. 2008 Sep;15(9):2542–9. [PubMed: 18618180]

1797.

Kurz KD, Roy S, Saleh A, et al. MRI features of intraductal papilloma of the breast: sheep in wolf’s clothing? Acta Radiol. 2011 Apr 1;52(3):264–72. [PubMed: 21498361]

1798.

Kushwaha AC, O’Toole M, Sneige N, et al. Mammographic-pathologic correlation of apocrine metaplasia diagnosed using vacuum-assisted stereotactic core-needle biopsy: our 4-year experience. AJR Am J Roentgenol. 2003 Mar;180(3):795–8. [PubMed: 12591698]

1799.

Kvasnovsky CL, Kesmodel SB, Gragasin JL, et al. Expansion of screening mammography in the Veterans Health Administration: implications for breast cancer treatment. JAMA Surg. 2013 Nov;148(11):999–1004. [PubMed: 24048217]

1800.

Kwok KMK, Lui CY, Fung PYE, et al. Incidence, causes, and implications of unsuccessful calcification retrieval at stereotactic breast biopsy - 5 years’ experience. J. HK Coll Radiol. 2009;11(4):154–60.

1801.

Kwok TC, Rakha EA, Lee AH, et al. Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation. Histopathology. 2010 Aug;57(2):212–9. [PMC free article: PMC3564399] [PubMed: 20716163]

1802.

Lacambra MD, Lam CC, Mendoza P, et al. Biopsy sampling of breast lesions: comparison of core needle- and vacuum-assisted breast biopsies. Breast Cancer Res Treat. 2012 Apr;132(3):917–23. [PubMed: 21698409]

1803.

Lau B, Romero LM. Does preoperative magnetic resonance imaging beneficially alter surgical management of invasive lobular carcinoma? Am Surg. 2011 Oct;77(10):1368–71. [PubMed: 22127091]

1804.

Lau K, Lui C, Tee L, et al. Role of Breast Magnetic Resonance Imaging in the Preoperative Assessment and Its Impact on Surgical Management of Patients with Newly Diagnosed Breast Cancer.

1805.

Lavoue V, Roger CM, Poilblanc M, et al. Pure flat epithelial atypia (DIN 1a) on core needle biopsy: study of 60 biopsies with follow-up surgical excision. Breast Cancer Res Treat. 2011 Jan;125(1):121–6. [PubMed: 20945087]

1806.

Law Y, Cheung PS, Lau S, et al. Impact of magnetic resonance imaging on preoperative planning for breast cancer surgery. Hong Kong Med J. 2013 Aug;19(4):294–9. [PubMed: 23832947]

1807.

Lebeau A, Turzynski A, Braun S, et al. Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies. J Clin Oncol. 2010 Jul 10;28(20):3264–70. [PubMed: 20498397]

1808.

Lee AH, Denley HE, Pinder SE, et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology. 2003 Apr;42(4):331–6. [PubMed: 12653944]

1809.

Lee AH, Key HP, Bell JA, et al. Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast. Histopathology. 2012 May;60(6):880–4. [PubMed: 22320892]

1810.

Lee AH, Rakha EA, Hodi Z, et al. Re-audit of revised method for assessing the mitotic component of histological grade in needle core biopsies of invasive carcinoma of the breast. Histopathology. 2012 Jun;60(7):1166–7. [PubMed: 22385388]

1811.

Lee CH, Philpotts LE, Horvath LJ, et al. Follow-up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: frequency of mammographic change and false-negative rate. Radiology. 1999 Jul;212(1):189–94. [PubMed: 10405741]

1812.

Lee E, Wylie E, Metcalf C. Ultrasound imaging features of radial scars of the breast. Australas Radiol. 2007 Jun;51(3):240–5. [PubMed: 17504315]

1813.

Lee JW, Han W, Ko E, et al. Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus. J Surg Oncol. 2008 Jul 1;98(1):15–20. [PubMed: 18459155]

1814.

Lee KA, Zuley ML, Chivukula M, et al. Risk of malignancy when microscopic radial scars and microscopic papillomas are found at percutaneous biopsy. AJR Am J Roentgenol. 2012 Feb;198(2):W141–5. [PubMed: 22268203]

1815.

Lee TY, Macintosh RF, Rayson D, et al. Flat epithelial atypia on breast needle core biopsy: a retrospective study with clinical-pathological correlation. Breast J. 2010 Jul–Aug;16(4):377–83. [PubMed: 20459431]

1816.

Leidenius MH, Vironen JH, von Smitten KA, et al. The outcome of sentinel node biopsy in breast cancer patients with preoperative surgical biopsy. J Surg Oncol. 2009 Jun 1;99(7):420–3. [PubMed: 19350567]

1817.

Lewis JL, Lee DY, Tartter PI. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast. Ann Surg Oncol. 2012 Dec;19(13):4124–8. [PubMed: 22847126]

1818.

Li J, Dershaw DD, Lee CH, et al. MRI follow-up after concordant, histologically benign diagnosis of breast lesions sampled by MRI-guided biopsy. AJR Am J Roentgenol. 2009 Sep;193(3):850–5. [PubMed: 19696301]

1819.

Li JL, Wang ZL, Su L, et al. Breast lesions with ultrasound imaging-histologic discordance at 16-gauge core needle biopsy: can re-biopsy with 10-gauge vacuum-assisted system get definitive diagnosis? Breast. 2010 Dec;19(6):446–9. [PubMed: 20869243]

1820.

Li S, Wu J, Chen K, et al. Clinical outcomes of 1,578 Chinese patients with breast benign diseases after ultrasound-guided vacuum-assisted excision: recurrence and the risk factors. Am J Surg. 2013 Jan;205(1):39–44. [PubMed: 23040695]

1821.

Li SP, Padhani AR, Taylor NJ, et al. Vascular characterisation of triple negative breast carcinomas using dynamic MRI. Eur Radiol. 2011 Jul;21(7):1364–73. [PubMed: 21258931]

1822.

Li X, Deavers MT, Guo M, et al. The effect of prolonged cold ischemia time on estrogen receptor immunohistochemistry in breast cancer. Mod Pathol. 2013 Jan;26(1):71–8. [PMC free article: PMC3881416] [PubMed: 22899286]

1823.

Li X, Weaver O, Desouki MM, et al. Microcalcification is an important factor in the management of breast intraductal papillomas diagnosed on core biopsy. Am J Clin Pathol. 2012 Dec;138(6):789–95. [PubMed: 23161711]

1824.

Liberman L, Cody HS 3rd. Percutaneous biopsy and sentinel lymphadenectomy: minimally invasive diagnosis and treatment of nonpalpable breast cancer. AJR Am J Roentgenol. 2001 Oct;177(4):887–91. [PubMed: 11566696]

1825.

Liberman L, Cody HS 3rd, Hill AD, et al. Sentinel lymph node biopsy after percutaneous diagnosis of nonpalpable breast cancer. Radiology. 1999 Jun;211(3):835–44. [PubMed: 10352613]

1826.

Liberman L, Dershaw DD, Rosen PP, et al. Stereotaxic core biopsy of breast carcinoma: accuracy at predicting invasion. Radiology. 1995 Feb;194(2):379–81. [PubMed: 7824713]

1827.

Liberman L, Morris EA, Dershaw DD, et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol. 2003 Apr;180(4):901–10. [PubMed: 12646427]

1828.

Liberman L, Zakowski MF, Avery S, et al. Complete percutaneous excision of infiltrating carcinoma at stereotactic breast biopsy: how can tumor size be assessed? AJR Am J Roentgenol. 1999 Nov;173(5):1315–22. [PubMed: 10541111]

1829.

Lieberman S, Sella T, Maly B, et al. Breast magnetic resonance imaging characteristics in women with occult primary breast carcinoma. Isr Med Assoc J. 2008 Jun;10(6):448–52. [PubMed: 18669145]

1830.

Lieske B, Ravichandran D, Alvi A, et al. Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised. Eur J Surg Oncol. 2008 Dec;34(12):1293–8. [PubMed: 18162359]

1831.

Lieu D. Value of cytopathologist-performed ultrasound-guided fine-needle aspiration as a screening test for ultrasound-guided core-needle biopsy in nonpalpable breast masses. Diagn Cytopathol. 2009 Apr;37(4):262–9. [PubMed: 19217029]

1832.

Lin SJ, Cawson J, Hill P, et al. Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue. Breast Cancer Res Treat. 2011 Jul;128(2):505–16. [PubMed: 21258862]

1833.

Lind DS, Minter R, Steinbach B, et al. Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer. Journal of Surgical Research. 1998;78(1):23–6. [PubMed: 9733612]

1834.

Linda A, Zuiani C, Bazzocchi M, et al. Borderline breast lesions diagnosed at core needle biopsy: can magnetic resonance mammography rule out associated malignancy? Preliminary results based on 79 surgically excised lesions. Breast. 2008 Apr;17(2):125–31. [PubMed: 18083514]

1835.

Linda A, Zuiani C, Furlan A, et al. Radial scars without atypia diagnosed at imaging-guided needle biopsy: how often is associated malignancy found at subsequent surgical excision, and do mammography and sonography predict which lesions are malignant? AJR Am J Roentgenol. 2010 Apr;194(4):1146–51. [PubMed: 20308524]

1836.

Linda A, Zuiani C, Furlan A, et al. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? AJR Am J Roentgenol. 2012 Feb;198(2):272–80. [PubMed: 22268168]

1837.

Linda A, Zuiani C, Londero V, et al. What to do with B3 lesions at needle biopsy. Eur J Radiol. 2012 Sep;81(Suppl 1):S90–2. [PubMed: 23083618]

1838.

Ling CM, Coffey CM, Rapelyea JA, et al. Breast-specific gamma imaging in the detection of atypical ductal hyperplasia and lobular neoplasia. Acad Radiol. 2012 Jun;19(6):661–6. [PubMed: 22578225]

1839.

Lips EH, Mukhtar RA, Yau C, et al. Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer. Breast Cancer Res Treat. 2012 Nov;136(1):35–43. [PMC free article: PMC5702179] [PubMed: 22961065]

1840.

Londero V, Zuiani C, Linda A, et al. Borderline breast lesions: comparison of malignancy underestimation rates with 14-gauge core needle biopsy versus 11-gauge vacuum-assisted device. Eur Radiol. 2011 Jun;21(6):1200–6. [PubMed: 21225267]

1841.

Londero V, Zuiani C, Linda A, et al. High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision. AJR Am J Roentgenol. 2012 Aug;199(2):W240–50. [PubMed: 22826427]

1842.

Lopes-Costa PV, dos Santos AR, dos Santos LG, et al. Evaluation of Ki-67 and Bcl-2 antigen expression in breast carcinomas of women treated with raloxifene. Cell Prolif. 2010 Apr;43(2):124–9. [PMC free article: PMC6496800] [PubMed: 20447057]

1843.

Lorenzetti MA, De Matteo E, Gass H, et al. Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma. PLoS One. 2010;5(10):e13603. [PMC free article: PMC2962632] [PubMed: 21042577]

1844.

Lorgis V, Algros MP, Villanueva C, et al. Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour. Breast. 2011 Jun;20(3):284–7. [PubMed: 21288720]

1845.

Lu Q, Tan EY, Ho B, et al. Surgical excision of intraductal breast papilloma diagnosed on core biopsy. ANZ J Surg. 2012 Mar;82(3):168–72. [PubMed: 22510128]

1846.

Lyon DE, McCain NL, Walter J, et al. Cytokine comparisons between women with breast cancer and women with a negative breast biopsy. Nurs Res. 2008 Jan–Feb;57(1):51–8. [PMC free article: PMC2234268] [PubMed: 18091292]

1847.

Macaskill EJ, Bartlett JM, Sabine VS, et al. The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study. Breast Cancer Res Treat. 2011 Aug;128(3):725–34. [PubMed: 20941539]

1848.

Macaskill EJ, Purdie CA, Jordan LB, et al. Axillary lymph node core biopsy for breast cancer metastases -- how many needle passes are enough? Clin Radiol. 2012 May;67(5):417–9. [PubMed: 22119100]

1849.

Majewski SA, Zuley ML, Pinnamaneni N, et al. Frequency of carcinoma at secondary imaging-guided percutaneous breast biopsy performed after a high-risk pathologic result at primary biopsy. AJR Am J Roentgenol. 2013 Aug;201(2):439–47. [PubMed: 23883227]

1850.

Manenti G, Bolacchi F, Perretta T, et al. Small breast cancers: in vivo percutaneous US-guided radiofrequency ablation with dedicated cool-tip radiofrequency system. Radiology. 2009 May;251(2):339–46. [PubMed: 19304918]

1851.

Manfrin E, Mariotto R, Remo A, et al. Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years’ experience of the Breast Cancer Screening Program in Verona (1999–2004). Cancer. 2009 Feb 1;115(3):499–507. [PubMed: 19117040]

1852.

Mansoor S, Ip C, Stomper PC. Yield of Terminal Duct Lobule Units in Normal Breast Stereotactic Core Biopsy Specimens: Implications for Biomarker Studies. Breast J. 2000 Jul;6(4):220–4. [PubMed: 11348369]

1853.

Marcotte-Bloch C, Balu-Maestro C, Chamorey E, et al. MRI for the size assessment of pure ductal carcinoma in situ (DCIS): a prospective study of 33 patients. Eur J Radiol. 2011 Mar;77(3):462–7. [PubMed: 19896789]

1854.

Margenthaler JA, Duke D, Monsees BS, et al. Correlation between core biopsy and excisional biopsy in breast high-risk lesions. Am J Surg. 2006 Oct;192(4):534–7. [PubMed: 16978969]

1855.

Marsden CG, Wright MJ, Pochampally R, et al. Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action. Methods Mol Biol. 2009;590:363–75. [PubMed: 19763516]

1856.

Mathew J, Crawford DJ, Lwin M, et al. Ultrasound-guided, vacuum-assisted excision in the diagnosis and treatment of clinically benign breast lesions. Ann R Coll Surg Engl. 2007 Jul;89(5):494–6. [PMC free article: PMC2048597] [PubMed: 17688722]

1857.

Matos AV, de Canella EO, Koch HA, et al. Fat necrosis in the breast after reconstruction with transverse rectus abdominis myocutaneous flap: MRI features. Eur J Radiol. 2012 Sep;81(Suppl 1):S97–8. [PubMed: 23083621]

1858.

Maxwell AJ, Mataka G, Pearson JM. Benign papilloma diagnosed on image-guided 14 G core biopsy of the breast: effect of lesion type on likelihood of malignancy at excision. Clin Radiol. 2013 Apr;68(4):383–7. [PubMed: 23206431]

1859.

Maxwell AJ, Pearson JM. Criteria for the safe avoidance of needle sampling in young women with solid breast masses. Clin Radiol. 2010 Mar;65(3):218–22. [PubMed: 20152278]

1860.

McCann B, Miaskowski C, Koetters T, et al. Associations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgery. J Pain. 2012 May;13(5):425–37. [PMC free article: PMC3348353] [PubMed: 22515947]

1861.

McCormack VA, Joffe M, van den Berg E, et al. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series. Breast Cancer Res. 2013;15(5):R84. [PMC free article: PMC3978918] [PubMed: 24041225]

1862.

McGhan LJ, Pockaj BA, Wasif N, et al. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy? Ann Surg Oncol. 2012 Oct;19(10):3264–9. [PubMed: 22878619]

1863.

McLaughlin JM, Anderson RT, Ferketich AK, et al. Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol. 2012 Dec 20;30(36):4493–500. [PMC free article: PMC3518728] [PubMed: 23169521]

1864.

Mehrotra R, Pandya S, Singhla M, et al. Spectrum of malignancies in Allahabad, North India: a hospital-based study. Asian Pac J Cancer Prev. 2008 Jul–Sep;9(3):525–8. [PubMed: 18990032]

1865.

Meloni GB, Dessole S, Becchere MP, et al. Effectiveness of “core biopsy” by the mammotome device for diagnosis of inflammatory carcinoma. Clin Exp Obstet Gynecol. 1999;26(3–4):181–2. [PubMed: 10668149]

1866.

Menes TS, Zissman S, Golan O, et al. Yield of selective magnetic resonance imaging in preoperative workup of newly diagnosed breast cancer patients planned for breast conserving surgery. Am Surg. 2012 Apr;78(4):451–5. [PubMed: 22472404]

1867.

Merdad AA, Bahadur YA, Fawzy EE, et al. Phase II study on the use of intraoperative radiotherapy in early breast cancer. Saudi Med J. 2013 Nov;34(11):1133–8. [PubMed: 24252890]

1868.

Mesurolle B, Sygal V, Lalonde L, et al. Sonographic and mammographic appearances of breast hemangioma. AJR Am J Roentgenol. 2008 Jul;191(1):W17–22. [PubMed: 18562711]

1869.

Meyer JE, Smith DN, Lester SC, et al. Large-needle core biopsy: nonmalignant breast abnormalities evaluated with surgical excision or repeat core biopsy. Radiology. 1998 Mar;206(3):717–20. [PubMed: 9494490]

1870.

Middleton LP, Price KM, Puig P, et al. Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases. Arch Pathol Lab Med. 2009 May;133(5):775–80. [PubMed: 19415952]

1871.

Mihalik JE, Krupka L, Davenport R, et al. The rate of imaging-histologic discordance of benign breast disease: a multidisciplinary approach to the management of discordance at a large university-based hospital. Am J Surg. 2010 Mar;199(3):319–23. discussion 23. [PubMed: 20226903]

1872.

Miller NA, Chapman JA, Qian J, et al. Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the Breast. Cancer Inform. 2010;9:209–16. [PMC free article: PMC2956621] [PubMed: 20981137]

1873.

Mimmi MC, Picotti P, Corazza A, et al. High-performance metabolic marker assessment in breast cancer tissue by mass spectrometry. Clin Chem Lab Med. 2011 Feb;49(2):317–24. [PubMed: 21143022]

1874.

Minot DM, Kipp BR, Root RM, et al. Automated cellular imaging system III for assessing HER2 status in breast cancer specimens: development of a standardized scoring method that correlates with FISH. Am J Clin Pathol. 2009 Jul;132(1):133–8. [PubMed: 19864244]

1875.

Mittendorf EA, Arciero CA, Gutchell V, et al. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg. 2005 Mar–Apr;62(2):253–7. [PubMed: 15796952]

1876.

Miyake T, Shimazu K, Ohashi H, et al. Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ. Am J Surg. 2011 Jul;202(1):59–65. [PubMed: 21741518]

1877.

Miyashita M, Amano G, Ishida T, et al. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy. Jpn J Clin Oncol. 2013 Jun;43(6):654–63. [PubMed: 23592884]

1878.

Mohammed S, Statz A, Lacross JS, et al. Granulomatous mastitis: a 10 year experience from a large inner city county hospital. J Surg Res. 2013 Sep;184(1):299–303. [PubMed: 23890401]

1879.

Mondal HP, Roy H, Mondal P, et al. Usefulness of serum CA-15.3 in the management of benign breast lesion. J Indian Med Assoc. 2012 Apr;110(4):242–4. [PubMed: 23025224]

1880.

Monticciolo DL. Histologic grading at breast core needle biopsy: comparison with results from the excised breast specimen. Breast J. 2005 Jan–Feb;11(1):9–14. [PubMed: 15647072]

1881.

Moon HG, Han W, Lee JW, et al. Limitations of conventional contrast-enhanced MRI in selecting sentinel node biopsy candidates among DCIS patients. J Breast Cancer. 2010;13(2):154–9.

1882.

Morgan EA, Kozono DE, Wang Q, et al. Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Ann Surg Oncol. 2012 Nov;19(12):3801–8. [PubMed: 22890593]

1883.

Morgan JM, Douglas-Jones AG, Gupta SK. Analysis of histological features in needle core biopsy of breast useful in preoperative distinction between fibroadenoma and phyllodes tumour. Histopathology. 2010 Mar;56(4):489–500. [PubMed: 20459556]

1884.

Mori M, Tsunoda H, Takamoto Y, et al. MRI and ultrasound evaluation of invasive lobular carcinoma of the breast after primary systemic therapy. Breast Cancer. 2013 Aug 9 [PubMed: 23929123]

1885.

Mori N, Ota H, Mugikura S, et al. Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters. Eur Radiol. 2013 Oct;23(10):2705–12. [PubMed: 23732688]

1886.

Mosier AD, Keylock J, Smith DV. Benign papillomas diagnosed on large-gauge vacuum-assisted core needle biopsy which span <1.5 cm do not need surgical excision. Breast J. 2013 Nov–Dec;19(6):611–7. [PubMed: 24102818]

1887.

Mudduwa L, Liyanage T. Immunohistochemical assessment of hormone receptor status of breast carcinoma: interobserver variation of the quick score. Indian J Med Sci. 2009 Jan;63(1):21–7. [PubMed: 19346635]

1888.

Mulheron B, Gray RJ, Pockaj BA, et al. Is excisional biopsy indicated for patients with lobular neoplasia diagnosed on percutaneous core needle biopsy of the breast? Am J Surg. 2009 Dec;198(6):792–7. [PubMed: 19969131]

1889.

Muller BM, Brase JC, Haufe F, et al. Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sections. J Clin Pathol. 2012 Jul;65(7):660–2. [PMC free article: PMC3426896] [PubMed: 22447922]

1890.

Murata Y, Hamada N, Kubota K, et al. Choline by magnetic spectroscopy and dynamic contrast enhancement curve by magnetic resonance imaging in neoadjuvant chemotherapy for invasive breast cancer. Mol Med Rep. 2009 Jan–Feb;2(1):39–43. [PubMed: 21475788]

1891.

Murray MP, Luedtke C, Liberman L, et al. Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision. Cancer. 2013 Mar 1;119(5):1073–9. [PubMed: 23132235]

1892.

Murthy SS, Sandhya DG, Ahmed F, et al. Assessment of HER2/Neu status by fluorescence in situ hybridization in immunohistochemistry-equivocal cases of invasive ductal carcinoma and aberrant signal patterns: a study at a tertiary cancer center. Indian J Pathol Microbiol. 2011 Jul–Sep;54(3):532–8. [PubMed: 21934215]

1893.

Muttarak M, Sangchan S, Kongmebhol P, et al. Mammographic and ultrasonographic features of invasive lobular carcinoma: A review of 16 patients. Biomed Imaging Intervent J. 2010;6(3)

1894.

Nagi CS, O’Donnell JE, Tismenetsky M, et al. Lobular neoplasia on core needle biopsy does not require excision. Cancer. 2008 May 15;112(10):2152–8. [PubMed: 18348299]

1895.

Nakai K, Mitomi H, Alkam Y, et al. Predictive value of MGMT, hMLH1, hMSH2 and BRCA1 protein expression for pathological complete response to neoadjuvant chemotherapy in basal-like breast cancer patients. Cancer Chemother Pharmacol. 2012 Apr;69(4):923–30. [PubMed: 22083523]

1896.

Nakano S, Sakamoto H, Ohtsuka M, et al. Evaluation and indications of ultrasound-guided vacuum-assisted core needle breast biopsy. Breast Cancer. 2007;14(3):292–6. [PubMed: 17690507]

1897.

Naoi Y, Kishi K, Tanei T, et al. High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy. Cancer. 2011 Feb 1;117(3):472–9. [PubMed: 20878674]

1898.

Nayak A, Carkaci S, Gilcrease MZ, et al. Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision. Clin Breast Cancer. 2013 Dec;13(6):439–49. [PMC free article: PMC4605914] [PubMed: 24119786]

1899.

Neuman HB, Brogi E, Ebrahim A, et al. Desmoid tumors (fibromatoses) of the breast: a 25-year experience. Ann Surg Oncol. 2008 Jan;15(1):274–80. [PubMed: 17896146]

1900.

Ngai JH, Zelles GW, Rumore GJ, et al. Breast biopsy techniques and adequacy of margins. Arch Surg. 1991 Nov;126(11):1343–6. discussion 6-7. [PubMed: 1747047]

1901.

Nguyen CV, Albarracin CT, Whitman GJ, et al. Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision. Ann Surg Oncol. 2011 Mar;18(3):752–61. [PubMed: 20972636]

1902.

Niell B, Specht M, Gerade B, et al. Is excisional biopsy required after a breast core biopsy yields lobular neoplasia? AJR Am J Roentgenol. 2012 Oct;199(4):929–35. [PubMed: 22997389]

1903.

Niraula S, Dowling RJ, Ennis M, et al. Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study. Breast Cancer Res Treat. 2012 Oct;135(3):821–30. [PubMed: 22933030]

1904.

Nishimura R, Osako T, Okumura Y, et al. Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis. Breast Cancer. 2010 Oct;17(4):269–75. [PubMed: 19730975]

1905.

Noel JC, Buxant F, Engohan-Aloghe C. Immediate surgical resection of residual microcalcifications after a diagnosis of pure flat epithelial atypia on core biopsy: a word of caution. Surg Oncol. 2010 Dec;19(4):243–6. [PubMed: 19783426]

1906.

Nofech-Mozes S, Holloway C, Hanna W. The role of cytokeratin 5/6 as an adjunct diagnostic tool in breast core needle biopsies. Int J Surg Pathol. 2008 Oct;16(4):399–406. [PubMed: 18499686]

1907.

Nori J, Bazzocchi M, Boeri C, et al. Role of axillary lymph node ultrasound and large core biopsy in the preoperative assessment of patients selected for sentinel node biopsy. Radiol Med. 2005 Apr;109(4):330–44. [PubMed: 15883518]

1908.

Noske A, Pahl S, Fallenberg E, et al. Flat epithelial atypia is a common subtype of B3 breast lesions and is associated with noninvasive cancer but not with invasive cancer in final excision histology. Hum Pathol. 2010 Apr;41(4):522–7. [PubMed: 20004938]

1909.

O’Flynn EA, Morel JC, Gonzalez J, et al. Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy. Clin Radiol. 2009 Feb;64(2):178–83. [PubMed: 19103348]

1910.

Ohlschlegel C, Kradolfer D, Hell M, et al. Comparison of automated and manual FISH for evaluation of HER2 gene status on breast carcinoma core biopsies. BMC Clin Pathol. 2013;13:13. [PMC free article: PMC3644269] [PubMed: 23601823]

1911.

Okunade G, Green AR, Ying M, et al. Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy. Crit Rev Oncol Hematol. 2009 Oct;72(1):76–82. [PubMed: 19515574]

1912.

O’Neil M, Madan R, Tawfik OW, et al. Lobular carcinoma in situ/atypical lobular hyperplasia on breast needle biopsies: does it warrant surgical excisional biopsy? A study of 27 cases. Ann Diagn Pathol. 2010 Aug;14(4):251–5. [PubMed: 20637429]

1913.

Ooi A, Inokuchi M, Harada S, et al. Gene amplification of ESR1 in breast cancers--fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study. J Pathol. 2012 May;227(1):8–16. [PubMed: 22170254]

1914.

Oran ES, Gurdal SO, Yankol Y, et al. Management of idiopathic granulomatous mastitis diagnosed by core biopsy: a retrospective multicenter study. Breast J. 2013 Jul–Aug;19(4):411–8. [PubMed: 23663101]

1915.

Osborn G, Wilton F, Stevens G, et al. A review of needle core biopsy diagnosed radial scars in the Welsh Breast Screening Programme. Ann R Coll Surg Engl. 2011 Mar;93(2):123–6. [PMC free article: PMC3293305] [PubMed: 21073820]

1916.

O’Shea AM, Rakha EA, Hodi Z, et al. Histological grade of invasive carcinoma of the breast assessed on needle core biopsy - modifications to mitotic count assessment to improve agreement with surgical specimens. Histopathology. 2011 Sep;59(3):543–8. [PubMed: 21906126]

1917.

Ough M, Velasco J, Hieken TJ. A comparative analysis of core needle biopsy and final excision for breast cancer: histology and marker expression. Am J Surg. 2011 May;201(5):692–4. [PubMed: 20850706]

1918.

Ozdemir A, Voyvoda NK, Gultekin S, et al. Can core biopsy be used instead of surgical biopsy in the diagnosis and prognostic factor analysis of breast carcinoma? Clin Breast Cancer. 2007 Oct;7(10):791–5. [PubMed: 18021481]

1919.

Ozel L, Unal A, Unal E, et al. Granulomatous mastitis: is it an autoimmune disease? Diagnostic and therapeutic dilemmas. Surg Today. 2012 Aug;42(8):729–33. [PubMed: 22068681]

1920.

Ozturk E, Akin M, Can MF, et al. Idiopathic granulomatous mastitis. Saudi Med J. 2009 Jan;30(1):45–9. [PubMed: 19139772]

1921.

Paajanen H, Hermunen H. Does preoperative core needle biopsy increase surgical site infections in breast cancer surgery? Randomized study of antibiotic prophylaxis. Surg Infect (Larchmt). 2009 Aug;10(4):317–21. [PubMed: 19673597]

1922.

Pachnicki JP, Czeczko NG, Tuon F, et al. Immunohistochemical evaluation of estrogen and progesterone receptors of pre and post-neoadjuvant chemotherapy for breast cancer. Rev Col Bras Cir. 2012 Apr;39(2):86–92. [PubMed: 22664513]

1923.

Papalas JA, Wylie JD, Dash RC. Recurrence risk and margin status in granular cell tumors of the breast: a clinicopathologic study of 13 patients. Arch Pathol Lab Med. 2011 Jul;135(7):890–5. [PubMed: 21732779]

1924.

Park HS, Kim HY, Park S, et al. A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy. Breast. 2013 Oct;22(5):869–73. [PubMed: 23601760]

1925.

Park HS, Park S, Cho J, et al. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy. J Surg Oncol. 2013 Mar;107(4):388–92. [PubMed: 23007901]

1926.

Park HS, Park S, Kim JH, et al. Clinicopathologic features and outcomes of metaplastic breast carcinoma: comparison with invasive ductal carcinoma of the breast. Yonsei Med J. 2010 Nov;51(6):864–9. [PMC free article: PMC2995974] [PubMed: 20879052]

1927.

Park JS, Park YM, Kim EK, et al. Sonographic findings of high-grade and non-high-grade ductal carcinoma in situ of the breast. J Ultrasound Med. 2010 Dec;29(12):1687–97. [PubMed: 21098839]

1928.

Park KJ, Kang SH, Park DH, et al. Usefulness of thallium-201 SPECT for prediction of early progression in low-grade astrocytomas diagnosed by stereotactic biopsy. Clin Neurol Neurosurg. 2012 Apr;114(3):223–9. [PubMed: 22104697]

1929.

Parsian S, Rahbar H, Allison KH, et al. Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. Radiology. 2012 Dec;265(3):696–706. [PMC free article: PMC3504319] [PubMed: 23033500]

1930.

Pathmanathan N, Albertini AF, Provan PJ, et al. Diagnostic evaluation of papillary lesions of the breast on core biopsy. Mod Pathol. 2010 Jul;23(7):1021–8. [PubMed: 20473278]

1931.

Pazaitou-Panayiotou K, Chemonidou C, Poupi A, et al. Gonadotropin-releasing hormone neuropeptides and receptor in human breast cancer: correlation to poor prognosis parameters. Peptides. 2013 Apr;42:15–24. [PubMed: 23287110]

1932.

Pediconi F, Kubik-Huch R, Chilla B, et al. Intra-individual randomised comparison of gadobutrol 1.0 M versus gadobenate dimeglumine 0.5 M in patients scheduled for preoperative breast MRI. Eur Radiol. 2013 Jan;23(1):84–92. [PubMed: 22797979]

1933.

Pediconi F, Padula S, Dominelli V, et al. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation. Radiology. 2010 Dec;257(3):653–61. [PubMed: 20884914]

1934.

Penel N, Yazdanpanah Y, Chauvet MP, et al. Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. J Surg Oncol. 2007 Aug 1;96(2):124–9. [PubMed: 17443747]

1935.

Peres A, Barranger E, Becette V, et al. Rates of upgrade to malignancy for 271 cases of flat epithelial atypia (FEA) diagnosed by breast core biopsy. Breast Cancer Res Treat. 2012 Jun;133(2):659–66. [PubMed: 22042365]

1936.

Perono Biacchiardi C, Brizzi D, Genta F, et al. Breast cancer preoperative staging: does contrast-enhanced magnetic resonance mammography modify surgery? Int J Breast Cancer. 2011;2011:757234. [PMC free article: PMC3262586] [PubMed: 22295233]

1937.

Peters NH, van Esser S, van den Bosch MA, et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer. 2011 Apr;47(6):879–86. [PubMed: 21195605]

1938.

Petrarca CR, Brunetto AT, Duval V, et al. Survivin as a predictive biomarker of complete pathologic response to neoadjuvant chemotherapy in patients with stage II and stage III breast cancer. Clin Breast Cancer. 2011 Apr;11(2):129–34. [PubMed: 21569999]

1939.

Pettit K, Swatske ME, Gao F, et al. The impact of breast MRI on surgical decision-making: are patients at risk for mastectomy? J Surg Oncol. 2009 Dec 1;100(7):553–8. [PMC free article: PMC3982382] [PubMed: 19757442]

1940.

Picouleau E, Denis M, Lavoue V, et al. Atypical hyperplasia of the breast: the black hole of routine breast cancer screening. Anticancer Res. 2012 Dec;32(12):5441–6. [PubMed: 23225449]

1941.

Pilewskie M, Kennedy C, Shappell C, et al. Effect of MRI on the management of ductal carcinoma in situ of the breast. Ann Surg Oncol. 2013 May;20(5):1522–9. [PubMed: 23224903]

1942.

Pimiento JM, Lee MC, Esposito NN, et al. Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion. J Oncol Pract. 2011 Sep;7(5):309–13. [PMC free article: PMC3170064] [PubMed: 22211128]

1943.

Pinhel IF, Macneill FA, Hills MJ, et al. Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer. Breast Cancer Res. 2010;12(5):R76. [PMC free article: PMC3096968] [PubMed: 20920193]

1944.

Piubello Q, Parisi A, Eccher A, et al. Flat epithelial atypia on core needle biopsy: which is the right management? Am J Surg Pathol. 2009 Jul;33(7):1078–84. [PubMed: 19390424]

1945.

Poellinger A, Diekmann S, Dietz E, et al. In patients with DCIS: is it sufficient to histologically examine only those tissue specimens that contain microcalcifications? Eur Radiol. 2008 May;18(5):925–30. [PubMed: 18183402]

1946.

Pohlodek K, Galbavy S, Bartosova M, et al. Semi-quantitative RT-PCR assessment of molecular markers in breast large-core needle biopsies. Neoplasma. 2004;51(6):415–21. [PubMed: 15640949]

1947.

Polat AK, Kanbour-Shakir A, Andacoglu O, et al. Atypical hyperplasia on core biopsy: is further surgery needed? Am J Med Sci. 2012 Jul;344(1):28–31. [PubMed: 22205116]

1948.

Polom K, Murawa D, Pawelska A, et al. Atypical lobular hyperplasia and lobular carcinoma in situ without other high-risk lesions diagnosed on vacuum-assisted core needle biopsy. The problem of excisional biopsy. Tumori. 2009 Jan–Feb;95(1):32–5. [PubMed: 19366053]

1949.

Polom K, Murawa D, Wasiewicz J, et al. The role of sentinel node biopsy in ductal carcinoma in situ of the breast. Eur J Surg Oncol. 2009 Jan;35(1):43–7. [PubMed: 18723312]

1950.

Porter AJ, Evans EB, Foxcroft LM, et al. Mammographic and ultrasound features of invasive lobular carcinoma of the breast. J Med Imaging Radiat Oncol. 2013 [PubMed: 24529050]

1951.

Provencher L, Jacob S, Cote G, et al. Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsy. Radiology. 2012 Apr;263(1):43–52. [PubMed: 22344406]

1952.

Puglisi F, Scalone S, Bazzocchi M, et al. Image-guided core breast biopsy: a suitable method for preoperative biological characterization of small (pT1) breast carcinomas. Cancer Lett. 1998 Nov 27;133(2):223–9. [PubMed: 10072173]

1953.

Purdie CA, Jordan LB, McCullough JB, et al. HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma. Histopathology. 2010 May;56(6):702–7. [PubMed: 20546335]

1954.

Purdie CA, McLean D, Stormonth E, et al. Management of in situ lobular neoplasia detected on needle core biopsy of breast. J Clin Pathol. 2010 Nov;63(11):987–93. [PubMed: 20972243]

1955.

Radisky DC, Santisteban M, Berman HK, et al. p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia. Cancer Prev Res (Phila). 2011 Dec;4(12):1953–60. [PMC free article: PMC3232312] [PubMed: 21920875]

1956.

Rahusen FD, Taets van Amerongen AH, van Diest PJ, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancers: A feasibility study looking at the accuracy of obtained margins. J Surg Oncol. 1999 Oct;72(2):72–6. [PubMed: 10518102]

1957.

Railo M, Nordling S, Krogerus L, et al. Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen. Diagn Cytopathol. 1996 Sep;15(3):205–10. [PubMed: 8955602]

1958.

Rajan S, Shaaban AM, Dall BJ, et al. New patient pathway using vacuum-assisted biopsy reduces diagnostic surgery for B3 lesions. Clin Radiol. 2012 Mar;67(3):244–9. [PubMed: 22014554]

1959.

Rajan S, Sharma N, Dall BJ, et al. What is the significance of flat epithelial atypia and what are the management implications? J Clin Pathol. 2011 Nov;64(11):1001–4. [PubMed: 21725040]

1960.

Rajan S, Wason AM, Carder PJ. Conservative management of screen-detected radial scars: role of mammotome excision. J Clin Pathol. 2011 Jan;64(1):65–8. [PubMed: 21097791]

1961.

Rakha EA, El-Sayed ME, Reed J, et al. Screen-detected breast lesions with malignant needle core biopsy diagnoses and no malignancy identified in subsequent surgical excision specimens (potential false-positive diagnosis). Eur J Cancer. 2009 May;45(7):1162–7. [PubMed: 19121932]

1962.

Rakha EA, Ho BC, Naik V, et al. Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia. Histopathology. 2011 Mar;58(4):626–32. [PubMed: 21371081]

1963.

Rakha EA, Lee AH, Jenkins JA, et al. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Int J Cancer. 2011 Sep 15;129(6):1417–24. [PubMed: 21128240]

1964.

Rakha EA, Lee AH, Reed J, et al. Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses. Eur J Cancer. 2010 Jul;46(10):1835–40. [PubMed: 20392631]

1965.

Rakha EA, Shaaban AM, Haider SA, et al. Outcome of pure mucocele-like lesions diagnosed on breast core biopsy. Histopathology. 2013 May;62(6):894–8. [PubMed: 23402386]

1966.

Reefy S, Osman H, Chao C, et al. Surgical excision for B3 breast lesions diagnosed by vacuum-assisted core biopsy. Anticancer Res. 2010 Jun;30(6):2287–90. [PubMed: 20651381]

1967.

Reisenbichler ES, Adams AL, Hameed O. The predictive ability of a CK5/p63/CK8/18 antibody cocktail in stratifying breast papillary lesions on needle biopsy: an algorithmic approach works best. Am J Clin Pathol. 2013 Dec;140(6):767–79. [PubMed: 24225742]

1968.

Rendi MH, Dintzis SM, Lehman CD, et al. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy. Ann Surg Oncol. 2012 Mar;19(3):914–21. [PubMed: 21861212]

1969.

Renshaw AA. Improved reporting methods for atypia and atypical ductal hyperplasia in breast core needle biopsy specimens. Potential for interlaboratory comparisons. Am J Clin Pathol. 2001 Jul;116(1):87–91. [PubMed: 11447757]

1970.

Renshaw AA. Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ. Arch Pathol Lab Med. 2002 Jan;126(1):39–41. [PubMed: 11800645]

1971.

Resetkova E, Edelweiss M, Albarracin CT, et al. Management of radial sclerosing lesions of the breast diagnosed using percutaneous vacuum-assisted core needle biopsy: recommendations for excision based on seven years’ of experience at a single institution. Breast Cancer Res Treat. 2011 Jun;127(2):335–43. [PubMed: 18626769]

1972.

Resetkova E, Khazai L, Albarracin CT, et al. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast. Breast J. 2010 Nov–Dec;16(6):573–80. [PubMed: 21070433]

1973.

Revelon G, Sherman ME, Gatewood OM, et al. Focal fibrosis of the breast: imaging characteristics and histopathologic correlation. Radiology. 2000 Jul;216(1):255–9. [PubMed: 10887257]

1974.

Richard F, Segna KG, Filiberti E. Can large gauge core biopsies for high risk benign breast lesions eliminate the need for excisional biopsy: a correlation between breast biopsy and final surgical pathology. Am Surg. 2012 Aug;78(8):906–8. [PubMed: 22856502]

1975.

Richter-Ehrenstein C, Muller S, Noske A, et al. Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients. Int J Surg Pathol. 2009 Aug;17(4):323–6. [PubMed: 19029173]

1976.

Richter-Ehrenstein C, Tombokan F, Fallenberg EM, et al. Intraductal papillomas of the breast: diagnosis and management of 151 patients. Breast. 2011 Dec;20(6):501–4. [PubMed: 21640590]

1977.

Riedl O, Fitzal F, Mader N, et al. Intraoperative frozen section analysis for breast-conserving therapy in 1016 patients with breast cancer. Eur J Surg Oncol. 2009 Mar;35(3):264–70. [PubMed: 18706785]

1978.

Rizzo M, Linebarger J, Lowe MC, et al. Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up. J Am Coll Surg. 2012 Mar;214(3):280–7. [PubMed: 22244207]

1979.

Romero Q, Bendahl PO, Klintman M, et al. Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies. BMC Cancer. 2011;11:341. [PMC free article: PMC3163632] [PubMed: 21819622]

1980.

Rosa M, Mohammadi A, Masood S. Lobular neoplasia displaying central necrosis: a potential diagnostic pitfall. Pathol Res Pract. 2010 Aug 15;206(8):544–9. [PubMed: 20359832]

1981.

Ross DS, Liu YF, Pipa J, et al. The diagnostic utility of the minimal carcinoma triple stain in breast carcinomas. Am J Clin Pathol. 2013 Jan;139(1):62–70. [PubMed: 23270900]

1982.

Roth WD, von Smitten K, Heikkila P, et al. Automated stereotactic core needle biopsy of microcalcifications with correlation to surgical biopsy. Acta Radiol. 1999 Jul;40(4):390–3. [PubMed: 10394866]

1983.

Rotter K, Haentschel G, Koethe D, et al. Evaluation of mammographic and clinical follow-up after 755 stereotactic vacuum-assisted breast biopsies. Am J Surg. 2003 Aug;186(2):134–42. [PubMed: 12885605]

1984.

Rouse HC, Ussher S, Kavanagh AM, et al. Examining the sensitivity of ultrasound-guided large core biopsy for invasive breast carcinoma in a population screening programme. J Med Imaging Radiat Oncol. 2013 Aug;57(4):435–43. [PubMed: 23870339]

1985.

Ruidiaz ME, Cortes-Mateos MJ, Sandoval S, et al. Quantitative comparison of surgical margin histology following excision with traditional electrosurgery and a low-thermal-injury dissection device. J Surg Oncol. 2011 Dec;104(7):746–54. [PubMed: 21744349]

1986.

Ryden L, Boiesen P, Jonsson PE. Assessment of microvessel density in core needle biopsy specimen in breast cancer. Anticancer Res. 2004 Jan–Feb;24(1):371–5. [PubMed: 15015623]

1987.

Saadai P, Moezzi M, Menes T. Preoperative and intraoperative predictors of positive margins after breast-conserving surgery: a retrospective review. Breast Cancer. 2011 Jul;18(3):221–5. [PubMed: 21465227]

1988.

Saarenmaa I, Salminen T, Geiger U, et al. Validity of radiological examinations of patients with breast cancer in different age groups in a population based study. Breast. 2001 Feb;10(1):78–81. [PubMed: 14965565]

1989.

Sabine VS, Sims AH, Macaskill EJ, et al. Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer. Breast Cancer Res Treat. 2010 Jul;122(2):419–28. [PubMed: 20480226]

1990.

Saedi HS, Nasiri MRG, Shahidsales S, et al. Comparison of hormone receptor status in primary and recurrent breast cancer. Iran. J Cancer Prev. 2012;5(2):69–73. [PMC free article: PMC4299621] [PubMed: 25628823]

1991.

Sakr R, Antoine M, Barranger E, et al. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma. Breast J. 2008 Jan–Feb;14(1):55–60. [PubMed: 18186866]

1992.

Sakr R, Rouzier R, Salem C, et al. Risk of breast cancer associated with papilloma. Eur J Surg Oncol. 2008 Dec;34(12):1304–8. [PubMed: 18440190]

1993.

Salkowski LR, Fowler AM, Burnside ES, et al. Utility of 6-month follow-up imaging after a concordant benign breast biopsy result. Radiology. 2011 Feb;258(2):380–7. [PubMed: 21079199]

1994.

Sancho Perez B, Hernandez Sanchez L, Noguero Meseguer R, et al. Ductal carcinoma in situ: A risk factor for mastectomy?: Carcinoma ductal in situ, factor de riesgo de mastectomia? Prog. Obstet Ginecol. 2011;54(6):281–93.

1995.

Sanger N, Effenberger KE, Riethdorf S, et al. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ. Int J Cancer. 2011 Nov 15;129(10):2522–6. [PubMed: 21207426]

1996.

Sangma MB, Panda K, Dasiah S. A clinico-pathological study on benign breast diseases. J Clin Diagn Res. 2013 Mar;7(3):503–6. [PMC free article: PMC3616566] [PubMed: 23634406]

1997.

Sanli Y, Kuyumcu S, Ozkan ZG, et al. Increased FDG uptake in breast cancer is associated with prognostic factors. Ann Nucl Med. 2012 May;26(4):345–50. [PubMed: 22359222]

1998.

Santamaria G, Velasco M, Farrus B, et al. Preoperative MRI of pure intraductal breast carcinoma--a valuable adjunct to mammography in assessing cancer extent. Breast. 2008 Apr;17(2):186–94. [PubMed: 17964786]

1999.

Saritas I. Prediction of breast cancer using artificial neural networks. J Med Syst. 2012 Oct;36(5):2901–7. [PubMed: 21837454]

2000.

Satheesha S, Cookson VJ, Coleman LJ, et al. Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer. Mol Cancer. 2011;10:19. [PMC free article: PMC3055230] [PubMed: 21320304]

2001.

Sauer G, Schneiderhan-Marra N, Muche R, et al. Molecular indicators of non-sentinel node status in breast cancer determined in preoperative biopsies by multiplexed sandwich immunoassays. J Cancer Res Clin Oncol. 2011 Aug;137(8):1175–84. [PubMed: 21516507]

2002.

Scheiden R, Sand J, Tanous AM, et al. Consequences of a National Mammography Screening Program on diagnostic procedures and tumor sizes in breast cancer. A retrospective study of 1540 cases diagnosed and histologically confirmed between 1995 and 1997. Pathol Res Pract. 2001;197(7):467–74. [PubMed: 11482576]

2003.

Schell AM, Rosenkranz K, Lewis PJ. Role of breast MRI in the preoperative evaluation of patients with newly diagnosed breast cancer. AJR Am J Roentgenol. 2009 May;192(5):1438–44. [PubMed: 19380574]

2004.

Schiffmann S, Sandner J, Birod K, et al. Ceramide synthases and ceramide levels are increased in breast cancer tissue. Carcinogenesis. 2009 May;30(5):745–52. [PubMed: 19279183]

2005.

Schilling K, Narayanan D, Kalinyak JE, et al. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):23–36. [PMC free article: PMC3005116] [PubMed: 20871992]

2006.

Schneider C, Trocha S, McKinley B, et al. The use of sentinel lymph node biopsy in ductal carcinoma in situ. Am Surg. 2010 Sep;76(9):943–6. [PubMed: 20836339]

2007.

Schoonjans JM, Brem RF. Sonographic appearance of ductal carcinoma in situ diagnosed with ultrasonographically guided large core needle biopsy: correlation with mammographic and pathologic findings. J Ultrasound Med. 2000 Jul;19(7):449–57. [PubMed: 10898298]

2008.

Schulz S, Sinn P, Golatta M, et al. Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy. Breast. 2013 Aug;22(4):537–42. [PubMed: 23237921]

2009.

Schwartz GF, Finkel GC, Garcia JC, et al. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer. 1992 Nov 15;70(10):2468–74. [PubMed: 1330281]

2010.

Sciallis AP, Chen B, Folpe AL. Cellular spindled histiocytic pseudotumor complicating mammary fat necrosis: a potential diagnostic pitfall. Am J Surg Pathol. 2012 Oct;36(10):1571–8. [PubMed: 22982900]

2011.

Scoggins M, Krishnamurthy S, Santiago L, et al. Lobular carcinoma in situ of the breast: clinical, radiological, and pathological correlation. Acad Radiol. 2013 Apr;20(4):463–70. [PubMed: 23498988]

2012.

Seferina SC, Nap M, van den Berkmortel F, et al. Reliability of receptor assessment on core needle biopsy in breast cancer patients. Tumour Biol. 2013 Apr;34(2):987–94. [PubMed: 23269610]

2013.

Segaert I, Mottaghy F, Ceyssens S, et al. Additional value of PET-CT in staging of clinical stage IIB and III breast cancer. Breast J. 2010 Nov–Dec;16(6):617–24. [PubMed: 21070439]

2014.

Senetta R, Campanino PP, Mariscotti G, et al. Columnar cell lesions associated with breast calcifications on vacuum-assisted core biopsies: clinical, radiographic, and histological correlations. Mod Pathol. 2009 Jun;22(6):762–9. [PubMed: 19287465]

2015.

Seo M, Chang JM, Kim WH, et al. Columnar cell lesions without atypia initially diagnosed on breast needle biopsies: is imaging follow-up enough? AJR Am J Roentgenol. 2013 Oct;201(4):928–34. [PubMed: 24059386]

2016.

Shah-Khan MG, Geiger XJ, Reynolds C, et al. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol. 2012 Oct;19(10):3131–8. [PubMed: 22847124]

2017.

Shamonki J, Chung A, Huynh KT, et al. Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision? Ann Surg Oncol. 2013 Dec;20(13):4137–44. [PubMed: 23943035]

2018.

Shimauchi A, Giger ML, Bhooshan N, et al. Evaluation of clinical breast MR imaging performed with prototype computer-aided diagnosis breast MR imaging workstation: reader study. Radiology. 2011 Mar;258(3):696–704. [PubMed: 21212365]

2019.

Shimizu D, Ishikawa T, Tanabe M, et al. Preoperative endocrine therapy with goserelin acetate and tamoxifen in hormone receptor-positive premenopausal breast cancer patients. Breast Cancer. 2012 Nov 25 [PubMed: 23184499]

2020.

Shin HJ, Kim HH, Kim SM, et al. Screening-detected and symptomatic ductal carcinoma in situ: differences in the sonographic and pathologic features. AJR Am J Roentgenol. 2008 Feb;190(2):516–25. [PubMed: 18212241]

2021.

Shouhed D, Amersi FF, Spurrier R, et al. Intraductal papillary lesions of the breast: clinical and pathological correlation. Am Surg. 2012 Oct;78(10):1161–5. [PubMed: 23025963]

2022.

Shousha S, Peston D, Amo-Takyi B, et al. Evaluation of automated silver-enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens. Histopathology. 2009 Jan;54(2):248–53. [PubMed: 19207950]

2023.

Shrestha DB, Ravichandran D, Baber Y, et al. Follow-up of benign screen-detected breast lesions with suspicious preoperative needle biopsies. Eur J Surg Oncol. 2009 Feb;35(2):156–8. [PubMed: 18353607]

2024.

Siegmann KC, Baur A, Vogel U, et al. Risk-benefit analysis of preoperative breast MRI in patients with primary breast cancer. Clin Radiol. 2009 Apr;64(4):403–13. [PubMed: 19264186]

2025.

Silberfein EJ, Hunt KK, Broglio K, et al. Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma. Clin Breast Cancer. 2010 Feb;10(1):52–8. [PubMed: 20133259]

2026.

Siziopikou KP, Jokich P, Cobleigh M. Pathologic findings in MRI-guided needle core biopsies of the breast in patients with newly diagnosed breast cancer. Int J Breast Cancer. 2011;2011:613285. [PMC free article: PMC3276071] [PubMed: 22332013]

2027.

Skenderi F, Krakonja F, Vranic S. Infarcted fibroadenoma of the breast: report of two new cases with review of the literature. Diagn Pathol. 2013;8:38. [PMC free article: PMC3598275] [PubMed: 23445683]

2028.

Sklair-Levy M, Sella T, Alweiss T, et al. Incidence and management of complex fibroadenomas. AJR Am J Roentgenol. 2008 Jan;190(1):214–8. [PubMed: 18094314]

2029.

Smith BL, Bertagnolli M, Klein BB, et al. Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer. Ann Surg. 1992 Jul;216(1):17–21. [PMC free article: PMC1242541] [PubMed: 1321595]

2030.

Smitt MC, Horst K. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer. Ann Surg Oncol. 2007 Mar;14(3):1040–4. [PubMed: 17203329]

2031.

Sohn V, Porta R, Brown T. Flat epithelial atypia of the breast on core needle biopsy: an indication for surgical excision. Mil Med. 2011 Nov;176(11):1347–50. [PubMed: 22165668]

2032.

Sohn VY, Causey MW, Steele SR, et al. The treatment of radial scars in the modern era--surgical excision is not required. Am Surg. 2010 May;76(5):522–5. [PubMed: 20506884]

2033.

Sohn YM, Park SH. Comparison of sonographically guided core needle biopsy and excision in breast papillomas: clinical and sonographic features predictive of malignancy. J Ultrasound Med. 2013 Feb;32(2):303–11. [PubMed: 23341387]

2034.

Solorzano S, Mesurolle B, Omeroglu A, et al. Flat epithelial atypia of the breast: pathological-radiological correlation. AJR Am J Roentgenol. 2011 Sep;197(3):740–6. [PubMed: 21862819]

2035.

Son EJ, Kim EK, Youk JH, et al. Imaging-histologic discordance after sonographically guided percutaneous breast biopsy: a prospective observational study. Ultrasound Med Biol. 2011 Nov;37(11):1771–8. [PubMed: 21856068]

2036.

Song HM, Styblo TM, Carlson GW, et al. The use of oncoplastic reduction techniques to reconstruct partial mastectomy defects in women with ductal carcinoma in situ. Breast J. 2010 Mar–Apr;16(2):141–6. [PubMed: 20102367]

2037.

Sonnenfeld MR, Frenna TH, Weidner N, et al. Lobular carcinoma in situ: mammographic-pathologic correlation of results of needle-directed biopsy. Radiology. 1991 Nov;181(2):363–7. [PubMed: 1924773]

2038.

Spangler ML, Zuley ML, Sumkin JH, et al. Detection and classification of calcifications on digital breast tomosynthesis and 2D digital mammography: a comparison. AJR Am J Roentgenol. 2011 Feb;196(2):320–4. [PubMed: 21257882]

2039.

Sperber F, Blank A, Metser U, et al. Diagnosis and treatment of breast fibroadenomas by ultrasound-guided vacuum-assisted biopsy. Arch Surg. 2003 Jul;138(7):796–800. [PubMed: 12860764]

2040.

Steffens RF, Wright HR, Hester MY, et al. Clinical, demographic, and situational factors linked to distress associated with benign breast biopsy. J Psychosoc Oncol. 2011;29(1):35–50. [PMC free article: PMC3319914] [PubMed: 21240724]

2041.

Stolier A, Stone JC, Moroz K, et al. A comparison of clinical and pathologic assessments for the prediction of occult nipple involvement in nipple-sparing mastectomies. Ann Surg Oncol. 2013 Jan;20(1):128–32. [PubMed: 23010730]

2042.

Stotter A, Walker R. Tumour markers predictive of successful treatment of breast cancer with primary endocrine therapy in patients over 70 years old: a prospective study. Crit Rev Oncol Hematol. 2010 Sep;75(3):249–56. [PubMed: 19969469]

2043.

Striebel JM, Bhargava R, Horbinski C, et al. The equivocally amplified HER2 FISH result on breast core biopsy: indications for further sampling do affect patient management. Am J Clin Pathol. 2008 Mar;129(3):383–90. [PubMed: 18285260]

2044.

Strien L, Leidenius M, Heikkila P. False-positive and false-negative sentinel node findings in 473 breast cancers. Hum Pathol. 2012 Nov;43(11):1940–7. [PubMed: 22575258]

2045.

Strigel RM, Eby PR, Demartini WB, et al. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI. AJR Am J Roentgenol. 2010 Sep;195(3):792–8. [PubMed: 20729462]

2046.

Stuver SO, Zhu J, Simchowitz B, et al. Identifying women at risk of delayed breast cancer diagnosis. Jt Comm J Qual Patient Saf. 2011 Dec;37(12):568–75. [PubMed: 22235542]

2047.

Subhawong AP, Subhawong TK, Khouri N, et al. Incidental minimal atypical lobular hyperplasia on core needle biopsy: correlation with findings on follow-up excision. Am J Surg Pathol. 2010 Jun;34(6):822–8. [PubMed: 20431477]

2048.

Suh YJ, Kim MJ, Kim EK, et al. Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy. Br J Radiol. 2012 Aug;85(1016):e349–56. [PMC free article: PMC3587071] [PubMed: 22422382]

2049.

Sullivan ME, Khan SA, Sullu Y, et al. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications. Arch Pathol Lab Med. 2010 Jul;134(7):1024–8. [PubMed: 20586632]

2050.

Sutandyo N, Suzanna E, Haryono SJ, et al. Signaling pathways in early onset sporadic breast cancer of patients in Indonesia. Acta Med Indones. 2008 Jul;40(3):139–45. [PubMed: 18838752]

2051.

Sutela A, Vanninen R, Sudah M, et al. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer. Acta Oncol. 2008;47(1):38–46. [PubMed: 17851859]

2052.

Sutton B, Davion S, Feldman M, et al. Mucocele-like lesions diagnosed on breast core biopsy: assessment of upgrade rate and need for surgical excision. Am J Clin Pathol. 2012 Dec;138(6):783–8. [PubMed: 23161710]

2053.

Swapp RE, Glazebrook KN, Jones KN, et al. Management of benign intraductal solitary papilloma diagnosed on core needle biopsy. Ann Surg Oncol. 2013 Jun;20(6):1900–5. [PubMed: 23314624]

2054.

Symmans WF, Ayers M, Clark EA, et al. Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma. Cancer. 2003 Jun 15;97(12):2960–71. [PubMed: 12784330]

2055.

Szynglarewicz B, Matkowski R, Halon A, et al. Lobular neoplasia found on breast biopsy: marker of increased risk of malignancy or direct pre-cancerous lesion? Folia Histochem Cytobiol. 2011;49(3):417–24. [PubMed: 22038220]

2056.

Tagaya N, Nakagawa A, Ishikawa Y, et al. Experience with ultrasonographically guided vacuum-assisted resection of benign breast tumors. Clin Radiol. 2008 Apr;63(4):396–400. [PubMed: 18325359]

2057.

Tamaki K, Sasano H, Ishida T, et al. Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients. Cancer Sci. 2010 Sep;101(9):2074–9. [PubMed: 20557310]

2058.

Tan H, Li R, Peng W, et al. Radiological and clinical features of adult non-puerperal mastitis. Br J Radiol. 2013 Apr;86(1024):20120657. [PMC free article: PMC3635790] [PubMed: 23392197]

2059.

Tang SW, Parker H, Winterbottom L, et al. Early primary breast cancer in the elderly - pattern of presentation and treatment. Surg Oncol. 2011 Mar;20(1):7–12. [PubMed: 19679464]

2060.

Taskin F, Koseoglu K, Ozbas S, et al. Sonographic features of histopathologically benign solid breast lesions that have been classified as BI-RADS 4 on sonography. J Clin Ultrasound. 2012 Jun;40(5):261–5. [PubMed: 22508447]

2061.

Taskin F, Unsal A, Ozbas S, et al. Fibrotic lesions of the breast: radiological findings and core-neddle biopsy results. Eur J Radiol. 2011 Dec;80(3):e231–6. [PubMed: 21071162]

2062.

Taucher S, Rudas M, Mader RM, et al. Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer. Wien Klin Wochenschr. 2004 Jan 31;116(1–2):26–31. [PubMed: 15030120]

2063.

Taylor D, Lazberger J, Ives A, et al. Reducing delay in the diagnosis of pregnancy-associated breast cancer: how imaging can help us. J Med Imaging Radiat Oncol. 2011 Feb;55(1):33–42. [PubMed: 21382187]

2064.

Tebbit CL, Zhai J, Untch BR, et al. Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care. Breast Cancer Res Treat. 2009 Dec;118(3):635–43. [PMC free article: PMC3786337] [PubMed: 19224362]

2065.

Teng-Swan Ho J, Tan PH, Hee SW, et al. Underestimation of malignancy of atypical ductal hyperplasia diagnosed on 11-gauge stereotactically guided Mammotome breast biopsy: an Asian breast screen experience. Breast. 2008 Aug;17(4):401–6. [PubMed: 18455920]

2066.

Tennant SL, Evans A, Hamilton LJ, et al. Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) - an alternative to surgery in selected cases. Breast. 2008 Dec;17(6):546–9. [PubMed: 18829318]

2067.

Tewari M, Pradhan S, Singh U, et al. Assessment of predictive markers of response to neoadjuvant chemotherapy in breast cancer. Asian J Surg. 2010 Oct;33(4):157–67. [PubMed: 21377101]

2068.

Tfayli A, Yang J, Kojouri K, et al. Neoadjuvant therapy with celecoxib to women with early stage breast cancer. Neoplasma. 2008;55(2):122–6. [PubMed: 18237249]

2069.

Tham TM, Iyengar KR, Taib NA, et al. Fine needle aspiration biopsy, core needle biopsy or excision biopsy to diagnose breast cancer - which is the ideal method? Asian Pac J Cancer Prev. 2009 Jan–Mar;10(1):155–8. [PubMed: 19469645]

2070.

Thomssen C, Harbeck N, Dittmer J, et al. Feasibility of measuring the prognostic factors uPA and PAI-1 in core needle biopsy breast cancer specimens. J Natl Cancer Inst. 2009 Jul 15;101(14):1028–9. [PubMed: 19535782]

2071.

Tohno E, Ueno E. Ultrasound (US) diagnosis of nonpalpable breast cancer. Breast Cancer. 2005;12(4):267–71. [PubMed: 16286906]

2072.

Tomasino RM, Morello V, Gullo A, et al. Assessment of “grading” with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atypia (FEA) and columnar cell lesions (CCLs) on core breast biopsy. J Cell Physiol. 2009 Nov;221(2):343–9. [PubMed: 19585492]

2073.

Tomasovic-Loncaric C, Milanovic R, Lambasa S, et al. Intraoperative imprint cytological assessment of the subareolar tissue of the nipple areola complex (NAC). Coll Antropol. 2010 Jun;34(2):431–5. [PubMed: 20698114]

2074.

Tonegutti M, Girardi V, Ciatto S, et al. B3 breast lesions determined by vacuum-assisted biopsy: how to reduce the frequency of benign excision biopsies. Radiol Med. 2010 Dec;115(8):1246–57. [PubMed: 20852955]

2075.

Trentin C, Dominelli V, Maisonneuve P, et al. Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases. Breast. 2012 Oct;21(5):635–40. [PubMed: 22795363]

2076.

Tsang AK, Chan SK, Lam CC, et al. Phyllodes tumours of the breast - differentiating features in core needle biopsy. Histopathology. 2011 Oct;59(4):600–8. [PubMed: 21916949]

2077.

Tse GM, Tan PH, Lacambra MD, et al. Papillary lesions of the breast--accuracy of core biopsy. Histopathology. 2010 Mar;56(4):481–8. [PubMed: 20459555]

2078.

Tseng HS, Chen YL, Chen ST, et al. The management of papillary lesion of the breast by core needle biopsy. Eur J Surg Oncol. 2009 Jan;35(1):21–4. [PubMed: 18640002]

2079.

Tsuda H, Kurosumi M, Umemura S, et al. HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens. BMC Cancer. 2010;10:534. [PMC free article: PMC2958945] [PubMed: 20925963]

2080.

Tunon-de-Lara C, Giard S, Buttarelli M, et al. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy. Breast J. 2008 Mar–Apr;14(2):135–40. [PubMed: 18315691]

2081.

Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010 Feb 13;375(9714):563–71. [PubMed: 20159292]

2082.

Turnbull LW, Brown SR, Olivier C, et al. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess. 2010 Jan;14(1):1–182. [PubMed: 20025837]

2083.

Tvrdik D, Skalova H, Dundr P, et al. Apoptosis - associated genes and their role in predicting responses to neoadjuvant breast cancer treatment. Med Sci Monit. 2012 Jan;18(1):BR60–7. [PMC free article: PMC3560664] [PubMed: 22207111]

2084.

Uematsu T, Kasami M. Soft-copy reading in digital mammography of mass: diagnostic performance of a 5-megapixel cathode ray tube monitor versus a 3-megapixel liquid crystal display monitor in a diagnostic setting. Acta Radiol. 2008 Jul;49(6):623–9. [PubMed: 18568553]

2085.

Uematsu T, Yuen S, Kasami M, et al. Comparison of magnetic resonance imaging, multidetector row computed tomography, ultrasonography, and mammography for tumor extension of breast cancer. Breast Cancer Res Treat. 2008 Dec;112(3):461–74. [PubMed: 18193352]

2086.

Ugburo AO, Olajide TO, Fadeyibi IO, et al. Differential diagnosis and management of giant fibroadenoma: comparing excision with reduction mammoplasty incision and excision with inframammary incision. J Plast Surg Hand Surg. 2012 Oct;46(5):354–8. [PubMed: 22998148]

2087.

Usami S, Moriya T, Amari M, et al. Reliability of prognostic factors in breast carcinoma determined by core needle biopsy. Jpn J Clin Oncol. 2007 Apr;37(4):250–5. [PubMed: 17485439]

2088.

Usmani S, Khan HA, Al Saleh N, et al. Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast. Nucl Med Commun. 2011 Nov;32(11):1084–7. [PubMed: 21862942]

2089.

Usmani S, Khan HA, Niaz K, et al. Tc-99m-methoxy isobutyl isonitrile scintimammography: imaging postexcision biopsy for residual and multifocal breast tumor. Nucl Med Commun. 2008 Sep;29(9):826–9. [PubMed: 18677211]

2090.

Uy GB, Laudico AV, Carnate JM Jr, et al. Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients. Clin Breast Cancer. 2010 Apr;10(2):154–9. [PMC free article: PMC3052378] [PubMed: 20299318]

2091.

Uzan C, Mazouni C, Ferchiou M, et al. A model to predict the risk of upgrade to malignancy at surgery in atypical breast lesions discovered on percutaneous biopsy specimens. Ann Surg Oncol. 2013 Sep;20(9):2850–7. [PubMed: 23702641]

2092.

Uzoaru I, Morgan BR, Liu ZG, et al. Flat epithelial atypia with and without atypical ductal hyperplasia: to re-excise or not. Results of a 5-year prospective study. Virchows Arch. 2012 Oct;461(4):419–23. [PubMed: 22961104]

2093.

Vamesu S. Angiogenesis and tumor grading in primary breast cancer patients: an analysis of 158 needle core biopsies. Rom J Morphol Embryol. 2006;47(3):251–7. [PubMed: 17308684]

2094.

Vamesu S. Angiogenesis and ER/PR status in primary breast cancer patients: an analysis of 158 needle core biopsies. Rom J Morphol Embryol. 2007;48(1):25–31. [PubMed: 17502947]

2095.

Vamesu S. Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies. Rom J Morphol Embryol. 2008;49(2):181–8. [PubMed: 18516324]

2096.

Vamesu S. Angiogenesis and co-expressed of ER and c-erbB-2 (HER2/neu) protein in primary breast cancer patients: an analysis of 158 needle core biopsies. Rom J Morphol Embryol. 2008;49(4):469–78. [PubMed: 19050794]

2097.

van Esser S, Peters NH, van den Bosch MA, et al. Surgical outcome of patients with core-biopsy-proven nonpalpable breast carcinoma: a large cohort follow-up study. Ann Surg Oncol. 2009 Aug;16(8):2252–8. [PMC free article: PMC2711911] [PubMed: 19437077]

2098.

van Esser S, Stapper G, van Diest PJ, et al. Ultrasound-guided laser-induced thermal therapy for small palpable invasive breast carcinomas: a feasibility study. Ann Surg Oncol. 2009 Aug;16(8):2259–63. [PMC free article: PMC2711908] [PubMed: 19506958]

2099.

Vandenbussche CJ, Khouri N, Sbaity E, et al. Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively. Am J Surg Pathol. 2013 Jun;37(6):913–23. [PMC free article: PMC3991135] [PubMed: 23598968]

2100.

Venta LA, Wiley EL, Gabriel H, et al. Imaging features of focal breast fibrosis: mammographic-pathologic correlation of noncalcified breast lesions. AJR Am J Roentgenol. 1999 Aug;173(2):309–16. [PubMed: 10430125]

2101.

Veronesi U, Luini A, Botteri E, et al. Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases. Oncologist. 2010;15(12):1248–52. [PMC free article: PMC3227928] [PubMed: 21147866]

2102.

Verschuur-Maes AH, Van Diest PJ. The mucinous variant of columnar cell lesions. Histopathology. 2011 May;58(6):847–53. [PubMed: 21585423]

2103.

Verschuur-Maes AH, Witkamp AJ, de Bruin PC, et al. Progression risk of columnar cell lesions of the breast diagnosed in core needle biopsies. Int J Cancer. 2011 Dec 1;129(11):2674–80. [PubMed: 21225627]

2104.

Vicini FA, Kestin LL, Goldstein NS, et al. Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Surg Oncol. 2001 Apr;76(4):245–54. [PubMed: 11320515]

2105.

Vicini FA, Lacerna MD, Goldstein NS, et al. Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):627–35. [PubMed: 9336142]

2106.

Vicini FA, Shaitelman S, Wilkinson JB, et al. Long-term impact of young age at diagnosis on treatment outcome and patterns of failure in patients with ductal carcinoma in situ treated with breast-conserving therapy. Breast J. 2013 Jul–Aug;19(4):365–73. [PubMed: 23815268]

2107.

Vilar VS, Goldman SM, Ricci MD, et al. Analysis by MRI of residual tumor after radiofrequency ablation for early stage breast cancer. AJR Am J Roentgenol. 2012 Mar;198(3):W285–91. [PubMed: 22358027]

2108.

Vilardell F, Novell A, Martin J, et al. Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA. Virchows Arch. 2012 Jun;460(6):569–75. [PMC free article: PMC3371326] [PubMed: 22555942]

2109.

Villa A, Tagliafico A, Chiesa F, et al. Atypical ductal hyperplasia diagnosed at 11-gauge vacuum-assisted breast biopsy performed on suspicious clustered microcalcifications: could patients without residual microcalcifications be managed conservatively? AJR Am J Roentgenol. 2011 Oct;197(4):1012–8. [PubMed: 21940593]

2110.

von Minckwitz G, Darb-Esfahani S, Loibl S, et al. Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40). Breast Cancer Res Treat. 2012 Apr;132(3):863–70. [PubMed: 21667238]

2111.

Voros A, Csorgo E, Nyari T, et al. An intra- and interobserver reproducibility analysis of the Ki-67 proliferation marker assessment on core biopsies of breast cancer patients and its potential clinical implications. Pathobiology. 2013;80(3):111–8. [PubMed: 23258384]

2112.

Wagoner MJ, Laronga C, Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol. 2009 Jan;131(1):112–21. [PubMed: 19095574]

2113.

Walker LC, Harris GC, Wells JE, et al. Association of chromosome band 8q22 copy number gain with high grade invasive breast carcinomas by assessment of core needle biopsies. Genes Chromosomes Cancer. 2008 May;47(5):405–17. [PubMed: 18273837]

2114.

Walls J, Knox F, Baildam AD, et al. Can preoperative factors predict for residual malignancy after breast biopsy for invasive cancer? Ann R Coll Surg Engl. 1995 Jul;77(4):248–51. [PMC free article: PMC2502342] [PubMed: 7574313]

2115.

Wang ZL, Li JL, Su L, et al. An evaluation of a 10-gauge vacuum-assisted system for ultrasound-guided excision of clinically benign breast lesions. Breast. 2009 Jun;18(3):192–6. [PubMed: 19446453]

2116.

Wang ZL, Liu G, Li JL, et al. Breast lesions with imaging-histologic discordance during 16-gauge core needle biopsy system: would vacuum-assisted removal get significantly more definitive histologic diagnosis than vacuum-assisted biopsy? Breast J. 2011 Sep–Oct;17(5):456–61. [PubMed: 21762244]

2117.

Wani SQ, Khan T, Wani SY, et al. Clinicoepidemiological analysis of female breast cancer patients in Kashmir. J Cancer Res Ther. 2012 Jul–Sep;8(3):389–93. [PubMed: 23174720]

2118.

Ward ST, Jewkes AJ, Jones BG, et al. The sensitivity of needle core biopsy in combination with other investigations for the diagnosis of phyllodes tumours of the breast. Int J Surg. 2012;10(9):527–31. [PubMed: 22892094]

2119.

Warner E, Causer PA, Wong JW, et al. Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study. Breast J. 2011 Jan–Feb;17(1):9–17. [PubMed: 21251121]

2120.

Watson P, Lieberman R, Snyder C, et al. Detecting BRCA2 protein truncation in tissue biopsies to identify breast cancers that arise in BRCA2 gene mutation carriers. J Clin Oncol. 2009 Aug 20;27(24):3894–900. [PMC free article: PMC2799150] [PubMed: 19620486]

2121.

Wei S, Kragel CP, Zhang K, et al. Factors associated with residual disease after initial breast-conserving surgery for ductal carcinoma in situ. Hum Pathol. 2012 Jul;43(7):986–93. [PubMed: 22221704]

2122.

Weigel S, Decker T, Korsching E, et al. Minimal invasive biopsy results of “uncertain malignant potential” in digital mammography screening: high prevalence but also high predictive value for malignancy. Rofo. 2011 Aug;183(8):743–8. [PubMed: 21506072]

2123.

Whiffen A, El-Tamer M, Taback B, et al. Predictors of breast cancer development in women with atypical ductal hyperplasia and atypical lobular hyperplasia. Ann Surg Oncol. 2011 Feb;18(2):463–7. [PubMed: 20878246]

2124.

White V, Pruden M, Kitchen P, et al. The impact of publication of Australian treatment recommendations for DCIS on clinical practice: A population-based, “before-after” study. Eur J Surg Oncol. 2010 Oct;36(10):949–56. [PubMed: 20724103]

2125.

Whitworth PW, Simpson JF, Poller WR, et al. Definitive diagnosis for high-risk breast lesions without open surgical excision: the Intact Percutaneous Excision Trial (IPET). Ann Surg Oncol. 2011 Oct;18(11):3047–52. [PubMed: 21947585]

2126.

Wieman SM, Landercasper J, Johnson JM, et al. Tumoral pseudoangiomatous stromal hyperplasia of the breast. Am Surg. 2008 Dec;74(12):1211–4. [PubMed: 19097540]

2127.

Wilke LG, Ballman KV, McCall LM, et al. Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010. Ann Surg Oncol. 2010 Aug;17(8):1989–94. [PMC free article: PMC2950006] [PubMed: 20309640]

2128.

Williams RT, Yao K, Stewart AK, et al. Needle versus excisional biopsy for noninvasive and invasive breast cancer: report from the National Cancer Data Base, 2003–2008. Ann Surg Oncol. 2011 Dec;18(13):3802–10. [PubMed: 21630122]

2129.

Wiratkapun C, Chansanti O, Wibulpolprasert B, et al. Focal fibrosis of the breast diagnosed by core needle biopsy under imaging guidance. J Med Assoc Thai. 2013 Mar;96(3):340–5. [PubMed: 23539939]

2130.

Wiratkapun C, Keeratitragoon T, Lertsithichai P, et al. Upgrading rate of papillary breast lesions diagnosed by core-needle biopsy. Diagn Interv Radiol. 2013 Sep–Oct;19(5):371–6. [PubMed: 23748032]

2131.

Wiratkapun C, Patanajareet P, Wibulpholprasert B, et al. Factors associated with upstaging of ductal carcinoma in situ diagnosed by core needle biopsy using imaging guidance. Jpn J Radiol. 2011 Oct;29(8):547–53. [PubMed: 21927996]

2132.

Wisinski KB, Faerber A, Wagner S, et al. Predictors of willingness to participate in window-of-opportunity breast trials. Clin Med Res. 2013 Sep;11(3):107–12. [PMC free article: PMC3788556] [PubMed: 23580787]

2133.

Wisner DJ, Hwang ES, Chang CB, et al. Features of occult invasion in biopsy-proven DCIS at breast MRI. Breast J. 2013 Nov–Dec;19(6):650–8. [PMC free article: PMC4036640] [PubMed: 24165314]

2134.

Wojnar A, Bartosz Pula B, Podhorska-Okolow M, et al. Discrepancies between HER2 assessment from core needle biopsies and surgical specimens of invasive ductal breast carcinoma. Adv Clin Exp Med. 2013 Jan–Feb;22(1):27–31. [PubMed: 23468259]

2135.

Xu HN, Tchou J, Chance B, et al. Imaging the redox states of human breast cancer core biopsies. Adv Exp Med Biol. 2013;765:343–9. [PMC free article: PMC4734374] [PubMed: 22879054]

2136.

Xu ZL, Zhu XQ, Lu P, et al. Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer. Ultrasound Med Biol. 2009 Jan;35(1):50–7. [PubMed: 18950932]

2137.

Yamaguchi R, Tanaka M, Mizushima Y, et al. Myxomatous fibroadenoma of the breast: correlation with clinicopathologic and radiologic features. Hum Pathol. 2011 Mar;42(3):419–23. [PubMed: 21195451]

2138.

Yamaguchi R, Tanaka M, Tse GM, et al. Pure flat epithelial atypia is uncommon in subsequent breast excisions for atypical epithelial proliferation. Cancer Sci. 2012 Aug;103(8):1580–5. [PMC free article: PMC7659289] [PubMed: 22533984]

2139.

Yamaguchi R, Tsuchiya S, Koshikawa T, et al. Evaluation of inadequate, indeterminate, false-negative and false-positive cases in cytological examination for breast cancer according to histological type. Diagn Pathol. 2012;7:53. [PMC free article: PMC3502405] [PubMed: 22607447]

2140.

Yamashita M, Hovanessian-Larsen L, Sener SF. The role of axillary ultrasound in the detection of metastases from primary breast cancers. Am J Surg. 2013 Mar;205(3):242–4. discussion 4-5. [PubMed: 23369307]

2141.

Yang H, Liu H, Peng W, et al. Magnetic resonance imaging of the breast in evaluating residual diseases at lumpectomy site soon after excisional biopsy. J Comput Assist Tomogr. 2012 Mar–Apr;36(2):196–9. [PubMed: 22446359]

2142.

Yildiz-Aktas IZ, Dabbs DJ, Bhargava R. The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma. Mod Pathol. 2012 Aug;25(8):1098–105. [PubMed: 22460807]

2143.

Yohe S, Yeh IT. “Missed” diagnoses of phyllodes tumor on breast biopsy: pathologic clues to its recognition. Int J Surg Pathol. 2008 Apr;16(2):137–42. [PubMed: 18417670]

2144.

Yoshida M, Tsuda H, Yamamoto S, et al. Loss of heterozygosity on chromosome 16q suggests malignancy in core needle biopsy specimens of intraductal papillary breast lesions. Virchows Arch. 2012 May;460(5):497–504. [PubMed: 22476400]

2145.

Youk JH, Jung I, Kim EK, et al. US follow-up protocol in concordant benign result after US-guided 14-gauge core needle breast biopsy. Breast Cancer Res Treat. 2012 Apr;132(3):1089–97. [PubMed: 22218886]

2146.

Youk JH, Kim EK, Kim MJ. Atypical ductal hyperplasia diagnosed at sonographically guided 14-gauge core needle biopsy of breast mass. AJR Am J Roentgenol. 2009 Apr;192(4):1135–41. [PubMed: 19304725]

2147.

Youk JH, Kim EK, Kim MJ, et al. Analysis of false-negative results after US-guided 14-gauge core needle breast biopsy. Eur Radiol. 2010 Apr;20(4):782–9. [PubMed: 19862531]

2148.

Youk JH, Kim EK, Kwak JY, et al. Atypical papilloma diagnosed by sonographically guided 14-gauge core needle biopsy of breast mass. AJR Am J Roentgenol. 2010 May;194(5):1397–402. [PubMed: 20410431]

2149.

Youk JH, Kim EK, Kwak JY, et al. Benign papilloma without atypia diagnosed at US-guided 14-gauge core-needle biopsy: clinical and US features predictive of upgrade to malignancy. Radiology. 2011 Jan;258(1):81–8. [PubMed: 20971773]

2150.

Youk JH, Kim MJ, Son EJ, et al. US-guided vacuum-assisted percutaneous excision for management of benign papilloma without atypia diagnosed at US-guided 14-gauge core needle biopsy. Ann Surg Oncol. 2012 Mar;19(3):922–8. [PubMed: 21863359]

2151.

Youn I, Choi SH, Moon HJ, et al. Phyllodes tumors of the breast: ultrasonographic findings and diagnostic performance of ultrasound-guided core needle biopsy. Ultrasound Med Biol. 2013 Jun;39(6):987–92. [PubMed: 23499344]

2152.

Yu CC, Chiang KC, Kuo WL, et al. Low re-excision rate for positive margins in patients treated with ultrasound-guided breast-conserving surgery. Breast. 2013 Oct;22(5):698–702. [PubMed: 23333255]

2153.

Yu J, Monaco SE, Onisko A, et al. A validation study of quantum dot multispectral imaging to evaluate hormone receptor status in ductal carcinoma in situ of the breast. Hum Pathol. 2013 Mar;44(3):394–401. [PubMed: 23039940]

2154.

Yuan XM, Wang N, Ouyang T, et al. Current status of diagnosis and treatment of primary breast cancer in beijing, 2008. Chin J Cancer Res. 2011 Mar;23(1):38–42. [PMC free article: PMC3587532] [PubMed: 23467615]

2155.

Zagouri F, Sergentanis TN, Nonni A, et al. Comparison of molecular markers expression in vacuum-assisted biopsies and surgical specimens of human breast carcinomas. Pathol Res Pract. 2010 Jan 15;206(1):30–3. [PubMed: 19836148]

2156.

Zhang X, Wu X, Su P, et al. Doxorubicin influences the expression of glucosylceramide synthase in invasive ductal breast cancer. PLoS One. 2012;7(11):e48492. [PMC free article: PMC3487728] [PubMed: 23133636]

2157.

Zhao C, Desouki MM, Florea A, et al. Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification. Am J Clin Pathol. 2012 Jul;138(1):72–8. [PubMed: 22706860]

2158.

Zheng J, Alsaadi T, Blaichman J, et al. Invasive ductal carcinoma of the breast: correlation between tumor grade determined by ultrasound-guided core biopsy and surgical pathology. AJR Am J Roentgenol. 2013 Jan;200(1):W71–4. [PubMed: 23255773]

2159.

Zhou W, Zha X, Liu X, et al. US-guided percutaneous microwave coagulation of small breast cancers: a clinical study. Radiology. 2012 May;263(2):364–73. [PubMed: 22438362]

2160.

Zhu Y, Li Q, Gao J, et al. Clinical features and treatment response of solid neuroendocrine breast carcinoma to adjuvant chemotherapy and endocrine therapy. Breast J. 2013 Jul–Aug;19(4):382–7. [PubMed: 23721399]

2161.

Zito FA, Verderio P, Simone G, et al. Reproducibility in the diagnosis of needle core biopsies of non-palpable breast lesions: an international study using virtual slides published on the world-wide web. Histopathology. 2010 May;56(6):720–6. [PubMed: 20546337]

2162.

Zografos GC, Zagouri F, Sergentanis TN, et al. Diagnosing papillary lesions using vacuum-assisted breast biopsy: should conservative or surgical management follow? Onkologie. 2008 Dec;31(12):653–6. [PubMed: 19060502]

2163.

Zwart W, Koornstra R, Wesseling J, et al. A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples. BMC Genomics. 2013;14(1):232. [PMC free article: PMC3637562] [PubMed: 23565824]

2164.

Zysk AM, Nguyen FT, Chaney EJ, et al. Clinical feasibility of microscopically-guided breast needle biopsy using a fiber-optic probe with computer-aided detection. Technol Cancer Res Treat. 2009 Oct;8(5):315–21. [PMC free article: PMC2883323] [PubMed: 19754207]